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ABSTRACT                       I 
ABSTRACT 
Part I: Tetracyclic meroterpenoid natural products are structurally fascinating molecules with 
intriguing biological activities. Their unique skeleton contains four to five stereogenic centers and 
bears a decalin ring-system which is fused to diverse aromatic moieties through a dihydropyran. The 
first part of this thesis presents the evolution of a novel cationic polyene cyclization cascade for the 
total synthesis of the meroterpenoid natural product (–)-cyclosmenospongine. A highly modular and 
efficient three fragment coupling strategy permitts the facile synthesis of the key cyclization precursor. 
The cyclization cascade forms three carbon–carbon bonds and sets four consecutive stereocenters, two 
of which are tetrasubstituted, to forge the tetracyclic scaffold of cyclosmenospongine in a single step 
on multi-gram scale. Sequential functionalization and oxidation of the arene allows the synthesis of 
more than 400 mg of (–)-cyclosmenospongine in one batch. 
 
 
 
Part II: In the second part of this thesis, the development of a novel gold(I)-catalyzed 
cyclization cascade of 1-halo-1,5-enynes in the presence of phenols is described. Reactions involving 
the cyclization of 1,n-enynes are of high value as they are capable of generating molecular complexity 
in a minimal number of steps. The developed one-pot procedure yields 2-halo-cyclopentenes, a 
structural motif that can be found in several bioactive molecules, through an unprecedented sequential 
O–H/C–H bond functionalization of phenols under mild reaction conditions. Mechanistic 
investigations revealed that the reaction cascade proceeds within two constitutive catalytic cycles via 
the intermediacy of an unstable aryl alkyl ether that collapses at ambient temperature to undergo a 
[1,2]-hydride shift followed by C–H insertion of the phenol. We found the reaction to be broadly 
applicable across a range of sterically and electronically diverse substrates by establishing a reaction 
scope of 18 examples. 
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1.1. General Introduction 
1.1.1.  Natural Products 
The simplest definition of a natural product is a molecule that is produced in nature by a living 
source.[1] Every organism needs these small molecules to live, grow and reproduce. Some of these 
crucially important and ubiquitous molecules of life are sugars, amino acids, fatty acids and nucleic 
acids. These compounds are called primary metabolites, and are found in all living organisms as their 
biosynthesis is highly conserved. In contrast, natural products that are classified as secondary 
metabolites are often only found in particular organisms to serve a distinct purpose and have 
increasingly specialized functions.[2] Plants for instance are known to produce a myriad of these highly 
specialized and unique molecules. The compound responsible for the smell of roses is the natural 
product damascenone (1), whereas anthocyanin (2), which was first isolated by Willstätter in the year 
1915, gives roses their distinctive red color (Figure 1).[3-4] Another natural product of great importance 
is indigo (7), an ancient natural dye that is now associated with the blue color of jeans.  
 
 
Figure 1: Selected natural products. 
 
For thousands of years mankind has benefited from the rich chemical diversity found in 
nature. Records from Mesopotamia dating back to 2600 B.C. show that extracts of cypress and myrrh 
were used in traditional medicine to treat the common cold.[5] Natural products have become part of 
our culture and traditions as is evident from the consumption of coffee, tea or tobacco, and other 
processed plant products that contain alkaloids with stimulating effects. The alkaloid quinine (3), 
which can be isolated from the bark of the cinchona tree, was historically used to prevent and treat 
malaria and is used today as the bitterant of tonic water.[5] Drugs like morphine (4), cocaine (5) or 
penicillin (8) have also had a significant influence on our modern society.[6] For instance, the 
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discovery of the excellent antibiotic properties of penicillin (8), a natural product produced by fungi, 
saved countless lives. In contrast to cocaine (4), which can be isolated in ample quantities from Coca 
shrubs, there are several natural products with a unique biological profile that cannot be accessed in 
sufficient quantities to allow for further biological testing and clinical applications. For instance, for 
the isolation of 18 g of bryostatin I, a natural product with promising biological activity against several 
types of cancer, more than 12,000 kilogram of the source organism, an aquatic invertebrate, had to be 
collected.[7-8] Due to the low natural abundance of this and several other potent therapeutic agents, 
chemical synthesis is the only option to meet the demand. 
 
1.1.2.  The History of Natural Product Synthesis 
The history of natural product synthesis dates back to the beginning of the 19th century. In 
1828, the first synthesis of the natural product urea (6) was accomplished by Wöhler from ammonium 
cyanate, a substance regarded as inorganic.[9] This accomplishment shifted the paradigm of natural 
products, and demonstrated for the first time that chemists can create the molecules of nature. Whether 
a compound is isolated from natural sources or synthesized in a laboratory makes no difference if the 
resulting compound is chemically identical.[1]  
Initially, the major aim of natural product synthesis was structural elucidation and to prove 
that one can indeed access these molecules in the laboratory.[10] As early as 1870, Baeyer was able to 
complete a synthesis of indigo (7), whereas the first industrial semi-synthesis of camphor was 
accomplished by Komppa in 1903. [10-11] However, it was not until the seminal work on the synthesis 
of cocaine (5) by Willstätter, when the term “total synthesis” was introduced for the first time.[12-13] 
The concept of total synthesis was taken to new heights in 1917, when Robinson disclosed his seminal 
synthesis of tropinone, heralding a new age of natural product synthesis.[14] 
The progress made in the theory of organic chemistry, for example the understanding of the 
nature of the chemical bond, pioneered by the work of Robinson, Ingold and Pauling and the 
introduction of the concept of retrosynthetic analysis, formalized by Corey, in combination with the 
advancement of chromatographic and spectroscopic methods (e.g. column chromatography and NMR 
spectroscopy) accelerated the advancement of synthetic chemistry to an unprecedented speed.[10] These 
factors redefined the way synthetic chemists chose their target structures. The focus of total synthesis 
expanded beyond the mere preparation of the desired compound, but also focused on the invention and 
implementation of new synthetic methodology, and moreover to prepare new molecules with a 
potential benefit for society.[10] For example, the war-driven efforts to provide soldiers fighting in Asia 
with the antimalarial drug quinine (3) culminated in its first total synthesis by Woodward and Doering 
in 1944.[15] Moreover, due to the development of new synthetic methods, such as metal catalyzed bond 
formations or asymmetric catalysis, more complex molecules like morphine (4),[16] strychnine (9)[17] or 
tetrodotoxin (10)[18] succumbed to total synthesis.  
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It is not only due to these developments in the field of organic chemistry that the discipline of 
total synthesis advanced to its current level of sophistication. It is more likely a synergistic effect that 
arises from the intrinsic motivation of the synthetic chemist to find new, more elegant and efficient 
ways to create the molecules provided to us by nature. Nevertheless, synthetic organic chemistry still 
suffers from several shortcomings, such as the necessity to exploit the reactivity of toxic reagents. In 
addition, the synthetic sequences to access complex molecules are generally too long and low-yielding 
to produce many natural products in sufficient quantities to allow for further applications. In order to 
overcome the drawbacks of synthetic methodology chemists have always strived to mimic nature´s 
ingenuity and efficiency in constructing these complex molecules.  
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1.2. Polyolefin Cyclizations 
1.2.1.  Learning from Nature 
In contrast to the synthetic chemist, who by now is able to choose from a wealth of methods to 
specifically modify a molecule, biology is generally constrained to a relatively narrow range of 
conditions that are tolerated by the individual organism.[19] Nevertheless, nature has developed and 
optimized the synthesis of natural products over millennia and came up with highly efficient ways to 
build molecular complexity by utilizing enzymes, which are indisputably the most selective 
catalysts.[20] These highly specialized enzymes are able to perform a variety of transformations under 
physiological conditions with great efficiency and selectivity.[19] Some of the most fascinating and 
complex transformations occurring in nature are cascade reactions of simple, linear polyolefinic 
precursors into diverse polycyclized products. These cascade reactions are capable of generating 
immense molecular complexity in a rapid and stereoselective manner through multiple subsequently 
occurring reactions.[20-21]  
 
1.2.2.  The Concept of Biomimetic Synthesis 
Biomimetic synthesis is the approach to synthesize a natural product through transformations 
or reaction sequences that mimic a biosynthetic proposal. [22] In contrast to biogenetic synthesis, where 
the synthetic route is planned strictly following a biosynthetic pathway, biomimetic is defined by the 
attempt to mimic single transformations occurring in nature, such as enzymatic processes.[23] This 
interplay between biomimicry and total synthesis can provide a deeper understanding of the biogenesis 
of natural products, and facilitates the development of new reactions and synthetic methodology to 
allow the construction of natural products in a minimum amount of steps.[20, 24] In traditional syntheses, 
a target molecule is assembled in a stepwise fashion and the molecular complexity is introduced 
sequentially with each chemical step. In contrast, a biomimetic approach can dramatically shorten the 
synthetic sequence as well as reduce the amount of time, labor and waste produced through the 
implementation of highly efficient and selective cascade reactions.[25]  
The first prime example of a biomimetic synthesis employing a cascade was published by 
Robinson in 1917.[14] In his seminal work he was able to access tropinone (11) in a one-pot procedure 
from the simple compounds acetone dicarboxylic acid, succinic aldehyde and methyl amine via a 
sequence of Mannich reactions (Figure 1). This remarkable study demonstrated the power and 
elegance of biomimetic synthesis, as it shortened Willstätter´s preparation of 11 dramatically. Inspired 
by this pioneering work, researchers have since been able to demonstrate the potential of this concept 
in numerous total syntheses. This can be exemplified by the elegant cationic cyclization approach to 
progesterone (12) developed by Johnson in 1971, the Heathcock synthesis of several 
homosecodaphniphyllate natural products starting from the cyclization of squalene-type precursors, or 
POLYOLEFIN CYCLIAZTIONS                7 
 
the masterful endiandric acid C (13) synthesis by Nicolaou exploiting an 8/6-electrocyclization 
cascade followed by an intramolecular Diels–Alder reaction. More recently, Trauner synthesized 
epicolactone (15) utilizing a sophisticated reaction cascade including a (5+2) heterodimerization, 
followed by an intramolecular nucleophilic attack and a vinylogous aldol addition.[26] All of these 
syntheses highlight the contribution of cascade reactions to both the science and art of organic 
synthesis. The design and implementation of reaction cascades poses not only a significant intellectual 
challenge, but also demands a large amount of creativity.[27] 
 
 
Figure 2: Landmark biomimetic total syntheses (bonds formed in the biomimetic key-step are highlighted in 
red). 
 
1.2.3.  Terpenoid Natural Products 
Terpenoids comprise the largest family of natural products and contain thousands of 
structurally diverse and unique members.[2] Biosynthetically, all terpenoid natural products originate 
from the C5 isoprene monomers isopentenyl pyrophosphate (16, IPP) and dimethylallyl pyrophosphate 
(17, DMAPP), which are derived from the mevalonate or the mevalonate-independent pathways.[2] 
These two subunits are fused by prenyltransferases in a tail-to-head fashion to form polyenes of 
different sizes. Sequential elongation in a head-to-tail fashion gives geranyl pyrophosphate (18, C10), 
farnesyl pyrophosphate (20, C15), geranylgeranyl pyrophosphate (22, C20) or geranylfarnesyl 
pyrophosphate (24, C25), whereas squalene (26, C30) is derived from the tail-to-tail fusion of two 
farnesyl subunits.[2] The myriad of natural products arising from these linear precursors are 
exemplified by carvone (19), longifolene (21), baccatin III (23) and retigeranic acid A (25) which can 
be further classified as mono- (C10), sesqui- (C15), di- (C20), sester (C25) or triterpenes (C30) (Scheme 
1).  
In a typical biosynthesis, these complex molecules are formed in two distinctive phases where 
the linear and achiral precursors undergo a series of enzymatic transformations.[24] In the first 
cyclization phase, the unique carbon skeleton is forged through the cyclization of various polyenes by 
enzymes called cyclases. The second phase is defined by selective, post-cyclase modifications of the 
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generated molecular framework, usually through a series of oxidations carried out by oxidase 
enzymes.[24]  
 
 
Scheme 1: Biosynthesis of higher terpenoids and their nomenclature including a representative member.  
 
It is thought that polyene cyclization cascade occurs in a four-step sequence orchestrated by a 
single cyclase.[22] These intricate polyene cyclizations are typically initiated electrophilically through 
the generation of a carbocationic intermediate. In the second step, the conformation of the terpenoid is 
controlled by the cyclase, allowing for the charge to be propagated throughout the molecule in a 
sequence of stereospecific bond-forming events that can include skeletal rearrangements. Finally, the 
cascade can be terminated through the loss of a proton, thereby generating an olefin moiety, or by the 
attack of an external nucleophile such as water to yield an alcohol functionality. These cyclases can be 
further divided into two subclasses based on their distinct mode of activation.[28-29] Class I cyclases 
initiate the formation of an allylic cation by cleavage of the pyrophosphate unit (tail), thereby 
generating an allylic cation, whereas class II terpenoid cyclases initiate carbocation formation through 
protonation of either the isoprene or the epoxide moiety (head).[29-30] As a result, the direction of the 
positive charge is propagated differently along the polyene chain. Tail-to-head cyclizations are 
observed for class I cyclases and give rise to diverse polycyclic skeletons like taxadiene, which is the 
biogenetic precursor of baccatin III (23). In contrast, head-to-tail cyclizations are initiated by class II 
cyclases and generally furnish poly-decalin frameworks, as can be found in steroids like hopene 
(27).[29] 
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Scheme 2: Polycyclic triterpenoids arising from head-to-tail cyclization of squalene (26) or oxidosqualene (28). 
 
In the defined environment of an enzymatic active site, squalene (26) can be cyclized 
selectively to different natural products, depending on the cyclase performing the reaction (Scheme 
2).[2] There are numerous squalene cyclases known, and each generates a specific polycyclic product. 
The relative stereochemistry of hopene (27) is the result of an all chair-type folding of squalene (26) in 
the enzyme´s active site. In contrast, the stabilization of the chair-boat-chair folding of 2,3-
oxidosqualene (28) gives rise to the stereochemistry found in cycloartenol (29) or lanosterol (31), 
which can be further converted into the ubiquitous steroid cholesterol (31). For example, only one out 
of the 128 possible lanosterol (30) stereoisomers that could be formed during cyclization of 2,3-
oxidosqualene (28) is generated, highlighting the unparalleled stereocontrol of these enzyme-mediated 
reactions.[31]  
The highly variable cyclization patterns of these unique enzymes contribute to the enormous 
structural diversity of the largest family of natural products. The elucidation of the mechanistic and 
biosynthetic principles involved during the formation of these complex and structurally diverse natural 
products has inspired many sophisticated studies.[28] Much of this seminal work was carried out to 
investigate the constitution of these polycyclic compounds and to shed light on the fundamental basics 
of 1,5-diene cyclization in order to understand the prevailing mechanism of polyene cyclization 
cascades.[32]  
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1.2.4.  Historic Context 
The cyclization of isoprenoids is by far the most studied field in biomimetic synthesis as it 
constitutes one of the most powerful reactions that could be successfully adapted from nature. The first 
investigations date back to 1945, and were conducted by Bloch and Rittenberg.[33] Their studies aimed 
to unravel the biosynthetic origin of cholesterol (31). They wanted to validate that the triterpenoid 
squalene (26) is a valid biomimetic intermediate through isotopic labelling of acetic acid. After the 
determination of the structure of lanosterol (30) in 1952, and the aforementioned labeling experiments, 
the biosynthetic connection between squalene (26) and cholesterol (31) became obvious (Scheme 
2).[34-36] On the basis of these findings, Stork and Eschenmoser independently postulated their famous 
hypothesis of polyalkene cyclizations in 1955.[37-38] Their proposal established the concept that 
polyalkenes, when aligned in a defined conformation, could be attacked by the adjacent double bond 
in an antiperiplanar manner, analogous to the stereospecific trans addition of bromine to alkenes. This 
concept allowed for the first time the prediction of the relative stereochemistry of cyclization products 
and established a complete picture of the biosynthesis of lanosterol (30) and its derivatives.[20]  
 
1.2.5.  Polyene Cyclizations in Total Synthesis 
The seminal work of Stork and Eschenmoser inspired chemists to further develop and advance 
polyene cyclization cascades. To successfully transform this attractive and powerful method into a 
synthetically useful reaction, several problems had to be addressed. Methods for the stereoselective 
synthesis of alkenes had to be developed, and suitable functional groups for selective initiation and 
termination of the cyclization had to found.[39] Although several Brønsted and Lewis acids were shown 
to sufficiently mediate monocyclizations, initial attempts to initiate the reaction by simple Brønsted 
acid catalysis proved difficult due to the indiscriminate protonation of the substrate leading to non-
productive, competing cyclization pathways.[32, 39]  
In his pioneering work on polyene cyclizations, Johnson was not only able to develop 
excellent initiating groups, he was also able to establish cation stabilizing groups and terminators 
(Scheme 3a-d) and furthermore apply these findings in the innovative total syntheses of various 
terpenoid natural products.[39-40] The problem of selective electrophilic activation could be overcome 
by the introduction of cyclic acetals to the polyolefin. Upon Lewis acid activation of the acetal moiety 
using tin tetrachloride, the generated oxonium ion serves as an excellent electrophile and triggers the 
subsequent bond forming events, exemplified by the tetracyclization of tetraenic acetal 32 to 33 
(Scheme 3a).[41] Moreover, the use of a chiral acetate and the incorporation of fluorine substituents at 
the C-8 position of polyene 34 allowed Johnson to access enantioenriched tetracycle 35 in moderate 
yield (Scheme 3b). The fluorine substituent was introduced as a cation-stabilizing auxiliary in order to 
favor cyclohexane ring formation over the preferred 5-exo ring-closure to yield a cyclopentane.[42] 
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Scheme 3: a) to c) Seminal contributions of Johnson to the field of polyene cyclization cascades and 
d) Carreira´s improvement of allylic alcohol activation through chiral iridium catalysis. 
 
With six further synthetic operations Johnson was able to transform 35 to the known steroid 
4-hydroxyandrostane-17-one (36).[43] In addition to the introduction of acetals, Johnson was also able 
to establish allylic alcohols as suitable functional groups to initiate polyene cyclizations (Scheme 3c). 
This method of activation was beautifully implemented in his classic synthesis of progesterone (12).[44] 
The electrophilic tertiary allylic cation was generated through cleavage of the carbon-oxygen bond 
upon exposure of 37 to trifluoroacetic acid, which subsequently participated in the tricyclization 
cascade. The resulting vinyl cation was then trapped by ethylene carbonate. After basic aqueous work, 
up tetracycle 38 could be isolated in excellent yield. The final two steps to progesterone (12) included 
an oxidative scission of the pentacyclic double bond, followed by an intramolecular aldol 
condensation.  
In 2012, Carreira reported an enantioselective iridium catalyzed variation of the polyene 
cyclization initiated by the activation of an allylic alcohol (Scheme 3d).[45] By applying this method, 
Carreira was able to synthesize the diterpene asperolide C (41) in an enantioselective fashion from 
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allylic alcohol 39. Exposure of 39 to the chiral iridium(I) catalyst bearing ligand 42 in the presence of 
zinc triflate generated an iridium-stabilized -allylic cation, which initiated the polyene cyclization to 
yield 40 in good yield and excellent enantioselectivity.[46] 
The extensive studies of van Tamelen to selectively active polyenes were another major 
contribution to the field. His attractive approach was inspired by nature´s cyclization of                   
2,3-oxidosqualene (28). In contrast to Johnson, he was more interested in the biochemical aspects of 
polyene cyclizations.[47] By utilizing an epoxy functional group, he was able to expand the scope of 
suitable polyene substrates and successfully apply this strategy to the biogenetic synthesis of several 
natural products (Scheme 4a and b).[48-50]  
 
 
Scheme 4: Polyene cyclization cascades initiated through epoxide opening. 
 
In 1970, van Tamelen synthesized the isoeuphenol system 44 through the tricyclization of 
epoxide 43 (Scheme 4a).[49] He chose 43 as his key intermediate with the preformed five-membered D-
ring for two reasons. First the tetrasubstituted double bond of the D-ring should prefer the formation of 
the six-membered C-ring and additionally serve as an “insulator” to prevent the side chain from 
participating in the cyclization. Further synthetic efforts culminated in the synthesis the pentacyclic 
terpenoid -dehydrotetrahymanol (46) from 45 (Scheme 4b). [51] 
In contrast to Johnson´s and van Tamelen´s work, Corey´s strategy to selectively gain access 
to the 6-membered C-ring was based on the reactivity of silylenol ethers (Scheme 4c).[52] After 
initiation of the polyene cyclization using methyl aluminum dichloride as a Lewis acid, followed by 
desilylation and oxidative thioacetal cleavage, tricycle 48 could be obtained in good yield from 
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epoxide 47 and further advanced to dammarenediol II (49) in six steps. Numerous modifications of the 
epoxide opening/polyene cyclization cascade enabled the Corey group to synthesize several other 
terpenoid natural products.[21] Since the early work of van Tamelen, the epoxide motif has emerged as 
a valuable initiator for cationic polyene cyclization cascades, and is frequently used in total 
synthesis.[21] It is noteworthy that this principle could as well be extended to aziridines (Scheme 4d). In 
2009, Loh reported the indium bromide-catalyzed opening of aziridine 50 to tricyclic amine 51[53] 
 
 
Scheme 5: Biomimetic tail-to-head cyclizations. 
 
Although both head-to-tail and tail-to-head polyene cyclizations can be found in nature, it was 
only recently that the first biomimetic synthesis of a natural product could be accomplished via a tail-
to-head cyclization. This underexplored approach allowed Shenvi to synthesize ß-cedrenes (58) and ß-
funebrenes (59) from racemic vinyl epoxide 52 (Scheme 5a).[54] After epoxide activation of 52 through 
a mixture of methylaluminum dichloride and dimethylaluminum chloride, the generated allylic cation 
53 was attacked by the adjacent double bond to yield 54, which underwent a [1,2]-hydride-shift 
followed by attack of the isoprene double bond to give 55. A final carbon–carbon bond formation 
afforded an epimeric mixture of cation 56. Aldehyde 57 arose from a terminal hydride shift and was 
further advanced in two steps into a 2:1 mixture of ß-cedrenes (58) and ß-funebrenes (59). The key to 
success was the use of a strong coordinating and non-dissociating Lewis acid to prevent elimination or 
cation-anion recombination processes to allow non-stop charge propagation.  
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Tiefenbacher succeeded in combining supramolecular chemistry and tail-to-head polyene 
cyclizations (Scheme 5b).[55] In his seminal report, he was able to mimic an enzymatic pocket by 
utilizing a self-assembled supramolecular capsule. Inside the capsule´s cavity, geranyl acetate (60), 
neryl acetate (61) or linalyl acetate (62) could undergo tail-to-head cyclizations to yield predominantly 
-terpinene (63) and terpinolene (64), along with other fully cyclized monoterpenes. 
In 1999, Yamamoto reported the first enantioselective proton-induced cyclization of polyenes 
(Scheme 6a).[56] His pioneering work was based on a Lewis acid-assisted chiral Brønsted acid 
protonation of an olefin, termed as “LBA”. This artificial cyclase is capable of enantioselective 
protonation of a suitable polyene to initiate the cyclization cascade. In his initial report LBA 68 
enabled the isolation of tricyclic ether 67 from diene 66 in good yield and stereocontrol. The utility of 
this method was demonstrated by its application to the total synthesis of chromazonarol (72) from 
polyene 70. After successful tricyclization, 71 was deprotected in a two-step sequence to give 72. 
Using their optimized LBA 69, Yamamoto was able to increase the enantiomeric excess from an initial 
44% to 88% (Scheme 6b).[57] 
 
 
Scheme 6: Lewis acid-assisted chiral Brønsted acid catalyzed polyene cyclization cascades. 
 
An alternative and equally valuable approach to initiate polyene cycloisomerizations is based 
on the electrophilicity of transition metal salts. The first reports which exploit the -acidic character of 
various mercury(I) salts to induce electrophilic activation of polyenes date back over 40 years.[58-60] 
Although mercury salts proved to be efficient and reliable initiators to promote the desired 
cyclizations, stoichiometric quantities of the toxic metal had to be used.[21] To overcome this 
drawback, Gagné demonstrated the utility of platinum(II) complexes in polyene cyclizations, 
exemplified by the cyclization of 73 to give enantio-enriched ether 74 (Scheme 7a).[61] In 2007, a 
report by Corey showed that alkynes, like 75, can be activated towards nucleophilic addition of an 
adjacent olefin in a 6-exo fashion by catalytic amounts of indium salts to yield polycyclic compounds 
POLYOLEFIN CYCLIAZTIONS                15 
 
such as 76 (Scheme 7b). Similar to other transition metals, gold(I) species are exceptionally good 
activating groups for alkynes. Toste exploited this selectivity and developed the first gold(I) catalyzed 
asymmetric cyclization for enynes (Scheme 7c).[62] Exposure of 77 to the optimized reaction 
conditions led to the clean formation of 78 in excellent yield and enantiocontrol. 
 
 
Scheme 7: Transition metal-catalyzed polyene cyclization cascade. 
 
A further benefit of the use of transition metals in such cascade reactions lies in their 
capability to react in a cationic and a “carbenoid-like” fashion.[63] This combined mode of reactivity 
was beautifully exploited in Fürstner´s total synthesis of -cubebene (84).[64] Exposure of enyne 79 to 
platinum(II) chloride gave 83 in an impressive 92% yield. After a 6-endo-dig cyclization of 79, the 
cationic intermediate 80 reacted further to furnish cyclopropyl-carbene complex 81. Subsequent attack 
of the adjacent carbonyl group yielded acetate 83 via 82, which could be transformed to -cubebene 
(84) in two further steps. 
 
 
 
 
16                        THEORETICAL SECTION 
Another landmark achievement in electrophilic polyene initiation was accomplished by 
Ishihara.[65] Several bio-active marine natural products bear halogenated polycycles and the 
enantioselective formation of these motifs has been a long standing challenge. Ishihara developed an 
unprecedented enantioselective halopolyenecyclization by combining the chiral phosphoramidite 87 
with N-iodosuccinimide (Scheme 8a). The resultant electrophilic chiral iodonium ion serves as an 
excellent initiating reagent to promote the desired cyclization, exemplified by the formation of 86 from 
85 in good yield and enantioselectivity. The exceptional level of stereocontrol can be explained by the 
formation of a tight ion-pair with a strong hydrogen bonding between the succinimide and the ligand, 
restricting the P-N bond rotation and constraining the iodonium ion in the sterically hindered region of 
the chiral pocket formed by the ligand. This method is limited to iodide, as the use of N-bromo-
succinimide or N-chlorosuccinimide gave either significantly diminished reactivity or enantio-
selectivity. Regardless, this is unquestionably a major discovery. 
 
 
Scheme 8: Halonium-ion induced polyene cyclizations. 
 
As brominated and chlorinated natural products outnumber the iodinated ones Snyder 
successfully developed a brominating reagent which allows for fast and selective polyene cyclizations 
under mild conditions (Scheme 8b).[66-67] A key design element of the initiating reagent BDSB 
(bromodiethylsulfonium bromopentachloroantimonat) was the use of a non-nucleophilic and non-basic 
counterion. The utility of this novel reagent was demonstrated in the racemic total syntheses of several 
brominated natural products. Exposure of polyene 88 to BDSB led to the formation of tetracycle 89, 
which could be further converted to peyssonoic acid A (90). Unfortunately, attempts to develop an 
enantioselective variant of BDSB have been unsuccessful so far. 
 
 
POLYOLEFIN CYCLIAZTIONS                17 
 
In 1978, Speckamp demonstrated that N-acyl iminium ions can serve as the starting point for 
polyene cyclizations for the first time (Scheme 10a).[68] Upon activation of hemiaminal 91 using a 
Brønsted acid, polycyclized product 92 could be obtained in excellent yield. Based on this seminal 
work, Jacobsen extended this method to an enantioselective variant. The use of chiral thiourea 
organocatalyst 95 provided cyclized products such as 94 from hemiaminal 93 in high yield and with 
exceptional enantioselectivity (Scheme 9b).[69] During the catalyst optimization studies, Jacobsen 
observed that larger aryl substituents on the catalyst proved beneficial for enantiocontrol and catalyst 
turnover. This provided evidence that the catalyst can stabilize the intermediate positive charge 
developed within the cyclization with cation- interactions. 
 
 
Scheme 9: Organocatalytic cyclization cascades. 
 
Breslow initially speculated that epoxysqualene (28) could be cyclized in a free-radical 
pathway during the biogenesis of terpenes.[70] This, along with his initial observation that the addition 
of radical species to the terminal position of polyenes can competently initiate cyclizations, laid the 
foundation for new remarkable radical-based methods to initiate polyene cyclizations.[70-74] For 
example Snider developed a manganese(III)-mediated oxidative protocol for the radical polyene 
cyclization of 1,3-dicarbonyls.[75] Through a photo-induced electron-transfer using 1,4-dicyano-
tetramethylbenzene (DCTMB) in the presence of biphenyl, Demuth was able to pentacyclize polyene 
96 to alcohol 97, via the intermediate formation of a radical cation (Scheme 10a).[76] Moreover, by 
using the remote auxiliary (–)-menthone, he could induce diastereoselectivity during the cyclization 
step. Mechanistically, the reaction can be divided into two distinctive events. After generation of the 
radical cation species, the cation was trapped by water to yield the secondary alcohol, whereas the 
radical species was propagated through the polyene to form the pentacyclic framework of 97.  
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Scheme 10: Radical-based approaches used for polycyclizations. 
 
In 2005, Cardenas demonstrated the utility of epoxides as initiating groups in radical-based 
cyclizations.[77] The use of bis(cyclopentadienyl)-titanium(III) chloride, a reagent first introduced by 
RajanBabu, initiated the polyene cyclization cascade through reductive epoxide opening and led to 
formation of 99 from epoxide 98 after two 6-endo and a final 7-endo cyclization.[78] Tricycle 99 was 
then further converted to barekoxide (100) within four additional steps. Even though several radical 
initiated cyclization cascades were previously reported, it was not until 2010 that an enantioselective 
variant was developed by MacMillan. He successfully applied his previously developed strategy of 
using chiral imidazolidinones as catalysts for enamine oxidations for the cyclization of polyenes 
bearing an aldehyde (Scheme 10c).[79] After enamine formation through condensation of the secondary 
amine of 103 with aldehyde 101, a single electron oxidation occurred generating an intermediate-
iminyl radical, which was best propagated through the polyene if the electronic nature of the 
participating olefins alternates from electron-rich to electron poor, exemplified by the pentacyclization 
to 102. 
Considering these discoveries, one can clearly see that polyene cyclizations are a powerful 
tool in organic synthesis. Within a minimum amount of synthetic operations, various structurally 
complex molecules can be built in a highly efficient and selective manner. Every approach explored 
addresses different features of the polyene cyclization event and finds application in the synthesis of 
various natural products. Nevertheless, it seems inevitable that new methods must be developed to 
further advance the field of cyclization cascades, and to access even more complex molecular 
architectures with scalable efficiency. 
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1.3. The Aureol Family of Meroterpenoids 
1.3.1  Overview and Introduction 
In recent years, a variety of structurally diverse sesquiterpene natural products have been 
isolated from marine and terrestrial organisms.[80-83] Since the isolation of avarol (104) from the 
extracts of the marine sponge Dysidea avara by Minale in 1974, more than 100 structurally related 
secondary metabolites have been obtained from various sources (Figure 3).[84-85] In particular, the 
excellent cytotoxic, antiproliferative and antiviral properties of these sesquiterpenes make them 
promising lead compounds for further pharmacological studies.[85]  
Structurally, one can further distinguish these natural products between “acyclic” congeners, 
in which the decalin is linked to the various arenes through a methylene bridge, and tetracyclic ones, 
in which the aromatic phenol forms a second bond to the decalin. Aureol (105) was the first member 
of the tetracyclic subclass and was isolated by Faulkner in 1980.[86] Since then, several natural 
products with this rare framework have been isolated from both marine sources and microorganisms 
(Figure 3). 
 
 
Figure 3: Selected tetracyclic members of the meroterpenoid family of natural products and their biological 
activities. 
 
These meroterpenoids feature a tetracyclic skeleton containing four to five stereogenic centers. 
The diverse aromatic moieties are fused to the rearranged drimane ring-system by a dihydropyran, 
thereby forming a benzo[d]xanthene. In contrast to aureol (105) and strongylin A (106), smenoqualone 
(107) and cyclosmenospongine (108) bear a unique quinone, whereas a relatively uncommon 
isoindolinone can be found in stachyflin (109). In comparison to these closely related meroterpenoids, 
which all have a cis-decalin incorporated in their skeleton, the decalin-ring system of 
cyclosmenospongine (108) is trans-fused. 
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1.3.2  Isolation and Biological Activity 
Apart from their appealing structure, most of these natural products possess a wide range of 
biological activities.[85] Aureol (105) was initially isolated from the Caribbean sponge Smenospongia 
aurea by Faulkner in 1980 and subsequently by Pansini from the Caribbean sponge Verongula 
gigantea in 2000.[86-87] This marine natural product shows selective cytotoxicity against human cancer 
cell lines, including colon adenocarcinoma HT-29 (IC50 = 15 M) and nonsmall cell lung cancer A549 
(IC50 = 15 M), antiviral activity against the influenza A strain H1N1(IC50 = 11 M) and antimicrobial 
activity against the Mycobacterium tuberculosis strain H37Rv (31% inhibition at 20 M).[88-90]  
In 1991, strongylin A (106) was isolated by Wright from the Caribbean sponge 
Strongylophora harmani and was also subsequently isolated from the Xestospongia wiedenmayeri 
Bahamian sponge by the Schering company in 1995.[91-92] Strongylin A (106) also displays antiviral 
activity against the influenza A H1N1 strain (IC50 = 19 M) and shows cytotoxicity against P388 
murine leukemia tumor cells (IC50 = 48 M).[91]  
The unique marine meroterpenoid smenoqualone (107) was isolated from sponge 
Smenospongia sp. in 1992 by Guyot as a minor product.[93] Although cyclosmenospongine (108) can 
be regarded as the aminoquinone derivative of 107, it is the only tetracyclic congener bearing a trans-
fused decalin ring system.[94] Cyclosmenospongine (108) was isolated by Utkina from the marine 
sponge Spongia sp. in 2003, and shows low cytotoxic effects (IC50 = 0.12 mM) against Ehrlich 
carcinoma cells.[95-96] 
Stachyflin (109), by far the most bioactive sesquiterpenoidal natural product of this class, is 
not of marine origin. It was first isolated by Shionogi & Co., Ltd. in Japan from the fungus 
Stachybotrys sp. RF-7260 by solid state fermentation.[97] With an IC50 of 3 nM against the influenza A 
H1N1 subtype, stachyflin (109) outperforms the biological activity of the approved drugs amantadine 
(Symmetrel®) and zanamivir (Relenza®) by a factor of 250 and 1800, respectively.[98] The observed 
novel mode of action makes stachyflin (1) a promising lead component for future pharmacological 
studies. Stachyflin (109) effectively binds to the viral protein hemagglutinin, thereby preventing virus-
cell membrane fusion from occurring.[99] In addition, stachyflin (109) displays cytotoxic effects against 
MDBK cells (IC50 = 65M).[98]  
The diverse biological activities that can be found within this class of tetracyclic 
meroterpenoids offer promising opportunities for the development of new therapeutic agents, which 
highlights the enormous potential of natural product based drug discovery.  
 
 
 
 
 
 
MEROTERPENOIDS                 21 
 
1.3.3  Biosynthesis 
All members of the aureol family of natural products can be classified as meroterpenoids. This 
term describes hybrid compounds which share a mixed biosynthetic origin (Scheme 11).[82, 100] In the 
case of the aureol family, the decalin core can be traced back to farnesyl pyrophosphate (20), which 
itself is derived from the terpenoid pathway.[2] The precise biogenesis of the various aromatic moieties 
incorporated into the different meroterpenoids probably differs for every congener. Nonetheless, the 
different phenols most likely originate from malonyl-CoA (110) and acetyl-CoA (111), which are 
assembled to the specific aromatic cores via the type I or II polyketide pathway.[2, 101-102] Farnesyl 
pyrophosphate (20), as already mentioned, has its biosynthetic origin in the terpenoid pathway. One 
molecule of dimethylallyl pyrophosphate (DMAPP, 17) is elongated sequentially in a tail-to-head 
manner with two molecules of isopentenyl pyrophosphate (IPP; 16). This process is catalyzed by 
enzymes called prenyl transferases and mechanistically resembles the catalytic cycle of class I 
terpenoid cyclases (cf. Chapter 1.2.3.). After enzymatic cleavage of the pyrophosphate unit of DMAPP 
(17) the allylic cation is attacked by the -bond of IPP (16). This is followed by the stereospecific 
elimination of a proton to furnish the elongated polyene. [28, 31] Both building blocks merge into 
polyene 112, the substrate for the polyene cyclization cascade, which is triggered by activation of the 
isoprene, or in the case of stachyflin (109) the corresponding epoxide. After decalin 113 is formed, 
two sigmatropic and stereospecific [1,2]-hydride and methyl shifts occur to generate cationic 
intermediate 114, which could be trapped by the phenolic alcohol to yield the cis-fused tetracyclic 
scaffold of aureol (105) and its congeners (106, 107 and 109), or eliminate to 115. Olefin 115 is 
considered to be the biosynthetic intermediate for the formation of the trans-fused decalin system, 
which can be found in cyclosmenospongine (108).[86, 103-105] A final double bond activation could 
regenerate the tertiary cation and allow for a diastereoselective ether formation. 
 
 
Scheme 11: Proposed biosynthesis of tetracyclic meroterpenoids (adapted from George).[106] 
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1.3.4 Previous Work 
Because of their diverse and promising biological profiles, along with their intriguing 
molecular scaffold, several groups have developed elegant syntheses to access these fascinating 
natural products. These efforts have culminated in a variety of synthetic studies and total syntheses. 
The first racemic total synthesis of the tetracyclic meroterpenoid stachyflin (109) was 
achieved by scientists from the Shionogi research group in 1998 (Scheme 12).[107] Their synthetic 
endeavor commenced with the preparation of dimethoxy acetal 117 in eight steps from commercially 
available 3,5-dihydroxybenzoic acid. A Noyori-type aldol condensation of acetal 117 with silylenol 
ether 118 furnished hemiketal 119 after a subsequent reductive debenzylation and removal of the 
benzylic methoxy group. Nine further transformations, including a Negishi cross-coupling and 
iodoetherification gave the advanced intermediate 120, which is the substrate for an intramolecular 
aldol cyclization. After dehydration and a base-induced isomerization of the double bond enone 121 
was obtained. Completion of the first total synthesis of stachyflin (109) included a critical 
stereoselective hydrogenation to give the desired cis-decalin ring system and construction of the -
lactam. 
 
Scheme 12: The first racemic synthesis of stachyflin (109) by Mori. 
 
In 2001, Katoh initiated a program for the collective synthesis of this class of natural products 
using a unified strategy for the assembly of the respective key-intermediates through coupling of 
different phenols to the preformed decalin, which stems from a Wieland–Miescher ketone 
derivative.[108] A final bioinspired Lewis-acid induced rearrangement/cyclization cascade was intended 
to form the cis-fused benzo[d]xanthene scaffold.[108-109] This cyclization strategy was based on the 
early work of Faulkner, van der Helm and Capon.[86, 103-105] They showed that upon treatment of 
arenarol (123) or 124 with Lewis- or Brønsted acids the cyclization to aureol (105) and 5-epi-aureol 
(122) could be accomplished selectively (Scheme 13). Simple variation of the reaction conditions led 
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to either the kinetically favored cis-decalin framework (boron trifluoride etherate, dichloromethane, 
T < –10 °C), or the thermodynamically more stable trans-decalin system (p-toluenesulfonic acid, 
benzene, 80 °C). 
 
Scheme 13: Selective synthesis of either the cis- or trans-fused decalin-ring system. 
 
In 2002, the first asymmetric total synthesis of aureol (105) was accomplished by Katoh 
(Scheme 14a).[110] His synthetic approach was based on his previous synthesis of arenarol (123).[111] 
Addition of aryl-lithium 126 onto aldehyde 125, which was synthesized in 13 steps from 5-epi-128, 
gave benzylic alcohol 127. After conversion of 127 to arenarol (123), a boron trifluoride etherate 
promoted cascade reaction yielded aureol (105) in excellent yield. One year later, Katoh developed a 
more efficient and concise route, based on a reductive alkylation of 129 under Birch conditions with 
ketone 128.[112] The use of ketone 128 instead of aldehyde 125 shortened to route tremendously. 
Exposure of neoavarol (131), which was synthesized in seven steps from 130, to boron trifluoride 
again resulted in the selective formation of aureol (105).  
 
 
Scheme 14: Katoh´s 1st and 2nd generation synthesis of aureol (105). 
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This approach could also be extended to the synthesis of stachyflin (109) (Scheme 15a).[113] 
Reductive coupling of isoindolinone 132 with known ketone 128 yielded 133, which could be 
advanced to epoxide 134 within seven synthetic operations. Again the use of boron trifluoride initiated 
the intended cyclization cascade to afford 135 as an isomeric mixture of alcohols. The final four step 
sequence to stachyflin (109) included deprotection and inversion of the neopentylic alcohol through an 
oxidation/reduction sequence.  
Utilizing the previously describe aldehyde coupling approach, Katoh was also able to 
synthesize strongylin A (106, Scheme 15b).[114] Addition of aryllithium species 136 to 5-epi-125 
resulted in the clean formation of 137. After formation of 138 from 137 within four steps the 
introduced tertiary alcohol severed as the starting point of the final cyclization cascade. Initiation of 
the cyclization/rearrangement cascade was again achieved using boron trifluoride and yielded 
strongylin A (106) in excellent yield.  
 
 
Scheme 15: The stachyflin (109) and strongylin A (106) syntheses by Katoh. 
 
In contrast to the Katoh syntheses, in which the decalin core was accessed from a Wieland–
Miescher ketone derivative, Marco´s synthetic strategy was based on a chiral-pool approach (Scheme 
16).[115] The synthesis of the first key intermediate 139, required eleven steps from commercially 
available ent-halimic acid. The first critical step was a previously established light initiated Barton 
radical decarboxylation/p-benzoquinone addition sequence of 139 in the presence of 1,4-benzoquinone 
(140) which gave quinone 141 in good yield over two steps starting from the corresponding carboxylic 
acid of 139.[116] From quinone 141, ent-aureol (105) was synthesized via reduction of the p-quinone to 
ent-124, the substrate for the well-established cyclization cascade. Moreover, in the same study Marco 
concluded the first total synthesis of the natural product smenoqualone (107). Quinone 141 was 
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converted into hydroxyquinone 125 in three additional steps. Carrying out the cyclization under 
Brønsted acid catalysis and thermodynamic conditions gave a mixture of ent-smenoqualone (107) and 
its 5H-epimer in a ratio of 1.2 to 1 in favor of the cis fused decalin. 
 
 
Scheme 16: Marco´s synthesis of ent-aureol (105) and ent-smenoqualone (107). 
 
Another synthesis of aureol (105) utilizing a chiral pool strategy was developed by George in 
2012 (Scheme 17).[106] Starting from commercially available sclareolide, he could synthesize aldehyde 
142 in eight steps. To avoid the cumbersome deprotection of the phenol methyl ethers, he chose bis-
silyl protected arene 143 as the coupling partner.[110] The resultant benzylic alcohol was subsequently 
removed under Birch conditions to directly yield 144. After desilylation, hydroquinone 124 was 
cyclized under standard Lewis acidic conditions to conclude the synthesis of aureol (105). 
 
 
Scheme 17: Synthesis of aureol (105) by George. 
 
Recently, Oltra developed a fully biomimetic total synthesis of 105 (Scheme 18).[117] In 
contrast to the previously reported syntheses, he was able to set the required stereochemistry of the 
decalin without the need of chiral precursors. A titanium(III) mediated radical cyclization of 
epoxypolyene 145, which was derived from farnesol, furnished 146 as a single diastereomer. The 
obtained bicyclic system was then converted into 147 through a Barton–McCombie deoxygenation 
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sequence, followed by the first boron trifluoride induced rearrangement to yield methoxy protected 
148. A final demethylation yielded the well-established cyclization precursor 124, which was again 
cyclized using boron trifluoride etherate to yield aureol (105). 
 
 
Scheme 18: Oltra´s biomimetic aureol (105) synthesis. 
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1.4. Results and Discussion 
1.4.1. Project Outline: Synthesis of Meroterpenoid Natural Products 
Due to emerging drug resistance of influenza viruses and the astonishing antiviral and 
cytotoxic activities of these meroterpenoid natural products, we sought to develop a robust and 
flexible synthetic platform that would allow us to access a library of natural and non-natural 
derivatives of this fascinating class of tetracyclic natural products. Since first structure-activity 
relationship studies revealed that the biological activities can be drastically altered by simple structural 
modifications, we aimed to develop a highly modular synthesis with respect to possible 
modifications.[118] 
In contrast to the previous syntheses, which were almost exclusively based on the well-
established late stage formation of the ether bridge (cf. Chapter 1.3.4), we envisioned assembly of the 
tetracyclic scaffold within one step via an unprecedented, non-biomimetic Lewis acid-promoted 
polyene cyclization cascade of epoxide 150 (Scheme 19). Our synthetic plan was guided by 
biosynthetic considerations and previous synthetic studies. It was shown that a polyene cyclization 
followed by subsequent Wagner–Meerwein rearrangements could produce the unique substitution 
pattern of these meroterpenoids.[117] Nevertheless, these two independently occurring events can only 
be performed in a stepwise manner using a traditional polyene cyclization approach. To account for 
the limitations of synthetic methodology to mimic these two independently occurring events in a 
single operation, we decided to investigate the cyclization of a polyene which already features the 
necessary substitution pattern. Based on these considerations we set out to develop a concise and 
highly modular retrosynthesis. 
 
Scheme 19: Retrosynthesis of aureol (105). 
 
A careful three dimensional analysis of aureol (105) allowed us to identify the retrosynthetic 
bond disconnections highlighted in red. After disconnection of the C4–C5, C9–C10 and the C15–C16 
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carbon bonds and unfolding of the dissected carbon skeleton, the highly simplified cyclization 
precursor 150 was revealed. We predicted that epoxide 150 could undergo a non-biomimetic cationic 
polyene cyclization after Lewis-acid activation. This remarkable and unprecedented transformation 
could forge the tetracyclic scaffold, and set two quaternary and one tertiary stereocenter in a single 
reaction. Further dissection of 150 led to identification of three building blocks of equal complexity, 
which could be united by convergent fragment coupling. A base-mediated phenol alkyne coupling of 
bromoenyne 152 with phenol 151 should generate the corresponding bromoenol ether, which serves as 
the substrate for a subsequent sp2-sp3 cross-coupling with iodide 153.  
Although we were uncertain about the influence of the arylenol-ether geometry on the folding 
and cyclization of 150 due to the lack of literature precedent, we hypothesized that the cyclization 
would proceed through a highly organized chair-like transition-state as depicted in Scheme 19. After 
the first bond formation, the sterically demanding aryl ether substituent should favor the pseudo-
equatorial alignment 149a over the energetically unfavored pseudoaxial folding of 149b. As such, 
subsequent nucleophilic attack of the adjacent olefin should exclusively occur from the top face to 
generate the cis-decalin framework, which is conserved amongst aureol (105) its several congeners. 
 
Scheme 20: Overview of substituted polyenes used in synthesis so far. 
 
Notably, this polyene cyclization cascade would extend the scope of cationic cyclization 
cascades tremendously. In a typical polyene cyclization, the double bond substitution pattern has so far 
been restricted to methyl substituents. Although a variety of terminating groups could be successfully 
implemented in such cascades, typically arenes, few substrates containing more complex substitutions 
have been investigated (Scheme 20). Thus far, Johnson utilized a fluoride to favor six versus five-
membered ring formation, MacMillan used nitriles to tune the electronics of the participating olefins, 
whereas Corey exploited the reactivity of silylenol ethers to again favor selective six-membered ring 
formation and introduce a ketone as a handle for further functionalization.  
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1.4.2. Convergent Assembly of the Tetracyclic Meroterpenoid (–)-Cyclosmenosongine via a 
 Non-Biomimetic Polyene Cyclization 
 
 
 
 
Reprinted with permission from: 
K. Speck, R. Wildermuth, T. Magauer, Angew. Chem. Int. Ed. 2016, 55, 14131–14135. 
Copyright © 2016 John Wiley and Sons. 
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1.4.3. Evolution of a Polyene Cyclization Cascade for the Total Synthesis of  
 (–)-Cyclosmenospongine 
 
 
 
 
Reprinted with permission from: 
K. Speck, T. Magauer, Chem. Eur. J. 2016, DOI: 10.1002/chem.201605029. 
Copyright © 2016 John Wiley and Sons. 
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1.5. Conclusion and Outlook 
 
In Part I of this thesis, an unprecedented cationic polyene cyclization cascade was developed 
and successfully implemented in the first enantioselective total synthesis of the tetracyclic 
meroterpenoid (–)-cyclosmenospongine. This remarkable cascade generated three carbon–carbon 
bonds, and set four consecutive stereocenters, two of which are tetrasubstituted, thereby forging the 
tetracyclic skeleton of (–)-cyclosmenospongine in a single operation.  
A highly convergent and modular three-component coupling strategy was established to 
synthesize the key cyclization precursors. Our strategy was based on a phenol-alkyne addition and an 
efficient B-alkyl Suzuki–Miyaura sp2-sp3 cross-coupling reaction. This modular and scalable synthetic 
approach allowed for facile modifications of the cyclization precursors, which were sequentially tested 
for their reactivity. Extensive mechanistic studies of the key cyclization revealed that the intricate 
reaction cascade proceeds through the intermediacy of an acetal that presumably prevents a top-face 
approach of the sidechain. This transient acetal species was attacked by the vinylsulfide after further 
Lewis acid activation to selectively yield the trans-fused decalin ring system found in (–)-
cyclosmenospongine. 
In our first generation synthesis, we were able to cyclize a simplified polyene on multi-gram 
scale and transform the generated tetracycle to 5-epi-aureol, which has yet to be isolated from natural 
sources. The eleven step procedure included a challenging enone formation via a Tschugaeff 
elimination, and installation of the missing vicinal cis-dimethylgroup through an unprecedented high-
pressure [2+3] cycloaddition of a thiocarbonyl ylide.  
Careful analysis of the impact of stereochemistry and the resultant steric interactions in the 
cyclization cascade allowed us to identify an optimized cyclization precursor, which shortened the 
synthesis of 5-epi-aureol by eight steps. Unfortunately, the seemingly trivial isomerization of 5-epi-
aureol to aureol could not be achieved. Nevertheless, 5-epi-aureol was further converted to                 
(–)-cyclosmenospongine through sequential functionalization and oxidation of the arene moiety. The 
streamlined synthesis allowed us to gain access to 420 mg of (–)-cyclosmenospongine. 
Future work will aim to implement the newly developed cyclization cascade in the synthesis 
of other complex natural products bearing trans-fused decalin ring systems. Moreover biological 
investigations will be carried out in collaboration with the group of Prof. Dr. Mark Brönstrup 
(Helmholtz Centre for Infection, Braunschweig) and Dr. Susanna Zierler (Walther-Straub Institute for 
Pharmacology and Toxicology, Munich) to further elucidate their biological activities. 
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PART II:  
GOLD(I)-CATALYZED CYCLIZATIONS OF 1,5-ENYNES 
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2.1. General Introduction 
2.1.1.  Gold in Homogenous Catalysis 
Within the last 20 years, homogenous gold catalysis has emerged as an extremely dynamic and 
innovative field in organic chemistry, and has proven to be a versatile tool in the synthetic chemist´s 
arsenal.[119-122] Although cationic gold was initially considered an inert catalytic species, gold salts and 
complexes have emerged as powerful catalysts for the selective electrophilic activation of carbon–
carbon multiple bonds towards nucleophilic addition.[123-125] The mild reaction conditions, high 
selectivity and functional group tolerance of gold catalysis has attracted great interest within the 
scientific community and led to what can be compared to the Californian gold rush of the 19th 
century.[126-127] This modern gold fever resulted in an exponential growth in the number of publications 
investigating the reactivity of this precious metal.[128] 
In 1986, almost ten years before the aforementioned growth in interest in homogenous gold 
catalysis began, Hayashi reported the first gold-catalyzed asymmetric aldol condensation of various 
aldehydes, for example 159, with isocyano acetate 160 to yield trans-oxazolines like 161 in excellent 
yield and enantioselectivity using the chiral ferrocene ligand 162 (Scheme 21a).[129] Shortly after 
Hayashi´s seminal work, Utimoto described the formation of tetrahydropyridine 164 from alkyne 163 
(Scheme 21b).[130] The activation of carbon–carbon multiple bonds by late transition metals was well 
known at that time, but in his work he beautifully demonstrated the superiority of gold(III) over other 
transition metals like palladium(II), which is in a similar d8-configuration. Although the seminal work 
carried out by Hayashi and Utimoto laid the foundation of homogeneous gold catalysis, the 
groundbreaking contribution of Teles truly marked a new era in gold catalysis. He discovered that 
cationic gold catalysts bearing phosphine ligands provide ketals like 168 with exceptional turnover 
frequencies, outperforming the previously developed methods for the hydration of alkynes by a 
significant margin.[131-132]  
 
 
Scheme 21: Landmark achievements in homogeneous gold catalysis. 
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Only recently the long standing paradigm that gold cannot be used in cross-coupling reactions 
due to the apparent redox stability of gold(I)-species has been overcome.[119, 133-134] Although the 
gold(III) oxidation state is easily accessible, gold complexes usually do not cycle between oxidation 
states. By using the external oxidant Selectfluor® in stoichiometric quantities, Zhang demonstrated that 
the prevalent steps occurring in typical late transition-metal catalysis, such as oxidative addition and 
reductive elimination, can also be induced for gold catalysis.[135]  
 
2.1.2.  Mechanistic Aspects 
By far the vast majority of reactions developed for homogenous gold catalysis exploit the 
propensity of gold salts to electrophilically activate carbon–carbon multiple bonds. In a typical 
reaction, gold(I) is the catalytically active species and acts as a soft -electrophilic Lewis-acid to form 
linear bicoordinated 2-complexes (Scheme 22a).[136-137] The coordination to the carbon–carbon 
multiple bond enables attack of a nucleophile. This typically occurs in an anti-fashion through an 
outer-sphere mechanism if a weakly coordinating nucleophile is present, or through an inner-sphere 
mechanism for strongly coordinating nucleophiles, to yield a syn-adduct.[136] Due to the fact that 
gold(I) typically does not undergo spontaneous -hydride elimination or oxidative addition a 
protodeauration is generally the final step of the catalytic cycle.[138-139]  
 
 
Scheme 22: a) General catalytic cycle for the electrophilic activation of carbon–carbon multiple bonds through 
cationic gold and dominant orbital interactions for b) a gold-alkyne complex and c) a gold carbene complex. 
 
The extraordinary -affinity of cationic gold species can be explained using relativistic 
effects.[63, 137] These effects, which are at a maximum for gold, cause a contraction of the atomic s and 
p orbitals and an expansion of the d and f orbitals in order to decrease the electron-electron 
repulsion.[140] This relativistic contraction of the 6s orbital is responsible for lowering the energy of the 
lowest unoccupied molecular orbital (LUMO), which is the primary acceptor of electron density from 
ligands and the substrates.[63, 120, 137, 139] Because of the relatively low-lying 6s-LUMO, gold is capable 
of forming strengthened gold-ligand bonds, which explains its high -acidity compared to other late-
transition metals. Moreover, the altered intrinsic energy and expansion of the 5d orbital are responsible 
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for the “soft” Lewis-acidic character of gold(I) and explain the preferential interaction with soft 
nucleophiles such as carbon–carbon  bonds, e.g. alkynes.[63] 
The binding behavior between gold and its ligands can be described in more detail using the 
molecular orbital theory (Scheme 22b).[63] The interaction of an alkyne with gold(I) has a ,  and - 
bond character. The -bonding is the result of an overlap of an in-plane II-orbital with an unoccupied 
orbital of gold with corresponding symmetry (M ← L donation). The -bonding results from a shift of 
electron density from the metal towards an unoccupied II*-orbital through back-donation (M → L), 
and through -donation (M ← L) of an out-of-plane ߨୄ-orbital. The last interaction a back donation 
with -symmetry can be neglected due to the relatively slight participation in the bonding.[63] The 
bonding of transient gold carbene species can be explained in a similar manner, and can again be 
divided into  and -character.[120, 139] A 3-centre/4-electron bond with -symmetry is proposed which 
is accompanied by orthogonal back-bonding -bonds from the gold species to the ligand and the 
substrate. This back-bonding can be explained by the fact that the 5d electrons of gold are too low in 
energy to engage in back-donation to anti-bonding ligand orbitals, but are able to delocalize into the 
lower-energy empty non-bonding orbitals.  
Based on this bonding model, the electronic nature of gold(I)-intermediates and their reactivity 
can be rationalized. Moreover, one can conclude why gold can act in both a -acidic and a carbenoid-
like fashion (cf. Chapter 1.2.5). After nucleophilic attack of the alkyne the intermediate vinylgold 
species stabilizes the resulting positive charge through back-donation. This suggests that carbene 
formation occurs through an increase in -bonding character with a concomitant decrease in -
bonding.[63]  
 
2.1.3. Ligand Effects 
Initially, simple gold salts like gold(I) and gold(III) chloride, or sodium tetrachloroaurate were 
used to catalytically activate carbon–carbon multiple bonds.[139] Nevertheless, the seminal work of 
Teles showed that ancillary ligands can have a significant influence on the reactivity of the cationic 
gold catalyst.[131] So far, phosphines and N-heterocyclic carbenes (NHC) have found the widest 
applications in gold catalysis as ligands (Figure 4).[122, 139]  
 
Figure 4: Typical ligands used in gold catalysis a) phosphorus based and b) N-heterocyclic carbenes. 
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The main advantage of the use of ligands in homogenous catalysis is that the reactivity of the 
catalyst can be easily tuned with respect to the electronic and steric demands. As described above (cf. 
Chapter 2.1.2), the ligand´s back-bonding capability has a direct influence on the electronics of the 
cationic gold(I)-species. Therefore, the choice of ligand can have a profound effect on the observed 
reactivity. In general, phosphorus based ligands are strongly -acidic and generate a more electrophilic 
gold center, whereas catalysts bearing NHC ligands are especially good in -donation and tend to be 
less electrophilic.[141] Due to the -donating properties of these ligands the carbon-gold bond order is 
decreased which results in a more “carbene-like” intermediate. In contrast, -acidic ligands decrease 
the -donation, hence a more carbocationic reactivity is observed.[120]  
Since gold complexes have a strong preference to form linear bicoordinated complexes 
precatalyst of the type LAuX, with L being the ligand and X the counterion, are most commonly found 
in literature. In general, these gold catalysts can be described as a cationic gold center that is stabilized 
through an anion. The stability of gold-chloride complexes can be explained as a result of the strong 
coordination of the chloride-ion to the gold center. This results in a diminished catalytic activity as the 
associative ligand exchange with the substrate is hampered.[139] The catalytically active LAu+ species 
are therefore generated through chloride abstraction through silver salts with less nucleophilic and 
bulkier counterions such as tetrafluoroborate (BF4), hexafluoroantimonate (SbF4) or bis(trifluoro-
methanesulfonyl)imide (NTf2). However, since silver itself can be catalytically active, silver salts are 
far from being innocent spectators in gold catalysis.[142-144] Therefore recently silver-free activation 
protocols have been developed.[145-146] Nolan for instance, utilizes Brønsted acid activation of NHC 
gold hydroxy complexes, to generate the catalytically active cationic gold(I)-species and producing 
water as the sole by-product.[147]  
Moreover, due to the aforementioned prevailing bicoordination, it is inherently difficult to 
induce enantioselectivity during gold-catalyzed reactions through the use bidentate ligands, which are 
arguably the most successful design principle in asymmetric catalysis, or through chiral monodentate 
ligands, as the chiral information is too distant to be translated to the substrates during the reaction.[63, 
122, 139] Nevertheless, by using dinuclear gold complexes or chiral counterions several groups were able 
to overcome this drawback and develop elegant gold-catalyzed asymmetric reactions.[139, 148-150] 
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2.2. Cyclization of Enynes 
2.2.1.  General Reactivity 
Cycloisomerizations of 1,n-enynes, especially 1,5- and 1,6-enynes, have emerged as 
exceptionally valuable reactions as they can provide an atom- and step-economical entry to the 
synthesis of functionalized cyclic systems in a single synthetic operation with excellent 
chemoselectivity under mild reaction conditions.[151] Since the pioneering work on palladium catalyzed 
rearrangement of enynes by Trost in 1984, several metals have been identified that efficiently promote 
these important transformations.[152-153]  
In contrast to other transition metal catalyzed enyne cyclizations, gold(I) is unable to promote 
cycloisomerization reactions in an Alder–ene fashion. This would require a simultaneous coordination 
of the cationic gold(I) species with both the alkyne and the alkene, and subsequent formation an 
intermediate metallacycle through an oxidative addition process. This cyclization mode is highly 
unfavored by gold(I), as it typically prefers a linear bicoordination and avoids changes in oxidation 
states. As previously mentioned, cationic gold species selectively activate carbon–carbon multiple 
bonds towards nucleophilic addition and are able to stabilize the resulting cationic intermediates (cf. 
Chapter 2.1.2.). Most of the early mechanistic studies on the gold catalyzed enyne cyclizations were 
carried out by Echavarren, Toste and Hashmi.[62, 120, 136, 139, 154]  
Their seminal work shed light on these elegant but sometimes promiscuous cascade reactions. 
The cyclization of 1,n-enynes proceed through an initial and chemoselective activation of the alkyne 
moiety allowing the adjacent alkene to attack the triple bond intramolecularly in either an exo or endo-
fashion, as exemplified for the cyclization of enyne 174 (Scheme 23a). The intermediate carbocationic 
species 173 or 175, which are in resonance with their corresponding cyclopropyl gold carbenes 172 
and 176, can subsequently undergo a variety of transformations depending on the exact reaction 
conditions and the availability of additional nucleophiles.[154-155]  
 
 
Scheme 23: Key mechanistic intermediates for the gold-catalyzed cyclization of 1,n-enynes. 
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The ability of gold to interconvert between these mesomeric structures explains the occurrence 
of a variety of skeletally rearranged products found in enyne cycloisomerization reactions. The basic 
principle of these rearrangements involves the generation of the homoallyl cation 177 after initial 
attack of an alkene, which can rearrange to cyclobutyl cation 178 or cyclopropylcarbinyl cation 179, 
which is in resonance with carbene 180 (Scheme 23b).  
 
2.2.2.  Cyclization of 1,6-Enynes 
The cyclization of 1,6-enynes are probably the best studied substrate class in the field of 
cycloisomerizations. One of the first examples of a gold-catalyzed 1,6-enyne cyclization was reported 
by Hashmi in 2000 (Scheme 24 a).[156] Upon exposure of alkyne 181 to gold(III) chloride, the initially 
formed carbene intermediate 182 underwent several skeletal rearrangements to yield oxepine 184, 
which after ring-contraction and aromatization afforded the highly substituted phenol 185 in good 
yield. 
 
 
Scheme 24: Selected gold-catalyzed cycloisomerizations of 1,6-enynes. 
 
In seminal work, Echavarren beautifully demonstrated the versatility of enyne cyclizations, 
and moreover validated the superiority of gold catalysis for the cyclization of various 1,6-enynes 
(Scheme 24b).[157] By simple variation of the reaction conditions, the gold mediated cyclization of 
enyne 187 yielded either 186 if methanol was present as an external nucleophile, or the skeletally 
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rearranged 1,3-diene 188 in its absence. In the same study, Echavarren also showed that the                
N-substituted enyne 190 selectively cyclized through a 6-endo process to yield piperidine 189 
(Scheme 24c). A simple exchange of the catalyst and the substitution of the terminal alkyne allowed 
Chung to access enantioenriched 1,4-diene 192 from 191.[158] The intermediacy of a gold-carbene 
could be unambiguously confirmed through interception of the cyclization cascade with norbornene to 
yield cyclopropanated 193 (Scheme 24d).[159] By using the -donating NHC ligand IMes (170), the 
gold-carbene was sufficiently stabilized to allow for an insertion into the norbornene double bond. 
Another mode of reactivity was observed for arylated enyne 194. The intermediate homoallylic cation 
195 could be trapped by the arene to give tricyclic compound 196 (Scheme 24d).[160] 
 
2.2.3.  Cyclization of 1,5-Enynes 
The first gold-initiated 1,5-enyne cyclization cascade was developed by Arcadi in 2003.[161] By 
establishing a one-pot procedure, he was able to synthesize a variety of substituted pyridine 
derivatives in excellent yields (Scheme 25a). Condensation of propargylamine with various ketones 
resulted in the formation of N-substituted 1,5-enynes, which upon heating in the presence of sodium 
tetrachloroaurate gave the desired pyridines as exemplified by the conversion of 197 to 198. In 2004, 
Toste reported the gold(I)-catalyzed cycloisomerization of enyne 199 to bicycle 200 (Scheme 25b).[162] 
This report was directly followed by a study of Kozmin on the cyclization of O-substituted 1,5-enynes 
(Scheme 25c).[163] The exposure of enyne 201 to gold(I) chloride led to the clean formation of 
cyclohexadiene 202 via a sequence of several rearrangements. It is interesting to note the simple 
alkyne substitution led to the formation of completely different products, which again showcases the 
mechanistic diversity which can occur during the cycloisomerization of enynes. 
 
 
Scheme 25: Selected cycloisomerizations of 1,5-enynes. 
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In analogy to 1,6-enynes, the cyclization of 1,5-enynes also proceeds through species that are 
intermediate between a bicyclic gold-carbene, like 204, and an open gold-stabilized homoallylic 
carbocation such as 205, but occur typically in an endo-fashion.[164] As previously described, the 
choice of ancillary ligands can influence the equilibrium of these mesomeric structures and thereby 
dramatically affect the reaction outcome. The same holds true for substituents on the enyne, which are 
able to alter the equilibrium between 204 and 205 through subtle electronic effects.[155] Depending on 
the substitution pattern the cationic intermediate can be attacked by a nucleophile on different sites (a 
or b, Scheme 25a). Gagosz observed that the cyclization of an enyne bearing an acetate (R3) yields 
203, whereas studies carried out by Toste demonstrated that an enyne with methyl substitution (R2) 
gives selectively the rearranged methoxy adduct 206.[122, 165]  
A beautiful synthetic application of a 1,5-enyne cyclization was reported by Toste in 2006.[166] 
A gold(I)-initiated 5-endo-dig cyclization of silyl enol ether 207 resulted in the clean formation of cis-
hydrindane 208, which was further advanced to the natural product lycopladine A (209) within three 
additional steps. 
 
2.2.3.  Miscellaneous 1,n-Enyne Cyclizations 
Whereas numerous cycloisomerization reactions of 1,5- and 1,6-enynes have been reported, 
the gold catalyzed cyclizations of other enynes are far less common. In 2006, Zhang succeeded in 
developing a cyclopentenone synthesis starting from 1,3-enynes (Scheme 26a).[167] After a gold-
initiated [1,3]-acetate migration of 210 to 211, the resultant bis-vinyl cation 212 underwent a Nazorav-
type electrocyclization to yield 213. A final [1,2]-hydride shift followed by protodeauration gave 214 
in excellent yield.  
 
 
Scheme 26: Selected examples for 1,n-enyne cyclizations. 
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The cyclization of 1,4-enynes that bear an adjacent carboxylate proceed through a similar 
mechanism, generally referred to as the Rautenstrauch reaction, as depicted in Scheme 26b.[168-169] 
Upon exposure of 215 to a gold catalyst, a [1,2]-acyl-shift occurs and the resultant cationic 
intermediate 216 cyclizes to 217, which after proteolysis and tautomerization gives ketone 218. The 
reaction occurs with remarkable chirality transfer and allows the efficient and enantiospecific 
synthesis of highly substituted cyclopentenones. 
Whereas the cyclization of 1,7-enynes generally give cyclization products arising from a 6-
endo pathway, as shown for the conversion of 219 to 220 (Scheme 26c), the cyclization of 1,8-enynes, 
like 221, can proceed via a formal [2+2] cycloaddition to from cyclobutene derivatives such as 222 
(Scheme 26d).[170-171] Although the [2+2] cycloaddition can also be observed for smaller 1,n-enynes, it 
is much less common due to the presence of other skeletal rearrangements which lead to potentially 
less strained cyclic products.[154] This mode of reactivity could also be observed for higher enynes and 
was beautifully utilized by Echavarren for the macrocyclization of various 1,n-enynes, (n = 10–16).[172] 
The enormous diversity of products which can arise from the cyclization of various 1,n-
enynes, along with the profound influence the exact reaction conditions on the reaction outcome 
renders these transformations highly valuable and worthwhile to investigate. The discovery of novel 
cycloisomerization pathways will allow to construct polyfunctionalized cyclic frameworks with 
extraordinary efficiency and elegance from simple acyclic compounds and enable unprecedented 
retrosynthetic disconnections. 
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2.3. Results and Discussion 
 
2.3.1.  Sequential O–H/C–H Bond Insertion of Phenols Initiated by the Gold(I)-Catalyzed 
 Cyclization of 1-Bromo-1,5-Enynes 
 
 
 
 
Reprinted with permission from: 
K. Speck, K. Karaghiosoff, T. Magauer, Org. Lett., 2015, 17, 1982–1985. 
Copyright © 2015 American Chemical Society. 
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2.4. Conclusions and Outlook 
In Part II of this thesis, a novel gold(I)-catalyzed domino reaction of 1-halo-1,5-enynes in the 
presence of phenols is described. The newly developed reaction constitutes a facile entry to highly 
functionalized halocyclopentenes, a structural motif that can be found in several biologically active 
compounds.  
Detailed mechanistic investigations, including deuterium labelling, cross-over experiments of 
reactive intermediates and NMR-studies, shed light on this unexplored transformation. The 
unprecedented cascade reaction proceeds through a dual catalytic cycle which requires a -acidic 
cationic gold species and a Brønsted-acidic counterion. The initial step, a gold(I)-catalyzed 5-endo-
cyclization of the enyne, generates an intermediate aryl alkyl ether which collapses at ambient 
temperatures through trace amounts of Brønsted-acid to undergo a [1,2]-hydride shift followed by 
subsequent C–H insertion of the phenol. 
The developed one-pot procedure proceeds efficiently under mild reaction conditions and was 
found to tolerate a variety of substituted phenols resutling in a total scope of 18 examples. The 
developed cascade beautifully highlights the profound influence of external nucleophiles and 
experimental conditions on the reaction pathway of gold(I)-catalyzed cyclization of enynes. In future 
work we aim to expand this methodology to the synthesis of bioactive molecules. 
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3.1. General Experimental Details 
3.1.1. General Working Methods 
All reactions were performed in flame-dried glassware fitted with rubber septa under a 
positive pressure of argon, unless otherwise noted. Air- and moisture-sensitive liquids were transferred 
via syringe or stainless steel cannula through rubber septa. Solids were added under inert gas counter 
flow or were dissolved in appropriate solvents. Low temperature-reactions were carried out in a Dewar 
vessel filled with a cooling agent: acetone/dry ice (−78 °C), H2O/ice (0 °C). Reaction temperatures 
above room temperature were conducted in a heated oil bath. The reactions were magnetically stirred 
and monitored by NMR spectroscopy or analytical thin-layer chromatography (TLC), using aluminum 
plates percolated with silica gel (0.25 mm, 60-Å pore size, Merck) impregnated with a fluorescent 
indicator (254 nm). TLC plates were visualized by exposure to ultraviolet light (UV), were stained by 
submersion in aqueous potassium permanganate solution (KMnO4), ceric ammonium molybdate 
solution (CAM) or p-anisaldehyde solution (Anis), and were developed by heating with a heat gun. 
Flash-column chromatography was performed as described by Still employing silica gel (60 Å, 40–63 
μm, Merck KGaA).[173] The yields refer to chromatographically and spectroscopically (1H and 13C 
NMR) pure material. 
 
3.1.2. Materials 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled under N2 atmosphere from 
sodium and benzophenone prior to use. Dichloromethane (CH2Cl2), triethylamine (Et3N), 
diisopropylamine (DIPA) and Hünig’s base (DIPEA) were distilled under nitrogen atmosphere from 
CaH2 prior to use. Dimethyl sulfoxide (DMSO), acetonitrile (MeCN), acetone, toluene, chloroform 
(CHCl3) and methanol (MeOH) were purchased from Acros Organics as 'extra dry' reagents and used 
as received. All other reagents and solvents were purchased from chemical suppliers (Sigma-Aldrich, 
Acros Organics, Alfa Aesar, Strem Chemicals, ABCR) and were used as received. Solvents for 
extraction, crystallization and flash column chromatography were purchased in technical grade and 
distilled under reduced pressure prior to use. Lithium chloride was dried at 100 °C under vacuum (0.1 
mmHg) for 12 h and stored in a drying oven at 150 °C (760 mmHg); the hot, dried solid was flame 
dried under vacuum (0.1 mmHg) for 4−5 min immediately prior to use. The molarity of n-butyllithium 
and t-butyllithium solutions was determined by titration against diphenylacetic acid as an indicator 
(average of three determinations).[174] The concentration of freshly prepared dimethyldioxirane 
solutions[175] was determined by iodometric titration as follows: A 0.02 M aqueous stock solution of 
sodium thiosulfate pentahydrate (124 mg Na2S2O3·5 H2O in 25 mL H2O) was prepared in a 25 mL 
graduated cylinder. A 100 mL flask was charged with water (30 mL), sodium iodide (2.00 g) and 
glacial acetic acid (1 mL), whereupon the dimethyldioxirane solution (2 mL) was added. The resulting 
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brown mixture was rapidly titrated with the sodium thiosulfate stock solution until disappearance of 
the yellow iodine color occurred. The concentration of the dimethyldioxirane solution was calculated 
according to the following equation: 
ܿሺܦܯܦܱሻ ൌ ܯሺݐ݅ݐݎܽ݊ݐሻ	ݔ	ܸሺݐ݅ݐݎܽ݊ݐሻܸሺܦܯܦܱሻ	ݔ	2  
and was generally in the range of 0.04 M to 0.06 M. 
 
3.1.3. NMR Spectroscopy 
NMR spectra were measured on a Bruker Avance III HD 400 MHz spectrometer equipped 
with a CryoProbeTM, Bruker AXR300, Varian VXR400 S, JOEL ECX400, Bruker AMX600 and 
Bruker Avance HD 800. Proton chemical shifts are expressed in parts per million (ppm, δ scale) and 
are referenced to residual proton in the NMR solvent (CHCl3: δ 7.26, C6D5H: δ 7.16, CDHCl2: δ 5.32). 
Carbon chemical shifts are expressed in parts per million (δ scale, assigned carbon atom) and are 
referenced to the carbon resonance of the NMR solvent (CDCl3: δ 77.16, C6D6: δ 128.06, CD2Cl2: δ 
54.00). 1H NMR spectroscopic data are reported as follows: Chemical shift in ppm (multiplicity, 
coupling constants J (Hz), integration intensity, assigned proton). The multiplicities are abbreviated 
with s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet) and m (multiplet). In case of 
combined multiplicities, the multiplicity with the larger coupling constant is stated first. Except for 
multiplets, the chemical shift of all signals, as well for centrosymmetric multiplets, is reported as the 
center of the resonance range. Additionally to 1H and 13C NMR measurements, 2D NMR techniques 
such as homonuclear correlation spectroscopy (COSY), total correlation spectroscopy (TOCSY), 
heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond coherence (HMBC) 
were used to assist signal assignment. For further elucidation of 3D structures of the products, nuclear 
Overhauser enhancement spectroscopy (NOESY) was conducted. Coupling constants J are reported in 
Hz. All raw fid files were processed and the spectra analyzed using the program MestReNOVA 9.0 
from Mestrelab Research S. L. 
 
3.1.4. Mass Spectroscopy 
All mass spectra were measured by the analytic section of the Department of Chemistry, 
Ludwig-Maximilians-Universität München. Mass spectra were recorded on the following 
spectrometers (ionization mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan 
GmbH or MS-700 (DEI) from JOEL. Mass spectra were recorded in high-resolution. The method used 
is reported at the relevant section of the experimental section. 
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3.1.5. IR Spectroscopy 
IR spectra were recorded on a PerkinElmer Spectrum BX II FT-IR system. If required, 
substances were dissolved in CH2Cl2 prior to direct application on the ATR unit. Data are represented 
as follows: frequency of absorption (cm−1), and intensity of absorption (vs = very strong, s = strong, m 
= medium, w = weak, br = broad). 
 
3.1.6. Optical Rotation 
Optical rotation values were recorded on a PerkinElmer 241 or Anton Paar MCP 200 
polarimeter. The specific rotation is calculated as follows:  
ሾߙሿఒఝ ൌ
ሾߙሿ ∙ 100
ܿ ∙ ݀  
Thereby, the wave length λ is reported in nm and the measuring temperature ϕ in °C. α 
represents the recorded optical rotation at the apparatus, c the concentration of the analyte in 10 
mg/mL and d the length of the cuvette in dm. Thus, the specific rotation is given in 10−1·deg·cm2·g−1. 
Usage of the sodium D line (λ = 589 nm) is indicated by D instead of the wavelength in nm. The 
respective concentration as well as the solvent is reported at the relevant section of the experimental 
section. 
 
3.1.7. Melting Points 
Melting points were determined on a B-450 melting point apparatus from BÜCHI 
Labortechnik AG. The values are uncorrected. 
 
3.1.8. High-pressure Reactions 
The high pressure reactions were performed in self-made Teflon reaction vials in an emulsion 
high pressure machine from Andreas Hofer Hochdrucktechnik GmbH (max. 14 kbar, piston Ø 25 mm, 
stroke 95 mm) equipped with a Julabo MA-4 circulation thermostat. 
 
3.1.9. Elemental Analysis 
Elemental analyses were performed in the micro analytical laboratory of the Department of 
Chemistry, Ludwig-Maximilians-Universität München, on an Elementar Vario EL apparatus. 
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Convergent Assembly of the Tetracyclic Meroterpenoid                      
(–)-Cyclosmenosongine via a  Non-Biomimetic Polyene Cyclization 
 
 
K. Speck, R. Wildermuth, T. Magauer, Angew. Chem. Int. Ed. 2016, 55, 14131–14135. 
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3.2.1. Experimental Procedures 
 
 
Iodide S22 
To a solution of 2-iodoethanol (25.0 g, 145 mmol, 1 equiv) in dichloromethane (360 mL) and 
imidazole (19.8 g, 291 mmol, 2.00 equiv) was added tert-butyldimethylsilyl chloride (21.9 g, 145 
mmol, 1.00 equiv) at 0 °C. After 30 min, the reaction mixture was allowed to warm to 23 °C. After 2 
h, the reaction mixture was diluted with dichloromethane (200 mL) and the organic layer was washed 
with saturated aqueous sodium bicarbonate solution (2 × 200 mL) and with saturated aqueous sodium 
chloride solution (200 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated to give iodide S22 (41.4 g, 99%) as a colorless oil. The crude 
product was directly used without further purification. Characterization data obtained for S22 were in 
full agreement with values previously reported.[176] 
 
 
(–)-(1R,2R)-pseudoephedrine propionylamide 9 
Propionic anhydride (21.2 mL, 165 mmol, 1.07 equiv) was added dropwise to a solution of     
(–)-(1R,2R)-pseudoepedrine (S23) (25.5 g, 154 mmol, 1 equiv) in tetrahydrofuran (300 mL) at 23 °C. 
After 30 min, excess propionic anhydride was quenched by the addition of saturated aqueous sodium 
bicarbonate solution (150 mL). The resulting biphasic mixture was partitioned between water 
(200 mL) and ethyl acetate (250 mL). The layers were separated and the aqueous phase was extracted 
with ethyl acetate (3 × 250 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was recrystallized from 
toluene to afford amide 9 (32.1 g, 94%) as a white solid. The obtained characterization data were in 
full agreement with those reported in literature.[177] 
 
 
Amide S24 
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N,N-Diisopropylamime (23.0 mL, 163 mmol, 2.25 equiv) was added dropwise to a suspension 
of lithium chloride (18.4 g, 434 mmol, 6.00 equiv) in tetrahydrofuran (72 mL) at 23 °C and the 
resulting suspension was cooled to –78 °C. A solution of n-butyllithium (2.52 M in hexanes, 60.3 mL, 
152 mmol, 2.10 equiv) was added via syringe. The reaction mixture was briefly warmed to 0 °C for 
5 min, then cooled to –78 °C. An ice-cooled solution of amide 9 (16.0 g, 72.3 mmol, 1 equiv) in 
tetrahydrofuran (180 mL) was added by cannula to the inner wall of the flask. The transfer was 
quantitated with tetrahydrofuran (15 mL). The reaction mixture was stirred at –78 °C for 1 h, at 0 °C 
for 15 min and at 23 °C for 5 min. Then the reaction mixture was cooled to 0 °C, whereupon iodide 
S22 (41.4 g, 145 mmol, 2.00 equiv) was added. Stirring was continued at 23 °C for 3.5 h. Saturated 
aqueous ammonium chloride solution (20 mL) was added to the ice-cold product mixture. The 
biphasic mixture was partitioned between ethyl acetate (200 mL) and aqueous hydrochloric acid 
solution (1 M, 150 mL). The layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 200 mL). The combined organic extracts were washed with saturated aqueous sodium 
chloride solution (150 mL), the washed organic solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (40% ethyl acetate in hexanes initially, grading to 50% ethyl acetate in 
hexanes) to give amide S24 (22.8 g, 83%) as a viscous yellow oil. Characterization data obtained for 
S24 were in full agreement with previously reported values.[177] 
 
 
Ketone 10 
Amide S24 was dried by azeotropic distillation (benzene, 2 × 40 mL) prior to use. To a 
solution of S24 (22.8 g, 60.1 mmol, 1 equiv) in diethyl ether (400 mL) was added methyllithium 
(1.6 M in diethyl ether, 97.6 mL, 156 mmol, 2.60 equiv) via syringe at –78 °C. The reaction mixture 
was allowed to warm to 0 °C. After 45 min, excess methyllithium was quenched at 0 °C by the 
addition of N,N-diisopropylamine (8.49 mL, 60.1 mmol, 1.00 equiv). A solution of acetic acid in 
diethyl ether (20% v/v, 75 mL) was added and the reaction mixture (pH = 6 to 7) was partitioned 
between diethyl ether (100 mL) and water (200 mL). The aqueous phase was separated and extracted 
with diethyl ether (3 × 200 mL). The combined organic layers were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (hexanes initially, grading to 10% ethyl acetate in hexanes) to provide 
ketone 10 (11.9 g, 83%) as a colorless oil. The obtained characterization data were in full agreement 
with those reported in literature.[177]  
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Trimethyl((phenylthio)methyl)silane S25 
Peterson reagent S25 was prepared according to the procedure described by D. J. Ager:[178] 
To a solution of n-butyllithium (2.52 M in hexanes, 34.7 mL, 87.4 mmol, 1.01 equiv) in diethyl ether 
(30 mL) was added thioanisole (10.2 mL, 86.6 mmol, 1 equiv) at 23 °C, then the mixture was heated 
to 50 °C. After 16 h, the reaction mixture was allowed to cool to 23 °C, chlorotrimethylsilane (13.3 
mL, 104 mmol, 1.20 equiv) was added dropwise to the now white suspension and heated to 50 °C. 
After 1 h, the reaction mixture was allowed to cool to 23 °C and poured into saturated aqueous 
ammonium chloride solution (40 mL). The layers were separated and the aqueous phase was extracted 
with diethyl ether (3 × 20 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by distillation to 
give sulfide S25 (13.7 g, 81%) as a colorless oil (boiling point: 125–128 °C, 20 mbar). The obtained 
analytical data were in full agreement with those reported in literature.[178]  
 
 
Vinylsulfide S26 
To a solution of Peterson reagent S25 (11.9 g, 60.8 mmol, 1.40 equiv) in tetrahydrofuran (100 
mL) was added a solution of n-butyllithium (2.45 M in hexanes, 23.9 mL, 58.6 mmol, 1.35 equiv) at 
0 °C. After 30 min, a solution of ketone 10 (10.0 g, 43.4 mmol, 1 equiv) in tetrahydrofuran (50 mL) 
was added and stirring was continued at 0°C. After 30 min, the reaction mixture was allowed to warm 
to 23 °C. After 5 h, the reaction mixture was diluted with diethyl ether (100 mL) and the organic layer 
was washed with saturated aqueous ammonium chloride solution (200 mL). The aqueous phase was 
extracted with diethyl ether (2 × 200 mL) and the combinded organic extracts were washed with 
saturated aqueous sodium chloride solution (200 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (hexanes initially grading to 2% ethyl acetate in hexanes) 
to provide vinylsulfide S26 as an inseparable mixture of double bond isomers (12.6 g, 86%, E:Z = 2:3) 
as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): (Z): δ = 7.33–7.24 (m, 4H), 7.20–7.12 (m, 1H), 5.89 (q, J = 1.2 Hz, 1H), 
3.66–3.49 (m, 2H), 3.19–3.04 (m, 1H), 1.78 (d, J = 1.3 Hz, 3H), 1.73–1.49 (m, 2H), 1.04 (d, J = 6.9 
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Hz, 3H), 0.89 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H); (E): δ = 7.32–7.22 (m, 4H), 7.19–7.13 (m, 1H), 5.98–
5.95 (m, 1H), 3.68–3.48 (m, 2H), 2.58–2.43 (m, 1H), 1.79 (d, J = 1.1 Hz, 3H), 1.74–1.51 (m, 2H), 1.08 
(d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 3H), 0.05 (s, 3H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 146.6, 137.7, 129.0, 128.1, 125.7, 115.8, 61.8, 37.8, 33.0, 26.1, 
19.0, 18.5, 18.4, –5.1, –5.1; (E): δ = 146.5, 137.5, 129.0, 128.1, 125.8, 115.6, 61.4, 39.3, 38.0, 26.1, 
19.7, 18.5, 14.7, –5.1, –5.1. 
IR (Diamond-ATR, neat) ෤߭max: 2955 (m), 2927 (m), 2855 (m), 1584 (w), 1479 (m), 1251 (m), 1090 (s), 
833 (vs), 773 (vs), 736 (vs), 689 (vs). 
HRMS (EI) calc. for C19H32O32S28Si [M]+: 336.1938 found: 336.1933. 
 
 
Alcohol S27 
To a solution of silylether S26 (12.5 g, 37.3 mmol, 1 equiv) in acetonitrile (120 mL) was 
added triethylamine trihydrofluoride (10.6 mL, 65.2 mmol, 1.75 equiv) at 23 °C. After 8 h, the 
reaction mixture was portioned between diethyl ether (150 mL) and a 1:1 mixture of saturated aqueous 
sodium bicarbonate solution (200 mL) and saturated aqueous sodium chloride solution (200 mL). The 
aqueous layer was extracted with diethyl ether (3 × 200 mL). The combined organic layers were dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the residue 
was purified by flash-column chromatography (30% ethyl acetate in hexanes) to yield alcohol S27 
(7.87 g, 95%, E:Z = 2:3) as a colorless oil. 
An analytical sample was purified by flash-column chromatography (10% ethyl acetate in 
hexanes) to give pure alcohol (Z)-27 and alcohol (E)-27 as colorless oils. Note: Since the double bond 
geometry is inconsequential for the subsequent steps the following transformations were performed 
using the mixture of double bond isomers. 
 
(Z)-27: 
TLC (40% ethyl acetate in hexane): Rf = 0.38 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.37–7.26 (m, 4H), 7.24–7.17 (m, 1H), 5.96 (q, J = 1.4 Hz, 1H), 
3.71–3.54 (m, 2H), 3.29–3.09 (m, 1H), 1.91 (s, 1H), 1.79 (d, J = 1.3 Hz, 3H), 1.74–1.59 (m, 2H), 1.10 
(d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 145.4, 136.9, 129.0, 128.4, 126.0, 116.5, 61.2, 37.4, 32.7, 19.0, 
18.1. 
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IR (Diamond-ATR, neat) ෤߭max: 3340 (br w), 2958 (w), 2930 (w), 2870 (w), 1582 (m), 1478 (m), 
1438(m), 1046 (s), 1024 (m), 809 (m), 735 (vs), 688 (vs). 
HRMS (EI) calc. for C13H18O32S [M]+: 222.1073 found: 222.1070. 
ሾࢻሿࡰ૛૙ = + 45.8° (c = 1.00, CH2Cl2). 
(E)-27: 
TLC (40% ethyl acetate in hexane): Rf = 0.31 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.34–7.27 (m, 4H), 7.21–7.14 (m, 1H), 6.02–6.00 (m, 1H), 3.64 (td, 
J = 6.8, 1.2 Hz, 2H), 2.59–2.45 (m, 1H), 1.80 (d, J = 1.1 Hz, 3H), 1.78–1.68 (m, 1H), 1.68–1.57 (m, 
1H), 1.36 (br s, 1H), 1.10 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 145.5, 137.1, 129.1, 128.3, 125.9, 116.3, 61.4, 39.6, 37.7, 19.8, 
14.6. 
IR (Diamond-ATR, neat) ෤߭max: 3324 (br w), 2958 (m), 2928 (m), 2870 (w), 1582 (m), 1478 (s), 1438 
(m), 1376 (w), 1047 (s), 816 (m), 736 (vs), 689 (s). 
HRMS (EI) calc. for C13H18O32S [M]+: 222.1073 found: 222.1072. 
ሾࢻሿࡰ૛૙ = + 5.4° (c = 1.00, CH2Cl2). 
 
 
Iodide 8 
To a solution of imidazole (2.87 g, 42.1 mmol, 1.20 equiv) and triphenylphosphine (11.0 g, 
42.1 mmol, 1.20 equiv) in dichloromethane (180 mL) was added iodide (10.7 gg, 42.1 mmol, 
1.20 equiv) at 0 °C. After 15 min, a solution of alcohol S27 (7.80 g, 35.1 mmol, 1 equiv) in 
dichloromethane (60 mL) was added to the reaction mixture. After 30 min, the mixture was diluted 
with hexanes (200 mL) and the organic layer was washed with saturated aqueous sodium thiosulfate 
solution (200 mL). The aqueous phase was extracted with a 1:1 mixture of diethyl ether and hexanes 
(3 × 200 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (hexanes initially, grading to 10% ethyl acetate in hexanes) to give iodide 8 (9.46 g, 81%, 
E:Z = 1:1.2) as a pale yellow oil. 
To obtain analytical pure samples, alcohol (Z)-27 and alcohol (E)-27 were converted to the 
corresponding analytical pure iodides (Z)-8 and (E)-8 using the above described procedure. 
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(Z)-8:   
TLC (10% ethyl acetate in hexanes): Rf = 0.78 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.16–7.04 (m, 4H), 7.04–6.95 (m, 1H), 5.79 (q, J = 1.3 Hz, 1H), 
2.94–2.89 (m, 3H), 1.91–1.67 (m, 2H), 1.58 (d, J = 1.3 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 143.9, 137.2, 129.0, 128.4, 126.0, 117.9, 39.1, 37.6, 18.4, 18.2, 3.6. 
IR (Diamond-ATR, neat) ෤߭max: 2960 (m), 2929 (w), 2362 (w), 1538 (m), 1478 (m), 1438 (m), 1238 (w), 
1024 (m), 738 (s), 689 (m). 
[]25 D = –38.7° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C13H17127I32S [M]+: 332.0090 found: 332.0084. 
(E)-8: 
TLC (10% ethyl acetate in hexanes): Rf = 0.78 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.36–7.27 (m, 4H), 7.23–7.15 (m, 1H), 6.08 (s, 1H), 3.24–3.14 (m, 
1H), 3.11–3.00 (m, 1H), 2.60–2.45 (m, 1H), 2.02–1.79 (m, 2H), 1.77 (d, J = 1.0 Hz, 3H), 1.10 (d, J = 
6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 143.0, 136.9, 129.1, 128.4, 126.0, 117.8, 43.4, 38.2, 19.1, 14.2, 5.2. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 1582 (m), 1478 (s), 1438 (m), 1377 (w), 1236 (w), 1024 (m), 
821 (w), 737 (s), 689 (s). 
ሾࢻሿࡰ૛૙  = +7.2° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C13H17127I32S [M]+: 332.0090 found: 332.0104. 
 
 
Bromoenolether S28 
A suspension of bromoalkyne 7[179] (7.00 g, 37.4 mmol, 1 equiv), cesium carbonate (36.6 g, 
112 mmol, 3.00 equiv) and 4-methoxyphenol (6) (46.4 g, 374 mmol, 10.0 equiv) in N,N-
dimethylformamide (38 mL) was heated to 80 °C in a pressure flask. After 72 h, the reaction mixture 
was partitioned between ethyl acetate (300 mL) and water (300 mL). The layers were separated, the 
aqueous layer was extracted with ethyl acetate (2 x 300 mL), and the combined organic extracts were 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
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residue was purified by flash-column chromatography on silica gel (2% ethyl aceate in hexanes 
initially, grading to 10% ethyl acetate in hexanes) to provide bromoenol ether S28 as a yellow oil 
(6.52 g, 56%). 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.55 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.94–6.88 (m, 2H), 6.87–6.79 (m, 2H), 5.65 (t, J = 0.9 Hz, 1H), 
5.05–4.99 (m, 1H), 3.78 (s, 3H), 2.23–2.12 (m, 4H), 1.66 (s, 3H), 1.54 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 155.7, 155.5, 148.8, 133.2, 122.5, 118.6, 114.8, 90.4, 55.8, 32.2, 
25.8, 25.2, 17.8. 
IR (Diamond-ATR, neat) ෤߭max: 3333 (w), 2922 (w), 2833 (w), 1633 (m), 1547 (m), 1501 (vs), 1243 
(m), 1208 (vs), 1036 (m), 803 (s). 
HRMS (EI) calc. for C15H1879BrO2 [M–H]+: 309.0490 found: 309.0491. 
 
 
Diol 3(S)-S29 
Potassium hexacyanoferrate (III (41.4 g, 126 mmol, 6.00 equiv), potassium carbonate (17.4 g, 
126 mmol, 6.00 equiv) and (DHQ)2Phal (676 mg, 0.84 mmol, 0.04 equiv) were grinded to a fine 
powder and were added to a 1:1 mixture of t-butanol and water (210 mL). Potassium osmate (IV) 
dihydrate (61.8 mg, 0.17 mmol, 0.8 mol%) was added to the orange suspension at 23 °C. After 30 min, 
the reaction mixture was cooled to 0 °C and methanesulfonamide (3.99 g, 41.9 mmol, 2.00 equiv) was 
added in one portion followed by a solution of alkene S28 (6.52 g, 20.9 mmol, 1 equiv) in t-butanol 
(110 mL). After 5 min, the reaction mixture was allowed to warm to 23 °C. After 15 h, sodium sulfate 
(26.4 g, 209 mmol, 10.0 equiv) was added. After 30 min, 5% aqueous sodium hydroxide solution (150 
mL) was added and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% methanol in 
dichloromethane) to give diol 3(S)-S29 (6.76 g, 94%) as a yellow oil. 
 
TLC (5% MeOH in dichloromethane): Rf = 0.31 (UV; CAM). 
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1H NMR (C6D6, 800 MHz): δ = 6.87–6.82 (m, 2H), 6.67–6.63 (m, 2H), 5.47 (t, J = 0.9 Hz, 1H), 3.25 
(s, 3H), 3.00 (d, J = 10.8 Hz, 1H), 2.41–2.34 (m, 1H), 2.16–2.10 (m, 1H), 1.75 (br d, J = 3.1 Hz, 1H), 
1.48–1.43 (m, 1H), 1.26–1.20 (m, 1H), 1.02 (br s, 1H), 0.88 (s, 3H), 0.87 (s, 3H). 
13C NMR (C6D6, 201 MHz): δ = 156.0, 155.9, 149.2, 118.7, 115.1, 91.0, 77.1, 72.5, 55.1, 29.4, 28.5, 
26.4, 23.4. 
IR (Diamond-ATR, neat) ෤߭max: 3405 (w), 2972 (w), 2359 (w), 1645 (w), 1503 (vs), 1207 (s), 1034 (w), 
830 (w). 
HRMS (EI) calc. for C15H2179BrO4 [M]+: 344.0618; found: 344.0612. 
ሾࢻሿࡰ૛૙ = +18.4 (c = 1.00, CH2Cl2). 
 
 
Mosher Ester 3(S)-S30 
The enantiomeric excess of 3(S)-S29 was determined as 94% by 1H analysis of its 
corresponding mono-(S)-MTPA esters 3(S)-S30 and 3(R)-S30.    
3(R)-S30 was synthesized in an analogous fashion to 3(S)-S29 using AD-mix-. The analytical data 
obtained were in full agreement with those of 3(R)-S29. (ሾߙሿ஽ଶ଴ = –5.9 (c = 1.00, CH2Cl2)). 
 
3(S)-S30 
 
To a solution of diol 3(S)-S29 (5.00 mg, 14.5 mol, 1 equiv) and 4-dimethylaminopyridine 
(7.08 mg, 57.9 mol, 4.00 equiv) in dichloromethane (0.8 ml) was added (S)-Mosher´s acid chloride 
(5.4 L, 2.90 mol, 2.00 equiv) at 23 °C. After 1h, 4-dimethylaminopyridine (7.08 mg, 57.9 mol, 
4.00 equiv) and (S)-Mosher´s acid chloride (5.4 L, 2.90 mol, 2.00 equiv) were added. After 1h, 
water (10 mL) was added and the mixture was extracted with dichloromethane (3 × 10 mL). The 
combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(10% ethylacetate in hexanes initially, grading to 20% ethyl acetate in hexanes) to yield mono-MTPA 
ester 3(S)-S30 (3.0 mg, 37%) as a colorless oil. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.26 (UV, KMnO4). 
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1H NMR (CDCl3, 800 MHz): δ = 7.56–7.50 (m, 2H), 7.42–7.39 (m, 1H), 7.39–7.37 (m, 2H), 6.88–
6.84 (m, 2H), 6.84–6.80 (m, 2H), 5.67 (s, 1H), 4.90 (dd, J = 9.8, 2.3 Hz, 1H), 3.78 (s, 3H), 3.44 (s, 
3H), 2.27–2.21 (m, 1H), 2.20–2.14 (m, 1H), 1.96–1.89 (m, 1H), 1.75–1.65 (m, 1H), 1.40 (s, 1H), 1.12 
(s, 3H), 1.09 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 166.5, 155.7, 154.4, 148.4, 132.1, 129.9, 128.7, 127.4, 123.5 (q, J = 
290 Hz), 118.3, 114.9, 91.8, 84.6 (q, J = 27.5 Hz), 81.9, 72.4, 55.8, 55.5, 29.0, 27.4, 26.2, 24.9. 
19F NMR (CDCl3, 377 MHz): δ = –70.7. 
IR (Diamond-ATR, neat) ෤߭max: 3519 (br w), 2948 (m), 1744 (m), 1503 (vs), 1247 (m), 1206 (s), 1168 
(s), 1033 (m), 829 (w), 718 (m). 
HRMS (ESI) calc. for C25H3279BrF3NO6[M+NH4]+: 578.1360; found: 578.1364. 
ሾࢻሿࡰ૛૙ = +12.8 (c = 0.30, CH2Cl2). 
 
 
Mosher Ester 3(S)-S30 
To a solution of diol 3(R)-S29 (5.00 mg, 14.5 mol, 1 equiv) and 4-dimethylaminopyridine 
(7.08 mg, 57.9 mol, 4.00 equiv) in dichloromethane (0.8 ml) was added (S)-Mosher´s acid chloride 
(5.4 L, 2.90 mol, 2.00 equiv) at 23 °C. After 1.5 h, water (10 mL) was added and the mixture was 
extracted with dichloromethane (3 × 10 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (10% ethylacetate in hexanes initially, grading to 20% 
ethyl acetate in hexanes) to yield mono-MTPA ester 3(S)-S30 (7.1 mg, 87%) as a colorless oil. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.27 (UV, KMnO4). 
1H NMR (CDCl3, 800 MHz): δ = 7.58–7.55 (m, 2H), 7.44–7.34 (m, 3H), 6.87–6.83 (m, 2H), 6.83–
6.78 (m, 2H), 5.61 (s, 1H), 4.90 (dd, J = 10.3, 2.2 Hz, 1H), 3.77 (s, 3H), 3.47 (s, 3H), 2.17–2.12 (m, 
1H), 2.12–2.06 (m, 1H), 1.86–1.81 (m, 1H), 1.66–1.60 (m, 1H), 1.42 (s, 1H), 1.17 (s, 3H), 1.11 (s, 
3H). 
13C NMR (CDCl3, 201 MHz): δ = 167.0, 155.7, 154.4, 148.4, 132.0, 129.9, 128.7, 127.8, 123.5 (q, J = 
288.7 Hz), 118.2, 114.9, 91.7, 84.9 (q, J = 27.8 Hz), 81.7, 72.60, 55.8, 55.5, 28.7, 27.4, 26.9, 24.1. 
19F NMR (CDCl3, 377 MHz): δ = –70.7. 
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IR (Diamond-ATR, neat) ෤߭max: 3452 (br w), 2948 (w), 1743 (m), 1503 (vs), 1247 (m), 1206 (s), 1168 
(s), 1033 (m), 828 (w), 717 (m). 
HRMS (EI) calc. for C25H2879BrF3O6[M]+: 560.1016; found: 560.1002. 
ሾࢻሿࡰ૛૙ = +38.0 (c = 0.33, CH2Cl2). 
 
 
Epoxide 13 
To a solution of diol 3(S)-S29 (6.76, 19.6 mmol, 1 equiv) and pyridine (7.92 mL, 97.9 mmol, 
5.00 equiv) in dichloromethane (100 mL) was added methanesulfonyl chloride (2.23 mL, 29.4 mmol, 
1.50 equiv) dropwise at 0 °C. After 30 min, the reaction mixture was allowed to warm to 23 °C. After 
15 h, water (150 mL) was added and the layers were separated. The aqueous phase was extracted with 
dichloromethane (3 × 150 mL) and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered, the filtrate was concentrated and the residue was dried azeotropically with 
benzene (2 × 30 mL). To a solution of the crude mesylate in methanol (100 mL) was added potassium 
carbonate (5.41 g, 39.2 mmol, 2.00 equiv) at 23 °C. After 1 h, the reaction mixture was partitioned 
between water (100 mL) and dichloromethane (100 mL). The aqueous phase was extracted with 
dichloromethane (3 × 100 mL) and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes initially, grading to 20% ethyl acetate in 
hexanes) to yield epoxide 13 (4.84 g, 76%) as a yellow oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.53 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.98–6.88 (m, 2H), 6.87–6.81 (m, 2H), 5.74 (s, 1H), 3.78 (s, 3H), 
2.67 (dd, J = 7.0, 5.5 Hz, 1H), 2.47–2.36 (m, 1H), 2.35–2.25 (m, 1H), 1.79–1.68 (m, 1H), 1.68–1.57 
(m, 1H), 1.28 (s, 3H), 1.22 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 155.6, 154.9, 148.5, 118.4, 114.9, 91.1, 63.2, 58.7, 55.8, 29.0, 26.2, 
24.9, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 1645 (w), 1502 (m), 1246 (w), 1205 (m), 1034 (w), 903 (s), 829 (w), 
724 (s). 
HRMS (EI) calc. for C15H1979BrO3[M]+: 326.0512; found: 326.0509. 
ሾࢻሿࡰ૛૙ = –1.9 (c = 0.50, CH2Cl2). 
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Enolether 5 
To a solution of iodide 8 (6.34 g, 19.1 mmol, 1.30 equiv) in tetrahydrofuran (76 mL) and B-
methoxy-9-BBN (1.0 M in hexanes, 44.0 mL, 44.0 mmol, 3.00 equiv) was added a solution of t-
butyllithium (1.65 M in hexanes, 34.7 mL, 57.2 mmol, 3.90 equiv) dropwise at –78 °C. After 5 min, 
the yellow solution was allowed to warm to 23 °C upon it turned colorless again. After 30 min, the 
reaction mixture was transferred to a suspension of bromoenol ether 13 (4.80 g, 14.7 mmol, 1 equiv), 
cesium carbonate (9.56 g, 29.3 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (529 mg, 0.73 mmol, 0.05 
equiv) and SPhos (301 mg, 0.73 mmol, 0.05 equiv) in a 9:1 mixture of N,N-dimethylformamide and 
water (140 mL) and heated to 40 °C. After 2 h, water (300 mL) was added and the reaction mixture 
was extracted with ethyl acetate (3 × 250 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (200 mL), the washed organic solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (5% ethyl acetate in hexanes) to give enolether 
5 (5.61 g, 85%) as a yellow oil. 
To obtain analytical pure samples, iodides (Z)-8 and (E)-8 were coupled separately under the 
same conditions to yield (Z)-5 and (E)-5 . 
(Z)-5: 
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 7.31–7.23 (m, 4H), 7.20–7.13 (m, 1H), 6.88–6.84 (m, 2H), 6.81 (d,  
J = 9.2 Hz, 2H), 5.87 (q, J = 1.3 Hz, 1H), 5.05 (t, J = 7.3 Hz, 1H), 3.78 (s, 3H), 3.07–2.96 (m, 1H), 
2.70 (t, J = 6.3 Hz, 1H), 2.34–2.23 (m, 1H), 2.23–2.13 (m, 1H), 2.12–2.02 (m, 1H), 2.02–1.92 (m, 
1H), 1.71 (d, J = 1.4 Hz, 3H), 1.70–1.62 (m, 2H), 1.49–1.39 (m, 2H), 1.28 (s, 3H), 1.21 (s, 3H), 0.99 
(d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.4, 150.4, 146.9, 137.7, 129.0, 128.1, 125.7, 117.2, 115.9, 
115.8, 114.8, 63.8, 58.6, 55.8, 35.8, 34.6, 29.2, 26.6, 25.0, 23.3, 18.8, 18.8, 18.2. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (w), 2925 (w), 1681 (w), 1584 (w), 1503 (vs), 1377 (w), 1209 (s), 
1038 (w), 828 (w), 740 (w). 
HRMS (ESI) calc. for C28H37O332S [M+H]+: 453.2458 found: 453.2466. 
ሾࢻሿࡰ૛૙ = –13.4° (c = 1.00, CH2Cl2). 
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(E)-5: 
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 7.33–7.23 (m, 4H), 7.22–7.12 (m, 1H), 6.90–6.79 (m, 4H), 5.94 (s, 
1H), 5.03 (t, J = 7.2 Hz, 1H), 3.78 (s, 3H), 2.72 (t, J = 6.3 Hz, 1H), 2.38–2.28 (m, 2H), 2.28–2.16 (m, 
1H), 2.08–1.96 (m, 2H), 1.74 (d, J = 1.1 Hz, 3H), 1.73–1.62 (m, 2H), 1.55–1.47 (m, 1H), 1.45–1.35 
(m, 1H), 1.29 (s, 3H), 1.24 (s, 3H), 1.05 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.5, 150.3, 146.5, 137.5, 129.0, 128.1, 125.7, 117.2, 115.9, 
115.6, 114.8, 63.8, 58.6, 55.8, 42.6, 34.8, 29.2, 26.6, 25.0, 23.4, 19.7, 18.8, 14.6. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (w), 2924 (w), 1681 (w), 1583 (w), 1502 (vs), 1377 (w), 1208 (s), 
1037 (w), 827 (w), 739 (m). 
HRMS (ESI) calc. for C28H37O332S [M+H]+: 453.2458 found: 453.2466. 
ሾࢻሿࡰ૛૙ = –16.0° (c = 1.00, CH2Cl2). 
 
 
Tetracycle 17 
Note: The cyclization was carried out in two parallel 2.8 g batches. 
To a solution epoxide 5 (2.80 g, 6.19 mmol, 1 equiv) in dichloromethane (620 mL) was added 
a solution of ethylaluminum dichloride (1.0 M in hexanes, 12.4 mL, 12.4 mmol, 2.00 equiv) in 
dichloromethane (30 mL) dropwise at –78 °C over a period of 5 min. After 30 min, saturated aqueous 
potassium sodium tartrate solution (300 mL) was added and the reaction mixture was allowed to warm 
to 23 °C under vigorous stirring. Water (150 mL) was added and the layers were separated. The 
aqueous layer was extracted with dichloromethane (2 × 200 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residues were combined and purified by flash-column chromatography on silica gel (15% ethyl acetate 
in hexanes) to yield decalin 17 (4.64 g, 83%) as an off white foam. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ 7.53 (dd, J = 8.3 Hz, 1.1, 2H), 7.38–7.33 (m, 2H), 7.28–7.24 (m, 1H), 
6.75–6.68 (m, 3H), 4.36 (s, 1H), 3.65 (s, 3H), 3.31–3.24 (m, 1H), 2.09–2.04 (m, 1H), 1.87–1.80 (m, 
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1H), 1.75–1.70 (m, 2H), 1.70–1.65 (m, 1H), 1.61–1.52 (m, 3H), 1.43 (dd, J = 12.7, 3.3 Hz, 1H), 1.39–
1.32 (m, 2H), 1.23 (s, 3H), 1.07 (s, 3H), 1.04 (s, 3H), 0.79 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.3, 144.3, 140.2, 131.2, 129.5, 127.0, 124.7, 118.2, 115.7, 114.4, 
80.5, 78.2, 55.7, 55.0, 45.3, 44.5, 39.2, 33.6, 31.3, 28.6, 27.6, 26.4, 21.2, 16.8, 15.8, 15.0. 
IR (Diamond-ATR, neat) ෤߭max: 3376(br w), 2956 (m), 1494 (vs), 1438 (m), 1236 (s), 1156 (m), 1041 
(m), 808 (m), 737 (s), 691 (s). 
HRMS (EI) calc. for C28H36 O332S [M]+: 452.2380; found: 452.2370. 
ሾࢻሿࡰ૛૙ = –193.8° (c = 1.00, CH2Cl2). 
 
Lewis Acid screen: 
To a solution epoxide 5 (10.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.20 mL) was 
added a solution of the Lewis acid (Table 1, 0.44 mmol, 2.00 equiv) in dichloromethane (0.50 mL) 
dropwise at –78 °C. After the time indicated, water (10 mL) was added. The mixture was extracted 
with dichloromethane (3 × 10 mL), the combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes) to yield the tetracycle 17 or acetal 14. 
 
Table 1: Lewis acid screening. 
 
 
Entry Lewis acid Time [min] Yield 14 [%] Yield 17 [%] 
1 EtAlCl2 10 83 – 
2 Et2AlCl 150 51 39 
3 SnCl4 10 – 66* 
4 B(C6F5)3 30 – 59 
* along with inseperable impurities 
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Acetal 14 
Note: The acetal formation was carried out with pure (Z)-5 and (E)-5 separately. The 
procedure is described for (Z)-5. Diethylaluminum chloride was used instead of ethylaluminum 
dichloride. 
To a solution epoxide (Z)-5 (10.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.20 mL) was 
added a solution of diethylaluminum chloride (1.0 M in hexanes, 44.2 L, 0.44 mmol, 2.00 equiv) in 
dichloromethane (0.50 mL) dropwise at –78 °C. After 10 min, water (10 mL) was added. The mixture 
was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to yield acetal 
(Z)-14 (7.3 mg, 73%) as a colorless oil. 
 
(Z)-14: 
TLC (20% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.29 (dt, J = 7.7, 1.1 Hz, 2H), 7.25–7.22 (m, 2H), 7.14–7.11 (m, 
1H), 7.10–7.07 (m, 2H), 6.81–6.77 (m, 2H), 5.88 (q, J = 1.3 Hz, 1H), 3.77 (s, 3H), 3.68 (d, J = 5.5 Hz, 
1H), 3.09–3.02 (m, 1H), 1.96–1.88 (m, 1H), 1.77 (d, J = 1.3 Hz, 3H), 1.76–1.73 (m, 2H), 1.73–1.64 
(m, 2H), 1.58–1.55 (m, 1H), 1.42–1.37 (m, 1H), 1.37–1.33 (m, 1H), 1.29–1.23 (m, 1H), 1.05 (s, 3H), 
1.05–1.04 (m, 6H). 
13C NMR (CDCl3, 201 MHz): δ = 155.8, 148.6, 148.1, 137.9, 128.9, 128.0, 125.6, 122.5, 115.4, 114.2, 
113.2, 81.4, 56.9, 55.7, 44.6, 36.8, 35.2, 29.9, 26.3, 25.4, 24.3, 24.0, 19.3, 18.3. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 1505 (vs), 1440 (w), 1299 (w), 1243 (m), 1213 (s), 1010 (w), 
836 (m), 739 (w), 690 (w). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380 found: 452.2378. 
ሾࢻሿࡰ૛૙= +3.1° (c = 0.37, CH2Cl2). 
(E)-14: 
TLC (20% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
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1H NMR (CDCl3, 800 MHz): δ = 7.30–7.28 (m, 2H), 7.23–7.20 (m, 2H), 7.11 (tt, J = 7.0, 1.2 Hz, 1H), 
7.09–7.03 (m, 2H), 6.81–6.75 (m, 2H), 5.96 (s, 1H), 3.77 (s, 3H), 3.70 (d, J = 5.4 Hz, 1H), 2.35–2.29 
(m, 1H), 1.95–1.89 (m, 1H), 1.78 (d, J = 1.1 Hz, 3H), 1.78–1.67 (m, 4H), 1.57 (t, J = 6.9 Hz, 1H), 
1.38–1.34 (m, 2H), 1.32–1.26 (m, 1H), 1.10 (s, 3H), 1.09 (d, J = 6.8 Hz, 3H), 1.07 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 155.8, 148.5, 147.9, 137.7, 129.0, 128.1, 125.6, 122.6, 115.1, 114.2, 
113.1, 81.4, 57.0, 55.7, 44.6, 43.9, 35.3, 29.9, 26.4, 25.3, 24.4, 23.9, 19.9, 14.7. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (m), 1504 (vs), 1439 (w), 1297 (m), 1242 (m), 1212 (s), 1009 (m), 
835 (m), 738 (m), 690 (w). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380 found: 452.2374. 
ሾࢻሿࡰ૛૙= –58.7° (c = 0.32, CH2Cl2). 
 
 
Tetracycle 17 
Note: A 1:1 mixture of acetal (Z)-14 and (E)-14 was used. 
To a solution acetal 14 (7.00 mg, 15.5 mol, 1 equiv) in dichloromethane (1.5 mL) was added 
a solution of ethylaluminum dichloride (1.0 M in hexanes, 30.9 L, 30.9 mol, 2.00 equiv) in 
dichloromethane (0.3 mL) dropwise at –78 °C. After 15 min, water (10 mL) was added and the 
reaction mixture was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residues were combined and purified by flash-column chromatography on silica gel (20% ethyl acetate 
in hexanes) to yield decalin 17 (6.3 mg, 90%) as a white foam. 
 
 
Ferrocene 18 
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To a suspension of ferrocene carboxylic acid (10.0 mg, 43.5 mol, 2.00 equiv) in 
dichloromethane (1.0 mL) was added oxalyl chloride solution (2 M in dichloromethane, 23.9 L, 47.8 
mol, 2.20 equiv), followed by 1 drop of N,N-dimethylformamide at 23 °C. After 45 min, toluene (1.0 
mL) was added and the mixture was concentrated. To a solution of tetracycle 17 (10.0 mg, 22.1 mol, 
1 equiv) and 4-dimethylaminopyridine (27.0 mg, 0.22 mmol, 10.0 equiv) in dichloromethane (0.5 mL) 
was added a solution of the freshly prepared ferrocenecarboxylic acid chloride in dichloromethane (0.5 
mL) at 23 °C. After 2 h, the reaction mixture was directly purified by flash-column chromatography 
on silica gel (dichloromethane) to yield ferrocene 18 (10.2 mg, 70%) as an orange foam. 
Crystallization from diethyl ether gave crystals suitable for X-ray diffraction. 
 
TLC (dichloromethane): Rf = 0.63 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.55–7.52 (m, 2H), 7.38–7.35 (m, 2H), 7.28–7.25 (m, 1H), 6.76 (d, J 
= 8.8 Hz, 1H), 6.75–6.71 (m, 2H), 4.86–4.80 (m, 2H), 4.67 (dd, J = 11.6, 3.9 Hz, 1H), 4.43–4.38 (m, 
2H), 4.38 (s, 1H), 4.20 (s, 5H), 3.65 (s, 3H), 2.15–2.07 (m, 1H), 1.94–1.79 (m, 3H), 1.73–1.68 (m, 
2H), 1.63–1.57 (m, 3H), 1.46–1.32 (m, 1H), 1.27 (s, 6H), 1.04 (s, 3H), 0.81 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 171.5, 153.4, 144.3, 140.1, 131.3, 129.5, 127.0, 124.8, 118.2, 115.8, 
114.4, 80.4, 79.5, 72.2, 71.3, 71.2, 70.4, 70.1, 69.8, 55.7, 54.9, 45.5, 44.5, 38.2, 33.7, 31.2, 28.4, 27.6, 
23.3, 21.1, 16.8, 16.6, 15.8. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (m), 1707 (s), 1495 (s), 1459 (m), 1374 (w), 1275 (s), 1140 (s), 
1040 (m), 963 (w), 821 (w). 
HRMS (EI) calc. for C39H4456FeO432S [M]+: 664.2310 found: 664.2307. 
ሾࢻሿࡰ૛૙ = –96.6° (c = 1.00, CH2Cl2). 
 
 
Alcohol S31 
To a solution of sulfide 17 (4.50 g, 9.94 mmol, 1 equiv) in dichloromethane (45 mL) and 
triethylsilane (8.03 mL, 49.7 mmol, 5.00 equiv) was added boron trifluoride etherate (48%, 6.53 mL, 
24.9 mmol, 2.50 equiv) at 23 °C. After 15 min, saturated sodium bicarbonate solution (250 mL) was 
added and the mixture was extracted with dichloromethane (3 × 200 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
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concentrated. The residue was purified by flash-column chromatography on silica gel (20% ethyl 
acetate in hexanes initially, grading to 50% ethyl acetate in hexanes) to afford S31 (3.34 g, 97%) as a 
white solid. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
melting point: 173–175 °C 
1H NMR (CDCl3, 800 MHz): δ = 6.72 (d, J = 8.8 Hz, 1H), 6.68 (dd, J = 8.8 Hz, 3.0, 1H), 6.54 (d, J = 
3.0 Hz, 1H), 3.74 (s, 3H), 3.26 (dd, J = 11.9, 3.7 Hz, 1H), 2.59 (d, J = 17.3 Hz, 1H), 2.52 (d, J = 17.3 
Hz, 1H), 1.85–1.77 (m, 2H), 1.77–1.70 (m, 1H), 1.69–1.64 (m, 1H), 1.60–1.56 (m, 1H), 1.53–1.47 (m, 
3H), 1.41 (dd, J = 12.7, 3.5 Hz, 1H), 1.35 (br s, 1H), 1.34–1.28 (m, 1H), 1.08 (s, 3H), 1.03 (s, 3H), 
0.90 (s, 3H), 0.76 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.2, 146.3, 121.7, 117.5, 114.1, 113.3, 80.5, 78.6, 55.8, 45.5, 
39.2, 37.5, 33.9, 31.7, 30.7, 27.6, 27.1, 26.5, 21.5, 17.0, 16.2, 15.2. 
IR (Diamond-ATR, neat) ෤߭max: 3263 (br w), 2943 (m), 1499 (vs), 1430 (m), 1222 (s), 1165 (m), 1044 
(s), 933 (m), 858 (w), 800 (m). 
HRMS (EI) calc. for C22H32O3 [M]+: 344.2346; found: 344.2347. 
ሾࢻሿࡰ૛૙= –14.0° (c = 1.00, CH2Cl2). 
 
 
Thiocarbonate S32 
To a solution of alcohol S31 (3.20 g, 9.29 mmol, 1 equiv) in dichloromethane (60 mL) and 4-
dimethylaminopyridine (3.41 g, 27.9 mmol, 3.00 equiv) was added pentafluorophenyl 
chlorothionoformate (2.98 mL, 18.6 mmol, 2.00 equiv) at 0 °C. After 5 min, the reaction mixture was 
allowed to warm to 23 °C. After 2 h, saturated aqueous sodium bicarbonate solution (200 mL) was 
added and the mixture was extracted with dichloromethane (4 × 200 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (4% ethyl 
acetate in hexanes) to furnish thiocarbonate S32 (3.72 g, 70%) as a colorless solid. 
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TLC (10% ethyl acetate in hexanes): Rf = 0.59 (UV, CAM). 
melting point: 189–191 °C 
1H NMR (CDCl3, 400 MHz): δ = 6.76 (d, J = 8.8 Hz, 1H), 6.70 (dd, J = 8.8 Hz, 2.9 Hz, 1H), 6.55 (d, 
J = 2.9 Hz, 1H), 4.98 (dd, J = 11.9 , 4.0 Hz, 1H), 3.75 (s, 3H), 2.63 (d, J = 17.5 Hz, 1H), 2.53 (d, J = 
17.5 Hz, 1H), 2.04–1.95 (m, 1H), 1.94–1.78 (m, 3H), 1.74–1.66 (m, 1H), 1.64–1.50 (m, 4H), 1.42–
1.29 (m, 1H), 1.26 (s, 3H), 1.05 (s, 3H), 0.94 (s, 3H), 0.78 (d, J = 6.8 Hz, 3H). 
13C NMR (1H decoupled, CDCl3, 101 MHz): δ = 191.9, 153.4, 145.9, 142.94–139.87 (m), 141.63–
138.42 (m), 139.71–136.17 (m), 128.14–127.20 (m), 121.6, 117.6, 114.2, 113.5, 94.7, 80.0, 55.8, 45.8, 
38.9, 37.5, 33.9, 31.7, 30.4, 27.2, 26.9, 21.6, 21.2, 17.0, 16.8, 16.1. 
13C NMR (19F decoupled, CDCl3, 101 MHz): δ = 191.9 (d, J = 4.2 Hz), 141.3, 140.0, 138.1, 127.7, 
56.5, 55.1. 
19F NMR (CDCl3, 376 MHz): δ = –152.25– –152.40 (m), –157.15 (t, J = 21.7 Hz), –162.18– –162.41. 
IR (Diamond-ATR, neat) ෤߭max: 2955 (w), 1520 (vs), 1496 (s), 1311 (m), 1222 (m), 1142 (s), 997 (s), 
954 (s), 736 (w). 
HRMS (EI) calc. for C29H31F5O432S [M]+: 570.1858; found: 570.1859. 
ሾࢻሿࡰ૛૙= –41.8° (c = 1.00, CH2Cl2). 
 
 
Methoxy-5-epi-aureol S33 
A solution of thiocarbonate S32 (3.72 g, 6.52 mmol, 1 equiv), tributyltin hydride (5.27 mL, 
19.6 mmol, 3.00 equiv) and azobisisobutyronitrile (214 mg, 1.30 mmol, 0.20 equiv) in benzene (150 
mL) was heated to 80 °C in a pressure flask. After 2 h, the reaction mixture was concentrated and the 
residue was purified by flash-column chromatography on silica gel (hexanes initially, grading to 2% 
ethyl acetate in hexanes) to give S33 (1.95 g, 91%) as a white solid. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
melting point: 143–146 °C 
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1H NMR (CDCl3, 800 MHz): δ = 6.73 (d, J = 8.7 Hz, 1H), 6.67 (dd, J = 8.7, 2.9 Hz, 1H), 6.53 (d, J = 
2.9 Hz, 1H), 3.74 (s, 3H), 2.57 (d, J = 17.3 Hz, 1H), 2.53 (d, J = 17.3 Hz, 1H), 1.75–1.70 (m, 2H), 
1.69–1.63 (m, 2H), 1.56–1.54 (m, 1H), 1.50–1.45 (m, 1H), 1.45–1.41 (m, 1H), 1.38 (dd, J = 12.7, 3.5 
Hz, 1H), 1.35–1.24 (m, 3H), 1.21–1.14 (m, 1H), 1.11 (s, 3H), 0.91 (s, 3H), 0.91 (s, 3H), 0.76 (d, J = 
6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.0, 146.8, 122.0, 117.5, 114.1, 113.2, 81.2, 55.8, 45.7, 42.2, 
37.4, 33.9, 33.6, 32.8, 31.9, 30.7, 28.7, 22.6, 22.0, 18.0, 17.0, 16.4. 
IR (Diamond-ATR, neat) ෤߭max: 2936 (m), 1496 (vs), 1250 (m), 1234 (s), 1223 (s), 1171 (m), 1151 (w), 
1043 (m), 933 (w), 801 (w). 
HRMS (EI) calc. for C22H32O2 [M]+: 328.2402; found: 328.2395. 
ሾࢻሿࡰ૛૙ = +13.1 (c = 1.00, CH2Cl2). 
 
 
5-epi-Aureol (19) 
To a solution of methyl ether S33 (1.90 g, 5.78 mol, 1 equiv) in dichloromethane (55 mL) was 
added boron tribromide (1 M in hexanes, 57.8 mL, 57.8 mmol, 10.0 equiv) at –78 °C. After 10 min, 
the reaction mixture was allowed to warm to 23 °C. After 1.5 h, methanol (20 mL) was carefully 
added and the mixture was partitioned between saturated aqueous sodium bicarbonate solution (300 
mL) and dichloromethane (150 mL). The layers were separated and the aqueous layer was extracted 
with dichloromethane (2 × 150 mL). The combined organic extracts were dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-
column chromatography on silica gel (5% ethyl aceate in hexanes) to give 5-epi-aureol (19) (1.55 g, 
85%) as a colorless solid. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.46 (UV, CAM). 
melting point: 114–116 °C (reported 115–116 °C)[104] 
1H NMR (CDCl3, 800 MHz): δ = 6.67 (d, 3J18/16 = 8.6 Hz, 1H, H-18), 6.58 (dd, 3J19/18 = 8.6 Hz, 4J19/21 
= 3.0 Hz, 1H, H-19), 6.47 (d, 4J21/19 = 3.0 Hz, 1H, H-21), 4.26 (br s, 1H, OH), 2.54 (d, 2J15A/15B = 17.3 
Hz, 1H, H-15A), 2.50 (d, 2J15B/15A = 17.3 Hz, 1H, 15B), 1.75–1.69 (m, 2H; H-1A, H-6A), 1.69–1.63 (m, 
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2H, H-2A, H-8), 1.58–1.52 (m, 1H, H-6B), 1.50–1.45 (m, 1H, H-7A), 1.45–1.42 (m, 1H, H-3A), 1.38 
(dd, 3J5/6A = 12.7 Hz, 3J5/6B = 3.6 Hz, 1H, H-5), 1.35–1.24 (m, 3H, H-1B, H-2B, H-7B), 1.21–1.16 (m, 
1H, H-3B), 1.10 (s, 3H, H-11), 0.91 (s, 3H, H-12), 0.90 (s, 3H, H-14), 0.75 (d, 3J13/8 = 6.8 Hz, 3H, H-
13). 
13C NMR (CDCl3, 201 MHz): δ = 148.5 (C-20), 146.8 (C-17), 122.2 (C-16), 117.6 (C-18), 115.5 (C-
21), 114.4 (C-19), 81.2 (C-10), 45.7 (C-5), 42.2 (C-3), 37.4 (C-9), 33.7 (C-15), 33.6 (C-4), 32.8 (C-
12), 31.9 (C-8), 30.7 (C-7), 28.7 (C-1), 22.6 (C-11), 22.0 (C-6), 18.0 (C-2), 17.0 (C-14), 16.4 (C-13). 
IR (Diamond-ATR, neat) ෤߭max: 3350 (br w), 2927 (vs), 2854 (s), 1710 (w), 1495 (s), 1454 (s), 1234 (s), 
1222 (vs), 1171 (s), 965 (m), 807 (m). 
HRMS (EI) calc. for C21H30O2 [M]+: 314.2240; found: 314.2243. 
ሾࢻሿࡰ૛૙ = +10.6 (c = 1.00, CHCl3); +12.5 (c = 0.17, CHCl3; (+)-5-epi-Aureol)[105] 
 
Table 2: Comparison of 1H NMR data for reported and synthetic 5-epi-Aureol (19). 
Proton 
 
Synthetic  
(800 MHz, CDCl3) 
Marcos  
(200 MHz, CDCl3)[115] 
Δδ  
(ppm) 
v. d. Helm 
(270 MHz, CDCl3)[104]  
Δδ  
(ppm) 
1A 1.75–1.69 (m) 
2.10–1.36 (m, 12H) 
 
not reported 
 
1B 1.35–1.24   
2A 1.69–1.63 (m)   
2B 1.35–1.24 (m)   
3A 1.45–1.42 (m)   
3B 1.21–1.16 (m)   
5 1.37 (dd, 12.7, 3.6 Hz)   
6A 1.75–1.69 (m)   
6B 1.58–1.52 (m)   
7A 1.50–1.45 (m)   
7B 1.35–1.24 (m)   
8 1.69–1.63 (m)   
11 1.10 (s) 1.10 (s) ± 0.00 1.13 (s) – 0.03 
12 0.91 (s) 0.96 (s, 6H) – 0.05 0.92 (br s, 6H) – 0.01 
13 0.75 (d, 6.8 Hz) 0.75 (d, 6.8 Hz) ± 0.00 0.77 (d, 7.5 Hz) – 0.02 
14 0.90 (s) 0.96 (s, 6H) – 0.06 0.92 (br s, 6H) – 0.02 
15A 2.54 (d, 17.3 Hz) 2.52 (s, 2H) + 0.02 2.54 (s,2H) ± 0.00 15B 2.50 (d, 17.3 Hz) – 0.02 – 0.04 
18 6.67 (d, 8.6 Hz) 6.69 (d, 9.0 Hz) – 0.02 6.69 (d, 9Hz) – 0.02 
19 6.59 (dd, 8.6, 3.0 Hz) 6.60 (dd, 9.0, 3.1 Hz) – 0.01 6.60 (dd, 9.0, 3.0 Hz) – 0.01 
21 6.47 (d, 3.0 Hz) 6.49 (d, 3.1 Hz) – 0.02 6.48 (d, 3 Hz) – 0.01 
OH 4.26 (br s) 4.26 (s) ± 0.00 4.30 (br s) – 0.04 
 
 
88                     EXPERIMENTAL SECTION 
 
Bromide S34 
To a solution of 5-epi-aureol (19) (1.55 g, 4.93 mmol, 1 equiv) in chloroform (150 mL) was 
added a solution of bromide in chloroform (0.22 M, 22.7 mL, 4.93 mmol, 1.00 equiv) dropwise at –55 
°C over a period of 15 min. After 30 min, saturated aqueous sodium thiosulfate solution (100 mL) and 
saturated aqueous sodium chloride solution (100 mL) were added and the mixture was extracted with 
dichloromethane (3 × 150 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl aceate in hexanes) to give bromide S34 (1.80 g, 93%) as a 
white solid. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.47 (UV, CAM). 
melting point: 158–160 °C 
1H NMR (CDCl3, 599 MHz): δ = 6.82 (d, J = 8.8 Hz, 1H), 6.73 (d, J = 8.8 Hz, 1H), 5.11 (s, 1H), 2.71 
(d, J = 17.8 Hz, 1H), 2.31 (d, J = 17.8 Hz, 1H), 1.74–1.65 (m, 2H), 1.63–1.54 (m, 3H), 1.51–1.46 (m, 
1H), 1.45–1.42 (m, 1H), 1.40 (dd, J = 12.7, 3.6 Hz, 1H), 1.35–1.24 (m, 3H), 1.22–1.15 (m, 1H), 1.10 
(s, 3H), 0.96 (s, 3H), 0.92 (s, 3H), 0.77 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 147.0, 145.8, 121.3, 117.1, 114.0, 112.3, 81.2, 45.6, 42.1, 37.9, 
35.1, 33.6, 32.7, 32.3, 30.6, 28.5, 22.5, 21.9, 17.9, 16.9, 16.5. 
IR (Diamond-ATR, neat) ෤߭max: 3487 (w), 2952 (m), 1475 (vs), 1431 (m), 1247 (m), 1193 (m), 1170 (s), 
949 (m), 881 (w), 810 (m), 740 (w). 
HRMS (EI) calc. for C21H29O279Br [M]+: 392.1345; found: 392.1358. 
ሾࢻሿࡰ૛૙ = 9.6 (c = 1.00, CH2Cl2). 
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Methyl ether 20 
To a suspension of phenol S34 (1.77 g, 4.50 mmol, 1 equiv) and potassium carbonate (2.18 g, 
15.7 mmol, 3.50 equiv) in acetone (25 mL) was added dimethyl sulfate (1.07 mL, 11.2 mmol, 2.50 
equiv) at 23 °C. After 15 h, the reaction mixture was filtered through a plug of Celite® and the filtrate 
was concentrated. The residue was purified by flash-column chromatography on silica gel (5% ethyl 
aceate in hexanes) to give methyl ether 20 (1.60 g, 87%) as a white solid. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
melting point: 202–204 °C 
1H NMR (CDCl3, 800 MHz): δ 6.76 (d, J = 8.9 Hz, 1H), 6.74 (d, J = 8.9 Hz, 1H), 3.84 (s, 3H), 2.82 
(d, J = 17.9 Hz, 1H), 2.32 (d, J = 17.9 Hz, 1H), 1.74–1.64 (m, 2H), 1.65–1.55 (m, 3H), 1.50–1.46 (m, 
1H), 1.45–1.42 (m, 1H), 1.40 (dd, J = 12.7, 3.6 Hz, 1H), 1.36–1.26 (m, 3H), 1.21–1.16 (m, 1H), 1.11 
(s, 3H), 0.97 (s, 3H), 0.92 (s, 3H), 0.77 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 149.7, 147.7, 123.0, 115.9, 114.2, 111.3, 81.2, 57.1, 45.6, 42.1, 
37.9, 35.2, 33.6, 32.7, 32.3, 30.6, 28.6, 22.6, 21.9, 18.0, 16.9, 16.5. 
IR (Diamond-ATR, neat) ෤߭max: 2930 (m), 1476 (vs), 1435 (m), 1387 (w), 1247 (s), 1170 (m), 1069 (m), 
949 (m), 873 (w), 804 (m), 739 (w). 
HRMS (EI) calc. for C22H31O279Br [M]+: 406.1502; found: 406.1503. 
ሾࢻሿࡰ૛૙ = 5.0 (c = 1.00, CH2Cl2). 
 
 
Phenol S35 
Isopropyl pinacol borate was dried by azeotropic distillation (benzene, 2 × 20 mL) prior to use. 
To a solution of bromide 20 (1.50 g, 3.68 mmol, 1 equiv) and isopropyl pinacol borate (3.01 mL, 14.7 
mmol, 4.00 equiv) in tetrahydrofuran (37 mL) was added a solution of t-butyllithium (1.60 M in 
hexanes, 6.91 mL, 11.0 mmol, 3.00 equiv) at –78 °C. After 1.5 h, the reaction mixture was allowed to 
warm to 0 °C. After 15 min, aqueous sodium hydroxide solution (10%; 15 mL) and aquoues hydrogen 
peroxide solution (30%; 30 mL) were added and the reaction mixture was allowed to warm to 23 °C. 
After 45 min, saturated aqueous ammonium chloride solution (200 mL) was added and the mixture 
was extracted with diethyl ether (3 × 200 mL). The combined organic extracts were dried over sodium 
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sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (5% ethyl aceate in hexanes) to give phenol S35 (949 mg, 
75%) as a white solid and methyl ether S33 (259 mg, 21%) as a white solid. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (UV, CAM). 
melting point: 197–200 °C 
1H NMR (CDCl3, 800 MHz): δ = 6.67 (d, J = 8.7 Hz, 1H), 6.33 (d, J = 8.7 Hz, 1H), 5.63 (s, 1H), 3.83 
(s, 3H), 2.79 (d, J = 17.6 Hz, 1H), 2.28 (d, J = 17.6 Hz, 1H), 1.79–1.74 (m, 1H), 1.74–1.69 (m, 1H), 
1.69–1.61 (m, 2H), 1.57–1.53 (m, 1H), 1.50–1.46 (m, 1H), 1.45–1.41 (m, 1H), 1.39 (dd, J = 12.7, 3.6 
Hz, 1H), 1.35–1.25 (m, 3H), 1.22–1.16 (m, 1H), 1.11 (s, 3H), 0.95 (s, 3H), 0.91 (s, 3H), 0.77 (d, J = 
6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 147.6, 143.6, 139.5, 109.7, 109.2, 106.7, 81.0, 56.8, 45.7, 42.2, 
36.8, 33.6, 32.8, 32.2, 30.7, 28.6, 28.1, 22.6, 22.0, 18.0, 17.1, 16.6. 
IR (Diamond-ATR, neat) ෤߭max: 3526 (w), 2949 (m), 1488 (vs), 1439 (s), 1242 (vs), 1170 (s), 1040 (s), 
1027 (s), 925 (m), 795 (m), 738 (m). 
HRMS (EI) calc. for C22H32O2 [M]+: 344.2346; found: 344.2352. 
ሾࢻሿࡰ૛૙ = –3.5 (c = 1.00, CH2Cl2). 
 
 
5-epi-Smenoqualone (21) 
N,N′-Bis(salicylidene)ethylenediaminocobalt(II) (444 mg, 1.36 mmol, 0.50 equiv) was added 
to a solution of phenol S35 (940 mg, 2.73 mmol, 1 equiv) in N,N-dimethylformamide (90 mL) at 23 
°C and oxygen was bubbled through the reaction mixture for 30 min. After 30 min, water (200 mL) 
was added and the mixture was extracted with diethyl ether (4 × 200 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (30% ethyl 
acetate in hexanes) to give 5-epi-smenoqualone (21) (749 mg, 77%) as a yellow foam. Crystallization 
from diethyl ether gave 21 as yellow crystals. 
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TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
melting point: 166–167 °C 
1H NMR (CDCl3, 800 MHz): δ 5.73 (s, 1H, H-19), 3.81 (s, 3H, H-22), 2.57 (d, 2J15A/15B = 18.8 Hz, 1H, 
H-15A), 2.00 (d, 2J15B/15A = 18.8 Hz, 1H, H-15B), 1.70–1.66 (m, 1H, H-1A), 1.64–1.57 (m, 3H, H-6, H-
2A), 1.52–1.48 (m, 1H, H-7A), 1.48–1.45 (m, 1H, H-3A), 1.45–1.40 (m, 2H, H-5, H-8), 1.39–1.33 (m, 
2H, H-1B, H-2B), 1.32–1.24 (m, 1H, H-7B), 1.22–1.19 (m, 1H, H-3B), 1.17 (s, 3H, H-11), 0.95 (s, 3H, 
H-14), 0.93 (s, 3H, H-12), 0.77 (d, 3J13/8 = 6.7 Hz, 3H, H-13). 
13C NMR (CDCl3, 201 MHz): δ = 181.6 (C-18), 181.5 (C-21), 159.6 (C-20), 152.8 (C-17), 115.3 (C-
16), 105.0 (C-19), 86.6 (C-10), 56.5 (C-22), 45.8 (C5), 41.8 (C-3), 37.4 (C-9), 33.6 (C-4), 32.6 (C-12), 
32.5 (C-8), 30.4 (C-7), 29.5 (C-1), 26.8 (C-15), 22.3 (C-11), 22.0 (C-6), 17.9 (C-2), 17.0 (C-14), 16.5 
(C-13). 
IR (Diamond-ATR, neat) ෤߭max: 2942 (w), 1661 (m), 1639 (w), 1599 (vs), 1456 (w), 1353 (w), 1353 (w), 
1227 (m), 1213 (m), 1161 (w), 1049 (m), 840 (w). 
HRMS (EI) calc. for C22H30O4 [M]+: 358.2139; found: 358.2140. 
ሾࢻሿࡰ૛૙ = –83.4 (c = 1.00, CHCl3); –75.6 (c = 0.16, CHCl3; (–)-5-epi-Smenoqualone)[103]; +69.3 (c = 
0.10, CHCl3; (+)-5-epi-Smenoqualone).[115]  
 
Table 3: Comparison of 1H NMR data for reported and synthetic 5-epi-smenoqualone (21). 
Proton 
 
Synthetic  
(800 MHz, CDCl3) 
Marcos  
(200 MHz, CDCl3)[115] 
Δδ  
(ppm) 
Capon 
(400 MHz, CDCl3)[103]  
Δδ  
(ppm) 
1A 1.70–1.66 (m) 
1.98–1.36 (m, 12H) 
 
not reported 
 
1B 1.39–1.33 (m)   
2A 1.64–1.57 (m)   
2B 1.39–1.33 (m)   
3A 1.48–1.45 (m)   
3B 1.22–1.19 (m)   
5 1.45–1.40 (m)   
6 1.64–1.57 (m)   
7A 1.52–1.48 (m)   
7B 1.32–1.24 (m)   
8 1.45–1.40 (m)   
11 1.17 (s) 1.17 (s) ± 0.00 1.17 ± 0.00 
12 0.93 (s) 0.94 + 0.01 0.94 + 0.01 
13 0.77 (d, 6.7 Hz) 0.77 (d, 6.0 Hz) ± 0.00 0.77 (d, 6.0 Hz) ± 0.00 
14 0.95(s) 0.96 (s) + 0.01 0.96 + 0.01 
15A 2.57 (d, 18.8 Hz) 2.57 (d, 20.0 Hz) ± 0.00 2.57 (d, 20.0 Hz ± 0.00 
15B 2.00 (d, 18.8 Hz) 2.00 (d, 20.0 Hz) ± 0.00 2.00 (d, 20.0 Hz) ± 0.00 
19 5.73 (s) 5.74 (s) + 0.01 5.74 + 0.01 
22 3.81 (s) 3.80 (s) – 0.01 3.81 ± 0.00 
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Table 4: Comparison of 13C NMR data for reported and synthetic 5-epi-smenoqualone (21). 
Carbon Synthetic  
(201 MHz, CDCl3) 
Marcos  
(50 MHz, CDCl3)[115] 
Δδ  
(ppm) 
Capon 
(100 MHz, CDCl3)[103]  
Δδ  
(ppm) 
1 29.5 29.5* ± 0.0 29.4 + 0.1 
2 17.9 17.8 + 0.1 17.8 + 0.1 
3 41.8 41.7 + 0.1 41.7 + 0.1 
4 33.6 33.5 + 0.1 33.5 + 0.1 
5 45.8 45.5 + 0.3 45.6 + 0.2 
6 22.0 22.0 ± 0.0 21.9 + 0.1 
7 30.4 30.3* + 0.1 30.3 + 0.1 
8 32.5 32.4 + 0.1 32.4 + 0.1 
9 37.4 37.0 + 0.4 37.2 + 0.2 
10 86.6 86.5 + 0.1 86.4 + 0.2 
11 22.3 22.3 ± 0.0 22.2 + 0.1 
12 32.6 32.5 + 0.1 32.5 + 0.1 
13 16.5 16.4 + 0.1 16.4 + 0.1 
14 17.0 17.0 ± 0.0 17.0 ± 0.0 
15 26.8 26.7* + 0.1 26.7 + 0.1 
16 115.3 115.1 + 0.2 115.2 + 0.1 
17 152.8 152.5 + 0.3 152.7 + 0.1 
18 181.6 181.5 + 0.1 181.4 + 0.2 
19 105.0 105.0 ± 0.0 104.9 + 0.1 
20 159.6 159.5 + 0.1 159.5 + 0.1 
21 181.5 181.5 ± 0.0 181.5 ± 0.0 
22 56.5 56.4 + 0.1 56.4 + 0.1 
* Carbon was reassigned by us on the basis of 2D NMR studies. 
 
 
(–)-Cyclosmenospongine (1) 
To a solution of 5-epi-smenoqualone (21) (740 mg, 2.06 mmol, 1 equiv) and pyridine (60 mL) 
in aqueous methanol (50%, 500 mL) was added aqueous ammonia (25%, 60 mL) at 23 °C. After 16h, 
the reaction mixture was concentrated and the residue was extracted with diethyl ether (5 × 300 mL). 
The combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(20% ethyl acetate in hexanes initially, grading to 30% ethyl acetate in hexanes) to yield (–)-
cyclosmenospongine (1) (423 mg, 60%) as a dark red crystalline solid. Recrystallization from ether 
gave crystals suitable for X-ray diffraction. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
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melting point: 240–242 °C 
1H NMR (CDCl3, 800 MHz): δ = 5.54 (s, 1H, H-19), 5.05 (s, 2H, NH2), 2.52 (d, 2J15A/15B = 18.3 Hz, 
1H, H-15A), 1.97 (d, 2J15B/15A = 18.3 Hz, 1H, H-15B), 1.74–1.69 (m, 1H, H-1A), 1.67–1.58 (m, 3H, H-
6, H-2A), 1.52–1.44 (m, 3H, H-7A, H-8, H-3A), 1.42 (dd, 3J5/6A = 12.2 Hz, 3J5/6B = 4.1 Hz, 1H, H-5), 
1.39–1.32 (m, 2H, H-1B, H-2B), 1.32–1.25 (m, 1H, H-7B), 1.22–1.16 (m, 4H, H-3B, H-11), 0.95 (s, 3H, 
H-14), 0.93 (s, 3H, H-12), 0.78 (d, 3J13/8 = 6.6 Hz, 3H, H-13). 
13C NMR (CDCl3, 201 MHz): δ = 182.6 (C-21), 180.3 (C-18), 154.8 (C-17), 147.6 (C-20), 113.0 (C-
16), 99.5 (C-19), 86.6 (C-10), 45.8 (C-5), 41.9 (C-3), 37.3 (C-9), 33.6 (C-4), 32.6 (C-12), 32.4 (C-8), 
30.4 (C-7), 29.7 (C-1), 26.7 (C-15), 22.3 (C-11), 22.0 (C-6), 18.0 (C-2), 17.0 (C-14), 16.5 (C-13). 
IR (Diamond-ATR, neat) ෤߭max: 3452 (w), 3335 (w), 2947 (w), 1640 (w), 1595 (vs), 1456 (w), 1371 (w), 
1215 (m), 1161 (m), 979 (w), 896 (w), 732 (w). 
HRMS (EI) calc. for C21H29O3N [M]+: 343.2142; found: 343.2140. 
ሾࢻሿࡰ૛૙ = –346.6 (c = 0.12, CHCl3); –18.0 (c = 0.10, CHCl3; (–)-cyclosmenospongine).[95] 
Elemental Analysis calc. (%) for C21H29O3N: C 73.44, H 8.51, N 4.08; found: C 72.90, H 8.51, N 
3.94. 
Table 5: Comparison of 1H NMR data for natural and synthetic (–)-cyclosmenospongine (1). 
Proton 
 
Synthetic 
(800 MHz, CDCl3)* 
Natural
(300 MHz, CDCl3)[95] 
Δδ  
(ppm) 
1A 1.74–1.69 (m) 1.84 (m) – 0.12 
1B 1.39–1.32 (m) 1.49 (m) – 0.13 
2A 1.67–1.58 (m) 1.59 (m) + 0.04 
2B 1.39–1.32 (m) 1.51 (m) – 0.15 
3A 1.52–1.44 (m) 1.51 (m) – 0.03 
3B 1.22–1.16 (m) 1.25 (m) – 0.06 
5 1.42 (dd, 12.2, 4.1 Hz) 1.51 (m) – 0.09 
6 1.67–1.58 (m) 1.66 (m), 1.51 (m)   
7A 1.52–1.44 (m) 1.54 (m) – 0.06 
7B 1.32–1.25 (m) 1.29 (m) ± 0.00 
8 1.52–1.44 (m) 0.98 (m) + 0.50 
11 1.19 (s) 1.02 (s)  + 0.17 
12 0.93 (s) 0.98 (s) – 0.05 
13 0.78 (d, 6.6 Hz) 0.78 (d, 6.4 Hz) ± 0.00 
14 0.95 (s) 0.97 (s) – 0.02 
15A 2.52 (d, 18.3 Hz) 2.57 (d, 18.8 Hz) – 0.05 
15B 1.97 (d, 18.3 Hz) 2.06 (d, 18.8 Hz) – 0.09 
19 5.54 (s) 5.54 (s) ± 0.00 
NH2 5.05 (br s) 5.65 (br) – 0.50 
* acid-free CDCl3 was used for the NMR measurement. 
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Table 6: Comparison of 13C NMR data for natural and synthetic (–)-cyclosmenospongine (1). 
Carbon Synthetic  
(201 MHz, CDCl3)* 
Natural 
(76 MHz, CDCl3)[95]  
Δδ  
(ppm) 
1 29.7 29.1 + 0.6 
2 18.0 17.8 + 0.2 
3 41.9 40.9 + 1.0 
4 33.6 33.2 + 0.4 
5 45.8 45.7 + 0.1 
6 22.0 22.0 ± 0.0 
7 30.4 30.1 + 0.3 
8 32.4 32.3 + 0.1 
9 37.3 37.6 – 0.3 
10 86.6 88.6 – 2.0 
11 22.3 22.4 – 0.1 
12 32.6 32.4 + 0.2 
13 16.5 16.3 + 0.2 
14 17.0 17.1 – 0.1 
15 26.7 26.7 ± 0.0 
16 113.0 113.3 – 0.3 
17 154.8 153.6 + 1.2 
18 180.3 177.6# + 2.7 
19 99.5 98.1 + 1.4 
20 147.6 152.3 – 4.7 
21 182.6 180.5# + 2.1 
* acid-free CDCl3 was used for the NMR measurement.  
# Carbon was reassigned by us on the basis of 2D-NMR studies. 
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3.2.2. NMR studies of (–)-Cyclosmenospongine (1) 
3.2.2.1. Concentration effects: 
A 1H NMR spectrum was recorded with different amounts of (–)-cyclosmenospongine (1)     
(1 mg, 5 mg, 10 mg, 30 mg) in CDCl3 (0.7 mL). 
 
Figure 5: 1H NMR (400MHz) of (–)-cyclosmenospongine (1) at different concentrations. 
 
3.2.2.2. Addition of HCl: 
Preparation of HCl/CDCl3 solution:  
Deuterated chloroform (CDCl3) was purged with hydrogen chloride gas (freshly prepared by the slow 
dropwise addition of concentrated aqueous sulfuric acid to a vigorously stirred suspension of sodium 
chloride and concentrated aqueous hydrogen chloride solution) for 15 min. 
To a solution of (–)-cyclosmenospongine (1) (30 mg) in CDCl3 (0.5 mL) was sequentially 
added a freshly prepared HCl/CDCl3 solution (50 L, 50 L, 100 L, 100 L and 200 L). After 
every addition a 1H and 13C NMR spectrum was recorded. 
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Figure 6: 1H NMR (400 MHz) spectra of 1 after the addition of CDCl3 saturated with HCl. 
 
 
Figure 7: 13C NMR (101 MHz) spectra of 1 after the addition of CDCl3 saturated with HCl. 
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Table 7: 13C NMR shifts of 1 after the addition of CDCl3 saturated with HCl and shift differences to the reported 
spectrum of natural 1.[95]  
 
 
 
 
Figure 8: Selected carbon atoms of (–)-cyclosmenospongine (1) and the influence of protonation on their          
13C NMR shifts. 
 
Carbon
Natural    
(76 MHz, 
CDCl3)95
Synthetic  
(201 Hz, 
CDCl3)

Synthetic  
(50 L;     
101 Hz, 
CDCl3)

Synthetic  
(100 L;    
101 Hz, 
CDCl3)

Synthetic  
(200 L;    
101 Hz, 
CDCl3)

Synthetic  
(300 L;    
101 Hz, 
CDCl3)

Synthetic  
(500 L;    
101 Hz, 
CDCl3)

1 29.1 29.7 0.6 29.7 0.6 29.7 0.6 29.8 0.7 29.9 0.8 29.9 0.8
2 17.8 18.0 0.2 17.9 0.1 17.9 0.1 17.9 0.1 17.9 0.1 17.7 –0.1
3 40.9 41.9 1.0 41.8 0.9 41.7 0.8 41.7 0.8 41.6 0.7 41.4 0.5
4 33.2 33.6 0.4 33.5 0.3 33.5 0.3 33.5 0.3 33.5 0.3 33.3 0.1
5 45.7 45.8 0.1 45.7 0.0 45.7 0.0 45.7 0.0 45.7 0.0 45.6 –0.1
6 22.0 22.0 0.0 22.0 0.0 22.0 0.0 22.0 0.0 22.0 0.0 21.9 –0.1
7 30.1 30.4 0.3 30.3 0.2 30.3 0.2 30.3 0.2 30.3 0.2 30.1 0.0
8 32.3 32.4 0.1 32.3 0.0 32.4 0.1 32.4 0.1 32.5 0.2 32.4 0.1
9 37.6 37.3 –0.3 37.2 –0.4 37.3 –0.3 37.3 –0.3 37.3 –0.3 37.2 –0.4
10 88.6 86.6 –2.0 86.8 –1.8 87.1 –1.5 87.7 –0.9 88.3 –0.3 89.0 0.4
11 22.4 22.3 –0.1 22.2 –0.2 22.2 –0.2 22.2 –0.2 22.2 –0.2 22.0 –0.4
12 32.4 32.6 0.2 32.6 0.2 32.6 0.2 32.6 0.2 32.6 0.2 32.4 0.0
13 16.3 16.5 0.2 16.5 0.2 16.5 0.2 16.5 0.2 16.5 0.2 16.3 0.0
14 17.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 16.9 –0.2
15 26.7 26.7 0.0 26.6 –0.1 26.6 –0.1 26.5 –0.2 26.5 –0.2 26.4 –0.3
16 113.3 113.0 –0.3 112.8 –0.5 112.8 –0.5 112.8 –0.5 112.8 –0.5 112.7 –0.6
17 153.6 154.8 1.2 155.2 1.6 155.5 1.9 156.1 2.5 156.7 3.1 157.3 3.7
18 177.6 180.3 2.7 179.6 2.0 178.9 1.3 177.3 –0.3 175.7 –1.9 173.3 –4.3
19 98.1 99.2 1.1 98.8 0.7 98.5 0.4 97.9 –0.2 97.3 –0.8 96.3 –1.8
20 152.3 147.6 –4.7 148.9 –3.4 149.9 –2.4 151.7 –0.6 153.6 1.3 156.1 3.8
21 180.5 182.6 2.1 182.0 1.5 181.4 0.9 180.3 –0.2 179.1 –1.4 177.3 –3.2
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Figure 9: left: (–)-cyclosmenospongine (1) in CDCl3 (bright red); right: (–)-cyclosmenospongine (1) in 
HCl/CDCl3 (purple, reported as wine-red[95])  
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3.2.3. X-Ray Crystallographic Data 
The data collections were performed either on an Oxford Diffraction Xcalibur diffractometer, 
on a Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα-
radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 
1.171.33.41)[S8] was applied for the integration, scaling and multi-scan absorption correction of the 
data. The structures were solved by direct methods with SIR97[180] and refined by least-squares 
methods against F2 with SHELXL-97.[181] All non-hydrogen atoms were refined anisotropically. The 
hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further details are 
summarized in the tables at the different sections. 
 
3.2.3.1. Ferrocenecarboxylate ester 18 
 
 
 
CCDC 1499443 contains the supplementary crystallographic data for ferrocenecarboxylate ester 18. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
 
Table 8:  Ferrocenecarboxylate ester 18. 
net formula C39H44FeO4S 
Mr/g mol−1 664.65 
crystal size/mm 0.100 × 0.030 × 0.010 
T/K 153.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21 1' 
a/Å 14.3768(19) 
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b/Å 7.3244(9) 
c/Å 17.1643(19) 
α/° 90 
β/° 111.981(4) 
γ/° 90 
V/Å3 1676.0(4) 
Z 2 
calc. density/g cm−3 1.317 
μ/mm−1 0.552 
absorption correction Multi-Scan 
transmission factor range 0.6807–0.7454 
refls. measured 23821 
Rint 0.0775 
mean σ(I)/I 0.0749 
θ range 3.168–26.371 
observed refls. 5507 
x, y (weighting scheme) 0.0267, 0.3292 
hydrogen refinement constr 
Flack parameter 0.008(10) 
refls in refinement 6743 
parameters 411 
restraints 1 
R(Fobs) 0.0447 
Rw(F2) 0.0844 
S 1.039 
shift/errormax 0.001 
max electron density/e Å−3 0.317 
min electron density/e Å−3 −0.433 
 
3.2.3.2. (–)-Cyclosmenospongine (1) 
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CCDC 1499442 contains the supplementary crystallographic data (–)-Cyclosmenospongine (1). These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
 
Table 9: (–)-Cyclosmenospongine (1). 
net formula C21H29NO3 
Mr/g mol−1 343.45 
crystal size/mm 0.100 × 0.060 × 0.050 
T/K 153.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 10.7772(8) 
b/Å 11.6369(8) 
c/Å 14.6780(10) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1840.8(2) 
Z 4 
calc. density/g cm−3 1.239 
μ/mm−1 0.082 
absorption correction Multi-Scan 
transmission factor range 0.9033–0.9590 
refls. measured 42454 
Rint 0.0806 
mean σ(I)/I 0.0501 
θ range 3.358–27.484 
observed refls. 3522 
x, y (weighting scheme) 0.0379, 0.4490 
hydrogen refinement C-H: constr, N-H: refall 
Flack parameter 0.1(2) 
refls in refinement 4086 
parameters 238 
restraints 0 
R(Fobs) 0.0489 
Rw(F2) 0.0947 
S 1.074 
shift/errormax 0.001 
max electron density/e Å−3 0.232 
min electron density/e Å−3 −0.191 
 
  
102                     EXPERIMENTAL SECTION 
3.2.4. 1H and 13C NMR Spectra 
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3.3. Supporting Information for Chapter 1.4.3. 
 
 
 
 
 
Evolution of a Polyene Cyclization Cascade  
for the Total Synthesis of (–)-Cyclosmenospongine 
 
 
Reprinted with permission from: 
K. Speck, T. Magauer, Chem. Eur. J. 2016, DOI: 10.1002/chem.201605029. 
Copyright © 2016 John Wiley and Sons. 
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3.3.1. Experimental Procedures 
3.3.1.1. Synthesis of Iodides 
 
Iodide S51 
To a solution of 2-iodoethanol (25.0 g, 145 mmol, 1 equiv) in dichloromethane (360 mL) and 
imidazole (19.8 g, 291 mmol, 2.00 equiv) was added t-butyldimethylsilyl chloride (21.9 g, 145 mmol, 
1.00 equiv) at 0 °C. After 30 min, the reaction mixture was allowed to warm to 23 °C. After 2 h, the 
reaction mixture was diluted with dichloromethane (200 mL) and the organic layer was washed with 
saturated aqueous sodium bicarbonate solution (2 × 200 mL) and with saturated aqueous sodium 
chloride solution (200 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated to give iodide S51 (41.4 g, 99%) as a colorless oil. The crude 
product was directly used without further purification. Characterization data obtained for S51 were in 
full agreement with values previously reported.[176] 
 
 
(–)-(1R,2R)-pseudoephedrine propionylamide S52 
Propionic anhydride (21.2 mL, 165 mmol, 1.07 equiv) was added dropwise to a solution of        
(–)-(1R,2R)-pseudoepedrine (25.5 g, 154 mmol, 1 equiv) in tetrahydrofuran (300 mL) at 23 °C. After 
30 min, excess propionic anhydride was quenched by the addition of saturated aqueous sodium 
bicarbonate solution (150 mL). The resulting biphasic mixture was partitioned between water 
(200 mL) and ethyl acetate (250 mL). The layers were separated and the aqueous phase was extracted 
with ethyl acetate (3 × 250 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was recrystallized from 
toluene to afford amide S52 (32.1 g, 94%) as a white solid. The obtained characterization data were in 
full agreement with those reported in literature.[177] 
 
 
Amide S53 
SUPPORTING INFORMATION FOR CHAPTER 1.4.3.            131 
 
N,N-Diisopropylamime (23.0 mL, 163 mmol, 2.25 equiv) was added dropwise to a suspension 
of lithium chloride (18.4 g, 434 mmol, 6.00 equiv) in tetrahydrofuran (72 mL) at 23 °C and the 
resulting suspension was cooled to –78 °C. A solution of n-butyllithium (2.52 M in hexanes, 60.3 mL, 
152 mmol, 2.10 equiv) was added via syringe. The reaction mixture was briefly warmed to 0 °C for 
5 min, then cooled to –78 °C. An ice-cooled solution of amide S52 (16.0 g, 72.3 mmol, 1 equiv) in 
tetrahydrofuran (180 mL) was added by cannula onto the inner wall of the flask. The transfer was 
quantitated with tetrahydrofuran (15 mL). The reaction mixture was stirred at –78 °C for 1 h, at 0 °C 
for 15 min and at 23 °C for 5 min. Then the reaction mixture was cooled to 0 °C, whereupon iodide 
S51 (41.4 g, 145 mmol, 2.00 equiv) was added. Stirring was continued at 23 °C for 3.5 h. Saturated 
aqueous ammonium chloride solution (20 mL) was added to the ice-cold product mixture. The 
biphasic mixture was partitioned between ethyl acetate (200 mL) and aqueous hydrochloric acid 
solution (1 M, 150 mL). The layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 200 mL). The combined organic extracts were washed with saturated aqueous sodium 
chloride solution (150 mL), the washed organic solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (40% ethyl acetate in hexanes initially, grading to 50% ethyl acetate in 
hexanes) to give amide S53 (22.8 g, 83%) as a viscous yellow oil. Characterization data obtained for 
S53 were in full agreement with previously reported values.[177]  
 
 
Ketone 19 
Amide S53 was dried by azeotropic distillation (benzene, 2 × 40 mL) prior to use. To a 
solution of S53 (22.8 g, 60.1 mmol, 1 equiv) in diethyl ether (400 mL) was added a solution of 
methyllithium (1.60 M in diethyl ether, 97.6 mL, 156 mmol, 2.60 equiv) via syringe at –78 °C. The 
reaction mixture was allowed to warm to 0 °C. After 45 min, excess methyllithium was quenched at 
0 °C by the addition of N,N-diisopropylamine (8.49 mL, 60.1 mmol, 1.00 equiv). A solution of acetic 
acid in diethyl ether (20% v/v, 75 mL) was added and the reaction mixture (pH = 6 to 7) was 
partitioned between diethyl ether (100 mL) and water (200 mL). The aqueous phase was separated and 
extracted with diethyl ether (3 × 200 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (hexanes initially, grading to 10% ethyl acetate in hexanes) 
to provide ketone 19 (11.9 g, 83%) as a colorless oil. The obtained characterization data were in full 
agreement with those reported in literature.[177]  
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Alkene S54 
To a suspension of methyltriphenylphosphonium bromide (29.5 g, 82.5 mmol, 2.00 equiv) in 
tetrahydrofuran (160 mL) was added potassium t-butoxide (6.94 g, 61.8 mmol, 1.50 equiv) at 0 °C. 
The yellow suspension was stirred for 30 min at 0 °C and then 10 min at 23 °C. The suspension was 
cooled to 0 °C and a solution of ketone 19 (9.50 g, 41.2 mmol, 1 equiv) in tetrahydrofuran (80 mL) 
was added dropwise. Stirring was continued for 10 min at 0 °C, then the reaction mixture was allowed 
to warm to 23 °C. After 1 h, the mixture was diluted with a mixture of hexane and diethyl ether (1:1, 
50 mL) and saturated aqueous ammonium chloride solution (20 mL) was added. The aqueous layer 
was separated and extracted with a mixture of hexane and diethyl ether (1:1, 3 × 10 mL). The organic 
layers were combined and dried over sodium sulfate. The dried solution was filtered through a plug of 
silica gel and the filtrate was concentrated. The residue was suspended in hexane and the mixture was 
filtered through a pad of Celite (the filtration was repeated twice). The filtrate was concentrated and 
the residue was purified by flash-column chromatography on silica gel (hexanes) to provide alkene 
S54 (8.60 g, 91%) as a colorless oil. 
TLC (hexane), Rf = 0.50 (CAM). 
1H NMR (CDCl3, 599 MHz): δ = 4.69–4.67 (m, 2H), 3.58–3.54 (m, 2H), 2.35–2.22 (m, 1H), 1.66 (t, 
J = 1.1 Hz, 3H), 1.66–1.58 (m, 1H), 1.52–1.45 (m, 1H), 1.01 (d, J = 7.0 Hz, 3H), 0.89 (s, 9H), 0.04 (s, 
6H). 
13C NMR (CDCl3, 151 MHz): δ = 150.0, 109.5, 61.7, 38.1, 37.7, 26.1, 19.9, 19.2, 18.5, –5.1,   –5.1.  
IR (Diamond-ATR, neat) ෤߭max: 2928 (w), 2857 (w), 1472 (w), 1255 (m), 1100 (m), 884 (m), 833 (s), 
773 (s). 
ሾࢻሿࡰ૛૙ = + 0.60° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C13H27O28Si [M–H]+: 227.1837 found: 227.1830. 
 
 
Alcohol S55 
To a solution of the alkene S54 (8.20 g, 35.9 mmol, 1 equiv) in acetonitrile (40 mL) was added 
triethylamine trihydrofluoride (10.3 mL, 62.9 mmol, 1.75 equiv) at 23 °C to give a colorless solution. 
After 18 h, the reaction mixture was diluted with diethyl ether (200 mL) and saturated aqueous sodium 
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bicarbonate solution (150 mL) and saturated aqueous sodium chloride solution (150 mL) were added. 
The aqueous layer was separated and extracted with diethyl ether (8 × 80 mL). The combined organic 
layers were washed with saturated aqueous sodium chloride solution (80 mL). The washed solution 
was dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated at 
23 °C (300 mbar). The residue was purified by flash-column chromatography (20% diethyl ether in 
pentane initially, grading to 50% diethyl ether in pentane) to yield alcohol S55 (3.90 g, 95%) as a 
colorless oil. 
TLC (40% ethyl acetate in hexane), Rf = 0.63 (CAM). 
1H NMR (CDCl3, 400 MHz): δ = 4.77–4.67 (m, 2H), 3.62 (t, J = 6.7 Hz, 2H), 2.43–2.25 (m, 1H), 
1.72–1.63 (m, 4H), 1.67–1.50 (m, 1H), 1.37 (s, 1H), 1.04 (d, J = 7.0 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 150.1, 110.0, 61.7, 38.3, 37.7, 19.9, 18.9. 
IR (Diamond-ATR, neat) ෤߭max: 3327 (br w), 2961 (m), 2932 (m), 1645 (m), 1455 (m), 1375 (m), 
1050(s), 1000 (s), 886 (s). 
ሾࢻሿࡰ૛૙ = + 1.90° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C7H14O [M]+: 114.1039 found: 114.1043. 
 
 
Iodide 15 
To a solution of S55 (1.00 g, 8.76 mmol, 1 equiv), imidazole (0.76 g, 10.5 mmol, 1.20 equiv) 
and triphenylphosphine (2.76 g, 10.5 mmol, 1.20 equiv) in dichloromethane (40 mL) was added iodine 
(2.67 g, 10.5 mmol, 1.20 equiv) at 0 °C. After 5 min, the reaction mixture was allowed to warm to 
23 °C. After 30 min, the mixture was diluted with pentane (200 mL) and the organic layer was washed 
with water (2 × 100 mL) and saturated aqueous sodium chloride solution (100 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (pentane) to give 
15 (1.58 g, 81%) as a colorless oil. 
TLC (hexane), Rf = 0.76 (CAM). 
1H NMR (CDCl3, 400 MHz): δ = 4.76 (dq, J = 1.1, 0.3 Hz, 2H), 3.24–3.00 (m, 2H), 2.41–2.22 (m, 
1H), 2.00–1.71 (m, 2H), 1.66 (t, J = 1.1 Hz, 3H), 1.03 (d, J = 6.9 Hz, 3H).  
13C NMR (CDCl3, 101 MHz): δ = 148.0, 111.0, 42.0, 38.7, 19.2, 18.8, 5.2. 
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IR (Diamond-ATR, neat) ෤߭max: 2961 (m), 1644 (m), 1453 (m), 1435 (m), 1375 (m), 1235 (m), 1175 (s), 
890 (vs). 
ሾࢻሿࡰ૛૙ = +15.6° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C7H13127I [M]+: 224.0056 found: 224.0051. 
 
 
Trimethyl((phenylthio)methyl)silane S56 
Peterson reagent S56 was prepared according to the procedure described by D. J. Ager[178]. 
To a solution of n-butyllithium (2.52 M in hexanes, 34.7 mL, 87.4 mmol, 1.01 equiv) in diethyl ether 
(30 mL) was added thioanisole (10.2 mL, 86.6 mmol, 1 equiv) at 23 °C, then the mixture was heated 
to 50 °C. After 16 h, the reaction mixture was allowed to cool to 23 °C, chlorotrimethylsilane (13.3 
mL, 104 mmol, 1.20 equiv) was added dropwise to the now white suspension and heated to 50 °C. 
After 1 h, the reaction mixture was allowed to cool to 23 °C and poured into saturated aqueous 
ammonium chloride solution (40 mL). The layers were separated and the aqueous phase was extracted 
with diethyl ether (3 × 20 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by distillation to 
give sulfide S56 (13.7 g, 81%) as a colorless oil (boiling point: 125–128 °C, 20 mbar). The obtained 
analytical data were in full agreement with those reported in literature.[178]  
 
 
Vinylsulfide S57 
To a solution of Peterson reagent S57 (11.9 g, 60.8 mmol, 1.40 equiv) in tetrahydrofuran 
(100 mL) was added a solution of n-butyllithium (2.45 M in hexanes, 23.9 mL, 58.6 mmol, 
1.35 equiv) at 0 °C. After 30 min, a solution of ketone 19 (10.0 g, 43.4 mmol, 1 equiv) in 
tetrahydrofuran (50 mL) was added and stirring was continued at 0 °C. After 30 min, the reaction 
mixture was allowed to warm to 23 °C. After 5 h, the reaction mixture was diluted with diethyl ether 
(100 mL) and the organic layer was washed with saturated aqueous ammonium chloride solution 
(200 mL). The aqueous phase was extracted with diethyl ether (2 × 200 mL) and the combinded 
organic extracts were washed with saturated aqueous sodium chloride solution (200 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (hexanes 
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initially, grading to 2% ethyl acetate in hexanes) to provide vinylsulfide S57 as an inseparable mixture 
of double bond isomers (12.6 g, 86%, E:Z = 2:3) as a colorless oil. 
TLC (5% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): (Z): δ = 7.33–7.24 (m, 4H), 7.20–7.12 (m, 1H), 5.89 (q, J = 1.2 Hz, 1H), 
3.66–3.49 (m, 2H), 3.19–3.04 (m, 1H), 1.78 (d, J = 1.3 Hz, 3H), 1.73–1.49 (m, 2H), 1.04 (d, 
J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H); (E): δ = 7.32–7.22 (m, 4H), 7.19–7.13 (m, 
1H), 5.98–5.95 (m, 1H), 3.68–3.48 (m, 2H), 2.58–2.43 (m, 1H), 1.79 (d, J = 1.1 Hz, 3H), 1.74–1.51 
(m, 2H), 1.08 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 3H), 0.05 (s, 3H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 146.6, 137.7, 129.0, 128.1, 125.7, 115.8, 61.8, 37.8, 33.0, 26.1, 
19.0, 18.5, 18.4, –5.1, –5.1; (E): δ = 146.5, 137.5, 129.0, 128.1, 125.8, 115.6, 61.4, 39.3, 38.0, 26.1, 
19.7, 18.5, 14.7, –5.1, –5.1. 
IR (Diamond-ATR, neat) ෤߭max: 2955 (m), 2927 (m), 2855 (m), 1584 (w), 1479 (m), 1251 (m), 1090 (s), 
833 (vs), 773 (vs), 736 (vs), 689 (vs). 
HRMS (EI) calc. for C19H32O32S28Si [M]+: 336.1938 found: 336.1933. 
 
 
Alcohol S58 
To a solution of silylether S57 (12.5 g, 37.3 mmol, 1 equiv) in acetonitrile (120 mL) was 
added triethylamine trihydrofluoride (10.6 mL, 65.2 mmol, 1.75 equiv) at 23 °C. After 8 h, the 
reaction mixture was portioned between diethyl ether (150 mL) and a 1:1 mixture of saturated aqueous 
sodium bicarbonate solution (200 mL) and saturated aqueous sodium chloride solution (200 mL). The 
aqueous layer was extracted with diethyl ether (3 × 200 mL). The combined organic layers were dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the residue 
was purified by flash-column chromatography (30% ethyl acetate in hexanes) to yield alcohol S58 
(7.87 g, 95%, E:Z = 1:1.5) as a colorless oil. 
An analytical sample was purified by flash-column chromatography (10% ethyl acetate in 
hexanes) to give pure alcohol (Z)-58 and alcohol (E)-58 as colorless oils. Note: Since the double bond 
geometry is inconsequential for the subsequent steps the following transformations were performed 
using the mixture of double bond isomers. 
(Z)-S58: 
TLC (40% ethyl acetate in hexane): Rf = 0.38 (UV, KMnO4). 
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1H NMR (CDCl3, 400 MHz): δ = 7.37–7.26 (m, 4H), 7.24–7.17 (m, 1H), 5.96 (q, J = 1.4 Hz, 1H), 
3.71–3.54 (m, 2H), 3.29–3.09 (m, 1H), 1.91 (s, 1H), 1.79 (d, J = 1.3 Hz, 3H), 1.74–1.59 (m, 2H), 1.10 
(d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 145.4, 136.9, 129.0, 128.4, 126.0, 116.5, 61.2, 37.4, 32.7, 19.0, 
18.1. 
IR (Diamond-ATR, neat) ෤߭max: 3340 (br w), 2958 (w), 2930 (w), 2870 (w), 1582 (m), 1478 (m), 
1438(m), 1046 (s), 1024 (m), 809 (m), 735 (vs), 688 (vs). 
HRMS (EI) calc. for C13H18O32S [M]+: 222.1073 found: 222.1070. 
ሾࢻሿࡰ૛૙ = + 45.8° (c = 1.00, CH2Cl2). 
(E)-S58: 
TLC (40% ethyl acetate in hexane): Rf = 0.31 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.34–7.27 (m, 4H), 7.21–7.14 (m, 1H), 6.02–6.00 (m, 1H), 3.64 (td, 
J = 6.8, 1.2 Hz, 2H), 2.59–2.45 (m, 1H), 1.80 (d, J = 1.1 Hz, 3H), 1.78–1.68 (m, 1H), 1.68–1.57 (m, 
1H), 1.36 (br s, 1H), 1.10 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 145.5, 137.1, 129.1, 128.3, 125.9, 116.3, 61.4, 39.6, 37.7, 19.8, 
14.6. 
IR (Diamond-ATR, neat) ෤߭max: 3324 (br w), 2958 (m), 2928 (m), 2870 (w), 1582 (m), 1478 (s), 1438 
(m), 1376 (w), 1047 (s), 816 (m), 736 (vs), 689 (s). 
HRMS (EI) calc. for C13H18O32S [M]+: 222.1073 found: 222.1072. 
ሾࢻሿࡰ૛૙ = + 5.4° (c = 1.00, CH2Cl2). 
 
 
Iodide S59 
To a solution of imidazole (2.87 g, 42.1 mmol, 1.20 equiv) and triphenylphosphine (11.0 g, 
42.1 mmol, 1.20 equiv) in dichloromethane (180 mL) was added iodine (10.7 g, 42.1 mmol, 
1.20 equiv) at 0 °C. After 15 min, a solution of alcohol S58 (7.80 g, 35.1 mmol, 1 equiv) in 
dichloromethane (60 mL) was added to the reaction mixture. After 30 min, the mixture was diluted 
with hexanes (200 mL) and the organic layer was washed with saturated aqueous sodium thiosulfate 
solution (200 mL). The aqueous phase was extracted with a mixture of diethyl ether and hexanes (1:1, 
3 × 200 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
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on silica gel (hexanes initially, grading to 10% ethyl acetate in hexanes) to give iodide S59 (9.46 g, 
81%, E:Z = 1:1.2) as a pale yellow oil. 
To obtain analytical pure samples, alcohol (Z)-S58 and alcohol (E)-S58 were converted to the 
corresponding analytical pure iodides (Z)-S59 and (E)-S59 using the above described procedure. 
(Z)-S59:  
TLC (10% ethyl acetate in hexanes): Rf = 0.78 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.16–7.04 (m, 4H), 7.04–6.95 (m, 1H), 5.79 (q, J = 1.3 Hz, 1H), 
2.94–2.89 (m, 3H), 1.91–1.67 (m, 2H), 1.58 (d, J = 1.3 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 143.9, 137.2, 129.0, 128.4, 126.0, 117.9, 39.1, 37.6, 18.4, 18.2, 3.6. 
IR (Diamond-ATR, neat) ෤߭max: 2960 (m), 2929 (w), 2362 (w), 1538 (m), 1478 (m), 1438 (m), 1238 (w), 
1024 (m), 738 (s), 689 (m). 
ሾࢻሿࡰ૛૙ = –38.7° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C13H17127I32S [M]+: 332.0090 found: 332.0084. 
(E)-S59: 
TLC (10% ethyl acetate in hexanes): Rf = 0.78 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.36–7.27 (m, 4H), 7.23–7.15 (m, 1H), 6.08 (s, 1H), 3.24–3.14 (m, 
1H), 3.11–3.00 (m, 1H), 2.60–2.45 (m, 1H), 2.02–1.79 (m, 2H), 1.77 (d, J = 1.0 Hz, 3H), 1.10 (d, 
J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 143.0, 136.9, 129.1, 128.4, 126.0, 117.8, 43.4, 38.2, 19.1, 14.2, 5.2. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 1582 (m), 1478 (s), 1438 (m), 1377 (w), 1236 (w), 1024 (m), 
821 (w), 737 (s), 689 (s). 
ሾࢻሿࡰ૛૙ = +7.2° (c = 1.00, CHCl3). 
HRMS (EI) calc. for C13H17127I32S [M]+: 332.0090 found: 332.0104. 
 
 
Aldehyde S60 
Ethyl acetate (0.88 mL, 8.96 mmol, 3.40 equiv) was added dropwise to a suspension of lithium 
aluminum hydride (230 mg, 6.06 mmol, 2.30 equiv) in hexanes (16 mL) at 0 °C over a period of 
30 min. After 1 h, the reaction mixture was cooled to –78 °C and a solution of amide S53 (1.00 g, 
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2.63 mmol, 1 equiv) in tetrahydrofuran (10 mL) was added dropwise within 5 min. After 10 min, the 
reaction was allowed to warm to 0 °C. After 2 h, the reaction mixture was transferred to a solution of 
trifluoroacetic acid (1.96 mL, 26.3 mmol, 10.0 equiv) in aqueous hydrogen chloride solution (1 N, 
40 mL). The transfer was quantitated with tetrahydrofuran (10 mL) and the biphasic mixture was 
stirred at 23 °C. After 5 min, the mixture was diluted with aqueous hydrogen chloride solution 
(60 mL) and diethyl ether (100 mL). The layers were separted and the aqueous phase was extracted 
with diethyl ether (2 × 100 mL). The combined organic extracts were washed with saturated aqueous 
sodium bicarbonate solution (100 mL) and the washed solution was dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford aldehyde S60 (379 mg, 66%) as 
a colorless oil. The obtained analytical data were in full agreement with the data previously 
reported.[182] 
 
 
Vinylsulfide S61 
To a solution of Peterson reagent S56 (462 mg, 2.35 mmol, 1.50 equiv) in tetrahydrofuran 
(4 mL) was added a solution of n-butyllithium (2.34 M in hexanes, 0.97 mL, 2.28 mmol, 1.45 equiv) 
at 0 °C. After 30 min, a solution of aldehyde S60 (340 mg, 1.57 mmol, 1 equiv) in tetrahydrofuran (2 
mL) was added and stirring was continued at 0 °C. After 30 min, the reaction mixture was allowed to 
warm to 23 °C. After 1.5 h, the reaction mixture was diluted with diethyl ether (20 mL) and the 
organic layer was washed with saturated aqueous ammonium chloride solution (20 mL). The aqueous 
phase was extracted with diethyl ether (2 × 40 mL) and the combinded organic extracts were washed 
with saturated aqueous sodium chloride solution (50 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (1% ethyl acetate in hexanes initially grading to 2% ethyl 
acetate in hexanes) to provide vinylsulfide S61 as an inseparable mixture of double bond isomers 
(415 mg, 82%, E:Z = 1:1.5) as a colorless oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.37 (UV, KMnO4). 
1H NMR (CDCl3, 599 MHz): (Z): δ = 7.36–7.27 (m, 4H), 7.21–7.15 (m, 1H), 6.14 (dd, J = 9.2, 
0.7 Hz, 1H), 5.66–5.57 (m, 1H), 3.71–3.57 (m, 2H), 2.85–2.77 (m, 1H), 1.69–1.49 (m, 2H), 1.05 (d, 
J = 6.7 Hz, 3H), 0.90 (s, 9H), 0.05 (s, 6H); (E): δ = 7.36–7.28 (m, 4H), 7.21–7.15 (m, 1H), 6.11 (dd, 
J = 15.0, 1.0 Hz, 1H), 5.88 (dd, J = 15.0, 8.1 Hz, 1H), 3.69–3.60 (m, 2H), 2.53–2.44 (m, 1H), 1.67–
1.52 (m, 2H), 1.06 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H). 
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13C NMR (CDCl3, 151 MHz): (Z): δ = 139.1, 136.8, 129.1, 128.9, 126.2, 121.8, 61.6, 40.2, 30.9, 26.1, 
20.7, 18.5, –5.1, –5.1; (E): δ = 142.7, 136.7, 129.1, 128.6, 126.2, 119.9, 61.1, 39.7, 34.2, 26.1, 20.5, 
18.5, –5.1, –5.1. 
IR (Diamond-ATR, neat) ෤߭max: 2955 (m), 2927 (m), 2856 (w), 1584 (m), 1471 (m), 1253 (m), 1094 
(vs), 833 (vs), 773 (vs), 736 (vs), 688i (s). 
HRMS (EI) calc. for C18H30O32S28Si [M]+: 322.1781 found: 322.1799. 
 
 
Alcohol S62 
To a solution of the silylether S61 (400 mg, 1.24 mmol, 1 equiv) in acetonitrile (4 mL) was 
added triethylamine trihydrofluoride (0.35 mL, 2.17 mmol, 1.75 equiv) at 23 °C. After 6 h, the 
reaction mixture was portioned between diethyl ether (30 mL) and a 1:1 mixture of saturated aqueous 
sodium bicarbonate solution (20 mL) and saturated aqueous sodium chloride solution (20 mL). The 
aqueous layer was extracted with diethyl ether (2 × 30 mL). The combined organic layers were dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the residue 
was purified by flash-column chromatography (30% ethyl acetate in hexanes) to yield alcohol S62 
(233 mg, 90%, E:Z = 1:1.5) as a colorless oil. 
TLC (20% ethyl acetate in hexane), Rf = 0.22 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): (E): δ = 7.38–7.27 (m, 4H), 7.24–7.17 (m, 1H), 6.17 (dd, J = 15.0, 
0.9  Hz, 1H), 5.86 (dd, J = 15.0, 8.2 Hz, 1H), 3.73–3.64 (m, 2H), 2.54–2.45 (m, 1H), 1.66–1.58 (m, 
2H), 1.23 (br s, 1H), 1.09 (d, J = 6.8 Hz, 3H); (Z): δ = 7.39–7.26 (m, 4H), 7.24–7.16 (m, 1H), 6.19 (dd, 
J = 9.2, 0.7 Hz, 1H), 5.68–5.55 (m, 1H), 3.74–3.64 (m, 2H), 2.94–2.80 (m, 1H), 1.80–1.67 (m, 1H), 
1.58–1.48 (m, 1H), 1.23 (br s, 1H), 1.08 (d, J = 6.7 Hz, 3H) 
13C NMR (CDCl3, 101 MHz): (Z): δ = 138.4, 136.1, 129.2, 128.8, 126.6, 122.6, 61.3, 39.9, 30.9, 20.9; 
(E): δ = 141.6, 136.4, 129.1, 126.6, 126.4, 120.6, 61.1, 39.6, 34.5, 20.6. 
IR (Diamond-ATR, neat) ෤߭max: 3339 (br w), 2957 (m), 2926 (m), 1583 (m), 1478 (m), 1439 (m), 
1050(m), 956 (w), 737 (s), 689 (s). 
HRMS (EI) calc. for C12H16O32S [M]+: 208.0916 found: 208.0918. 
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Iodide S63 
To a solution of imidazole (84.5 mg, 1.24 mmol, 1.20 equiv) and triphenylphosphine (326 mg, 
1.24 mmol, 1.20 equiv) in dichloromethane (4.8 mL) was added iodine (315 mg, 1.24 mmol, 
1.20 equiv) at 0 °C. After 15 min, a solution of alcohol S62 (230 mg, 1.03 mmol, 1 equiv) in 
dichloromethane (2.0 mL) was added to the reaction mixture. After 40 min, the mixture was diluted 
with hexanes (40 mL) and the organic layer was washed with saturated aqueous sodium thiosulfate 
solution (40 mL). The aqueous phase was extracted with hexanes (3 × 40 mL) and diethyl ether (3 × 
40 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was filtered 
and the filtrate was concentrated. The residue was purified by flash-column chromatography on silica 
gel (10% ethyl acetate in hexanes) to give S63 (331 mg, 96%) as a pale yellow oil 
TLC (10% ethyl acetate in hexanes), Rf = 0.63 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): (E): δ = 7.31–7.21 (m, 4H), 7.17–7.11 (m, 1H), 6.22–6.14 (m, 1H), 5.66 
(dd, J = 15.0, 8.5 Hz, 1H), 3.23–3.00 (m, 2H), 2.47–2.34 (m, 1H), 1.98–1.69 (m, 2H), 1.01 (d, J = 6.9 
Hz, 3H); (Z): δ = 7.31–7.21 (m, 4H), 7.17–7.11 (m, 1H), 6.22–6.14 (m, 1H), 5.51–5.44 (m, 1H), 3.23–
3.00 (m, 2H), 2.81–2.67(m, 1H), 1.98–1.69 (m, 2H), 0.99 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 136.7, 136.3, 129.2, 129.2, 126.5, 123.9, 41.3, 35.5, 20.1, 3.9; 
(E): δ = 139.4, 136.1, 129.2, 129.0, 126.5, 122.0, 40.0, 38.6, 20.1, 5.0. 
IR (Diamond-ATR, neat) ෤߭max: 2957 (m), 2926 (m), 1583 (m), 1478 (m), 1438 (m), 1024 (m), 737 (s), 
689 (s). 
HRMS (EI) calc. for C12H15127I32S [M]+: 317.9934 found: 317.9945. 
 
 
Furan S64 
Furan S64 was prepared according to the procedure described by A. G. Fallis.[183]   
To a solution of diphenyldisulfide (9.51 g, 43.5 mmol, 0.50 equiv) and pyridine (50 L) in acetonitrile 
(150 mL) was added sulfuryl chloride (3.60 mL, 44.4 mmol, 0.51 equiv) dropwise at 0 °C. After 
20 min, the orange solution was added to a solution of 4-penten-1-ol (7.50 g, 87.1 mmol, 1 equiv) in 
acetonitrile (150 mL) at 23 °C. After 1 h, a solution of N,N-diisopropylethylamine (18.1 mL, 
104 mmol, 1.20 equiv) in acetonitrile (75 mL) was added dropwise to the reaction mixture. After 
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30 min, the reaction mixture was concentrated and the residue was extracted with diethyl ether 
(400 mL). The organic extract was washed with water (3 × 300 mL) and saturated aqueous ammonium 
chloride solution (2 × 200 mL). The washed solution was dried over sodium sulfate, the dried solution 
was filtred and the filtrate was concentrated. The residue was purified by distillation to yield furan S64 
(11.5 g, 68%) as a yellow oil (boiling point 144 °C, 7 mbar). The obtained characterization data were 
in full agreement with those reported in literature.[183] 
 
 
Alcohol S65 
Alcohol S64 was prepared according to the procedure described by A. G. Fallis.[183]   
To a solution of tetrahydrofuran S64 (11.5 g, 59.4 mmol, 1 equiv) in tetrahydrofuran (60 mL) was 
added a solution of n-butyllithium (2.40 M in hexanes, 29.7 mL, 71.3 mmol, 1.20 equiv) dropwise at 0 
°C within 30 min. After 45 min, water (100 mL) was added and the mixture was extracted with diethyl 
ether (4 × 100 mL). The combined organic extracts were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The residue was purified by bulb-to-bulb distillation 
(Set up: 1st bulb filled with crude product, 2nd outside the heating device as trap at 23 °C, 3rd bulb 
cooled to 0 °C, mantle temperature 270 °C, high vacuum < 1 mbar) to give alcohol S65 (9.76 g, 85%; 
E:Z = 1.4:1) as a yellow oil. The obtained characterization data were in full agreement with those 
reported in literature.[183]  
 
 
Iodide S66 
To a solution of imidazole (4.08 g, 59.9 mmol, 1.20 equiv) and triphenylphosphine (15.7 g, 
59.9 mmol, 1.20 equiv) in dichloromethane (260 mL) was added iodine (15.2 g, 59.9 mmol, 
1.20 equiv) at 0 °C. After 25 min, a solution of alcohol S65 (9.70 mg, 49.9 mmol, 1 equiv) in 
dichloromethane (20 mL) was added to the reaction mixture. After 40 min, the mixture was diluted 
with hexanes (300 mL) and the organic layer was washed with saturated aqueous sodium thiosulfate 
solution (300 mL). The aqueous phase was extracted with hexanes (2 × 300 mL). The combined 
organic extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% ethyl 
acetate in hexanes initially, grading to 10% ethyl acetate in hexanes) to give iodide S66 (14.2 g, 94%) 
as a pale yellow oil. 
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TLC (10% ethyl acetate in hexanes), Rf = 0.71 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): (Z): δ = 7.40–7.28 (m, 4H), 7.25–7.16 (m, 1H), 6.31–6.20 (m, 1H), 5.76 
(dt, J = 9.3, 7.3 Hz, 1H), 3.27–3.15 (m, 2H), 2.42–2.34 (m, 2H), 2.04–1.97 (m, 2H); (E): δ = 7.40–7.28 
(m, 4H), 7.25–7.16 (m, 1H), 6.31–6.20 (m, 1H), 5.87 (dt, J = 15.0, 7.1 Hz, 1H), 3.27–3.15 (m, 2H), 
2.34–2.24 (m, 2H), 1.97–1.89 (m, 2H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 136.1, 130.5, 129.2, 129.0, 126.5, 125.0, 33.0, 30.2, 5.9; 
(E): δ = 136.0, 133.6, 129.2, 129.0, 126.5, 123.4, 33.7, 32.5, 6.2. 
IR (Diamond-ATR, neat) ෤߭max: 3057 (w), 3006 (w), 2930 (w), 2836 (w), 1583 (m), 1478 (s), 1438 (s), 
1205 (vs), 1166 (m), 945 (m), 737 (vs), 689 (vs). 
HRMS (EI) calc. for C11H13127I32S [M]+: 303.9777 found: 303.9782. 
 
3.3.1.2. Synthesis of Bromoenol Ethers 
 
Bromoenol ether S67 
A suspension of bromoalkyne 14[179] (7.00 g, 37.4 mmol, 1 equiv), cesium carbonate (36.6 g, 
112 mmol, 3.00 equiv) and 4-methoxyphenol (46.4 g, 374 mmol, 10.0 equiv) in N,N-dimethyl-
formamide (38 mL) was heated to 80 °C in a pressure flask. After 2 d, the reaction mixture was 
partitioned between ethyl acetate (300 mL) and water (300 mL). The layers were separated, the 
aqueous layer was extracted with ethyl acetate (2 × 300 mL), and the combined organic extracts were 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash-column chromatography on silica gel (2% ethyl aceate in hexanes 
initially, grading to 15% ethyl acetate in hexanes) to provide bromoenol ether S67 as a yellow oil 
(6.20 g, 53%). 
TLC (10% ethyl acetate in hexanes), Rf = 0.55 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.94–6.88 (m, 2H), 6.87–6.79 (m, 2H), 5.65 (t, J = 0.9 Hz, 1H), 
5.05–4.99 (m, 1H), 3.78 (s, 3H), 2.23–2.12 (m, 4H), 1.66 (s, 3H), 1.54 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 155.7, 155.5, 148.8, 133.2, 122.5, 118.6, 114.8, 90.4, 55.8, 32.2, 
25.8, 25.2, 17.8. 
IR (Diamond-ATR, neat) ෤߭max: 3333 (w), 2922 (w), 2833 (w), 1633 (m), 1547 (m), 1501 (vs), 1243 
(m), 1208 (vs), 1036 (m), 803 (s). 
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HRMS (EI) calc. for C10H1879BrO2 [M–H]+: 309.0490 found: 309.0491. 
 
 
Diol (3R)-S68 
Potassium hexacyanoferrate (III) (39.4 g, 120 mmol, 6.00 equiv), potassium carbonate (16.5 g, 
120 mmol, 6.00 equiv) and (DHQD)2Phal (621 mg, 0.80 mmol, 0.04 equiv) were grinded to a fine 
powder and were added to a mixture of t-butanol and water (1:1, 200 mL). Potassium osmate (VI) 
dihydrate (58.7 mg, 0.16 mmol, 0.8 mol%) was added to the orange suspension at 23 °C. After 30 min, 
the reaction mixture was cooled to 0 °C and methanesulfonamide (3.79 g, 39.8 mmol, 2.00 equiv) was 
added in one portion followed by a solution of alkene S67 (6.20 g, 19.9 mmol, 1 equiv) in t-butanol 
(100 mL). After 5 min, the reaction mixture was allowed to warm to 23 °C. After 18 h, sodium sulfite 
(25.1 g, 199 mmol, 10.0 equiv) was added. After 30 min, aqueous sodium hydroxide solution (5%, 
300 mL) was added and the mixture was extracted with ethyl acetate (3 × 300 mL). The combined 
organic extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% methanol in 
dichloromethane) to give diol (3R)-S68 (6.07g, 88%) as a yellow oil. 
TLC (5% MeOH in dichloromethane), Rf = 0.31 (UV; CAM). 
1H NMR (C6D6, 800 MHz): δ = 6.87–6.82 (m, 2H), 6.67–6.63 (m, 2H), 5.47 (t, J = 0.9 Hz, 1H), 3.25 
(s, 3H), 3.00 (d, J = 10.8 Hz, 1H), 2.41–2.34 (m, 1H), 2.16–2.10 (m, 1H), 1.75 (br d, J = 3.1 Hz, 1H), 
1.48–1.43 (m, 1H), 1.26–1.20 (m, 1H), 1.02 (br s, 1H), 0.88 (s, 3H), 0.87 (s, 3H). 
13C NMR (C6D6, 201 MHz): δ = 156.0, 155.9, 149.2, 118.7, 115.1, 91.0, 77.1, 72.5, 55.1, 29.4, 28.5, 
26.4, 23.4. 
IR (Diamond-ATR, neat) ෤߭max: 3405 (w), 2972 (w), 2359 (w), 1645 (w), 1503 (vs), 1207 (s), 1034 (w), 
830 (w). 
HRMS (EI) calc. for C15H2179BrO4 [M]+: 344.0618; found: 344.0612. 
ሾࢻሿࡰ૛૙ = –5.9 (c = 1.00, CH2Cl2). 
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Diol (3S)-S68 
Potassium hexacyanoferrate (III) (41.4 g, 126 mmol, 6.00 equiv), potassium carbonate (17.4 g, 
126 mmol, 6.00 equiv) and (DHQ)2Phal (676 mg, 0.84 mmol, 0.04 equiv) were grinded to a fine 
powder and were added to a mixture of t-butanol and water (1:1, 210 mL). Potassium osmate (VI) 
dihydrate (61.8 mg, 0.17 mmol, 0.8 mol%) was added to the orange suspension at 23 °C. After 30 min, 
the reaction mixture was cooled to 0 °C and methanesulfonamide (3.99 g, 41.9 mmol, 2.00 equiv) was 
added in one portion followed by a solution of alkene S67 (6.52 g, 20.9 mmol, 1 equiv) in t-butanol 
(110 mL). After 5 min, the reaction mixture was allowed to warm to 23 °C. After 15 h, sodium sulfite 
(26.4 g, 209 mmol, 10.0 equiv) was added. After 30 min, aqueous sodium hydroxide solution (5%, 
150 mL) was added and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined 
organic extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% methanol in 
dichloromethane) to give diol (3S)-S68 (6.76 g, 94%) as a yellow oil. The obtained characterization 
data were in full agreement with those of (3R)-S68. 
ሾࢻሿࡰ૛૙ = +18.4 (c = 1.00, CH2Cl2). 
 
 
Mosher Ester (3R)-S69 
The enantiomeric excess of (3S)-S68 was determined as 67% by 1H analysis of its 
corresponding mono-(S)-MTPA esters (3S)-S69 and 3(3R)-S69.  
To a solution of diol (3R)-S68 (5.00 mg, 14.5 mol, 1 equiv) and 4-dimethylaminopyridine 
(7.08 mg, 57.9 mol, 4.00 equiv) in dichloromethane (0.8 ml) was added (S)-Mosher´s acid chloride 
(5.4 L, 2.90 mol, 2.00 equiv) at 23 °C. After 1.5 h, water (10 mL) was added and the mixture was 
extracted with dichloromethane (3 × 10 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
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flash-column chromatography on silica gel (10% ethylacetate in hexanes initially, grading to 20% 
ethyl acetate in hexanes) to yield mono-MTPA ester (3S)-S69 (7.1 mg, 87%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.27 (UV, KMnO4). 
1H NMR (CDCl3, 800 MHz): δ = 7.58–7.55 (m, 2H), 7.44–7.34 (m, 3H), 6.87–6.83 (m, 2H), 6.83–
6.78 (m, 2H), 5.61 (s, 1H), 4.90 (dd, J = 10.3, 2.2 Hz, 1H), 3.77 (s, 3H), 3.47 (s, 3H), 2.17–2.12 (m, 
1H), 2.12–2.06 (m, 1H), 1.86–1.81 (m, 1H), 1.66–1.60 (m, 1H), 1.42 (s, 1H), 1.17 (s, 3H), 1.11 (s, 
3H). 
13C NMR (CDCl3, 201 MHz): δ = 167.0, 155.7, 154.4, 148.4, 132.0, 129.9, 128.7, 127.8, 123.5 (q, J = 
288.7 Hz), 118.2, 114.9, 91.7, 84.9 (q, J = 27.8 Hz), 81.7, 72.60, 55.8, 55.5, 28.7, 27.4, 26.9, 24.1. 
19F NMR (CDCl3, 377 MHz): δ = –70.7. 
IR (Diamond-ATR, neat) ෤߭max: 3452 (br w), 2948 (w), 1743 (m), 1503 (vs), 1247 (m), 1206 (s), 1168 
(s), 1033 (m), 828 (w), 717 (m). 
HRMS (EI) calc. for C25H2879BrF3O6 [M]+: 560.1016; found: 560.1002. 
ሾࢻሿࡰ૛૙ = +38.0 (c = 0.33, CH2Cl2). 
 
 
Mosher Ester (3S)-S69 
The enantiomeric excess of (3S)-S68 was determined as 94% by 1H analysis of its 
corresponding mono-(S)-MTPA esters (3S)-S69 and (3R)-S69.   
To a solution of diol (3S)-S68 (5.00 mg, 14.5 mol, 1 equiv) and 4-dimethylaminopyridine 
(7.08 mg, 57.9 mol, 4.00 equiv) in dichloromethane (0.8 ml) was added (S)-Mosher´s acid chloride 
(5.4 L, 2.90 mol, 2.00 equiv) at 23 °C. After 1h, 4-dimethylaminopyridine (7.08 mg, 57.9 mol, 
4.00 equiv) and (S)-Mosher´s acid chloride (5.4 L, 2.90 mol, 2.00 equiv) were added. After 1h, 
water (10 mL) was added and the mixture was extracted with dichloromethane (3 × 10 mL). The 
combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(10% ethylacetate in hexanes initially, grading to 20% ethyl acetate in hexanes) to yield mono-MTPA 
ester (3S)-S69 (3.0 mg, 37%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.26 (UV, KMnO4). 
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1H NMR (CDCl3, 800 MHz): δ = 7.56–7.50 (m, 2H), 7.42–7.39 (m, 1H), 7.39–7.37 (m, 2H), 6.88–
6.84 (m, 2H), 6.84–6.80 (m, 2H), 5.67 (s, 1H), 4.90 (dd, J = 9.8, 2.3 Hz, 1H), 3.78 (s, 3H), 3.44 (s, 
3H), 2.27–2.21 (m, 1H), 2.20–2.14 (m, 1H), 1.96–1.89 (m, 1H), 1.75–1.65 (m, 1H), 1.40 (s, 1H), 1.12 
(s, 3H), 1.09 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 166.5, 155.7, 154.4, 148.4, 132.1, 129.9, 128.7, 127.4, 123.5 (q, J = 
290 Hz), 118.3, 114.9, 91.8, 84.6 (q, J = 27.5 Hz), 81.9, 72.4, 55.8, 55.5, 29.0, 27.4, 26.2, 24.9. 
19F NMR (CDCl3, 377 MHz): δ = –70.7. 
IR (Diamond-ATR, neat) ෤߭max: 3519 (br w), 2948 (m), 1744 (m), 1503 (vs), 1247 (m), 1206 (s), 1168 
(s), 1033 (m), 829 (w), 718 (m). 
HRMS (ESI) calc. for C25H3279BrF3NO6 [M+NH4]+: 578.1360; found: 578.1364. 
ሾࢻሿࡰ૛૙ = +12.8 (c = 0.30, CH2Cl2). 
 
 
Epoxide (3S)-20 
To a solution of diol (3R)-S68 (6.07 g, 17.6 mmol, 1 equiv) and pyridine (7.11 mL, 
87.9 mmol, 5.00 equiv) in dichloromethane (79 mL) was added methanesulfonyl chloride (2.04 mL, 
26.4 mmol, 1.50 equiv) dropwise at 0 °C. After 10 min, the reaction mixture was allowed to warm to 
23 °C. After 19 h, water (150 mL) was added and the phases were separated. The aqueous phase was 
extracted with dichloromethane (3 × 150 mL) and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, the filtrate was concentrated and the residue dried by 
azeotropic distillation with benzene (2 × 30 mL).  
To a solution of the crude mesylate in methanol (80 mL) was added potassium carbonate 
(4.86 g, 35.2 mmol, 2.00 equiv) at 23 °C. After 2.5 h, the reaction mixture was partitioned between 
water (100 mL) and dichloromethane (100 mL). The aqueous phase was extracted with 
dichloromethane (3 × 100 mL) and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (15% ethyl acetate in hexane) to yield epoxide (3S)-20 (4.63 g, 81%) as 
a yellow oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.53 (UV, KMnO4). 
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1H NMR (CDCl3, 400 MHz): δ = 6.98–6.88 (m, 2H), 6.87–6.81 (m, 2H), 5.74 (s, 1H), 3.78 (s, 3H), 
2.67 (dd, J = 7.0, 5.5 Hz, 1H), 2.47–2.36 (m, 1H), 2.35–2.25 (m, 1H), 1.79–1.68 (m, 1H), 1.68–1.57 
(m, 1H), 1.28 (s, 3H), 1.22 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 155.6, 154.9, 148.5, 118.4, 114.9, 91.1, 63.2, 58.7, 55.8, 29.0, 26.2, 
24.9, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 1645 (w), 1502 (m), 1246 (w), 1205 (m), 1034 (w), 903 (s), 829 (w), 
724 (s). 
HRMS (EI) calc. for C15H1979BrO3 [M]+: 326.0512; found: 326.0509. 
ሾࢻሿࡰ૛૙ = +0.5 (c = 1.00, CH2Cl2). 
 
 
Epoxide (3R)-20 
To a solution of diol (3S)-S68 (6.76 g, 19.6 mmol, 1 equiv) and pyridine (7.92 mL, 
97.9 mmol, 5.00 equiv) in dichloromethane (100 mL) was added methanesulfonyl chloride (2.23 mL, 
29.4 mmol, 1.50 equiv) dropwise at 0 °C. After 30 min, the reaction mixture was allowed to warm to 
23 °C. After 15 h, water (150 mL) was added and the layers were separated. The aqueous phase was 
extracted with dichloromethane (3 × 150 mL) and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, the filtrate was concentrated and the residue was dried 
by azeotropic distillation with benzene (2 × 30 mL).  
To a solution of the crude mesylate in methanol (100 mL) was added potassium carbonate 
(5.41 g, 39.2 mmol, 2.00 equiv) at 23 °C. After 1 h, the reaction mixture was partitioned between 
water (100 mL) and dichloromethane (100 mL). The aqueous phase was extracted with 
dichloromethane (3 × 100 mL) and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes initially, grading to 20% ethyl acetate in 
hexanes) to yield epoxide (3R)-20 (4.84 g, 76%) as a yellow oil. The obtained characterization data 
were in full agreement with those of (3S)-20. 
ሾࢻሿࡰ૛૙ = –1.9 (c = 0.50, CH2Cl2). 
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3.3.1.3. Synthesis of Cylization Precursors and Cyclization Studies 
O
Br
20
O
Me
I+ OO
Me15 12
OMe OMe
HH
i) 15, t-BuLi, B-OMe-9-BBN,
THF, –78 23 °C
ii) SPhos Pd G2, Cs2CO3,
DMF/H2O, 40 °C
(72%)
 
Enol Ether 12 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.  
To a solution of iodide 15 (178 mg, 0.90 mmol, 1.30 equiv) in tetrahydrofuran (3.2 mL) and               
B-methoxy-9-BBN (1.00 M in hexanes, 1.83 mL, 1.83 mmol, 3.00 equiv) was added a solution of       
t-butyllithium (1.70 M in pentane, 1.40 mL, 2.38 mmol, 3.90 equiv) dropwise a –78 °C. After 5 min, 
the yellow solution solution was allowed to warm to 23 °C upon it turned colorless again. After 
15 min, the reaction mixture was transferred to a suspension of bromoenol ether 20 (200 mg, 
0.61 mmol, 1 equiv), cesium carbonate (398 mg, 1.22 mmol, 2.00 equiv), SPhos Pd G2 precatalyst 
(22.0 mg, 0.03 mmol, 0.05 equiv) and SPhos (12.5 mg, 0.03 mmol, 0.05 equiv) in a mixture of           
N,N-dimethylformamide and water (9:1, 6.0 mL) and heated to 40 °C. After 1 h, water (75 mL) was 
added the mixture was extracted with ethyl acetate (3 × 75 mL). The combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue 
was purified by flash-column chromatography on silica gel (initially 5% ethyl acetate in hexanes, 
grading to 10% ethyl acetate in hexanes) to furnish enol ether 12 (152 mg, 72%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, Anis). 
1H NMR (CDCl3, 599 MHz): δ = 6.93–6.74 (m, 4H), 5.01 (t, J = 7.3 Hz, 1H), 4.65–4.63 (m, 2H), 3.77 
(s, 3H), 2.70 (t, J = 6.3 Hz, 1H), 2.33–2.25 (m, 1H), 2.22–2.16 (m, 1H), 2.15–2.09 (m, 1H), 2.02–1.96 
(m, 2H), 1.72–1.63 (m, 2H), 1.61 (t, J = 1.2 Hz, 3H), 1.47–1.40 (m, 1H), 1.35–1.29 (m, 1H), 1.28 (s, 
3H), 1.23 (s, 3H), 0.96 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 154.6, 150.4, 150.2, 150.0, 117.2, 116.3, 114.8, 109.6, 63.8, 58.6, 
55.9, 40.9, 35.0, 29.2, 26.6, 25.0, 23.3, 19.7, 19.1, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 2960 (w), 1682 (w), 1503 (vs), 1442 (w), 1377 (w), 1296 (w), 1209 (s), 
1038 (m), 888 (w), 828 (w). 
HRMS (EI) calc. for C22H32O3 [M]+: 344.2346; found: 344.2345. 
ሾࢻሿࡰ૛૙ = 0.0° (c = 0.60, CHCl3). 
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Acetal 21  
To a solution of epoxide 12 (9.5 mg, 0.03 mmol, 1 equiv) in dichloromethane (3.0 mL) was 
added a solution of diethylaluminumchloride solution (1.00 M in hexanes, 82.7 L, 0.08 mol, 3.00 
equiv) in dichloromethane (0.5 mL) dropwise onto the inner wall of the flask at –78 °C. After 45 min, 
saturated aquoues ammonium chloride solution (10 mL) was added and the reaction mixture was 
extracted with dichloromethane (3 × 10 mL), the combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to yield acetal 21 (7.7 mg, 
81%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): δ = 7.16–7.01 (m, 2H), 6.86–6.74 (m, 2H), 4.73–4.64 (m, 2H), 3.77 (s, 
3H), 3.72–3.62 (m, 1H), 2.21–2.09 (m, 1H), 1.96–1.87 (m, 1H), 1.78–1.63 (m, 6H), 1.57–1.53 (m, 
1H), 1.53–1.38 (m, 2H), 1.36–1.17 (m, 2H), 1.08 (s, 3H), 1.06 (s, 3H), 1.02 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 155.7, 150.5, 148.6, 122.5, 114.2, 113.1, 109.4, 81.4, 57.1, 55.7, 
44.6, 42.0, 35.4, 30.0, 26.5, 25.3, 24.0, 23.9, 19.8, 19.3. 
IR (Diamond-ATR, neat) ෤߭max: 2960 (m), 1505 (vs), 1463 (w), 1299 (w), 1213 (s), 1037 (w), 1009 (m), 
886 (w), 836 (m), 751 (w). 
HRMS (ESI) calc. for C22H33O3 [M+H]+: 345.2424; found: 345.2424. 
ሾࢻሿࡰ૛૙ = –29.0° (c = 0.39, CH2Cl2). 
 
 
Ketone 22  
To a solution of epoxide 21 (15.0 mg, 0.04 mmol, 1 equiv) in dichloromethane (4.5 mL) was 
added a solution of tris(pentafluorophenyl)borane (33.4 mg, 0.07 mmol, 1.50 equiv) in 
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dichloromethane (1.0 mL) dropwise onto the inner wall of the flask at –78 °C. After 30 min, water 
(10 mL) was added and the reaction mixture was extracted with dichloromethane (3 × 10 mL), the 
combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(20% ethyl acetate in hexanes) to yield ketone 22 (5.6 mg, 54%) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.13 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 4.68 (s, 2H), 3.78 (dd, J = 10.9, 4.4 Hz, 1H), 2.43–2.35 (m, 2H), 
2.18–2.10 (m, 2H), 2.02 (dd, J = 10.3, 1.9 Hz, 1H), 1.87–1.77 (m, 1H), 1.75–1.65 (m, 1H), 1.64 (s, 
3H), 1.55 (s, 1H), 1.41–1.29 (m, 1H), 1.27–1.15 (m, 1H), 1.10 (s, 3H), 1.08–1.03 (m, 1H), 1.00 (d, J = 
6.9 Hz, 3H), 0.70 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 211.2, 150.2, 109.6, 76.2, 58.8, 43.7, 41.7, 39.4, 34.8, 31.0, 26.0, 
21.3, 19.8, 19.1, 14.9. 
IR (Diamond-ATR, neat) ෤߭max: 3399 (br s), 2963 (s), 1703 (vs), 1644 (m), 1456 (m), 1368 (m), 1163 
(w), 1030 (m), 1014 (m), 887 (s). 
HRMS (EI) calc. for C15H27O2 [M+H]+: 239.2006; found: 239.2005. 
ሾࢻሿࡰ૛૙ = +19.2° (c = 0.28, CH2Cl2). 
 
 
Enol ether 23 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.  
To a solution of 5-iodopentene[184] (27.0 mg, 0.14 mmol, 1.50 equiv) in tetrahydrofuran (0.55 mL) and 
B-methoxy-9-BBN (1.00 M in hexanes, 0.32 mL, 0.32 mmol, 3.50 equiv) was added a solution of t-
butyllithium (1.70 M in pentane, 0.243 mL, 0.413 mmol, 4.50 equiv) dropwise at –78 °C. After 5 min, 
the yellow solution solution was allowed to warm to 23 °C upon it turned colorless again. After 15 
min, the reaction mixture was transferred to a suspension of bromoenol ether 20 (30 mg, 0.09 mmol, 1 
equiv), cesium carbonate (59.7 mg, 018 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (3.3 mg, 4.58 
mol, 0.05 equiv) and SPhos (1.9 mg, 4.58 mol, 0.05 equiv) in a mixture of N,N-dimethylformamide 
and water (9:1, 0.9 mL) and heated to 40 °C. After 3 d, water (20 mL) was added the mixture was 
extracted with ethyl acetate (3 × 20 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
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flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to furnish epoxide 23 
(9.9 mg, 34%) as a pale yellow oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.44 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 6.93–6.76 (m, 4H), 5.90–5.74 (m, 1H), 5.12–4.91 (m, 3H), 3.80 (s, 
3H), 2.73 (t, J = 6.2 Hz, 1H), 2.37–2.28 (m, 1H), 2.27–2.17 (m, 1H), 2.15–2.01 (m, 4H), 1.77–1.63 
(m, 2H), 1.53–1.41 (m, 2H), 1.31 (s, 3H), 1.25 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.3, 150.3, 138.8, 117.2, 116.1, 114.8, 114.6, 63.8, 58.6, 
55.8, 33.6, 29.2, 29.0, 26.6, 25.0, 24.8, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 2924 (w), 1683 (w), 1501 (vs), 1441 (w), 1206 (s), 1036 (m), 909 (m), 
826 (m), 730 (w). 
HRMS (EI) calc. for C20H28O3 [M]+: 316.2038; found: 316.2033. 
ሾࢻሿࡰ૛૙ = –12.1° (c = 0.50, CH2Cl2). 
 
 
Enol ether 24 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.  
To a solution of iodide S59 (152 mg, 0.92 mmol, 1.50 equiv) in tetrahydrofuran (1.2 mL) and B-
methoxy-9-BBN (1.00 M in hexanes, 1.07 mL, 1..07 mmol, 3.50 equiv) was added a solution of          
t-butyllithium (1.60 M in pentane, 0.86 mL, 1.38 mmol, 4.50 equiv) dropwise at –78 °C. After 5 min, 
the yellow solution was allowed to warm to 23 °C upon it turned colorless again. After 15 min, the 
reaction mixture was transferred to a suspension of bromoenol ether 20 (100 mg, 0.31 mmol, 1 equiv), 
cesium carbonate (199 mg, 0.61 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (11.0 mg, 0.02 mmol, 
0.05 equiv) and SPhos (6.3 mg, 0.02 mmol, 0.05 equiv) in a mixture of N,N-dimethylformamide and 
water (9:1, 3.1 mL) and heated to 40 °C. After 2 h, the reaction mixture was diluted with ethyl acetate 
(50 mL) and filtered through a plug of celite. The organic layer was washed with water (50 mL) and 
the aqueous phase was extracted with ethyl acetate (2 × 50 mL). The combined organic extracts were 
washed with saturated aqueous sodium chloride solution (50 mL), the washed organic solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue 
was purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to give 
epoxide 24 (123 mg, 89%) as a yellow oil. 
152                     EXPERIMENTAL SECTION 
To obtain analytical pure samples, iodides (Z)-S59 and (E)-S59 were coupled separately under the 
same conditions to yield (Z)-24 and (E)-24. 
(Z)-24: 
TLC (10% ethyl acetate in hexanes), Rf = 0.26 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 7.39–7.20 (m, 4H), 7.18–7.11 (m, 1H), 6.91–6.74 (m, 4H), 5.86 (q, 
J = 1.3 Hz, 1H), 5.04 (t, J = 7.3 Hz, 1H), 3.77 (s, 3H), 3.08–2.91 (m, 1H), 2.69 (t, J = 6.3 Hz, 1H), 
2.34–2.21 (m, 1H), 2.22–2.11 (m, 1H), 2.10–1.88 (m, 2H), 1.71 (d, J = 1.4 Hz, 3H), 1.69–1.57 (m, 
2H), 1.52–1.34 (m, 2H), 1.27 (s, 3H), 1.21 (s, 3H), 0.98 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.4, 150.4, 146.9, 137.7, 129.0, 128.1, 125.7, 117.3, 115.8, 
115.8, 114.8, 63.8, 58.6, 55.8, 35.8, 34.6, 29.2, 26.6, 25.0, 23.3, 18.8, 18.8, 18.2. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 2925 (m), 1584 (w), 1503 (vs), 1440 (m), 1209 (s), 1037 (m), 
828 (m), 740 (m). 
HRMS (EI) calc. for C28H36 O332S [M]+: 452.2380; found: 452.2385. 
ሾࢻሿࡰ૛૙ = –15.6° (c = 1.00, CH2Cl2) 
(E)-24: 
TLC (10% ethyl acetate in hexanes), Rf = 0.26 (UV, Anis). 
1H NMR (CDCl3, 800 MHz): δ = 7.29–7.21 (m, 4H), 7.17–7.12 (m, 1H), 6.85–6.83 (m, 2H), 6.82–
6.79 (m, 2H), 5.93–5.92 (m, 1H), 5.02 (t, J = 7.3 Hz, 1H), 3.76 (s, 3H), 2.70 (t, J = 6.3 Hz, 1H), 2.34–
2.27 (m, 2H), 2.23–2.17 (m, 1H), 2.05–1.99 (m, 2H), 1.73 (d, J = 1.1 Hz, 3H), 1.72–1.61 (m, 2H), 
1.54–1.47 (m, 1H), 1.43–1.35 (m, 1H), 1.28 (s, 3H), 1.22 (s, 3H), 1.03 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 154.7, 150.5, 150.4, 146.5, 137.5, 129.0, 128.2, 125.7, 117.2, 115.8, 
115.7, 114.8, 63.8, 58.6, 55.8, 42.6, 34.9, 29.3, 26.6, 25.0, 23.4, 19.6, 18.8, 14.6. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (m), 2924 (m), 1583 (w), 1501 (vs), 1439 (m), 1206 (vs), 1036 
(m), 826 (m), 737 (m). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380; found: 452.2381. 
ሾࢻሿࡰ૛૙ = –14.6° (c = 1.00, CH2Cl2) 
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Cyclization Studies of Enol ether 24: 
To a solution of epoxide 24 (20.0 mg, 0.04 mmol, 1 equiv) in dichloromethane (4.5 mL) was 
added a solution of Lewis acid (Table 1, 0.09 mmol, 2.00 equiv) in dichloromethane (0.5 mL) 
dropwise onto the inner wall of the flask at –78 °C. After the time indicated, water (10 mL) was added. 
The mixture was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue 
was purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to yield the 
products indicated in Table 1. 
 
Table 10: Conditions tested for the cyclization of 24. 
Entry Lewis acid Solvent T[°C] Yield S70 [%] 
Yield S71 
[%] 
Yield S72 
[%] 
Yield S73 
[%] 
Yield S74 
[%] 
1 EtAlCl2 CH2Cl2 –78 10 – 59 – – 
2 BF3•Et2O MTBE –78 to 0 – – – 62 3 
3 B(C6F5)3 CH2Cl2 23 9 – – – 32 
4 B(C6F5)3 CH2Cl2 –78 45 12 – – – 
 
Acetal S70: 
TLC (20% ethyl acetate in hexanes), Rf = 0.52 (UV, KMnO4). 
1H NMR (CDCl3, 599 MHz): δ = 7.32–7.29 (m, 2H), 7.26–7.21 (m, 2H), 7.14–7.11 (m, 1H), 7.08–
7.04 (m, 2H), 6.80–6.76 (m, 2H), 5.91 (q, J = 1.3 Hz, 1H), 3.77 (s, 3H), 3.69–3.67 (m, 1H), 3.09–3.01 
(m, 1H), 1.95–1.89 (m, 1H), 1.79 (d, J = 1.3 Hz, 3H), 1.78–1.74 (m, 1H), 1.73–1.65 (m, 2H), 1.64–
1.56 (m, 2H), 1.50–1.41 (m, 1H), 1.35–1.30 (m, 1H), 1.30–1.23 (m, 1H), 1.10 (s, 3H), 1.07 (s, 3H), 
1.04 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 155.8, 148.6, 147.6, 137.8, 129.0, 128.2, 125.6, 122.6, 115.6, 114.2, 
113.0, 81.4, 56.5, 55.7, 44.6, 36.4, 34.7, 29.9, 26.5, 25.3, 23.9, 23.9, 18.9, 18.5. 
154                     EXPERIMENTAL SECTION 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 1584 (w), 1505 (vs), 1439 (w), 1299 (w), 1214 (s), 1010 (w), 
836 (w), 739 (w), 690 (w). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380; found: 455.2383. 
ሾࢻሿࡰ૛૙ = –41.4° (c = 0.45, CH2Cl2). 
Enol ether S71: 
TLC (20% ethyl acetate in hexanes), Rf = 0.15 (UV, KMnO4). 
1H NMR (CDCl3, 800 MHz): δ = 7.32–7.26 (m, 4H), 7.18–7.14 (m, 1H), 6.92–6.89 (m, 2H), 6.85–
6.82 (m, 2H), 5.91 (d, J = 1.4 Hz, 1H), 4.47–4.45 (m, 1H), 3.78 (s, 3H), 3.54–3.46 (m, 1H), 3.01–2.94 
(m, 1H), 2.26–2.20 (m, 1H), 2.06–2.03 (m, 1H), 2.00–1.94 (m, 1H), 1.81–1.77 (m, 1H), 1.76 (d, 
J = 1.4 Hz, 3H), 1.58–1.52 (m, 2H), 1.42–1.35 (m, 2H), 1.04 (s, 3H), 0.99 (d, J = 6.8 Hz, 3H), 0.86 (s, 
3H). 
13C NMR (CDCl3, 201 MHz): δ = 157.8, 155.7, 149.6, 147.7, 137.9, 129.0, 128.0, 125.6, 121.4, 115.5, 
114.7, 98.3, 74.8, 55.8, 47.9, 38.9, 36.9, 36.5, 29.8, 26.3, 25.4, 18.9, 18.4, 15.5. 
IR (Diamond-ATR, neat) ෤߭max: 3415 (br w), 2959 (m), 1667 (w), 1584 (w), 1503 (vs), 1211 (vs), 1089 
(m), 1037 (m), 841 (m), 738 (m). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380; found: 452.2379. 
ሾࢻሿࡰ૛૙ = –77.3° (c = 0.23, CH2Cl2). 
Enol ether S72:  
TLC (30% ethyl acetate in hexanes), Rf = 0.33 (UV, KMnO4). 
1H NMR (CDCl3, 800 MHz): δ = 7.25–7.20 (m, 4H), 7.13 (tt, J = 7.2, 1.8 Hz, 1H), 6.83–6.80 (m, 2H), 
6.79–6.75 (m, 2H), 5.84 (q, J = 1.4 Hz, 1H), 3.77 (s, 3H), 3.59–3.53 (m, 1H), 2.99–2.89 (m, 1H), 
2.19–2.13 (m, 1H), 2.10–2.05 (m, 1H), 1.96–1.86 (m, 3H), 1.85–1.77 (m, 1H), 1.69 (d, J = 1.4 Hz, 
3H), 1.52–1.46 (m, 3H), 1.12 (s, 3H), 1.10 (s, 3H), 0.96 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 154.5, 150.5, 147.3, 144.2, 137.9, 129.6, 128.9, 128.0, 125.6, 117.0, 
115.7, 114.8, 75.4, 55.8, 40.0, 37.0, 35.2, 26.6, 26.5, 24.8, 23.2, 21.9, 19.0, 18.1. 
IR (Diamond-ATR, neat) ෤߭max: 3410 (br w), 2959 (w), 1502 (vs), 1439 (w), 1209 (s), 1104 (w), 
1037 (m), 825 (w), 739 (m), 690 (w). 
HRMS (EI) calc. for C30H39O532S [M+OAc]–: 511.2524; found: 511.2516. 
ሾࢻሿࡰ૛૙ = –56.6° (c = 0.36, CH2Cl2). 
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Fluorohydrine S73:  
TLC (30% ethyl acetate in hexanes), Rf = 0.57 (UV, KMnO4). 
1H NMR (CDCl3, 599 MHz): δ = 7.291–7.22 (m, 4H), 7.18–7.11 (m, 1H), 6.88–6.83 (m, 2H), 6.82–
6.79 (m, 2H), 5.86 (q, J = 1.4 Hz, 1H), 5.05 (t, J = 7.3 Hz, 1H), 3.76 (s, 3H), 3.58–3.49 (m, 1H), 3.07–
2.93 (m, 1H), 2.43–2.34 (m, 1H), 2.21–2.13 (m, 1H), 2.12–2.01 (m, 1H), 2.01–1.90 (m, 2H), 1.71 (d, 
J = 1.4 Hz, 3H), 1.65–1.57 (m, 1H), 1.48–1.33 (m, 3H), 1.31 (d, J = 4.2 Hz, 3H), 1.27 (d, J = 4.2 Hz, 
3H), 0.99 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 154.6, 150.8, 150.5, 146.9, 137.7, 129.0, 128.2, 125.7, 117.2, 116.0, 
115.9, 114.8, 98.1 (d, J = 164.8 Hz), 76.1 (d, J = 22.7 Hz), 55.9, 35.7, 34.6, 29.1, 28.6 (d, J = 2.8 Hz), 
23.8 (d, J = 24.7 Hz), 23.3, 21.3 (d, J = 24.6 Hz), 18.7, 18.2. 
19F NMR (CDCl3, 377 MHz): δ = –145.2 
IR (Diamond-ATR, neat) ෤߭max: 3483 (br w), 2929 (m), 1503 (vs), 1440 (m), 1296 (w), 1209 (s), 
1086 (m), 1038 (m), 829 (m), 740 (m). 
HRMS (ESI) calc. for C30H40FO532S [M+OAc]–: 531.2586; found: 531.2575. 
ሾࢻሿࡰ૛૙ = –9.5° (c = 0.42, CH2Cl2). 
Ketone S74:  
TLC (30% ethyl acetate in hexanes), Rf = 0.18 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.32–7.24 (m, 4H), 7.19–7.12 (m, 1H), 5.89 (q, J = 1.4 Hz, 1H), 
3.79–3.72 (m, 1H), 3.06–2.93 (m, 1H), 2.41–2.28 (m, 2H), 2.13–2.08 (m, 1H), 2.08–2.04 (m, 1H), 
1.82–1.76 (m, 2H), 1.74 (d, J = 1.4 Hz, 3H), 1.54 (d, J = 5.0 Hz, 1H), 1.49–1.42 (m, 1H), 1.23–1.17 
(m, 1H), 1.11 (s, 3H), 1.10–1.06 (m, 1H), 1.02 (d, J = 6.9 Hz, 3H), 0.68 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 211.0, 147.6, 137.7, 129.0, 128.0, 125.7, 115.5, 76.1, 58.5, 43.7, 
39.3, 36.4, 34.4, 31.0, 26.0, 21.3, 18.6, 18.4, 14.9. 
IR (Diamond-ATR, neat) ෤߭max: 3444 (br w), 2960 (s), 1709 (vs), 1584 (m), 1478 (s), 1439 (s), 
1037 (m), 1024 (s), 739 (vs), 690 (s). 
HRMS (EI) calc. for C21H30O232S [M]+: 346.1961; found: 346.1958. 
ሾࢻሿࡰ૛૙ = –11.6° (c = 1.00, CH2Cl2). 
 
 
 
 
156                     EXPERIMENTAL SECTION 
 
Enol ether 25 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.   
To a solution of iodide S63 (120 mg, 0.37 mmol, 1.50 equiv) in tetrahydrofuran (1.5 mL) and B-
methoxy-9-BBN (1.00 M in hexanes, 0.88 mL, 0.88 mmol, 3.50 equiv) was added a solution of t-
butyllithium (1.70 M in pentane, 0.67 mL, 1.13 mmol, 4.50 equiv) dropwise at –78 °C. After 5 min, 
the yellow solution was allowed to warm to 23 °C upon it turned colorless again. After 15 min, the 
reaction mixture was transferred to a suspension of bromoenol ether 20 (82.0 mg, 0.25 mmol, 
1 equiv), cesium carbonate (164 mg, 0.50 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (9.1 mg, 
0.01 mmol, 0.05 equiv) and SPhos (5.2 mg, 0.01 mmol, 0.05 equiv) in a mixture of                          
N,N-dimethylformamide and water (9:1, 2.5 mL) and heated to 40 °C. After 3 h, the reaction mixture 
was diluted with water (50 mL) and the aqueous phase was extracted with ethyl acetate (3 × 50 mL). 
The combined organic extracts were washed with saturated aqueous sodium chloride solution (50 mL), 
the washed organic solution was dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(10% ethyl acetate in hexanes) to give enol ether 25 (105 mg, 95%) as a yellow oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.30 (KMnO4). 
1H NMR (CDCl3, 599 MHz): (Z): δ = 7.33–7.22 (m, 4H), 7.21–7.13 (m, 1H), 6.87–6.84 (m, 2H), 
6.83–6.79 (m, 2H), 6.12 (dd, J = 9.2, 0.8 Hz, 1H), 5.58 (dd, J = 9.2, 9.2 Hz, 1H), 5.05 (t, J = 7.2 Hz, 
1H), 3.76 (s, 3H), 2.73–2.62 (m, 2H), 2.33–2.25 (m, 1H), 2.23–2.16 (m, 1H), 2.15–2.02 (m, 2H), 
1.71–1.62 (m, 2H), 1.46–1.33 (m, 2H), 1.28 (s, 3H), 1.21 (s, 3H), 1.00 (d, J = 6.7 Hz, 3H); 
(E):  δ = 7.33–7.22 (m, 4H), 7.21–7.13 (m, 1H), 6.87–6.84 (m, 2H), 6.83–6.79 (m, 2H), 6.08 (dd, 
J = 15.0, 1.0 Hz, 1H), 5.83 (dd, J = 15.0, 8.0 Hz, 1H), 5.00 (t, J = 7.3 Hz, 1H), 3.77 (s, 3H), 2.70 (t, 
J = 6.3 Hz, 1H), 2.33–2.25 (m, 2H), 2.23–2.16 (m, 1H), 2.15–2.02 (m, 2H), 1.71– 1.62 (m, 2H), 1.46–
1.33 (m, 2H), 1.28 (s, 3H), 1.23 (s, 3H), 1.02 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): (Z): δ = 154.6, 150.4, 150.3, 139.4, 136.7, 129.1, 128.8, 126.2, 121.7, 
117.2, 115.8, 114.8, 63.8, 58.6, 55.8, 36.9, 33.7, 29.2, 26.6, 25.0, 23.1, 20.4, 18.8; (E): δ = 154.7, 
150.6, 150.4, 142.7, 136.7, 129.0, 128.6, 126.1, 119.9, 117.3, 115.9, 114.8, 63.8, 58.6, 55.8, 37.3, 
36.6, 29.2, 26.6, 25.0, 23.1, 20.3, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (w), 2923 (w), 1683 (w), 1584 (w), 1502 (vs), 1440 (w), 1209 (s), 
1037 (m), 828 (w), 739 (m). 
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HRMS (EI) calc. for C27H3432SO3 [M]+: 438.2229; found: 438.2218. 
 
 
Tetracycle S75 
To a solution epoxide 25 (10.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.2 mL) was 
added a solution of ethylaluminum dichloride (1.00 M in hexanes, 0.07 mL, 0.07 mmol, 3.00 equiv) in 
dichloromethane (0.5 mL) dropwise at –78 °C. After 20 min, water (10 mL) was added. The aqueous 
layer was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to obtain S75 
(0.8 mg, 8%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes), Rf = 0.26 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.50–7.46 (m, 2H), 7.34–7.31 (m, 2H), 7.27 (dd, J = 2.9, 1.1 Hz, 
1H), 7.24 (tt, J = 7.1, 1.2 Hz, 1H), 6.72–6.70 (m, 1H), 6.69 (s, 1H), 4.86 (d, J = 6.4, 1H), 3.73 (s, 3H), 
3.33–3.27 (m, 1H), 2.53–2.45 (m, 1H), 2.15–2.11 (m, 1H), 1.87–1.80 (m, 1H), 1.76 (dd, J = 6.6, 5.3 
Hz, 1H), 1.74–1.66 (m, 2H), 1.53–1.49 (m, 3H), 1.27–1.25 (m, 1H), 1.20–1.14 (m, 1H), 1.09 (s, 3H), 
1.07 (dd, J = 12.6 Hz, 3.1, 1H), 1.05 (s, 3H), 0.77 (d, J = 7.3 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.6, 147.8, 137.4, 130.3, 129.4, 126.8, 123.9, 118.0, 114.6, 113.0, 
78.3, 78.3, 55.8, 53.2, 47.5, 44.0, 39.4, 34.2, 32.4, 29.3, 27.6, 26.4, 16.5, 15.9, 15.4. 
IR (Diamond-ATR, neat) ෤߭max: 3425 (br w), 2942 (m), 1582 (w), 1490 (vs), 1221 (s), 1156 (m), 
1043 (s), 1023 (m), 952 (m), 734 (m). 
HRMS (EI) calc. for C27H34O332S [M]+: 438.2223; found: 438.2224. 
ሾࢻሿࡰ૛૙ = +7.6° (c = 0.26, CH2Cl2). 
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Ketone S76 
To a solution epoxide 25 (5.0 mg, 11.4 mol, 1 equiv) in toluene (1.1 mL) was added a 
solution of tris(pentafluorophenyl)borane (8.75 mg, 17.1 mol, 1.50 equiv) in toluene (0.25 mL) 
dropwise at –78  °C. After 40 min, the reaction mixture was slowly allowed to warm to 10 °C within 
3h. After 1h, saturated aqueous ammonium chloride solution (10 mL) was added and mixture was 
extracted with dichloromethane (3 × 10 mL), the combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silca gel (15% ethyl acetate in hexanes initially, grading to 
25% ethyl acetate in hexanes) to obtain ketone S76 (0.4 mg, 11%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes), Rf = 0.32 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): (Z): δ = 7.37–7.26 (m, 4H), 7.23–7.14 (m, 1H), 6.18–6.08 (m, 1H), 5.61 
(dd, J = 9.4, 9,4 Hz, 1H), 3.78 (dd, J = 10.7, 3.6 Hz, 1H), 2.73–2.59 (m, 1H), 2.43–2.33 (m, 2H), 2.18–
2.10 (m, 1H), 2.09–2.01 (m, 1H), 1.87–1.72 (m, 2H), 1.50–1.40 (m, 1H), 1.38–1.24 (m, 1H), 1.12 (s, 
3H), 1.08–0.99 (m, 4H), 0.70 (s, 3H); (E): δ = (Z): 7.37–7.26 (m, 4H), 7.23–7.14 (m, 1H), 6.18–6.08 
(m, 1H), 5.86 (dd, J = 15.0, 8.1 Hz, 1H), 3.78 (dd, J = 10.7, 3.6 Hz, 1H), 2.43–2.33 (m, 2H), 2.32–2.22 
(m, 1H), 2.18–2.10 (m, 1H), 2.09–2.01 (m, 1H), 1.87–1.72 (m, 2H), 1.50–1.40 (m, 1H), 1.38–1.24 
(m,1H), 1.12 (s, 3H), 1.08–0.99 (m, 4H), 0.72 (s, 3H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 211.0, 139.8, 136.7, 129.1, 128.8, 126.2, 121.6, 76.2, 58.5, 
43.7, 39.3, 36.7, 34.5, 31.0, 26.0, 21.3, 20.5, 14.9; (E): δ = 211.0, 143.2, 136.8, 129.1, 128.6, 126.2, 
119.8, 76.1, 58.7, 43.7, 39.3, 38.3, 36.5, 31.0, 26.1, 21.4, 20.6, 15.0. 
IR (Diamond-ATR, neat) ෤߭max: 3422 (br m), 2964 (m), 1708 (s), 1583 (w), 1477 (m), 1439 (m), 
1367 (m), 1024 (m), 741 (s), 690 (s). 
HRMS (EI) calc. for C20H28O232S [M]+: 332.1805; found: 332.1801. 
 
 
SUPPORTING INFORMATION FOR CHAPTER 1.4.3.            159 
 
 
Enol ether 26 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.    
To a solution of iodide S66 (5.56 g, 18.3 mmol, 1.30 equiv) in tetrahydrofuran (74 mL) and                
B-methoxy-9-BBN (1.00 M in hexanes, 42.2 mL, 42.2 mmol, 3.00 equiv) was added a solution of             
t-butyllithium (1.60 M in pentane, 34.3 mL, 54.8 mmol, 3.90 equiv) dropwise at –78 °C. After 10 min, 
the yellow solution was allowed to warm to 23 °C upon it turned colorless again. After 25 min, the 
reaction mixture was transferred to a suspension of bromoenol ether 20 (4.60 g, 14.1 mmol, 1 equiv), 
cesium carbonate (9.16 g, 28.1 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (507 mg, 0.70 mmol, 
0.05 equiv) and SPhos (289 mg, 0.70 mmol, 0.05 equiv) in a mixture of N,N-dimethylformamide and 
water (9:1, 140 mL) and heated to 40 °C. After 19 h, water (400 mL) was added and the reaction 
mixture was extracted with ethyl acetate (3 × 300 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (200 mL), the washed organic solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to give enol 
ether 26 (4.01 g, 67%) as a yellow oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.47 (UV, anis). 
1H NMR (CDCl3, 400 MHz): (Z): δ = 7.37–7.24 (m, 4H), 7.24–7.15 (m, 1H), 6.93–6.84 (m, 4H), 6.20 
(d, J = 9.2 Hz, 1H), 5.86–5.77 (m, 1H), 5.08 (t, J = 5.8 Hz, 1H), 3.79 (s, 3H), 2.73 (t, J = 6.2 Hz, 1H), 
2.39–2.05 (m, 6H), 1.78–1.62 (m, 2H), 1.58–1.47 (m, 2H), 1.31 (s, 3H), 1.25 (s, 3H); (E): δ = 7.37–
7.24 (m, 4H), 7.24–7.15 (m, 1H), 6.93–6.84 (m, 4H), 6.14 (d, J = 14.6, 1H), 5.97 (dt, J = 14.6, 6.9 Hz, 
1H), 5.04 (t, J = 5.7 Hz, 1H), 3.79 (s, 3H), 2.73 (t, J = 6.2 Hz, 1H), 2.39–2.05 (m, 6H), 1.78–1.62 (m, 
2H), 1.58–1.47 (m, 2H), 1.31 (s, 3H), 1.25 (s, 3H). 
13C NMR (CDCl3, 101 MHz): (Z): δ = 154.6, 150.6, 150.3, 136.5, 133.2, 129.1, 128.9, 126.2, 123.0, 
117.3, 114.8, 114.8, 63.8, 58.6, 55.8, 29.2, 29.0, 28.9, 26.6, 25.0, 24.8, 18.8; (E): δ = 154.6, 150.7, 
150.2, 137.1, 136.6, 129.0, 128.5, 126.2, 121.2, 117.2, 115.7, 114.8, 63.8, 58.6, 55.8, 32.8, 29.2, 29.0, 
26.6, 25.0, 24.7, 18.8. 
IR (Diamond-ATR, neat) ෤߭max: 2926 (w), 1683 (w), 1584 (w), 1503 (vs), 1440 (w), 1209 (s), 1037 (m), 
829 (w), 739 (m), 690 (w). 
HRMS (EI) calc. for C26H32O332S [M]+: 424.2072; found: 424.2064. 
 
160                     EXPERIMENTAL SECTION 
 
Tetracycle 28 
To a solution epoxide 26 (1.90 g, 4.47 mmol, 1 equiv) in dichloromethane (450 mL) was 
added a solution of ethylaluminum dichloride (1.00 M in hexanes, 4.92 mL, 4.92 mmol, 1.15 equiv) in 
dichloromethane (20 mL) dropwise at –78 °C over a period of 5 min. After 15 min, saturated aqueous 
ammonium chloride solution (500 mL) and saturated aqueous sodium chloride solution (200 mL) were 
added and the layers were separated. The aqueous layer was extracted with dichloromethane 
(2 × 500 mL), the combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was filtered through a short plug of silica, the 
filtrate was concentrated and the crude tetracycle 28 was directly used in the following reactions. 
Note: When performing the reaction on 60 mg scale tetracycle 28 (55 mg, 91%) was isolated 
as a colorless foam after flash-column chromatography on silca gel (20% ethyl acetate in hexanes). 
TLC (30% ethyl acetate in hexanes), Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.47 (t, J = 8.6 Hz, 1.1, 2H), 7.33 (t, J = 7.7 Hz, 2H), 7.24 (dd, 
J = 7.3, 1.1 Hz, 1H), 7.21–7.20 (m, 1H), 6.77–6.74 (m, 2H), 4.77 (d, J = 5.2 Hz, 1H), 3.72 (s, 3H), 
3.29 (dd, J = 11.8, 3.4 Hz, 1H), 2.13–2.09 (m, 1H), 2.04–2.00 (m, 1H), 1.88–1.83 (m, 1H), 1.79–1.69 
(m, 1H), 1.68–1.61 (m, 3H), 1.58–1.53 (m, 1H), 1.36 (br s, 1H), 1.29–1.23 (m, 1H), 1.22–1.16 (m, 
1H), 1.12–1.07 (m, 1H), 1.06 (s, 3H), 1.06–1.03 (m, 1H), 1.02 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.4, 146.3, 136.8, 130.3, 129.3, 126.8, 121.4, 118.1, 115.3, 113.6, 
78.2, 77.3, 55.8, 52.0, 47.8, 43.0, 39.2, 31.6, 27.3, 26.4, 25.9, 23.3, 21.3, 15.1. 
IR (Diamond-ATR, neat) ෤߭max: 3424 (br w), 2939 (s), 1582 (w), 1489 (vs), 1271 (m), 1220 (s), 
1038 (s), 909 (m), 736 (s), 691 (m). 
HRMS (EI) calc. for C26H32O332S [M]+: 424.2072; found: 424.2066. 
ሾࢻሿࡰ૛૙ = –3.2° (c = 1.00, CH2Cl2). 
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3.3.1.4. Synthesis of Enone 30 
O
OMe
HO H
H SO2Ph
S77
m-CPBA
CH2Cl2, 0 °C
(70%)
O
OMe
HO H
H SPh
28  
Sulfone S77 
To a solution of crude tetracycle 28 (550 mg, 1.30 mmol, 1 equiv) in dichloromethane (19 mL) 
was added m-chloroperbenzoic acid (626 mg, 2.72 mmol, 2.10 equiv) at 0 °C. After 2 h, saturated 
aqueous sodium bicarbonate solution (75 mL) was added and the mixture was extracted with 
dichloromethane (3 × 75 mL). The combined oranic extracts were dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silca gel (50% ethyl acetate in hexanes) to yield sulfone S77 (416 mg, 70%) as a 
white foam. 
TLC (50% ethyl acetate in hexanes), Rf = 0.24 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 8.07–7.94 (m, 2H), 7.72–7.68 (m, 1H), 7.64–7.61 (m, 2H), 7.32 (d, 
J = 2.6 Hz, 1H), 6.82 (dd, J = 8.9, 2.6 Hz, 1H), 6.79 (d, J = 8.9 Hz, 1H), 4.85 (d, J = 4.8 Hz, 1H), 3.69 
(s, 3H), 3.26 (dd, J = 11.9, 4.0 Hz, 1H), 2.10–2.05 (m, 1H), 1.98–1.93 (m, 1H), 1.84–1.78 (m, 1H), 
1.71–1.63 (m, 2H), 1.63–1.59 (m, 2H), 1.55–1.51 (m, 1H), 1.34–1.28 (m, 1H), 1.26 (s, 1H), 1.16–1.10 
(m, 2H), 1.03 (s, 3H), 1.01–1.00 (m, 1H), 0.99 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.4, 146.6, 140.9, 134.0, 129.6, 128.1, 119.0, 117.1, 113.2, 112.3, 
77.9, 76.8, 62.7, 55.9, 51.8, 40.6, 39.3, 31.3, 27.1, 26.3, 25.4, 23.2, 21.0, 15.0. 
IR (Diamond-ATR, neat) ෤߭max: 3536 (br w), 2939 (m), 1492 (s), 1446 (m), 1306 (m), 1224 (s), 
1141 (vs), 1085 (m), 1038 (s), 910 (m), 726 (vs). 
HRMS (ESI) calc. for C26H31O532S [M–H]–: 455.1898; found: 455.1901. 
ሾࢻሿࡰ૛૙ = +31.9° (c = 0.84, CH2Cl2). 
 
 
Ketone S78 
162                     EXPERIMENTAL SECTION 
To a solution of sulfone S77 (200 mg, 0.44 mmol, 1 equiv) in tetrahydrofuran (26 mL) was 
added lithium bis(trimethylsilyl)amine solution (1.00 M in tetrahydrofuran, 2.63 mL, 2.63 mmol, 
6.00 equiv) at 0 °C. After 30 min, a solution of MoOPH[185] (228 mg, 0.53 mmol, 1.20 equiv) in 
tetrahydrofuran (13 mL) was added at 0 °C. After 30 min, the reaction mixture was allowed to warm 
to 23 °C. After 3 h, saturated aqueous sodium sulfite solution (60 mL) was added and the mixture was 
extracted with diethyl ether (3 × 60 mL). The combined oranic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silca gel (30% ethyl acetate in hexanes) to yield ketone S78 
(107 mg, 74%) as an off-white foam. 
TLC (40% ethyl acetate in hexanes), Rf = 0.21 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.27 (d, J = 3.2 Hz, 1H), 7.09 (dd, J = 9.0, 3.2 Hz, 1H), 6.89 (d, J = 
9.0 Hz, 1H), 3.79 (s, 3H), 3.34 (dd, J = 11.8, 3.9 Hz, 1H), 2.22–2.18 (m, 1H), 2.13 (dd, J = 12.9, 4.7 
Hz, 1H), 1.94–1.89 (m, 1H), 1.78–1.73 (m, 2H), 1.73–1.68 (m, 1H), 1.68–1.63 (m, 1H), 1.54–1.47 (m, 
2H), 1.40 (s, 1H), 1.37–1.32 (m, 1H), 1.21–1.15 (m, 1H), 1.11 (s, 3H), 1.10–1.07 (m, 1H), 1.07 (s, 
3H). 
13C NMR (CDCl3, 201 MHz): δ = 196.4, 154.0, 152.8, 125.3, 119.7, 119.4, 107.5, 80.6, 78.2, 55.9, 
54.4, 50.9, 39.3, 30.6, 27.3, 26.9, 26.5, 25.4, 21.2, 15.4. 
IR (Diamond-ATR, neat) ෤߭max: 3451 (br w), 2939 (m), 1678 (m), 1486 (vs), 1431 (s), 1282 (s), 1216 
(s), 1126 (m), 1035 (s), 914 (m), 731 (s). 
HRMS (ESI) calc. for C20H27O4 [M+H]+: 331.1904; found: 331.1907. 
ሾࢻሿࡰ૛૙ = –49.6° (c = 1.00, CH2Cl2). 
 
 
Silyl ether 29 
To a solution of alcohol S78 (50.0 mg, 0.15 mmol, 1 equiv) in dichloromethane (2.5 mL) and 
triethylamine (84.1 L, 0.61 mmol, 4.00 equiv) was added freshly distilled (over CaH2)                        
t-butyldimthylsilyl trifluoromethanesulfonate (76.5 L, 0.33 mmol, 2.20 equiv) at –78 °C. After 
15 min, the reaction mixture was allowed to warm to 23 °C. After 15 min, saturated aqueous sodium 
bicarbonate solution (20 mL) was added and the mixture was extracted with dichloromethane 
(2 × 20 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
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filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silca gel (10% ethyl acetate in hexanes) to give silyl ether 29 (64.7 mg, 96%) as an off-white foam. 
Crystallization from dichloromethane gave crystals suitable for X-ray diffraction. 
TLC (10% ethyl acetate in hexanes), Rf = 0.36 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): δ = 7.27–7.25 (m, 1H), 7.08 (dd, J = 9.0, 3.2 Hz, 1H), 6.91 (d, 
J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.29 (dd, J = 11.6, 4.1 Hz, 1H), 2.18–2.05 (m, 2H), 1.94–1.84 (m, 1H), 
1.83–1.61 (m, 4H), 1.56–1.44 (m, 1H), 1.42–1.30 (m, 2H), 1.17–1.09 (m, 1H), 1.08 (s, 3H), 1.06–1.00 
(m, 1H), 0.97 (s, 3H), 0.89 (s, 9H), 0.03 (s, 3H), 0.01 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 196.7, 153.8, 153.0, 125.3, 119.9, 119.3, 107.3, 80.6, 78.7, 55.9, 
54.4, 50.9, 39.9, 30.5, 27.7, 26.9, 26.9, 26.0, 25.4, 21.3, 18.2, 15.9, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2935 (m), 1687 (m), 1486 (vs), 1430 (m), 1280 (s), 1216 (m), 1099 (s), 
944 (m), 879 (s), 934 (s), 773 (s). 
HRMS (ESI) calc. for C26H41O4Si [M+H]+: 445.2769; found: 445.2768. 
ሾࢻሿࡰ૛૙ = –44.3° (c = 0.32, CH2Cl2). 
 
 
Enone S79 
To a solution of ketone 29 (5.0 mg, 0.01 mmol, 1 equiv) in tetrahydrofuran (0.3 mL) was 
added lithium bis(trimethylsilyl)amine solution (1.00 M in tetrahydrofuran, 67.5 mL, 0.07 mmol, 
6.00 equiv) at 23 °C and heated to 70 °C. After 1 h, the reaction mixture was allowed to cool to 23 °C 
and freshly distilled (over CaH2) trimethylsilyl chloride (14.4 mL, 0.11 mmol, 10.0 equiv) was added. 
After 10 min saturated aqueous sodium bicarbonate solution (10 mL) was added and the mixture was 
extracted with diethyl ether (3 × 10 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give enone S79 (3.9 mg, 
67%) as pale yellow oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.41 (UV, CAM). 
1H NMR (CD2Cl2, 400 MHz): δ = 6.98 (d, J = 3.2 Hz, 1H), 6.90 (dd, J = 8.8, 3.2 Hz, 1H), 6.78 (d, 
J = 8.8 Hz, 1H), 3.76 (s, 3H), 3.39 (dd, J = 11.3, 4.6 Hz, 1H), 2.59 (ddd, J = 14.4, 4.3, 2.7 Hz, 1H), 
2.33–2.23 (m, 1H), 1.98–1.92 (m, 1H), 1.86–1.61 (m, 4H), 1.52–1.31 (m, 4H), 0.99 (s, 3H), 0.88 (s, 
9H), 0.80 (s, 3H), 0.21 (s, 9H), 0.05 (s, 3H), 0.02 (s, 3H). 
164                     EXPERIMENTAL SECTION 
13C NMR (CD2Cl2, 101 MHz): δ = 199.9, 154.4, 148.2, 142.4, 136.3, 133.2, 122.1, 119.0, 115.1, 78.6, 
56.2, 47.3, 42.8, 31.6, 30.0, 28.2, 26.2, 25.7, 24.5, 23.1, 18.5, 14.9, 0.6, –3.7, –4.6. 
IR (Diamond-ATR, neat) ෤߭max: 2952 (m), 1655 (w), 1488 (s), 1251 (s), 1218 (m), 1101 (m), 1075 (m), 
1042 (m), 913 (m), 835 (vs), 773 (m). 
HRMS (EI) calc. for C29H48O4Si2 [M]+: 516.3086; found: 516.3091. 
ሾࢻሿࡰ૛૙ = –56.9° (c = 0.13, CH2Cl2). 
 
 
Stryrene 31 
To a solution of crude tetracycle 28 (1.90 g, 4.47 mmol, 1 equiv) in dichloromethane (53 mL) 
was added m-chloroperbenzoic acid (978 mg, 4.25 mmol, 0.95 equiv) at 0 °C. After 15 min, saturated 
aqueous sodium bicarbonate solution (250 mL) was added and the mixture was extracted with 
dichloromethane (3 × 250 mL). The combined oranic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was filtered through a short 
plug of silica, the filtrate was concentrated and the crude sulfoxide (obtained as an inconsequential 
diastereomeric mixture) was directly used in the next reaction.  
To a solution of the crude sulfoxide (1.81 g, 4.11 mmol, 1 equiv) in dichloromethane (22 mL) 
and triethylamine (2.29 mL, 16.5 mmol, 4.00 equiv) was added freshly distilled (over CaH2) t-butyl-
dimethylsilyl trifluoromethanesulfonate (1.89 mL, 8.23 mmol, 2.00 equiv) at –78 °C. After 1 h, 
saturated aqueous sodium bicarbonate solution (300 mL) was added and the mixture was extracted 
with dichloromethane (2 × 200 mL). The combined organic extracts were dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The residue was filtered through a 
short plug of silica, the filtrate was concentrated and the crude silyl ether S80 (obtained as an 
inconsequential diastereomeric mixture) was directly used in the next reaction.  
A solution of crude sulfoxide S80 (1.80 g, 3.24 mmol, 1 equiv) in chloroform (45 mL) in a 
pressure flask was heated to 105 °C. After 24 h, the reaction mixture was concentrated and the residue 
was purified by flash-column chromatography on silca gel (10% ethyl acetate in hexanes) to furnish 
styrene 31 (1.13 g, 59%, over 3 steps) as a yellow oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.53 (UV, CAM). 
1H NMR (CDCl3, 599 MHz): δ = 6.83 (d, J = 8.6 Hz, 1H), 6.64 (dd, J = 8.6, 3.0 Hz, 1H), 6.57 (d, 
J = 3.0 Hz, 1H), 6.12 (d, J = 1.8 Hz, 1H), 3.75 (s, 3H), 3.35 (dd, J = 11.5, 4.5 Hz, 1H), 2.32–2.24 (m, 
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1H), 2.17–2.12 (m, 1H), 2.01–1.94 (m, 1H), 1.91–1.81 (m, 1H), 1.79–1.71 (m, 1H), 1.71–1.58 (m, 
3H), 1.49–1.45 (m, 1H), 1.42 –1.36 (m, 1H), 1.22–1.15 (m, 1H), 1.08 (s, 3H), 0.99 (s, 3H), 0.91 (s, 
9H), 0.06 (s, 3H), 0.04 (s, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 154.0, 146.0, 141.4, 125.0, 118.4, 117.2, 113.2, 110.9, 79.3, 78.6, 
55.9, 48.0, 39.9, 29.2, 28.4, 27.6, 26.5, 26.1, 22.2, 18.3, 16.6, 16.4, –3.6, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2933 (s), 1609 (w), 1490 (s), 1361 (w), 1226 (s), 1102 (s), 1066 (s), 
953 (m), 881 (s), 835 (vs). 
HRMS (EI) calc. for C26H40O328Si [M]+: 428.2747; found: 428.2741. 
ሾࢻሿࡰ૛૙ = –18.0° (c = 0.27, CH2Cl2). 
 
 
Hydroxyketone S81 
To a solution of styrene 31 (1.13 g, 2.64 mmol, 1 equiv) in acetone/water mixture (12 mL, 
5:1 v/v%) was added N-methylmorpholin-N-oxide (1.54 g, 13.2 mmol, 5.00 equiv), followed by 
potassium oxmate(VI) dihydrate (48.6 mg, 0.13 mmol, 0.05 equiv) at 0 °C. After 10 min, the reaction 
mixture was allowed to warm to 23 °C. After 18 h, sodium sulfite (6.65 g, 52.7 mmol, 20.0 equiv) was 
added. After 30 min, the reaction mixture was separated between water (200 mL) and dichloromethane 
(200 mL). The phases were separated and the aqueous phase was extracted with dichloromethane 
(2 × 200 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (10% ethyl acetate in hexanes) to give -hydroxyketone S81 (841 mg, 69%) as a white 
foam. 
TLC (10% ethyl acetate in hexanes), Rf = 0.46 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.23 (d, J = 3.1 Hz, 1H), 7.13 (dd, J = 9.0, 3.1 Hz, 1H), 6.91 (d, 
J = 9.0 Hz, 1H), 3.80 (s, 3H), 3.59 (s, 1H), 3.30 (dd, J = 10.9, 4.2 Hz, 1H), 1.86–1.78 (m, 2H), 1.78–
1.68 (m, 4H), 1.69–1.61 (m, 2H), 1.54 (dd, J = 12.1, 3.1 Hz, 1H), 1.39–1.32 (m, 2H), 1.06 (s, 3H), 
0.99 (s, 3H), 0.88 (s, 9H), 0.03 (s, 3H), –0.00 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 197.8, 154.0, 153.1, 126.2, 120.2, 118.1, 107.4, 84.9, 78.3, 75.9, 
56.0, 45.7, 39.7, 33.2, 27.6, 26.6, 26.0, 24.4, 21.0, 20.7, 18.2, 15.7, –3.7, –4.8. 
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IR (Diamond-ATR, neat) ෤߭max: 3485 (w), 2952 (m), 1685 (m), 1487 (vs), 1433 (m), 1220 (s), 1085 (s), 
942 (m), 883 (s), 838 (s), 773 (s). 
HRMS (ESI) calc. for C26H41O528Si [M+H]+: 461.2718; found: 461.2724. 
ሾࢻሿࡰ૛૙ = –111.2° (c = 0.53, CH2Cl2). 
 
 
Xanthogenate 32 
To a solution of -hydroxyketone S81 (841 mg, 1.83 mmol, 1 equiv) in tetrahydrofuran 
(25 mL) was added sodium hydride (60% dispersion in mineral oil, 730 mg, 18.3 mmol, 10.0 equiv) at 
0 °C. After 5 min, the reaction mixture was allowed to warm to 23 °C. After 1 h, carbon disulfide 
(3.30 mL, 54.8 mmol, 30.0 equiv) was added to the grey suspension. After 1 h, methyl iodide 
(1.71 mL, 27.4 mL, 15.0 equiv) was added to the orange suspension. After 1.5 h, saturated aqueous 
ammonium chloride solution (200 mL) was added to the now yellow mixture and the aqueous phase 
was extracted with diethyl ether (3 × 200 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silca gel (5% ethyl acetate in hexanes) to give xanthogenate 32 
(876 mg, 87%) as a yellow crystalline solid. Crystallization from dichloromethane gave crystals 
suitable for X-ray diffraction. 
TLC (10% ethyl acetate in hexanes), Rf = 0.51 (UV, CAM). 
melting point: 114–116 °C  
1H NMR (CDCl3, 800 MHz): δ = 7.23 (d, J = 3.2 Hz, 1H), 7.10 (dd, J = 9.0, 3.2 Hz, 1H), 6.90 (d, 
J = 9.0 Hz, 1H), 3.78 (s, 3H), 3.75–3.72 (m, 1H), 3.31 (dd, J = 11.0, 4.0 Hz, 1H), 2.60 (s, 3H), 1.98 
(ddd, J = 14.7, 13.5, 4.0 Hz, 1H), 1.93–1.84 (m, 2H), 1.79–1.73 (m, 2H), 1.72–1.64 (m, 2H), 1.57–
1.53 (m, 1H), 1.53–1.49 (m, 1H), 1.44–1.41 (m, 1H),1.09 (s, 3H), 1.00 (s, 3H), 0.89 (s, 9H), 0.06 (s, 
3H), 0.03 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 214.0, 190.1, 154.4, 151.2, 125.4, 120.4, 119.6, 108.2, 92.4, 84.8, 
78.3, 55.9, 45.6, 40.1, 27.8, 26.7, 26.5, 26.0, 24.9, 20.7, 20.4, 20.2, 18.2, 15.7, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2953 (m), 1707 (m), 1618 (w), 1488 (vs), 1430 (m), 1276 (m), 1218 (s), 
1036 (s), 834 (m), 774 (m). 
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HRMS (EI) calc. for C28H42O532S228Si [M]+: 550.2243; found: 550.2239. 
ሾࢻሿࡰ૛૙ = +46.1° (c = 0.46, CH2Cl2). 
 
 
Enone 30 
A suspension of xanthogenate 32 (870 mg, 1.58 mmol, 1 equiv) in sulfulane (2 mL) was 
heated to 200 °C, whereupon the mixture becomes a clear solution. After 15 min, the reaction mixture 
is directly purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes, 
initially, grading to 15% ethyl acetate in hexanes) to furnish enone 30 (648 mg, 93%) as a white foam. 
TLC (10% ethyl acetate in hexanes), Rf = 0.29 (UV, CAM). 
1H NMR (CDCl3, 599 MHz): δ = 7.35 (d, J = 3.2 Hz, 1H), 7.07 (dd, J = 8.9, 3.2 Hz, 1H), 6.91 (d, 
J = 8.9 Hz, 1H), 6.69 (d, J = 5.2 Hz, 1H), 3.80 (s, 3H), 3.36 (dd, J = 11.5, 4.5 Hz, 1H), 2.48–2.39 (m, 
1H), 2.37–2.32 (m, 1H), 2.16 – 2.07 (m, 1H), 1.86–1.79 (m, 1H), 1.78–1.71 (m, 1H), 1.67–1.58 (m, 
1H), 1.48–1.41 (m, 1H), 1.31–1.27 (m, 1H), 1.23–1.16 (m, 1H), 1.11 (s, 3H), 1.04 (s, 3H), 0.90 (s, 
9H), 0.05 (s, 3H), 0.02 (s, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 186.0, 154.0, 153.5, 140.3, 138.0, 124.9, 122.9, 120.1, 107.5, 79.2, 
78.7, 56.0, 50.5, 40.0, 30.1, 28.3, 28.0, 27.4, 26.0, 18.8, 18.3, 16.4, –3.6, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2954 (m), 1679 (m), 1640 (m), 1485 (vs), 1428 (m), 1282 (s), 1109 (m), 
1074 (s), 882 (s), 835 (s), 776 (s). 
HRMS (EI) calc. for C26H38O428Si [M]+: 442.2539; found: 442.2539. 
ሾࢻሿࡰ૛૙ = +133.6° (c = 1.00, CH2Cl2). 
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Ketone 33 
A suspension of copper(I) iodide (258 mg, 1.36 mmol, 10.0 equiv) in diethyl ether (6.0 mL) 
was added a solution of methyl lithium (1.60 M in diethyl ether, 1.69 mL, 2.71 mmol, 20.0 equiv) 
dropwise at 0 °C. After 30 min, a solution of enone 30 (60.0 mg, 0.14 mmol, 1 equiv) in diethyl ether 
(2.5 mL) was added to the reaction mixture at 0 °C. The transfer was quantitated with diethyl ether 
(2 × 0.5 mL). After 30 min, saturated aqueous ammonium chloride solution (40 mL) was added and 
the mixture was extracted with diethyl ether (3 × 50 mL). The combined organic extracts were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (5% ethyl acete in hexanes) to give ketone 33 
(60.1 mg, 98%) as a white foam. 
TLC (10% ethyl acetate in hexanes), Rf = 0.40 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): δ = 7.25 (d, J = 3.2 Hz, 1H), 7.07 (dd, J = 9.0, 3.2 Hz, 1H), 6.88 (d, 
J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.28 (dd, J = 11.6, 4.1 Hz, 1H), 2.14–2.06 (m, 1H), 1.92–1.77 (m, 2H), 
1.78–1.60 (m, 4H), 1.40–1.30 (m, 1H), 1.18–1.08 (m, 1H), 1.09–1.00 (m, 5H), 0.97 (s, 3H), 0.88 (s, 
9H), 0.84 (d, J = 6.0 Hz, 3H), 0.04 (s, 3H), 0.01 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 196.0, 153.7, 152.8, 125.0, 119.6, 119.6, 107.4, 81.0, 78.6, 61.1, 
55.9, 51.0, 39.8, 34.7, 31.1, 30.5, 27.7, 26.9, 26.0, 21.3, 19.6, 18.2, 15.9, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2951 (m), 2854 (w), 1686 (m), 1485 (vs), 1429 (m), 1280 (s), 1175 (m), 
1101 (s), 879 (s), 834 (s), 772 (s). 
HRMS (EI) calc. for C27H42O428Si [M]+: 458.2847; found: 458.2851. 
ሾࢻሿࡰ૛૙ = –37.3° (c = 0.23, CH2Cl2). 
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3.3.1.5. Installation of the vicinal cis-Dimethylgroup 
 
 
Ketone 33 
A suspension of copper(I) iodide (258 mg, 1.36 mmol, 10.0 equiv) in diethyl ether (6.0 mL) 
was added a solution of methyl lithium (1.60 M in diethyl ether, 1.69 mL, 2.71 mmol, 20.0 equiv) 
dropwise at 0 °C. After 30 min, a solution of enone 30 (60.0 mg, 0.14 mmol, 1 equiv) in diethyl ether 
(2.5 mL) was added to the reaction mixture at 0 °C. The transfer was quantitated with diethyl ether 
(2 × 0.5 mL). After 30 min, saturated aqueous ammonium chloride solution (40 mL) was added and 
the mixture was extracted with diethyl ether (3 × 50 mL). The combined organic extracts were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (5% ethyl acete in hexanes) to give ketone 33 
(60.1 mg, 98%) as a white foam. 
TLC (10% ethyl acetate in hexanes), Rf = 0.40 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): δ = 7.25 (d, J = 3.2 Hz, 1H), 7.07 (dd, J = 9.0, 3.2 Hz, 1H), 6.88 (d, J = 
9.0 Hz, 1H), 3.79 (s, 3H), 3.28 (dd, J = 11.6, 4.1 Hz, 1H), 2.14–2.06 (m, 1H), 1.92–1.77 (m, 2H), 
1.78–1.60 (m, 4H), 1.40–1.30 (m, 1H), 1.18–1.08 (m, 1H), 1.09–1.00 (m, 5H), 0.97 (s, 3H), 0.88 (s, 
9H), 0.84 (d, J = 6.0 Hz, 3H), 0.04 (s, 3H), 0.01 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 196.0, 153.7, 152.8, 125.0, 119.6, 119.6, 107.4, 81.0, 78.6, 61.1, 
55.9, 51.0, 39.8, 34.7, 31.1, 30.5, 27.7, 26.9, 26.0, 21.3, 19.6, 18.2, 15.9, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2951 (m), 2854 (w), 1686 (m), 1485 (vs), 1429 (m), 1280 (s), 1175 (m), 
1101 (s), 879 (s), 834 (s), 772 (s). 
HRMS (EI) calc. for C27H42O428Si [M]+: 458.2847; found: 458.2851. 
ሾࢻሿࡰ૛૙ = –37.3° (c = 0.23, CH2Cl2). 
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Alcohol 34 
To a solution of silyl ether 33 (12.0 mg, 0.03 mmol, 1 equiv) in acetonitrile (0.2 mL) was 
added triethylamine trihydrofluoride (93.2 L, 0.53 mmol, 20.0 equiv) at 40 °C. After 7 days, 
saturated aqueous sodium bicarbonate solution (10 mL) was added and the mixture was extracted with 
diethyl ether (3 × 10 mL). The combined organic extracts were dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (30% ethyl acete in hexanes initially, grading to 40% ethyl acetate in 
hexanes) to give alcohol 34 (5.3 mg, 59%) as a white foam. Crystallization from diethyl ether gave 
crystals suitable for X-ray diffraction. 
TLC (40% ethyl acetate in hexanes), Rf = 0.23 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.26 (d, J = 3.2 Hz, 1H), 7.08 (dd, J = 9.0, 3.2 Hz, 1H), 6.86 (d, 
J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.33 (dd, J = 11.8, 4.1 Hz, 1H), 2.18–2.12 (m, 1H), 1.91–1.80 (m, 2H), 
1.78–1.72 (m, 2H), 1.71–1.62 (m, 2H), 1.53–1.49 (m, 1H), 1.25 (s, 1H), 1.21–1.15 (m, 1H), 1.10 (s, 
3H), 1.09–1.04 (m, 5H), 0.84 (d, J = 6.4 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 195.7, 153.9, 152.6, 125.1, 119.7, 119.5, 107.5, 81.0, 78.2, 61.0, 
55.9, 50.9, 39.2, 34.6, 31.0, 30.6, 27.3, 26.5, 21.1, 19.6, 15.4. 
IR (Diamond-ATR, neat) ෤߭max: 3448 (w), 2938 (w), 1681 (m), 1486 (vs), 1430 (m), 1283 (s), 1216 (m), 
1035 (m), 941 (w), 733 (w). 
HRMS (EI) calc. for C21H28O4 [M]+: 344.1982; found: 344.1982. 
ሾࢻሿࡰ૛૙ = –50.6° (c = 0.32, CH2Cl2). 
 
 
Tetrahydrothiophene 36 
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Preparation of bis(trimethylsilylmethyl) sulfoxide 35:   
To a solution of bis(trimethylsilylmethyl) sulfide (350 mg, 1.69 mmol, 1 equiv) in dichloromethane 
(3.5 mL) was added a solution of m-chloroperoxybenzoic acid (77%, 418 mg, 1.86 mmol, 1.10 equiv) 
in dichloromethane (3.5 mL) dropwise at –78 °C. After 30 min, the reaction mixture was briefly 
allowed to warm to 0 °C. After 2 min, the mixture was diluted with dichloromethane (10 mL) and the 
organic phase was washed with ice-cold water (10 mL) and saturated aqueous sodium bicarbonate 
solution (2 × 10 mL). The washed organic solution was dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated at 10 °C to give crude sulfoxide 35.   
Note: it is of crucial importance for a successful dipolar cycloaddition to remove any residual m-
chlorobenzoic acid; the sulfoxide can be stored at 10 °C for several hours.  
To a solution of enone 30 (75 mg, 0.17 mmol, 1 equiv) in dichloromethane and                     
N,N'-dimethylpropyleneurea (1:1, 7.5 mL) in a high pressure Teflon vial was added freshly prepared 
sulfoxide 35 (188 mg, 0.85 mmol, 5.00 equiv). The closed vial was shaken and put under 14 kbar at 
20 °C. After 3 h, the pressure was released and sulfoxide 35 (188 mg, 0.85 mmol, 5.00 equiv) was 
added. After 3 h, the reaction mixture was partitioned between 10% aqueous lithium chloride solution 
(30 mL) and diethyl ether (30 mL). The aquoues phase was extracted with diethyl ether (2 × 30 mL) 
and the combined organic extracts were dried over sodium sulfate. The dried solution was filtered and 
the filtrate was concentrated. The residue was purified by flash-column chromatography on silca gel to 
yield tetrahydrothiophene 36 (58.2 mg, 68%) and starting enone 30 (11.7 mg, 16%) as a colorless 
foam. (Note: The scale of the reaction is limited by the size of the teflon vial (max. 8.0 mL)). 
 
 
Figure 1: Left: Teflon vials used to carry out the high pressure reactions. Right: High Pressure apparatus by 
Andreas Hofer Hochdrucktechnik GmbH with a Julabo MA-4 circulation thermostat. 
TLC (10% ethyl acetate in hexanes), Rf = 0.37 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ 7.28 (d, J = 3.2 Hz, 1H), 7.09 (dd, J=9.0, 3.2 Hz, 1H), 6.88 (d, 
J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.24 (dd, J = 11.6, 4.0 Hz, 1H), 3.22 (d, J = 10.3 Hz, 1H), 2.74 (d, 
J = 10.3 Hz, 1H), 2.69 (dd, J = 10.9, 4.8 Hz, 1H), 2.48–2.44 (m, 2H), 2.01–1.96 (m, 2H), 1.81–1.72 
(m, 3H), 1.68–1.62 (m, 1H), 1.40 (dd, J = 12.2, 3.0 Hz, 1H), 1.36–1.31 (m, 1H), 1.24–1.18 (m, 1H), 
1.09 (s, 3H), 1.00 (s, 3H), 0.89 (s, 9H), 0.04 (s, 3H), 0.01 (s, 3H). 
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13C NMR (CDCl3, 201 MHz): δ = 194.9, 153.9, 151.9, 125.4, 119.5, 118.5, 108.0, 84.1, 78.5, 63.8, 
55.9, 46.0, 44.6, 39.8, 36.2, 31.1, 28.4, 28.2, 27.6, 26.6, 26.0, 20.4, 18.2, 15.8, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2951(m), 1683 (m), 1618 (w), 1488 (vs), 1430 (m), 1288 (s), 1223 (m), 
1105 (m), 1035 (m), 835 (m). 
HRMS (EI) calc. for C28H42O432S28Si [M]+: 502.2573; found: 502.2572. 
ሾࢻሿࡰ૛૙ = –32.8° (c = 0.25, CH2Cl2). 
 
 
Ketone S82 
To a solution of tetrahydrothiophene 36 (160 mg, 0.32 mmol, 1 equiv) in tetrahydrofuran 
(19 mL) Raney®-Nickel (2800, slurry in water, 1.00 g) was added and the reaction mixture was heated 
to 65 °C. After 2 h, the reaction mixture was filtered through a plug of Celite® which was washed 
thoroughly with diethyl ether (50 mL). The filtrate was washed with saturated aqueous sodium 
chloride solution (50 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (5% ethyl acetate in hexanes) to give ketone S82 (134.5 mg, 87%) as a white foam. 
TLC (10% ethyl acetate in hexanes), Rf = 0.45 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.27 (d, J = 3.2 Hz, 1H), 7.07 (dd, J = 9.0, 3.2 Hz, 1H), 6.86 (d, 
J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.23 (dd, J = 11.6, 4.0 Hz, 1H), 2.05–1.99 (m, 1H), 1.96–1.89 (m, 1H), 
1.85–1.80 (m, 1H), 1.73–1.64 (m, 2H), 1.63–1.59 (m, 1H), 1.44–1.39 (m, 1H), 1.36 (dd, J = 12.6, 3.6 
Hz, 1H), 1.34–1.27 (m, 2H), 1.09 (s, 3H), 1.07 (s, 3H), 0.97 (s, 3H), 0.89 (s, 9H), 0.66 (d, J = 6.9 Hz, 
3H), 0.04 (s, 3H), 0.01 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 197.8, 153.7, 151.9, 124.7, 119.5, 119.4, 108.0, 85.6, 78.9, 55.9, 
53.1, 45.5, 39.9, 32.8, 29.6, 28.1, 26.8, 26.6, 26.0, 21.7, 18.3, 16.2, 15.7, 9.7, –3.7, –4.8. 
IR (Diamond-ATR, neat) ෤߭max: 2956 (m), 1683 (m), 1488 (vs), 1429 (m), 1287 (m), 1222 (m), 
1104 (m), 878 (m), 835 (s), 773 (m). 
HRMS (EI) calc. for C28H44O428Si [M]+: 472.3009; found: 472.2999. 
ሾࢻሿࡰ૛૙	= –48.1° (c = 1.00, CH2Cl2). 
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Alcohol 37 
To a suspension of lithium aluminum hydride (41.7 mg, 1.10 mmol, 4.00 equiv) in 
tetrahydrofuran (1.5 mL) was added a solution of ketone S82 (130 mg, 0.28 mmol, 1 equiv) at 23 °C. 
After 15 min, the reaction mixture was diluted with diethyl ether (5 mL) then aqueous sodium 
hydroxide solution (10%, 25 L) was added, followed by water (25 L), After 10 min, sodium sulfate 
was added. The dried solution was filtered and the filtrate was concentrated to give the corresponding 
crude benzylic alcohol.   
To a solution of benzylic alcohol and triethylsilane (88.4 L, 0.55 mmol, 2.00 equiv) in 
dichloromethane (8.0 mL) was added boron trifluoride etherate (47% in diethyl ether, 0.14 mL, 
0.55 mmol, 2.00 equiv) at 0 °C. After 5 min, the reaction mixture was allowed to warm to 23 °C. After 
2 h, triethylsilane (0.11 mL, 0.69 mmol, 2.50 equiv) and boron trifluoride etherate (47% in diethyl 
ether, 0.18 mL, 0.69 mmol, 2.50 equiv) were added. After 45 min, saturated aqueous sodium 
bicarbonate solution (40 mL) was added and the mixture was extracted with dichloromethane 
(3 × 40 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (20% ethyl acetae in hexanes) to furnish alcohol 37 (87 mg, 92%) as a white solid. 
TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
melting point: 173–175 °C 
1H NMR (CDCl3, 800 MHz): δ = 6.72 (d, J = 8.8 Hz, 1H), 6.68 (dd, J = 8.8 Hz, 3.0, 1H), 6.54 (d, J = 
3.0 Hz, 1H), 3.74 (s, 3H), 3.26 (dd, J = 11.9, 3.7 Hz, 1H), 2.59 (d, J = 17.3 Hz, 1H), 2.52 (d, J = 17.3 
Hz, 1H), 1.85–1.77 (m, 2H), 1.77–1.70 (m, 1H), 1.69–1.64 (m, 1H), 1.60–1.56 (m, 1H), 1.53–1.47 (m, 
3H), 1.41 (dd, J = 12.7, 3.5 Hz, 1H), 1.35 (br s, 1H), 1.34–1.28 (m, 1H), 1.08 (s, 3H), 1.03 (s, 3H), 
0.90 (s, 3H), 0.76 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.2, 146.3, 121.7, 117.5, 114.1, 113.3, 80.5, 78.6, 55.8, 45.5, 
39.2, 37.5, 33.9, 31.7, 30.7, 27.6, 27.1, 26.5, 21.5, 17.0, 16.2, 15.2. 
IR (Diamond-ATR, neat) ෤߭max: 3263 (br w), 2943 (m), 1499 (vs), 1430 (m), 1222 (s), 1165 (m), 1044 
(s), 933 (m), 858 (w), 800 (m). 
HRMS (EI) calc. for C22H32O3 [M]+: 344.2346; found: 344.2347. 
ሾࢻሿࡰ૛૙	= +11.3° (c = 0.74, CH2Cl2). 
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Thiocarbonate S83 
To a solution of alcohol 37 (80.0 mg, 0.23 mmol, 1 equiv), pyridine (93.9 l, 1.16 mmol, 
5.00 equiv) in dichloromethane (11.0 mL) and 4-dimethylaminopyridine (2.84 mg, 0.02 mmol, 
0.10 equiv) was added pentafluorophenyl chlorothionoformate (93.2 L, 0.58 mmol, 2.50 equiv) at 
0 °C. After 5 min, the reaction mixture was allowed to warm to 23 °C. After 3.5 h, saturated aqueous 
sodium bicarbonate solution (30 mL) was added and the mixture was extracted with dichloromethane 
(4 × 30 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (3% ethyl acetate in hexanes) to furnish thiocarbonate S83 (127.4 mg, 96%) as a colorless 
solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.59 (UV, CAM). 
melting point: 189–191 °C 
1H NMR (CDCl3, 400 MHz): δ = 6.76 (d, J = 8.8 Hz, 1H), 6.70 (dd, J = 8.8 Hz, 2.9 Hz, 1H), 6.55 (d, 
J = 2.9 Hz, 1H), 4.98 (dd, J = 11.9 , 4.0 Hz, 1H), 3.75 (s, 3H), 2.63 (d, J = 17.5 Hz, 1H), 2.53 (d, 
J = 17.5 Hz, 1H), 2.04–1.95 (m, 1H), 1.94–1.78 (m, 3H), 1.74–1.66 (m, 1H), 1.64–1.50 (m, 4H), 1.42–
1.29 (m, 1H), 1.26 (s, 3H), 1.05 (s, 3H), 0.94 (s, 3H), 0.78 (d, J = 6.8 Hz, 3H). 
13C NMR (1H decoupled, CDCl3, 101 MHz): δ = 191.9, 153.4, 145.9, 142.94–139.87 (m), 141.63–
138.42 (m), 139.71–136.17 (m), 128.14–127.20 (m), 121.6, 117.6, 114.2, 113.5, 94.7, 80.0, 55.8, 45.8, 
38.9, 37.5, 33.9, 31.7, 30.4, 27.2, 26.9, 21.6, 21.2, 17.0, 16.8, 16.1. 
13C NMR (19F decoupled, CDCl3, 101 MHz): δ = 191.9 (d, J = 4.2 Hz), 141.3, 140.0, 138.1, 127.7, 
56.5, 55.1. 
19F NMR (CDCl3, 376 MHz): δ = –152.25– –152.40 (m), –157.15 (t, J = 21.7 Hz), –162.18– –162.41. 
IR (Diamond-ATR, neat) ෤߭max: 2955 (w), 1520 (vs), 1496 (s), 1311 (m), 1222 (m), 1142 (s), 997 (s), 
954 (s), 736 (w). 
HRMS (EI) calc. for C29H31F5O432S [M]+: 570.1858; found: 570.1855. 
ሾࢻሿࡰ૛૙ = +30.8° (c = 0.24, CH2Cl2). 
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Methoxy-5-epi-aureol S84 
A solution of thiocarbonate S83 (127.0 mg, 0.22 mmol, 1 equiv), tributyltin hydride (0.18 mL, 
0.67 mmol, 3.00 equiv) and azobisisobutyronitrile (7.31 mg, 0.04 mmol, 0.20 equiv) in benzene 
(5.2 mL) was heated to 80 °C in a pressure flask. After 3 h, the reaction mixture was concentrated and 
the residue was purified by flash-column chromatography on silica gel (hexanes initially, grading to 
2% ethyl acetate in hexanes) to give S84 (63.8 mg, 87%) as a white solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
melting point: 143–146 °C 
1H NMR (CDCl3, 800 MHz): δ = 6.73 (d, J = 8.7 Hz, 1H), 6.67 (dd, J = 8.7, 2.9 Hz, 1H), 6.53 (d, 
J = 2.9 Hz, 1H), 3.74 (s, 3H), 2.57 (d, J = 17.3 Hz, 1H), 2.53 (d, J = 17.3 Hz, 1H), 1.75–1.70 (m, 2H), 
1.69–1.63 (m, 2H), 1.56–1.54 (m, 1H), 1.50–1.45 (m, 1H), 1.45–1.41 (m, 1H), 1.38 (dd, J = 12.7, 3.5 
Hz, 1H), 1.35–1.24 (m, 3H), 1.21–1.14 (m, 1H), 1.11 (s, 3H), 0.91 (s, 3H), 0.91 (s, 3H), 0.76 (d, 
J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.0, 146.8, 122.0, 117.5, 114.1, 113.2, 81.2, 55.8, 45.7, 42.2, 
37.4, 33.9, 33.6, 32.8, 31.9, 30.7, 28.7, 22.6, 22.0, 18.0, 17.0, 16.4. 
IR (Diamond-ATR, neat) ෤߭max: 2936 (m), 1496 (vs), 1250 (m), 1234 (s), 1223 (s), 1171 (m), 1151 (w), 
1043 (m), 933 (w), 801 (w). 
HRMS (EI) calc. for C22H32O2 [M]+: 328.2402; found: 328.2395. 
ሾࢻሿࡰ૛૙ = –7.4 (c = 1.00, CH2Cl2). 
 
 
(–)-5-epi-Aureol (38) 
To a solution of methyl ether S84 (58.0 mg, 0.18 mmol, 1 equiv) in dichloromethane (1.8 mL) 
was added boron tribromide (1.00 M in hexanes, 1.80 mL, 1.77 mmol, 10.0 equiv) at –78 °C. After 
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10 min, the reaction mixture was allowed to warm to 23 °C. After 50 min, methanol (2 mL) was 
carefully added and the mixture was partitioned between saturated aqueous sodium bicarbonate 
solution (20 mL) and dichloromethane (20 mL). The phases were separated and the aqueous layer was 
extracted with dichloromethane (2 × 20 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (5% ethyl acetate in hexanes) to give (–)-5-epi-aureol (38) 
(47.5 mg, 86%) as a colorless solid. 
TLC (30% ethyl acetate in hexanes): Rf = 0.46 (UV, CAM). 
melting point: 114–116 °C (reported 115–116 °C)[104]  
1H NMR (CDCl3, 800 MHz): δ = 6.67 (d, 3J18/16 = 8.6 Hz, 1H, H-18), 6.58 (dd, 3J19/18 = 8.6 Hz,     
4J19/21 = 3.0 Hz, 1H, H-19), 6.47 (d, 4J21/19 = 3.0 Hz, 1H, H-21), 4.26 (br s, 1H, OH), 2.54 (d,       
2J15A/15B = 17.3 Hz, 1H, H-15A), 2.50 (d, 2J15B/15A = 17.3 Hz, 1H, 15B), 1.75–1.69 (m, 2H; H-1A, H-6A), 
1.69–1.63 (m, 2H, H-2A, H-8), 1.58–1.52 (m, 1H, H-6B), 1.50–1.45 (m, 1H, H-7A), 1.45–1.42 (m, 1H, 
H-3A), 1.38 (dd, 3J5/6A = 12.7 Hz, 3J5/6B = 3.6 Hz, 1H, H-5), 1.35–1.24 (m, 3H,    H-1B, H-2B, H-7B), 
1.21–1.16 (m, 1H, H-3B), 1.10 (s, 3H, H-11), 0.91 (s, 3H, H-12), 0.90 (s, 3H, H-14), 0.75 (d,          
3J13/8 = 6.8 Hz, 3H, H-13). 
13C NMR (CDCl3, 201 MHz): δ = 148.5 (C-20), 146.8 (C-17), 122.2 (C-16), 117.6 (C-18), 115.5 (C-
21), 114.4 (C-19), 81.2 (C-10), 45.7 (C-5), 42.2 (C-3), 37.4 (C-9), 33.7 (C-15), 33.6 (C-4), 32.8 (C-
12), 31.9 (C-8), 30.7 (C-7), 28.7 (C-1), 22.6 (C-11), 22.0 (C-6), 18.0 (C-2), 17.0 (C-14), 16.4 (C-13). 
IR (Diamond-ATR, neat) ෤߭max: 3350 (br w), 2927 (vs), 2854 (s), 1710 (w), 1495 (s), 1454 (s), 1234 (s), 
1222 (vs), 1171 (s), 965 (m), 807 (m). 
HRMS (EI) calc. for C21H30O2 [M]+: 314.2240; found: 314.2243. 
ሾࢻሿࡰ૛૙ = –12.7 (c = 0.57, CHCl3). +15.5 (c = 0.17, CHCl3; (+)-5-epi-Aureol[105]) 
 
Table 11: Comparison of 1H NMR data for reported and synthetic 5-epi-aureol (38). 
Proton 
 
Synthetic  
(800 MHz, CDCl3) 
Marcos  
(200 MHz, CDCl3)[115] 
Δδ  
(ppm) 
v. d. Helm 
(270 MHz, CDCl3)[104]  
Δδ  
(ppm) 
1A 1.75–1.69 (m) 
2.10–1.36 (m, 12H) 
 
not reported 
 
1B 1.35–1.24   
2A 1.69–1.63 (m)   
2B 1.35–1.24 (m)   
3A 1.45–1.42 (m)   
3B 1.21–1.16 (m)   
5 1.37 (dd, 12.7, 3.6 Hz)   
6A 1.75–1.69 (m)   
6B 1.58–1.52 (m)   
7A 1.50–1.45 (m)   
7B 1.35–1.24 (m)   
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8 1.69–1.63 (m)   
11 1.10 (s) 1.10 (s) ± 0.00 1.13 (s) – 0.03 
12 0.91 (s) 0.96 (s, 6H) – 0.05 0.92 (br s, 6H) – 0.01 
13 0.75 (d, 6.8 Hz) 0.75 (d, 6.8 Hz) ± 0.00 0.77 (d, 7.5 Hz) – 0.02 
14 0.90 (s) 0.96 (s, 6H) – 0.06 0.92 (br s, 6H) – 0.02 
15A 2.54 (d, 17.3 Hz) 2.52 (s, 2H) + 0.02 2.54 (s,2H) ± 0.00 15B 2.50 (d, 17.3 Hz) – 0.02 – 0.04 
18 6.67 (d, 8.6 Hz) 6.69 (d, 9.0 Hz) – 0.02 6.69 (d, 9Hz) – 0.02 
19 6.59 (dd, 8.6, 3.0 Hz) 6.60 (dd, 9.0, 3.1 Hz) – 0.01 6.60 (dd, 9.0, 3.0 Hz) – 0.01 
21 6.47 (d, 3.0 Hz) 6.49 (d, 3.1 Hz) – 0.02 6.48 (d, 3 Hz) – 0.01 
OH 4.26 (br s) 4.26 (s) ± 0.00 4.30 (br s) – 0.04 
 
 
Acetate S85 
To a solution of 5-epi-aureol (38) (2.0 mg, 6.36 mol, 1 equiv) in acetic anhydride (0.4 mL) 
was added boron trifluoride etherate (47% in diethyl ether, 1 drop) at 23 °C. After 60 min, water (10 
mL) was added and mixture was extracted with diethyl ether (3 × 10 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% ethyl 
acetate in hexanes) to give acetate S85 (1.5 mg, 66%) as a colorless oil. The obtained characterization 
data were in full agreement with those reported in literature.[115]  
TLC (5% ethyl acetate in hexanes): Rf = 0.35 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): δ = 6.79–6.76 (m, 2H), 6.71–6.68 (m, 1H), 2.55 (s, 2H), 2.26 (s, 3H), 
1.77–1.59 (m, 4H), 1.59–1.55 (m, 1H), 1.51–1.41 (m, 2H), 1.38 (dd, J = 12.7, 3.6 Hz, 1H), 1.35–1.23 
(m, 3H), 1.23–1.13 (m, 1H), 1.10 (s, 3H), 0.91 (s, 3H), 0.91 (s, 3H), 0.74 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 170.2, 150.5, 143.4, 122.0, 121.8, 120.2, 117.5, 81.8, 45.8, 42.1, 
37.3, 33.6, 33.6, 32.7, 31.9, 30.6, 28.9, 22.5, 22.0, 21.3, 18.0, 17.0, 16.3. 
IR (Diamond-ATR, neat) ෤߭max: 2941 (m), 1761 (m), 1494 (m), 1367 (w), 1202 (s), 1170 (m), 1140 (w), 
1015 (w), 932 (w), 814 (w). 
HRMS (EI) calc. for C23H32O3 [M]+: 356.2346; found: 356.2348. 
ሾࢻሿࡰ૛૙ = –28.0 (c = 0.10, CHCl3); –42.0 (c = 0.10, CHCl3)[115]   
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3.3.1.6. 2nd Generation Synthesis 
 
Enol ether ent-41 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.   
To a solution of iodide S59 (6.34 g, 19.1 mmol, 1.30 equiv) in tetrahydrofuran (76 mL) and                
B-methoxy-9-BBN (1.00 M in hexanes, 44.0 mL, 44.0 mmol, 3.00 equiv) was added a solution of         
t-butyllithium (1.65 M in pentane, 34.7 mL, 57.2 mmol, 3.90 equiv) dropwise at –78 °C. After 5 min, 
the yellow solution was allowed to warm to 23 °C upon it turned colorless again. After 30 min, the 
reaction mixture was transferred to a suspension of bromoenol ether 20 (4.80 g, 14.7 mmol, 1 equiv), 
cesium carbonate (9.56 g, 29.3 mmol, 2.00 equiv), SPhos Pd G2 precatalyst (529 mg, 0.73 mmol, 
0.05 equiv) and SPhos (301 mg, 0.73 mmol, 0.05 equiv) in a mixture of N,N-dimethylformamide and 
water (9:1, 140 mL) and heated to 40 °C. After 2 h, water (300 mL) was added and the reaction 
mixture was extracted with ethyl acetate (3 × 250 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (200 mL), the washed organic solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (5% ethyl acetate in hexanes) to give enol ether 
ent-41 (5.61 g, 85%) as a yellow oil. 
To obtain analytical pure samples, iodides (Z)-S59 and (E)-S59 were coupled separately 
under the same conditions to yield (Z)-ent-41 and (E)-ent-41. 
(Z)-ent-41: 
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 7.31–7.23 (m, 4H), 7.20–7.13 (m, 1H), 6.88–6.84 (m, 2H), 6.81 (d, J 
= 9.2 Hz, 2H), 5.87 (q, J = 1.3 Hz, 1H), 5.05 (t, J = 7.3 Hz, 1H), 3.78 (s, 3H), 3.07–2.96 (m, 1H), 2.70 
(t, J = 6.3 Hz, 1H), 2.34–2.23 (m, 1H), 2.23–2.13 (m, 1H), 2.12–2.02 (m, 1H), 2.02–1.92 (m, 1H), 
1.71 (d, J = 1.4 Hz, 3H), 1.70–1.62 (m, 2H), 1.49–1.39 (m, 2H), 1.28 (s, 3H), 1.21 (s, 3H), 0.99 (d, 
J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.4, 150.4, 146.9, 137.7, 129.0, 128.1, 125.7, 117.2, 115.9, 
115.8, 114.8, 63.8, 58.6, 55.8, 35.8, 34.6, 29.2, 26.6, 25.0, 23.3, 18.8, 18.8, 18.2. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (w), 2925 (w), 1681 (w), 1584 (w), 1503 (vs), 1377 (w), 1209 (s), 
1038 (w), 828 (w), 740 (w). 
HRMS (ESI) calc. for C28H37O332S [M+H]+: 453.2458 found: 453.2466. 
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ሾࢻሿࡰ૛૙ = –13.4° (c = 1.00, CH2Cl2). 
(E)-ent-41: 
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (UV, Anis). 
1H NMR (CDCl3, 400 MHz): δ = 7.33–7.23 (m, 4H), 7.22–7.12 (m, 1H), 6.90–6.79 (m, 4H), 5.94 (s, 
1H), 5.03 (t, J = 7.2 Hz, 1H), 3.78 (s, 3H), 2.72 (t, J = 6.3 Hz, 1H), 2.38–2.28 (m, 2H), 2.28–2.16 (m, 
1H), 2.08–1.96 (m, 2H), 1.74 (d, J = 1.1 Hz, 3H), 1.73–1.62 (m, 2H), 1.55–1.47 (m, 1H), 1.45–1.35 
(m, 1H), 1.29 (s, 3H), 1.24 (s, 3H), 1.05 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.6, 150.5, 150.3, 146.5, 137.5, 129.0, 128.1, 125.7, 117.2, 115.9, 
115.6, 114.8, 63.8, 58.6, 55.8, 42.6, 34.8, 29.2, 26.6, 25.0, 23.4, 19.7, 18.8, 14.6. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (w), 2924 (w), 1681 (w), 1583 (w), 1502 (vs), 1377 (w), 1208 (s), 
1037 (w), 827 (w), 739 (m). 
HRMS (ESI) calc. for C28H37O332S [M+H]+: 453.2458 found: 453.2466. 
ሾࢻሿࡰ૛૙ = –16.0° (c = 1.00, CH2Cl2). 
 
 
Tetracycle ent-43 
Note: The cyclization was carried out in two parallel 2.8 g batches.  
To a solution epoxide ent-41 (2.80 g, 6.19 mmol, 1 equiv) in dichloromethane (620 mL) was added a 
solution of ethylaluminum dichloride (1.00 M in hexanes, 12.4 mL, 12.4 mmol, 2.00 equiv) in 
dichloromethane (30 mL) dropwise at –78 °C over a period of 5 min. After 30 min, saturated aqueous 
potassium sodium tartrate solution (300 mL) was added and the reaction mixture was allowed to warm 
to 23 °C under vigorous stirring. Water (150 mL) was added and the layers were separated. The 
aqueous layer was extracted with dichloromethane (2 × 200 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residues were combined and purified by flash-column chromatography on silica gel (15% ethyl acetate 
in hexanes) to yield decalin ent-43 (4.64 g, 83%) as an off white foam. 
TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ 7.53 (dd, J = 8.3 Hz, 1.1, 2H), 7.38–7.33 (m, 2H), 7.28–7.24 (m, 1H), 
6.75–6.68 (m, 3H), 4.36 (s, 1H), 3.65 (s, 3H), 3.31–3.24 (m, 1H), 2.09–2.04 (m, 1H), 1.87–1.80 (m, 
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1H), 1.75–1.70 (m, 2H), 1.70–1.65 (m, 1H), 1.61–1.52 (m, 3H), 1.43 (dd, J = 12.7, 3.3 Hz, 1H), 1.39–
1.32 (m, 2H), 1.23 (s, 3H), 1.07 (s, 3H), 1.04 (s, 3H), 0.79 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 153.3, 144.3, 140.2, 131.2, 129.5, 127.0, 124.7, 118.2, 115.7, 114.4, 
80.5, 78.2, 55.7, 55.0, 45.3, 44.5, 39.2, 33.6, 31.3, 28.6, 27.6, 26.4, 21.2, 16.8, 15.8, 15.0. 
IR (Diamond-ATR, neat) ෤߭max: 3376(br w), 2956 (m), 1494 (vs), 1438 (m), 1236 (s), 1156 (m), 1041 
(m), 808 (m), 737 (s), 691 (s). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380; found: 452.2370. 
ሾࢻሿࡰ૛૙ = –193.8° (c = 1.00, CH2Cl2). 
 
Lewis Acid screen: 
To a solution epoxide ent-41 (10.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.2 mL) was 
added a solution of the Lewis acid (Table 1, 0.44 mmol, 2.00 equiv) in dichloromethane (0.5 mL) 
dropwise at –78 °C. After the time indicated, water (10 mL) was added. The mixture was extracted 
with dichloromethane (3 × 10 mL), the combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes) to yield the tetracycle ent-43 or acetal 
ent-42. 
 
Table 12: Lewis acid screen for the cyclization of ent-41. 
 
Entry Lewis acid Time [min] Yield ent-42 [%] Yield ent-43 [%] 
1 EtAlCl2 10  – 83 
2 Et2AlCl 150 51 39 
3 SnCl4 10 – 66* 
4 B(C6F5)3 30 – 59  
* along with inseperable impurities 
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Acetal ent-42 
Note: The acetal formation was carried out with pure (Z)-ent-41b and (E)-ent-41b separately. 
The procedure is described for (Z)-ent-42. Diethylaluminum chloride was used instead of 
ethylaluminum dichloride. 
To a solution epoxide (Z)-ent-41 (10.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.2 mL) 
was added a solution of diethylaluminum chloride (1.00 M in hexanes, 44.2 L, 0.44 mmol, 
2.00 equiv) in dichloromethane (0.5 mL) dropwise at –78 °C. After 10 min, water (10 mL) was added. 
The mixture was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue 
was purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to yield 
acetal (Z)-ent-42 (7.3 mg, 73%) as a colorless oil. 
(Z)-ent-42: 
TLC (20% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.29 (dt, J = 7.7, 1.1 Hz, 2H), 7.25–7.22 (m, 2H), 7.14–7.11 (m, 
1H), 7.10–7.07 (m, 2H), 6.81–6.77 (m, 2H), 5.88 (q, J = 1.3 Hz, 1H), 3.77 (s, 3H), 3.68 (d, J = 5.5 Hz, 
1H), 3.09–3.02 (m, 1H), 1.96–1.88 (m, 1H), 1.77 (d, J = 1.3 Hz, 3H), 1.76–1.73 (m, 2H), 1.73–1.64 
(m, 2H), 1.58–1.55 (m, 1H), 1.42–1.37 (m, 1H), 1.37–1.33 (m, 1H), 1.29–1.23 (m, 1H), 1.05 (s, 3H), 
1.05–1.04 (m, 6H). 
13C NMR (CDCl3, 201 MHz): δ = 155.8, 148.6, 148.1, 137.9, 128.9, 128.0, 125.6, 122.5, 115.4, 114.2, 
113.2, 81.4, 56.9, 55.7, 44.6, 36.8, 35.2, 29.9, 26.3, 25.4, 24.3, 24.0, 19.3, 18.3. 
IR (Diamond-ATR, neat) ෤߭max: 2959 (m), 1505 (vs), 1440 (w), 1299 (w), 1243 (m), 1213 (s), 1010 (w), 
836 (m), 739 (w), 690 (w). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380 found: 452.2378. 
ሾࢻሿࡰ૛૙ = +3.1° (c = 0.37, CH2Cl2). 
(E)-ent-42: 
TLC (20% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.30–7.28 (m, 2H), 7.23–7.20 (m, 2H), 7.11 (tt, J = 7.0, 1.2 Hz, 1H), 
7.09–7.03 (m, 2H), 6.81–6.75 (m, 2H), 5.96 (s, 1H), 3.77 (s, 3H), 3.70 (d, J = 5.4 Hz, 1H), 2.35–2.29 
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(m, 1H), 1.95–1.89 (m, 1H), 1.78 (d, J = 1.1 Hz, 3H), 1.78–1.67 (m, 4H), 1.57 (t, J = 6.9 Hz, 1H), 
1.38–1.34 (m, 2H), 1.32–1.26 (m, 1H), 1.10 (s, 3H), 1.09 (d, J = 6.8 Hz, 3H), 1.07 (s, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 155.8, 148.5, 147.9, 137.7, 129.0, 128.1, 125.6, 122.6, 115.1, 114.2, 
113.1, 81.4, 57.0, 55.7, 44.6, 43.9, 35.3, 29.9, 26.4, 25.3, 24.4, 23.9, 19.9, 14.7. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (m), 1504 (vs), 1439 (w), 1297 (m), 1242 (m), 1212 (s), 1009 (m), 
835 (m), 738 (m), 690 (w). 
HRMS (EI) calc. for C28H36O332S [M]+: 452.2380 found: 452.2374. 
ሾࢻሿࡰ૛૙ = –58.7° (c = 0.32, CH2Cl2). 
 
 
Tetracycle ent-43 
Note: A 1:1 mixture of acetal (Z)-ent-42 and (E)-ent-42 was used.  
To a solution acetal ent-42 (7.00 mg, 15.5 mol, 1 equiv) in dichloromethane (1.5 mL) was added a 
solution of ethylaluminum dichloride (1.00 M in hexanes, 30.9 L, 30.9 mol, 2.00 equiv) in 
dichloromethane (0.3 mL) dropwise at –78 °C. After 15 min, water (10 mL) was added and the 
reaction mixture was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residues were combined and purified by flash-column chromatography on silica gel (20% ethyl acetate 
in hexanes) to yield ent-43 (6.3 mg, 90%) as a white foam. 
 
 
Ferrocene S86 
To a suspension of ferrocene carboxylic acid (10.0 mg, 43.5 mol, 2.00 equiv) in 
dichloromethane (1.0 mL) was added oxalyl chloride solution (2.00 M in dichloromethane, 23.9 L, 
47.8 mol, 2.20 equiv), followed by 1 drop of N,N-dimethylformamide at 23 °C. After 45 min, toluene 
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(1.0 mL) was added and the mixture was concentrated. To a solution of tetracycle ent-43 (10.0 mg, 
22.1 mol, 1 equiv) and 4-dimethylaminopyridine (27.0 mg, 0.22 mmol, 10.0 equiv) in 
dichloromethane (0.5 mL) was added a solution of the freshly prepared ferrocenecarboxylic acid 
chloride in dichloromethane (0.5 mL) at 23 °C. After 2 h, the reaction mixture was directly purified by 
flash-column chromatography on silica gel (dichloromethane) to yield ferrocene S86 (10.2 mg, 70%) 
as an orange foam. Crystallization from diethyl ether gave crystals suitable for X-ray diffraction. 
TLC (dichloromethane): Rf = 0.63 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): δ = 7.55–7.52 (m, 2H), 7.38–7.35 (m, 2H), 7.28–7.25 (m, 1H), 6.76 (d, 
J = 8.8 Hz, 1H), 6.75–6.71 (m, 2H), 4.86–4.80 (m, 2H), 4.67 (dd, J = 11.6, 3.9 Hz, 1H), 4.43–4.38 (m, 
2H), 4.38 (s, 1H), 4.20 (s, 5H), 3.65 (s, 3H), 2.15–2.07 (m, 1H), 1.94–1.79 (m, 3H), 1.73–1.68 (m, 
2H), 1.63–1.57 (m, 3H), 1.46–1.32 (m, 1H), 1.27 (s, 6H), 1.04 (s, 3H), 0.81 (d, J = 6.7 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 171.5, 153.4, 144.3, 140.1, 131.3, 129.5, 127.0, 124.8, 118.2, 115.8, 
114.4, 80.4, 79.5, 72.2, 71.3, 71.2, 70.4, 70.1, 69.8, 55.7, 54.9, 45.5, 44.5, 38.2, 33.7, 31.2, 28.4, 27.6, 
23.3, 21.1, 16.8, 16.6, 15.8. 
IR (Diamond-ATR, neat) ෤߭max: 2958 (m), 1707 (s), 1495 (s), 1459 (m), 1374 (w), 1275 (s), 1140 (s), 
1040 (m), 963 (w), 821 (w). 
HRMS (EI) calc. for C39H4456FeO432S [M]+: 664.2310 found: 664.2307. 
ሾࢻሿࡰ૛૙	= –96.6° (c = 1.00, CH2Cl2). 
 
 
Alcohol ent-37 
To a solution of sulfide ent-43 (4.50 g, 9.94 mmol, 1 equiv) in dichloromethane (45 mL) and 
triethylsilane (8.03 mL, 49.7 mmol, 5.00 equiv) was added boron trifluoride etherate (47% in diethyl 
ether, 6.53 mL, 24.9 mmol, 2.50 equiv) at 23 °C. After 15 min, saturated sodium bicarbonate solution 
(250 mL) was added and the mixture was extracted with dichloromethane (3 × 200 mL). The 
combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(20% ethyl acetate in hexanes initially, grading to 50% ethyl acetate in hexanes) to afford ent-37 
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(3.34 g, 97%) as a white solid. The obtained characterization data were in full agreement with those of 
37 (see page172). 
ሾࢻሿࡰ૛૙	= –14.0° (c = 1.00, CH2Cl2). 
 
 
Thiocarbonate ent-S83 
To a solution of alcohol ent-37 (3.20 g, 9.29 mmol, 1 equiv) in dichloromethane (60 mL) and 
4-dimethylaminopyridine (3.41 g, 27.9 mmol, 3.00 equiv) was added pentafluorophenyl 
chlorothionoformate (2.98 mL, 18.6 mmol, 2.00 equiv) at 0 °C. After 5 min, the reaction mixture was 
allowed to warm to 23 °C. After 2 h, saturated aqueous sodium bicarbonate solution (200 mL) was 
added and the mixture was extracted with dichloromethane (4 × 200 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (4% ethyl 
acetate in hexanes) to furnish thiocarbonate ent-S83 (3.72 g, 70%) as a colorless solid. The obtained 
characterization data were in full agreement with those of S83 (see page 173). 
ሾࢻሿࡰ૛૙	= –41.8° (c = 1.00, CH2Cl2). 
 
 
Methoxy-5-epi-aureol ent-S84 
A solution of thiocarbonate ent-S83 (3.72 g, 6.52 mmol, 1 equiv), tributyltin hydride 
(5.27 mL, 19.6 mmol, 3.00 equiv) and azobisisobutyronitrile (214 mg, 1.30 mmol, 0.20 equiv) in 
benzene (150 mL) was heated to 80 °C in a pressure flask. After 2 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (hexanes 
initially, grading to 2% ethyl acetate in hexanes) to give ent-S84 (1.95 g, 91%) as a white solid. The 
obtained characterization data were in full agreement with those of S84 (see page 174). 
ሾࢻሿࡰ૛૙ = +13.1 (c = 1.00, CH2Cl2). 
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(+)-5-epi-Aureol (38) 
To a solution of methyl ether ent-S84 (1.90 g, 5.78 mol, 1 equiv) in dichloromethane (55 mL) 
was added boron tribromide (1.00 M in hexanes, 57.8 mL, 57.8 mmol, 10.0 equiv) at –78 °C. After 
10 min, the reaction mixture was allowed to warm to 23 °C. After 1.5 h, methanol (20 mL) was 
carefully added and the mixture was partitioned between saturated aqueous sodium bicarbonate 
solution (300 mL) and dichloromethane (150 mL). The layers were separated and the aqueous layer 
was extracted with dichloromethane (2 × 150 mL). The combined organic extracts were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silica gel (5% ethyl aceate in hexanes) to give (+)-5-epi-
aureol (38) (1.55 g, 85%) as a colorless solid. The obtained characterization data were in full 
agreement with those of (–)-5-epi-aureol (38) (see page 175). 
ሾࢻሿࡰ૛૙ = +10.6 (c = 1.00, CHCl3); +12.5 (c = 0.17, CHCl3; (+)-5-epi-Aureol)[105] 
 
 
Bromide S87 
To a solution of (+)-5-epi-aureol (38) (1.55 g, 4.93 mmol, 1 equiv) in chloroform (150 mL) 
was added a solution of bromide in chloroform (0.22 M, 22.7 mL, 4.93 mmol, 1.00 equiv) dropwise at 
–55 °C over a period of 15 min. After 30 min, saturated aqueous sodium thiosulfate solution (100 mL) 
and saturated aqueous sodium chloride solution (100 mL) were added and the mixture was extracted 
with dichloromethane (3 × 150 mL). The combined organic extracts were dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The residue was purified by flash-
column chromatography on silica gel (10% ethyl aceate in hexanes) to give bromide S87 (1.80 g, 
93%) as a white solid. 
TLC (20% ethyl acetate in hexanes): Rf = 0.47 (UV, CAM). 
melting point: 158–160 °C 
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1H NMR (CDCl3, 599 MHz): δ = 6.82 (d, J = 8.8 Hz, 1H), 6.73 (d, J = 8.8 Hz, 1H), 5.11 (s, 1H), 2.71 
(d, J = 17.8 Hz, 1H), 2.31 (d, J = 17.8 Hz, 1H), 1.74–1.65 (m, 2H), 1.63–1.54 (m, 3H), 1.51–1.46 (m, 
1H), 1.45–1.42 (m, 1H), 1.40 (dd, J = 12.7, 3.6 Hz, 1H), 1.35–1.24 (m, 3H), 1.22–1.15 (m, 1H), 1.10 
(s, 3H), 0.96 (s, 3H), 0.92 (s, 3H), 0.77 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 147.0, 145.8, 121.3, 117.1, 114.0, 112.3, 81.2, 45.6, 42.1, 37.9, 
35.1, 33.6, 32.7, 32.3, 30.6, 28.5, 22.5, 21.9, 17.9, 16.9, 16.5. 
IR (Diamond-ATR, neat) ෤߭max: 3487 (w), 2952 (m), 1475 (vs), 1431 (m), 1247 (m), 1193 (m), 1170 (s), 
949 (m), 881 (w), 810 (m), 740 (w). 
HRMS (EI) calc. for C21H29O279Br [M]+: 392.1345; found: 392.1358. 
ሾࢻሿࡰ૛૙ = 9.6 (c = 1.00, CH2Cl2). 
 
 
Methyl ether 44 
To a suspension of phenol S87 (1.77 g, 4.50 mmol, 1 equiv) and potassium carbonate (2.18 g, 
15.7 mmol, 3.50 equiv) in acetone (25 mL) was added dimethyl sulfate (1.07 mL, 11.2 mmol, 
2.50 equiv) at 23 °C. After 15 h, the reaction mixture was filtered through a plug of Celite® and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(5% ethyl aceate in hexanes) to give methyl ether 44 (1.60 g, 87%) as a white solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
melting point: 202–204 °C 
1H NMR (CDCl3, 800 MHz): δ 6.76 (d, J = 8.9 Hz, 1H), 6.74 (d, J = 8.9 Hz, 1H), 3.84 (s, 3H), 2.82 
(d, J = 17.9 Hz, 1H), 2.32 (d, J = 17.9 Hz, 1H), 1.74–1.64 (m, 2H), 1.65–1.55 (m, 3H), 1.50–1.46 (m, 
1H), 1.45–1.42 (m, 1H), 1.40 (dd, J = 12.7, 3.6 Hz, 1H), 1.36–1.26 (m, 3H), 1.21–1.16 (m, 1H), 1.11 
(s, 3H), 0.97 (s, 3H), 0.92 (s, 3H), 0.77 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 149.7, 147.7, 123.0, 115.9, 114.2, 111.3, 81.2, 57.1, 45.6, 42.1, 
37.9, 35.2, 33.6, 32.7, 32.3, 30.6, 28.6, 22.6, 21.9, 18.0, 16.9, 16.5. 
IR (Diamond-ATR, neat) ෤߭max: 2930 (m), 1476 (vs), 1435 (m), 1387 (w), 1247 (s), 1170 (m), 1069 (m), 
949 (m), 873 (w), 804 (m), 739 (w). 
HRMS (EI) calc. for C22H31O279Br [M]+: 406.1502; found: 406.1503. 
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ሾࢻሿࡰ૛૙ = 5.0 (c = 1.00, CH2Cl2). 
 
 
Phenol S88 
Isopropyl pinacol borate was dried by azeotropic distillation (benzene, 2 × 20 mL) prior to use. 
To a solution of bromide 44 (1.50 g, 3.68 mmol, 1 equiv) and isopropyl pinacol borate (3.01 mL, 
14.7 mmol, 4.00 equiv) in tetrahydrofuran (37 mL) was added a solution of t-butyllithium (1.60 M in 
pentane, 6.91 mL, 11.0 mmol, 3.00 equiv) at –78 °C. After 1.5 h, the reaction mixture was allowed to 
warm to 0 °C. After 15 min, aqueous sodium hydroxide solution (10%; 15 mL) and aquoues hydrogen 
peroxide solution (30%; 30 mL) were added and the reaction mixture was allowed to warm to 23 °C. 
After 45 min, saturated aqueous ammonium chloride solution (200 mL) was added and the mixture 
was extracted with diethyl ether (3 × 200 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash-column chromatography on silica gel (5% ethyl aceate in hexanes) to give phenol S88 (949 mg, 
75%) as a white solid and methyl ether ent-S84 (259 mg, 21%) as a white solid. 
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (UV, CAM). 
melting point: 197–200 °C 
1H NMR (CDCl3, 800 MHz): δ = 6.67 (d, J = 8.7 Hz, 1H), 6.33 (d, J = 8.7 Hz, 1H), 5.63 (s, 1H), 3.83 
(s, 3H), 2.79 (d, J = 17.6 Hz, 1H), 2.28 (d, J = 17.6 Hz, 1H), 1.79–1.74 (m, 1H), 1.74–1.69 (m, 1H), 
1.69–1.61 (m, 2H), 1.57–1.53 (m, 1H), 1.50–1.46 (m, 1H), 1.45–1.41 (m, 1H), 1.39 (dd, J = 12.7, 3.6 
Hz, 1H), 1.35–1.25 (m, 3H), 1.22–1.16 (m, 1H), 1.11 (s, 3H), 0.95 (s, 3H), 0.91 (s, 3H), 0.77 (d, J = 
6.8 Hz, 3H). 
13C NMR (CDCl3, 201 MHz): δ = 147.6, 143.6, 139.5, 109.7, 109.2, 106.7, 81.0, 56.8, 45.7, 42.2, 
36.8, 33.6, 32.8, 32.2, 30.7, 28.6, 28.1, 22.6, 22.0, 18.0, 17.1, 16.6. 
IR (Diamond-ATR, neat) ෤߭max: 3526 (w), 2949 (m), 1488 (vs), 1439 (s), 1242 (vs), 1170 (s), 1040 (s), 
1027 (s), 925 (m), 795 (m), 738 (m). 
HRMS (EI) calc. for C22H32O2 [M]+: 344.2346; found: 344.2352. 
ሾࢻሿࡰ૛૙ = –3.5 (c = 1.00, CH2Cl2). 
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5-epi-Smenoqualone (45) 
N,N′-Bis(salicylidene)ethylenediaminocobalt(II) (444 mg, 1.36 mmol, 0.50 equiv) was added 
to a solution of phenol S88 (940 mg, 2.73 mmol, 1 equiv) in N,N-dimethylformamide (90 mL) at 
23 °C and oxygen was bubbled through the reaction mixture for 30 min. After 30 min, water (200 mL) 
was added and the mixture was extracted with diethyl ether (4 × 200 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (30% ethyl 
acetate in hexanes) to give 5-epi-smenoqualone (45) (749 mg, 77%) as a yellow foam. Crystallization 
from diethyl ether gave 45 as yellow crystals. 
TLC (30% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
melting point: 166–167 °C 
1H NMR (CDCl3, 800 MHz): δ 5.73 (s, 1H, H-19), 3.81 (s, 3H, H-22), 2.57 (d, 2J15A/15B = 18.8 Hz, 1H, 
H-15A), 2.00 (d, 2J15B/15A = 18.8 Hz, 1H, H-15B), 1.70–1.66 (m, 1H, H-1A), 1.64–1.57 (m, 3H, H-6, H-
2A), 1.52–1.48 (m, 1H, H-7A), 1.48–1.45 (m, 1H, H-3A), 1.45–1.40 (m, 2H, H-5, H-8), 1.39–1.33 (m, 
2H, H-1B, H-2B), 1.32–1.24 (m, 1H, H-7B), 1.22–1.19 (m, 1H, H-3B), 1.17 (s, 3H, H-11), 0.95 (s, 3H, 
H-14), 0.93 (s, 3H, H-12), 0.77 (d, 3J13/8 = 6.7 Hz, 3H, H-13). 
13C NMR (CDCl3, 201 MHz): δ = 181.6 (C-18), 181.5 (C-21), 159.6 (C-20), 152.8 (C-17), 115.3 (C-
16), 105.0 (C-19), 86.6 (C-10), 56.5 (C-22), 45.8 (C5), 41.8 (C-3), 37.4 (C-9), 33.6 (C-4), 32.6 (C-12), 
32.5 (C-8), 30.4 (C-7), 29.5 (C-1), 26.8 (C-15), 22.3 (C-11), 22.0 (C-6), 17.9 (C-2), 17.0 (C-14), 16.5 
(C-13). 
IR (Diamond-ATR, neat) ෤߭max: 2942 (w), 1661 (m), 1639 (w), 1599 (vs), 1456 (w), 1353 (w), 1353 (w), 
1227 (m), 1213 (m), 1161 (w), 1049 (m), 840 (w). 
HRMS (EI) calc. for C22H30O4 [M]+: 358.2139; found: 358.2140. 
ሾࢻሿࡰ૛૙ = –83.4 (c = 1.00, CHCl3); –75.6 (c = 0.16, CHCl3; (–)-5-epi-Smenoqualone)[103]; +69.3 (c = 
0.10, CHCl3; (+)-5-epi-Smenoqualone).[115]  
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Table 13: Comparison of 1H NMR data for reported and synthetic 5-epi-smenoqualone (21). 
Proton 
 
Synthetic  
(800 MHz, CDCl3) 
Marcos  
(200 MHz, CDCl3)[115] 
Δδ  
(ppm) 
Capon 
(400 MHz, CDCl3)[103]  
Δδ  
(ppm) 
1A 1.70–1.66 (m) 
1.98–1.36 (m, 12H) 
 
not reported 
 
1B 1.39–1.33 (m)   
2A 1.64–1.57 (m)   
2B 1.39–1.33 (m)   
3A 1.48–1.45 (m)   
3B 1.22–1.19 (m)   
5 1.45–1.40 (m)   
6 1.64–1.57 (m)   
7A 1.52–1.48 (m)   
7B 1.32–1.24 (m)   
8 1.45–1.40 (m)   
11 1.17 (s) 1.17 (s) ± 0.00 1.17 ± 0.00 
12 0.93 (s) 0.94 + 0.01 0.94 + 0.01 
13 0.77 (d, 6.7 Hz) 0.77 (d, 6.0 Hz) ± 0.00 0.77 (d, 6.0 Hz) ± 0.00 
14 0.95(s) 0.96 (s) + 0.01 0.96 + 0.01 
15A 2.57 (d, 18.8 Hz) 2.57 (d, 20.0 Hz) ± 0.00 2.57 (d, 20.0 Hz ± 0.00 
15B 2.00 (d, 18.8 Hz) 2.00 (d, 20.0 Hz) ± 0.00 2.00 (d, 20.0 Hz) ± 0.00 
19 5.73 (s) 5.74 (s) + 0.01 5.74 + 0.01 
22 3.81 (s) 3.80 (s) – 0.01 3.81 ± 0.00 
 
 
Table 14: Comparison of 13C NMR data for reported and synthetic 5-epi-smenoqualone (21). 
Carbon Synthetic  
(201 MHz, CDCl3) 
Marcos  
(50 MHz, CDCl3)[115] 
Δδ  
(ppm) 
Capon 
(100 MHz, CDCl3)[103]  
Δδ  
(ppm) 
1 29.5 29.5* ± 0.0 29.4 + 0.1 
2 17.9 17.8 + 0.1 17.8 + 0.1 
3 41.8 41.7 + 0.1 41.7 + 0.1 
4 33.6 33.5 + 0.1 33.5 + 0.1 
5 45.8 45.5 + 0.3 45.6 + 0.2 
6 22.0 22.0 ± 0.0 21.9 + 0.1 
7 30.4 30.3* + 0.1 30.3 + 0.1 
8 32.5 32.4 + 0.1 32.4 + 0.1 
9 37.4 37.0 + 0.4 37.2 + 0.2 
10 86.6 86.5 + 0.1 86.4 + 0.2 
11 22.3 22.3 ± 0.0 22.2 + 0.1 
12 32.6 32.5 + 0.1 32.5 + 0.1 
13 16.5 16.4 + 0.1 16.4 + 0.1 
14 17.0 17.0 ± 0.0 17.0 ± 0.0 
15 26.8 26.7* + 0.1 26.7 + 0.1 
16 115.3 115.1 + 0.2 115.2 + 0.1 
17 152.8 152.5 + 0.3 152.7 + 0.1 
18 181.6 181.5 + 0.1 181.4 + 0.2 
19 105.0 105.0 ± 0.0 104.9 + 0.1 
20 159.6 159.5 + 0.1 159.5 + 0.1 
21 181.5 181.5 ± 0.0 181.5 ± 0.0 
22 56.5 56.4 + 0.1 56.4 + 0.1 
* Carbon was reassigned by us on the basis of 2D NMR studies. 
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(–)-Cyclosmenospongine (4) 
To a solution of 5-epi-smenoqualone (45) (740 mg, 2.06 mmol, 1 equiv) and pyridine (60 mL) 
in aqueous methanol (50%, 500 mL) was added aqueous ammonia (25%, 60 mL) at 23 °C. After 16h, 
the reaction mixture was concentrated and the residue was extracted with diethyl ether (5 × 300 mL). 
The combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash-column chromatography on silica gel 
(20% ethyl acetate in hexanes initially, grading to 30% ethyl acetate in hexanes) to yield                        
(–)-cyclosmenospongine (4) (423 mg, 60%) as a dark red crystalline solid. Recrystallization from 
diethyl ether gave crystals suitable for X-ray diffraction. 
TLC (30% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
melting point: 240–242 °C 
1H NMR (CDCl3, 800 MHz): δ = 5.54 (s, 1H, H-19), 5.05 (s, 2H, NH2), 2.52 (d, 2J15A/15B = 18.3 Hz, 
1H, H-15A), 1.97 (d, 2J15B/15A = 18.3 Hz, 1H, H-15B), 1.74–1.69 (m, 1H, H-1A), 1.67–1.58 (m, 3H, H-
6, H-2A), 1.52–1.44 (m, 3H, H-7A, H-8, H-3A), 1.42 (dd, 3J5/6A = 12.2 Hz, 3J5/6B = 4.1 Hz, 1H, H-5), 
1.39–1.32 (m, 2H, H-1B, H-2B), 1.32–1.25 (m, 1H, H-7B), 1.22–1.16 (m, 4H, H-3B, H-11), 0.95 (s, 3H, 
H-14), 0.93 (s, 3H, H-12), 0.78 (d, 3J13/8 = 6.6 Hz, 3H, H-13). 
13C NMR (CDCl3, 201 MHz): δ = 182.6 (C-21), 180.3 (C-18), 154.8 (C-17), 147.6 (C-20), 113.0 (C-
16), 99.5 (C-19), 86.6 (C-10), 45.8 (C-5), 41.9 (C-3), 37.3 (C-9), 33.6 (C-4), 32.6 (C-12), 32.4 (C-8), 
30.4 (C-7), 29.7 (C-1), 26.7 (C-15), 22.3 (C-11), 22.0 (C-6), 18.0 (C-2), 17.0 (C-14), 16.5 (C-13). 
IR (Diamond-ATR, neat) ෤߭max: 3452 (w), 3335 (w), 2947 (w), 1640 (w), 1595 (vs), 1456 (w), 1371 (w), 
1215 (m), 1161 (m), 979 (w), 896 (w), 732 (w). 
HRMS (EI) calc. for C21H29O3N [M]+: 343.2142; found: 343.2140. 
ሾࢻሿࡰ૛૙ = –346.6 (c = 0.12, CHCl3); –18.0 (c = 0.10, CHCl3; (–)-cyclosmenospongine).[95]  
Elemental Analysis calc. (%) for C21H29O3N: C 73.44, H 8.51, N 4.08; found: C 72.90, H 8.51, N 
3.94. 
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Table 15: Comparison of 1H NMR data for natural and synthetic (–)-cyclosmenospongine (4). 
Proton 
 
Synthetic 
(800 MHz, CDCl3)* 
Natural
(300 MHz, CDCl3)[95] 
Δδ  
(ppm) 
1A 1.74–1.69 (m) 1.84 (m) – 0.12 
1B 1.39–1.32 (m) 1.49 (m) – 0.13 
2A 1.67–1.58 (m) 1.59 (m) + 0.04 
2B 1.39–1.32 (m) 1.51 (m) – 0.15 
3A 1.52–1.44 (m) 1.51 (m) – 0.03 
3B 1.22–1.16 (m) 1.25 (m) – 0.06 
5 1.42 (dd, 12.2, 4.1 Hz) 1.51 (m) – 0.09 
6 1.67–1.58 (m) 1.66 (m), 1.51 (m)   
7A 1.52–1.44 (m) 1.54 (m) – 0.06 
7B 1.32–1.25 (m) 1.29 (m) ± 0.00 
8 1.52–1.44 (m) 0.98 (m) + 0.50 
11 1.19 (s) 1.02 (s)  + 0.17 
12 0.93 (s) 0.98 (s) – 0.05 
13 0.78 (d, 6.6 Hz) 0.78 (d, 6.4 Hz) ± 0.00 
14 0.95 (s) 0.97 (s) – 0.02 
15A 2.52 (d, 18.3 Hz) 2.57 (d, 18.8 Hz) – 0.05 
15B 1.97 (d, 18.3 Hz) 2.06 (d, 18.8 Hz) – 0.09 
19 5.54 (s) 5.54 (s) ± 0.00 
NH2 5.05 (br s) 5.65 (br) – 0.50 
* acid-free CDCl3 was used for the NMR measurement. 
 
Table 16: Comparison of 13C NMR data for natural and synthetic (–)-cyclosmenospongine (4). 
Carbon Synthetic  
(201 MHz, CDCl3)* 
Natural 
(76 MHz, CDCl3)[95]  
Δδ  
(ppm) 
1 29.7 29.1 + 0.6 
2 18.0 17.8 + 0.2 
3 41.9 40.9 + 1.0 
4 33.6 33.2 + 0.4 
5 45.8 45.7 + 0.1 
6 22.0 22.0 ± 0.0 
7 30.4 30.1 + 0.3 
8 32.4 32.3 + 0.1 
9 37.3 37.6 – 0.3 
10 86.6 88.6 – 2.0 
11 22.3 22.4 – 0.1 
12 32.6 32.4 + 0.2 
13 16.5 16.3 + 0.2 
14 17.0 17.1 – 0.1 
15 26.7 26.7 ± 0.0 
16 113.0 113.3 – 0.3 
17 154.8 153.6 + 1.2 
18 180.3 177.6# + 2.7 
19 99.5 98.1 + 1.4 
20 147.6 152.3 – 4.7 
21 182.6 180.5# + 2.1 
* acid-free CDCl3 was used for the NMR measurement.  
# Carbon was reassigned by us on the basis of 2D-NMR studies. 
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3.3.2. NMR studies of (–)-Cyclosmenospongine (4) 
 
3.3.2.1 Concentration effects: 
A 1H NMR spectrum was recorded with different amounts of (–)-cyclosmenospongine (4)       
(1 mg, 5 mg, 10 mg, 30 mg) in CDCl3 (0.7 mL). 
 
Figure 10: 1H NMR (400MHz) of (–)-cyclosmenospongine (4) at different concentrations. 
 
3.3.2.2.Addition of HCl: 
Preparation of HCl/CDCl3 solution:  
Deuterated chloroform (CDCl3) was purged with hydrogen chloride gas (freshly prepared by the slow 
dropwise addition of concentrated aqueous sulfuric acid to a vigorously stirred suspension of sodium 
chloride and concentrated aqueous hydrogen chloride solution) for 15 min. 
To a solution of (–)-cyclosmenospongine (4) (30 mg) in CDCl3 (0.5 mL) was sequentially 
added a freshly prepared HCl/CDCl3 solution (50 L, 50 L, 100 L, 100 L and 200 L). After 
every addition a 1H and 13C NMR spectrum was recorded. 
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Figure 11: 1H NMR (400 MHz) spectra of 4 after the addition of CDCl3 saturated with HCl. 
 
 
Figure 12: 13C NMR (101 MHz) spectra of 4 after the addition of CDCl3 saturated with HCl. 
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Table 17: 13C NMR shifts of 4 after the addition of CDCl3 saturated with HCl and shift differences to the 
reported spectrum of natural 4.[95]  
 
 
 
 
Figure 13: Selected carbon atoms of (–)-cyclosmenospongine (4) and the influence of protonation on their          
13C NMR shifts. 
 
Carbon
Natural    
(76 MHz, 
CDCl3)95
Synthetic  
(201 Hz, 
CDCl3)

Synthetic  
(50 L;     
101 Hz, 
CDCl3)

Synthetic  
(100 L;    
101 Hz, 
CDCl3)

Synthetic  
(200 L;    
101 Hz, 
CDCl3)

Synthetic  
(300 L;    
101 Hz, 
CDCl3)

Synthetic  
(500 L;    
101 Hz, 
CDCl3)

1 29.1 29.7 0.6 29.7 0.6 29.7 0.6 29.8 0.7 29.9 0.8 29.9 0.8
2 17.8 18.0 0.2 17.9 0.1 17.9 0.1 17.9 0.1 17.9 0.1 17.7 –0.1
3 40.9 41.9 1.0 41.8 0.9 41.7 0.8 41.7 0.8 41.6 0.7 41.4 0.5
4 33.2 33.6 0.4 33.5 0.3 33.5 0.3 33.5 0.3 33.5 0.3 33.3 0.1
5 45.7 45.8 0.1 45.7 0.0 45.7 0.0 45.7 0.0 45.7 0.0 45.6 –0.1
6 22.0 22.0 0.0 22.0 0.0 22.0 0.0 22.0 0.0 22.0 0.0 21.9 –0.1
7 30.1 30.4 0.3 30.3 0.2 30.3 0.2 30.3 0.2 30.3 0.2 30.1 0.0
8 32.3 32.4 0.1 32.3 0.0 32.4 0.1 32.4 0.1 32.5 0.2 32.4 0.1
9 37.6 37.3 –0.3 37.2 –0.4 37.3 –0.3 37.3 –0.3 37.3 –0.3 37.2 –0.4
10 88.6 86.6 –2.0 86.8 –1.8 87.1 –1.5 87.7 –0.9 88.3 –0.3 89.0 0.4
11 22.4 22.3 –0.1 22.2 –0.2 22.2 –0.2 22.2 –0.2 22.2 –0.2 22.0 –0.4
12 32.4 32.6 0.2 32.6 0.2 32.6 0.2 32.6 0.2 32.6 0.2 32.4 0.0
13 16.3 16.5 0.2 16.5 0.2 16.5 0.2 16.5 0.2 16.5 0.2 16.3 0.0
14 17.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 17.0 –0.1 16.9 –0.2
15 26.7 26.7 0.0 26.6 –0.1 26.6 –0.1 26.5 –0.2 26.5 –0.2 26.4 –0.3
16 113.3 113.0 –0.3 112.8 –0.5 112.8 –0.5 112.8 –0.5 112.8 –0.5 112.7 –0.6
17 153.6 154.8 1.2 155.2 1.6 155.5 1.9 156.1 2.5 156.7 3.1 157.3 3.7
18 177.6 180.3 2.7 179.6 2.0 178.9 1.3 177.3 –0.3 175.7 –1.9 173.3 –4.3
19 98.1 99.2 1.1 98.8 0.7 98.5 0.4 97.9 –0.2 97.3 –0.8 96.3 –1.8
20 152.3 147.6 –4.7 148.9 –3.4 149.9 –2.4 151.7 –0.6 153.6 1.3 156.1 3.8
21 180.5 182.6 2.1 182.0 1.5 181.4 0.9 180.3 –0.2 179.1 –1.4 177.3 –3.2
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Figure 14: left: (–)-cyclosmenospongine (1) in CDCl3 (bright red); right: (–)-cyclosmenospongine (1) in 
HCl/CDCl3 (purple, reported as wine-red[95])  
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3.3.3. (E)-Enol Ether Synthesis 
 
Alcohol S90 
Aldehyde S89 was prepared according to the procedure described by Dulcère.[186]   
To a solution of 2-methyl-3-buten-2-ol (21.8 mL, 209 mmol, 1 equiv) and vinyl ethyl ether (42.0 mL, 
439 mmol, 2.10 equiv) in a pressure tube was added concentrated phosphoric acid (61.0 μL, 
1.04 mmol, 0.01 equiv) and the reaction mixture was heated to 150 °C. After 2 h, the mixture was 
allowed to cool to 23 °C. The crude aldehyde S89 (22.4 g) was used in the next step without further 
purification.   
Alcohol S90 was prepared according to the procedure described by Corey.[187]  
A solution of crude aldehyde S89 (22.4 g, 200 mmol, 1 equiv) in diethyl ether (100 mL) was added to 
a suspension of lithium aluminum hydride (9.28 g, 220 mmol, 1.10 equiv) in diethyl ether (200 mL) at 
0 °C. After 5 min, the reaction mixture was allowed to warm to 23 °C. After 2 h, the mixture was 
cooled to 0 °C and aqueous sodium hydroxide solution (10%, 10 mL) and water (10 mL) were added 
carefully. The mixture was allowed to warm to 23 °C and sodium sulfate was added. After 10 min, the 
dried solution was filtrated and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (10% ethyl acetate in hexanes initially, grading to 50% ethyl acetate in 
hexanes) to yield alcohol S90 (13.0 g, 55% over two steps) as a colourless oil. Characterization data 
obtained for S90 were in full agreement with values previously reported.[187]  
 
 
Iodide S91 
Iodide S91 was prepared according to the procedure described by Heathcock.[188]  
To a solution of alcohol S90 (13.0 g, 114 mmol, 1 equiv) in dichloromethane (240 mL) was added 
triphenylphosphine (32.9 g, 125 mmol, 1.10 equiv) and imidazole (9.31 g, 137 mmol, 1.20 equiv) at 
23 °C. After 30 min, the reaction mixture was cooled to 0 °C and iodide (39.1 g, 154 mmol, 
1.35 equiv) was added in small portions. After 2 h, saturated aqueous sodium thiosulfate solution 
(300 mL) was added and the aqueous layer was extracted with dichloromethane (3 × 150 mL).The 
combined organic extracts were dried over sodium sulfate, the dried solution was filtrated and the 
filtrate was concentrated. The residue was dissolved in a minimum amount of dichloromethane 
(20 mL) and a mixture of hexanes and diethyl ether (1:1, 200 mL) was added. The precipitating 
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triphenylphosphine oxide was removed by filtration through a pad of Celite®. The filtrate was 
concentrated the residue was purified by flash-column chromatography on silica gel (hexanes) to yield 
iodide S91 (22.3 g, 87%) as a yellowish oil. Characterization data obtained for S91 were in full 
agreement with values previously reported.[189] 
 
 
Phosphonium salt S92 
Phosphonium iodide S92 was prepared according to the procedure described by Ksander.[190]  
To a solution of iodide S91 (12.0 g, 53.6 mmol, 1.10 equiv) in toluene (100 mL) was added 
triphenylphosphine (12.8 g, 48.7 mmol, 1 equiv) in a pressure tube and the reaction mixture was 
heated to 115 °C. After 19 h, the mixture was allowed to cool to 23 °C and the mixture was 
concentrated. The residue was washed with ethyl acetate (3 × 5 mL) and diethyl ether (3 × 5 mL). The 
washed solid was dried by azeotropic distillation with toluene (2 × 5 mL). The residue was dried under 
high vacuum to yield phosphonium salt S92 (21.1 g, 89%) as an off-white solid. Characterization data 
obtained for S92 were in full agreement with values previously reported.[190]  
 
S
S93
PhSCl, DIPEA
CH3CN, 23 °C
(23%)
OH
O
 
Pyran S93 
Pyran S93 was prepared according to the procedure described by A. G. Fallis.[183]   
To a solution of diphenyldisulfide (5.45 g, 25.0 mmol, 0.50 equiv) and pyridine (40 L) in acetonitrile 
(75 mL) was added sulfuryl chloride (2.06 mL, 25.5 mmol, 0.51 equiv) dropwise at 0 °C. After 
20 min, the orange solution was added to a solution of 5-hexen-1-ol (5.00 g, 49.9 mmol, 1 equiv) in 
acetonitrile (75 mL) at 23 °C. After 2 h, a solution of N,N-diisopropylethylamine (10.4 mL, 
59.9 mmol, 1.20 equiv) in acetonitrile (30 mL) was added dropwise to the reaction mixture. After 
30 min, the reaction mixture was concentrated and the residue was extracted with diethyl ether 
(200 mL). The organic extract was washed with water (3 × 100 mL) and saturated aqueous ammonium 
chloride solution (2 × 75 mL). The washed solution was dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (5% ethyl acetate in hexanes) to give pyran S93 (2.35 g, 23%) as a 
yellow oil. The obtained characterization data were in full agreement with those reported in 
literature.[183]  
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Alcohol S94 
Alcohol S94 was prepared according to the procedure described by S. Takano.[191]   
To a solution of pyran S93 (2.18 g, 10.5 mmol, 1 equiv) in tetrahydrofuran (20 mL) was added a 
solution of n-butyllithium (2.31 M in hexanes, 5.44 mL, 12.6 mmol, 1.20 equiv) dropwise at –78 °C 
within 10 min. After 20 min, water (30 mL) was added and the mixture was extracted with diethyl 
ether (3 × 50 mL). The combined organic extracts were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash-column 
chromatography on silica gel (30% ethyl acetate in hexanes) to give alcohol S94 (1.99 g, 91%, E:Z = 
1.8:1) as a yellow oil.  
TLC (40% ethyl acetate in hexanes), Rf = 0.31 (UV, KMnO4) 
1H NMR (CDCl3, 599 MHz): (E): δ = 7.37–7.27 (m, 4H), 7.24–7.15 (m, 1H), 6.16 (dt, J = 14.9, 
1.4 Hz, 1H), 5.98 (dt, J = 14.9, 7.0 Hz, 1H), 3.71–3.64 (m, 2H), 2.24–2.18 (m, 2H), 1.67–1.58 (m, 
2H), 1.57–1.48 (m, 2H), 1.27 (br s, 1H); (Z): δ = 7.37–7.27 (m, 4H), 7.24–7.15 (m, 1H), 6.22 (dt, 
J = 9.2, 1.4 Hz, 1H), 5.82 (dt, J = 9.2, 7.3 Hz, 1H), 3.70–3.63 (m, 2H), 2.36–2.26 (m, 2H), 1.66–1.58 
(m, 2H), 1.57–1.48 (m, 2H), 1.27 (br s, 1H). 
13C NMR (CDCl3, 151 MHz): (E): δ = 136.8, 136.5, 129.1, 128.7, 126.3, 121.5, 62.9, 32.9, 32.3, 25.4. 
(Z): δ = 136.5, 133.1, 129.1, 128.9, 126.3, 123.3, 62.9, 32.4, 28.9, 25.3. 
IR (Diamond-ATR, neat) ෤߭max: 3331 (br m), 2933 (m), 2859 (m), 1583 (m), 1479 (m), 1439 (m), 
1089 (m), 1068 (m), 1025 (m), 952 (m), 738 (s), 690 (s). 
HRMS (ESI) calc. for C12H16OS [M]+: 208.0916 found: 208.0908. 
 
 
Aldehyde S95 
To a suspenion of alcohol S94 (900 mg, 4.32 mmol, 1 equiv) and sodium bicarbonate (1.81 g, 
21.6 mmol, 5.00 equiv) in dichloromethane (20 mL) was added Dess–Martin-periodinane (2.38 g, 
5.62 mmol, 1.30 equiv) at 0 °C. After 10 min, the reaction mixture was allowed to warm to 23 °C. 
After 1 h, saturated aqueous sodium bicarbonate solution (100 mL) was added and the mixture was 
extracted with dichloromethane (3 × 200 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
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flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to give the aldehyde S95 
(540 mg, 60%, E:Z = 1.2:1) as a colorless oil.  
TLC (20% ethyl acetate in hexanes), Rf = 0.31 (UV, KMnO4) 
1H NMR (CDCl3, 599 MHz): (Z): δ = 9.80 (t, J = 1.6 Hz, 1H), 7.36–7.27 (m, 4H), 7.24–7.18 (m, 1H), 
6.26 (dt, J = 9.3, 1.3 Hz, 1H), 5.77 (dt, J = 9.3, 7.3 Hz, 1H), 2.53–2.46 (m, 2H), 2.24–2.19 (m, 2H), 
1.84–1.74 (m, 2H); (E): δ = 9.79 (t, J = 1.5 Hz, 1H), 7.36–7.27 (m, 4H), 7.24–7.18 (m, 1H), 6.18 (dt, 
J = 15.0, 1.4 Hz, 1H), 5.90 (dt, J = 15.0, 7.1 Hz, 1H), 2.53–2.46 (m, 2H), 2.35–2.28 (m, 2H), 1.84–
1.74 (m, 2H). 
13C NMR (CDCl3, 151 MHz): (Z): δ = 202.4, 136.2, 131.6, 129.2, 129.1, 126.5, 124.6, 43.4, 28.5, 
21.5; (E): δ = 202.2, 136.1, 134.8, 129.2, 129.1, 126.5, 122.9, 43.2, 32.4, 21.6. 
IR (Diamond-ATR, neat) ෤߭max: 2933 (w), 2722 (w), 1722 (vs), 1583 (w), 1479 (m), 1439 (m), 
1089 (w), 1024 (w), 953 (w), 739 (s), 690 (m).  
HRMS (EI) calc. for C12H14O32S [M]+: 206.0760 found: 206.0770. 
 
 
Vinyl iodide S96 
To a suspension of phosphonium iodide S92 (1.77 g, 3.64 mmol, 1.50 equiv) in 
tetrahydrofuran (16 mL) was added a solution of n-butyl lithium (2.31 M in hexanes, 1.52 mL, 
3.51 mmol, 1.45 equiv) at –78 °C. After 5 min, the reaction mixture was allowed to warm to 23 °C. 
After 30 min, the mixture was cooled to –78 °C and a solution of iodide (800 mg, 3.15 mmol, 
1.30 equiv) was added. After 20 min, a solution of lithium bis(trimethylsilyl)amine solution (1.00 M in 
tetrahydrofuran, 0.64 mL, 3.39 mmol, 1.40 equiv) was added and the mixture was allowed to warm to 
–20 °C. After 30 min, the reaction mixture was cooled to –78 °C and a solution of aldehyde S95 
(500 mg, 2.42 mmol, 1 equiv) in tetrahydrofuran (4.5 mL) was added. After 30 min, the reaction 
mixture was allowed to warm to 23 °C. After 3 h, saturated aqueous sodium thiosulfate solution 
(75 mL) was added and the mixture was extracted with diethyl ether (3 × 100 mL). The combined 
organic extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (2% ethyl 
acetate in hexanes) to yield vinyl iodide S96 (664 mg, 66%) as an inseparable mixture of double bond 
isomers (664 mg, 66% E:Z = 1:2.2, for vinyl iodide) as a pale yellow oil.   
Note: Since the reaction afforded an inseparable mixture of four diastereomers purified S96 was 
directly used in the next reaction without further characterization. 
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Diol S97 
Potassium hexacyanoferrate (III) (3.16 g, 9.60 mmol, 6.00 equiv), potassium carbonate 
(1.33 g, 9.60 mmol, 6.00 equiv) and (DHQD)2Phal (49.9 mg, 0.06 mmol, 0.04 equiv) were grinded to 
a fine powder and were added to a mixture of t-butanol and water (1:1, 200 mL). Potassium osmate 
(VI) dihydrate (4.72 mg, 12.8 mol, 0.8 mol%) was added to the orange suspension at 23 °C. After 
30 min, the reaction mixture was cooled to 0 °C and methanesulfonamide (304 mg, 3.20 mmol, 
2.00 equiv) was added in one portion followed by a solution of alkene S96 (660 mg, 1.60 mmol, 
1 equiv) in t-butanol (8 mL). After 5 min, the reaction mixture was allowed to warm to 23 °C. After 
22 h, sodium sulfite (2.01 g, 16.0 mmol, 10.0 equiv) was added. After 20 min, aqueous sodium 
hydroxide solution (5%, 75 mL) was added and the mixture was extracted with ethyl acetate 
(3 × 75 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (0.5% methanol in dichloromethane initially, grading to 5% methanol in 
dichloromethane) to give diol (E)-S97 (105 mg, 15%, E:Z = 1:1.2) as a pale yellow oil and diol (Z)-
S97 (166 mg, 23%, E:Z = 1:1.2) as a pale yellow oil. 
(E)-S97: 
TLC (2% methanol in dichloromethane): Rf = 0.39 (UV, KMnO4). 
1H NMR (C6D6, 599 MHz): (Z): δ = 7.34–7.30 (m, 1H), 7.30–7.26 (m, 1H), 7.08–7.02 (m, 1H), 7.02–
6.98 (m, 1H), 6.97–6.89 (m, 1H), 6.20 (dd, J = 8.0, 7.2 Hz, 1H), 6.16–6.10 (m, 1H), 5.53 (dt, 
J = 9.2 7.2 Hz, 1H), 3.18–3.10 (m, 1H), 2.61–2.54 (m, 1H), 2.53–2.44 (m, 1H), 2.19–2.12 (m, 2H), 
2.00–1.90 (m, 3H), 1.74–1.67 (m, 1H), 1.39–1.23 (m, 3H), 1.02 (br s, 1H), 0.98 (s, 3H), 0.95 (s, 3H); 
(E): δ = 7.34–7.30 (m, 1H), 7.30–7.26 (m, 1H), 7.08–7.02 (m, 1H), 7.02–6.98 (m, 1H), 6.97–6.89 (m, 
1H), 6.16–6.10 (m, 1H), 6.01 (dt, J = 15.0, 1.4 Hz, 1H), 5.80 (dt, J = 15.0, 7.0 Hz, 1H), 3.18–3.10 (m, 
1H), 2.61–2.54 (m, 1H), 2.53–2.44 (m, 1H), 1.99–1.92 (m, 1H), 1.92–1.83 (m, 2H), 1.82–1.76 (m, 
2H), 1.74–1.67 (m, 1H), 1.39–1.23 (m, 1H), 1.17–1.08 (m, 2H), 1.02 (br s, 1H), 0.97 (s, 3H), 0.94 (s, 
3H). 
13C NMR (C6D6, 151 MHz): (Z): δ = 142.1, 136.9, 132.5, 129.3, 129.3, 126.4, 124.1, 104.1, 76.6, 
72.6, 35.7, 31.3, 30.6, 28.8, 28.7, 26.7, 23.2; (E): δ = 142.0, 137.0, 136.1, 129.3, 129.2, 126.4, 122.4, 
104.1, 76.6, 72.6, 35.7, 32.4, 31.3, 30.3, 28.5, 26.7, 23.2.  
IR (Diamond-ATR, neat) ෤߭max: 3418 (br w), 2927 (w), 2280 (m), 1584 (w), 1453 (w), 1330 (m), 
1161 (w), 957 (w), 812 (vs), 739 (m). 
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HRMS (EI) calc. for C19H27O2127I 32S [M]+: 446.0771 found: 446.0771. 
(Z)-S97: 
TLC (2% methanol in dichloromethane): Rf = 0.35 (UV, KMnO4). 
1H NMR (C6D6, 599 MHz): (Z): δ = 7.36–7.32 (m, 1H), 7.31–7.26 (m, 1H), 7.06–7.01 (m, 1H), 7.01–
6.97 (m, 1H), 6.95–6.90 (m, 1H), 6.14 (dt, J = 9.3, 1.4 Hz, 1H), 5.59 (dt, J = 9.3, 7.3 Hz, 1H), 5.40 (t, 
J = 6.8 Hz, 1H), 3.19–3.11 (m, 1H), 2.77–2.65 (m, 1H), 2.61–2.48 (m, 1H), 2.28–2.20 (m, 2H), 2.18–
2.11 (m, 2H), 1.86–1.81 (m, 1H), 1.76–1.66 (m, 1H), 1.44–1.34 (m, 3H), 1.11 (br s, 1H), 0.97 (s, 3H), 
0.95 (s, 3H). (E): δ = 7.36–7.32 (m, 1H), 7.31–7.26 (m, 1H), 7.06–7.01 (m, 1H), 7.01–6.97 (m, 1H), 
6.95–6.90 (m, 1H), 6.06 (dt, J = 14.9, 1.3 Hz, 1H), 5.85 (dt, J = 14.9, 7.0 Hz, 1H), 5.33 (t, J = 6.7 Hz, 
1H), 3.19–3.11 (m, 1H), 2.77–2.65 (m, 1H), 2.61–2.48 (m, 1H), 2.08–2.01 (m, 2H), 1.91–1.81 (m, 
3H), 1.76–1.66 (m, 1H), 1.44–1.34 (m, 1H), 1.28–1.20 (m, 2H), 1.06 (s, 1H), 0.96 (s, 3H), 0.95 (s, 
3H). 
13C NMR (C6D6, 151 MHz): (Z): δ = 136.9, 135.3, 132.7, 129.3, 129.3, 126.4, 124.0, 110.3, 76.8, 
72.6, 42.5, 36.3, 31.7, 28.9, 28.0, 26.6, 23.4; (E): δ = 137.1, 136.3, 135.3, 129.3, 129.2, 126.4, 122.4, 
110.3, 76.7, 72.6, 42.5, 36.2, 32.7, 31.7, 27.9, 26.6, 23.4. 
IR (Diamond-ATR, neat) ෤߭max: 3395 (br m), 2926 (m), 1583 (w), 1478 (m), 1439 (m), 1157 (m), 1070 
(m), 948 (m), 737 (vs), 689 (s). 
HRMS (EI) calc. for C19H27O2127I 32S [M]+: 446.0771 found: 446.0791. 
 
 
Epoxide 46 
To a solution of diol (E)-S97 (92.0 mg, 0.19 mmol, 1 equiv) and pyridine (78.4 L, 
0.97 mmol, 5.00 equiv) in dichloromethane (1 mL) was added methanesulfonyl chloride (22.5 L, 
0.29 mmol, 1.50 equiv) at 0 °C. After 30 min, the reaction mixture was allowed to warm to 23 °C. 
After 14 h, water (10 mL) was added and the aqueous phase was extracted with dichloromethane 
(3 × 10 mL). The combined organic extracts were dried over sodium sulfate. The dried solution was 
filtered, the filtrate was concentrated and the residue was dried by azeotropic distillation with benzene 
(2 × 5 mL). To a solution of the crude mesylate in methanol (1 mL) was added potassium carbonate 
(53.6 mg, 0.39 mmol, 2.00 equiv) at 23 °C. After 2 h, the reaction mixture was partitioned between 
water (10 mL) and dichloromethane (10 mL). The aqueous phase was extracted with dichloromethane 
(3 × 10 mL) and the combined organic extracts were dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
202                     EXPERIMENTAL SECTION 
on silica gel (10% ethyl acetate in hexanes) to yield epoxide 46 (49.6 mg, 56%, E:Z = 1:1.2) as a 
colorless oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.52 (UV, CAM). 
1H NMR (CDCl3, 800 MHz): (Z): δ = 7.35–7.33 (m, 1H), 7.31–7.28 (m, 3H), 7.22–7.18 (m, 1H), 
6.27–6.21 (m, 2H), 5.78 (dt, J = 9.3, 7.2 Hz, 1H), 2.76–2.71 (m, 1H), 2.61–2.52 (m, 2H), 2.29–2.23 
(m, 2H), 2.15–2.10 (m, 2H), 1.84–1.77 (m, 1H), 1.70–1.62 (m, 1H), 1.55–1.50 (m, 2H), 1.31 (s, 3H), 
1.30 (s, 3H); (E): δ = 7.35–7.33 (m, 1H), 7.31–7.28 (m, 3H), 7.22–7.18 (m, 1H), 6.27–6.21 (m, 1H), 
6.16 (dt, J = 15.0, 1.4 Hz, 1H), 5.93 (dt, J = 15.0, 7.0 Hz, 1H), 2.76–2.71 (m, 1H), 2.61–2.52 (m, 2H), 
2.21–2.15 (m, 2H), 2.15–2.10 (m, 2H), 1.84–1.77 (m, 1H), 1.70–1.62 (m, 1H), 1.55–1.50 (m, 2H), 
1.31 (s, 3H), 1.30 (s, 3H). 
13C NMR (CDCl3, 201 MHz): (Z): δ = 141.9, 136.4, 132.3, 129.1, 129.0, 126.4, 123.9, 101.9, 63.0, 
58.8, 35.9, 30.6, 28.7, 28.7, 28.5, 25.0, 19.1; (E): δ =141.7, 136.3, 135.9, 129.1, 128.9, 126.4, 122.1, 
102.0, 62.9, 58.8, 35.9, 32.5, 30.4, 28.7, 28.5, 25.0, 19.1. 
IR (Diamond-ATR, neat) ෤߭max: 2923 (s), 1734 (w), 1583 (w), 1478 (m), 1456 (m), 1439 (m), 1376 (m), 
1024 (w), 875 (w), 737 (s), 689 (m). 
HRMS (EI) calc. for C19H25O127I 32S [M]+: 428.0665 found: 428.0641. 
 
 
Enol ether 47 
Note: 1,4-dioxane was degassed via freeze-pump-thaw (three cycles) prior to use.  
A suspension of vinyl iodide 46 (31.0 mg, 67.9 mol, 1 equiv) 4-methoxyphenol (12.6 mg, 
0.10 mmol, 1.50 equiv), cesium carbonate (99.6 mg, 0.31 mmol, 4.50 equiv), N,N-dimethylglycine 
hydrochloride (28.4 mg, 0.20 mmol, 3.00 equiv) and copper(I) iodide (12.9 mg, 67. 9 mol, 
1.00 equiv) in 1,4-dioxane (1.2 mL) was heated to 100 °C. After 20 h, the reaction mixture was 
allowed to cool to 23 °C, water (10 mL) was added and the mixture was extracted with ethyl acetate 
(3 × 15 mL). The combined organic extracts were dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash-column chromatography 
on silica gel (5% ethyl acetate in hexanes) to yield enol ether 47 (18.8 mg, 61%, E:Z = 1:1.1) as a 
colorless oil and vinyl iodide 46 (10 mg, 32%) as a colorless oil. 
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TLC (20% ethyl acetate in hexanes): Rf = 0.42 (UV, CAM). 
1H NMR (CDCl3, 599 MHz): (Z): δ 7.35–7.32 (m, 1H), 7.32–7.27 (m, 3H), 7.22–7.16 (m, 1H), 6.92–
6.87 (m, 2H), 6.86–6.79 (m, 2H), 6.20 (dt, J = 9.2, 1.4 Hz, 1H), 5.79 (dt, J = 9.2, 7.2 Hz, 1H), 4.66 (t, 
J = 7.7 Hz, 1H), 3.78 (s, 3H), 2.83–2.75 (m, 1H), 2.50–2.35 (m, 2H), 2.27–2.21 (m, 2H), 2.10–2.01 
(m, 2H), 1.86–1.75 (m, 2H), 1.52–1.42 (m, 2H), 1.32 (s, 3H), 1.29 (s, 3H); (E): δ = 7.35–7.32 (m, 1H), 
7.32–7.27 (m, 3H), 7.22–7.16 (m, 1H), 6.92–6.87 (m, 2H), 6.86–6.79 (m, 2H), 6.13 (dt, J = 15.0, 1.4 
Hz, 1H), 5.95 (dt, J = 14.9, 7.0 Hz, 1H), 4.62 (t, J = 7.7 Hz, 1H), 3.77 (s, 3H), 2.83–2.75 (m, 1H), 
2.50–2.35 (m, 2H), 2.18–2.12 (m, 2H), 2.10–2.01 (m, 2H), 1.86–1.75 (m, 2H), 1.52–1.42 (m, 2H), 
1.32 (s, 3H), 1.29 (s, 3H). 
13C NMR (CDCl3, 151 MHz): (Z): δ = 155.6, 155.0, 149.5, 136.5, 133.0, 129.1, 128.9, 126.3, 123.3, 
120.8, 114.7, 107.9, 63.9, 58.6, 55.8, 29.8, 28.8, 26.9, 26.3, 26.0, 25.1, 18.9; (E): δ = 155.6, 155.1, 
149.5, 136.8, 136.5, 129.1, 128.7, 126.3, 121.5, 120.9, 114.8, 107.5, 63.9, 58.6, 55.7, 32.7, 29.8, 26.9, 
26.2, 26.0, 25.1, 18.9. 
IR (Diamond-ATR, neat) ෤߭max: 2926 (w), 1670 (w), 1502 (vs), 1440 (m), 1208 (vs), 1099 (m), 
1036 (m), 830 (m), 738 (s), 690 (s). 
HRMS (EI) calc. for C26H32O332S [M]+: 424.2067 found: 424.2055. 
 
 
Ketone 50 
To a solution epoxide 47 (9.0 mg, 0.02 mmol, 1 equiv) in dichloromethane (2.0 mL) was added a 
solution of ethylaluminum dichloride (1.00 M in hexanes, 0.06 mL, 0.06 mmol, 3.00 equiv) in 
dichloromethane (0.5 mL) dropwise at –78 °C. After 30 min, water (10 mL) was added. The aqueous 
layer was extracted with dichloromethane (3 × 10 mL), the combined organic extracts were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash-column chromatography on silca gel (10% ethyl acetate in hexanes) to obtain 50 
(3.0 mg, 44%, E:Z = 1.1:1) as a colorless oil. 
TLC (20% ethyl acetate in hexanes), Rf = 0.33 (UV, CAM). 
1H NMR (CDCl3, 400 MHz): (Z) δ = 7.36–7.26 (m, 4H), 7.22–7.16 (m, 1H), 6.20 (dt, J = 9.2, 1.4 Hz, 
1H), 5.80 (dt, J = 9.2, 7.3 Hz, 1H), 2.77–2.69 (m, 2H), 2.69–2.60 (m, 3H), 2.53–2.45 (m, 2H), 2.30–
2.23 (m, 2H), 1.70–1.56 (m, 2H), 1.51–1.39 (m, 2H), 1.12 (d, J = 6.9 Hz, 3H); 1.11 (d, J = 6.9 Hz, 
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3H); (E) δ = 7.36–7.26 (m, 4H), 7.22–7.16 (m, 1H), 6.14 (dt, J = 14.9 Hz, 1.3, 1H), 5.95 (dt, J = 14.9, 
6.9 Hz, 1H), 2.77–2.69 (m, 2H), 2.69–2.60 (m, 3H), 2.53–2.45 (m, 2H), 2.21–2.13 (m, 2H), 1.70–1.56 
(m, 2H), 1.51–1.39 (m, 2H), 1.12 (d, J = 6.9 Hz, 3H); 1.11 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): (Z) δ = 213.5, 209.7, 136.5, 133.0, 129.1, 128.9, 126.3, 123.3, 42.7, 
41.0, 36.2, 34.0, 28.9, 28.6, 23.4, 18.5, 18.5; (E) δ = 213.5, 209.6, 136.8, 136.6, 129.1, 128.7, 126.2, 
121.4, 42.7, 41.0, 36.2, 33.9, 33.0, 28.7, 23.4, 18.5, 18.5. 
IR (Diamond-ATR, neat) ෤߭max: 2930 (m), 1709 (s), 1583 (w), 1479 (w), 1439 (w), 1216 (w), 1089 (w), 
1025 (w), 740 (m), 691 (w). 
HRMS (EI) calc. for C19H26O232S [M]+: 318.1648; found: 318.1664. 
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3.3.4. Suzuki–Miyaura Cross-Coupling Scope 
3.3.4.1. Reaction Scope 
 
Entry R Yield [%] 
1 H 96 
2 NO2 78 
3 CN 90 
4 F 94 
5 OMe 93 
 
3.3.4.2. Bromoenol Ether Synthesis 
 
Bromo alkyne S98 
To a solution of ethynylbenzene (5.00 g, 49.0 mmol, 1 equiv) in acetone (160 mL) were 
sequentially added silver nitrate (0.83 g, 4.90 mmol, 0.10 equiv) and N-bromosuccinimide (10.5 g, 
59.0 mmol, 1.20 equiv) at 23 °C. After 1.5 h, the grey suspension was poured into water (100 mL). 
The aqueous phase was extracted with hexanes (4 × 100 mL) and the combined organic extracts were 
washed with saturated aqueous sodium chloride solution (100 mL). The washed solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by column chromatography on silica gel (hexanes) to yield bromo alkyne S98 (8.30 g, 94%) 
as a yellow oil. The obtained data were in full agreement with those reported in literature.[192] 
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General Procedure A: 
 
A glass vial equipped with a screw cap was charged with the corresponding phenol 
(3.30 mmol, 1.10 equiv), cesium carbonate (1.96 g, 6.00 mmol, 2.00 equiv), bromo alkyne S98 (543 
mg, 3.00 mmol, 1 equiv) and N,N-dimethylformamide (6.0 mL). The obtained suspension was heated 
to 110 °C. After complete conversion, the reaction mixture was cooled to 23 °C, diluted with ethyl 
acetate and filtered through a plug of Celite®, which was thoroughly washed with ethyl acetate. The 
filtrate was concentrated and the residue was purified by flash-column chromatography on silica gel. 
 
 
Bromoenol ether S99 
Bromoenol ether S99 was prepared by following general procedure A. After 3.5 h, the 
standard work-up procedure was performed. The residue was purified by flash-column 
chromatography on silica gel (5% toluene in hexanes) to yield bromoenol ether S99 (209 mg, 25%) as 
a pale gray solid. The obtained characterization data were in full agreement with the values previously 
reported.[193] 
 
 
Bromoenol ether S100 
Bromoenol ether S100 was prepared by following general procedure A. After 3.5 h, the 
standard work-up procedure was performed. The residue was purified by flash-column 
chromatography on silica gel (5% ethyl acetate in hexanes) to yield bromoenol ether S100 (397 mg, 
41%) as a yellow oil. The obtained characterization data were in full agreement with the values 
previously reported.[193]  
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Bromoenol ether S101 
Compound S101 was prepared by following general procedure A. After 3 h, the standard 
work-up procedure was performed. The residue was purified by flash-column chromatography on 
silica gel (1% acetone in toluene) to yield bromoenol ether S101 (484 mg, 54%) as a yellow oil. The 
obtained data were in full agreement with those reported in literature.[193]  
 
 
Bromoenol ether S102 
Compound S102 was prepared by following general procedure A. After 3 h, the standard 
work-up procedure was performed. The residue was purified by flash-column chromatography on 
silica gel (2% toluene in hexanes) to yield bromoenol ether S102 (183 mg, 21%) as a pale yellow 
solid. 
TLC (2% toluene in hexanes), Rf = 0.18 (UV, KMnO4) 
1H NMR (CDCl3, 300 MHz): δ = 7.48–7.42 (m, 2H), 7.35–7.29 (m, 3H), 6.94–6.93 (m, 2H), 6.92–
6.91 (m, 2H), 6.48 (s, 1H). 
13C NMR (CDCl3, 75 MHz): δ = 159.9, 156.7, 153.6, 151.9, 133.5, 129.5, 129.0, 126.1, 117.4, 117.3, 
116.4, 116.1, 95.3. 
19F NMR (CDCl3; 282 MHz): δ = –121.7. 
IR (Diamond-ATR, neat) ෤߭max: 1626 (w), 1498 (vs), 1444 (w), 1277 (w), 1192 (s), 1092 (w), 1045 (m), 
830 (m), 726 (s), 694 (w). 
HRMS (EI) calc. for C14H10BrFO [M]+: 291.9899; found: 291.9902. 
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Bromoenol ether S103 
Compound S103 was prepared by following general procedure A. After 3.5 h, the standard 
work-up procedure was performed. The residue was purified by flash-column chromatography on 
silica gel (40% toluene in hexanes) to yield bromoenol ether S103 (202 mg, 27%) as a yellow oil. The 
obtained data were in full agreement with those reported in literature.[193]  
 
3.3.4.3. Suzuki–Miyaura Coupling 
General Procedure B: 
 
Note: All solvents were degassed via freeze-pump-thaw (three cycles) prior to use.    
To a solution of B-methoxy-9-BBN (1.00 M in hexanes, 1.00 mL, 1.00 mmol, 2.00 equiv) in 
tetrahydrofuran (3.2 mL) was added a solution of n-butyllithium (2.30 M in hexanes, 0.33 mL, 
0.75 mmol, 1.50 equiv) dropwise at –78 °C. After 5 min, the reaction mixture was allowed to warm to 
23 °C. After 10 min, the borinate solution was added dropwise to a suspension of the corresponding 
bromoenol ether S99–S103 (0.50 mmol, 1 equiv), cesium carbonate (326 mg, 1.00 mmol, 2.00 equiv), 
SPhos Pd G2 precatalyst (7.2 mg, 0.01 mmol, 0.02 equiv) and SPhos (4.1 mg, 0.01 mmol, 0.02 equiv) 
in a mixture of N,N-dimethylformamide and water (9:1, 6.0 mL) at 23 °C and heated to 40 °C. After 
1 h, the reaction mixture was cooled to 23 °C water (60 mL) was added and the mixture was extracted 
with ethyl acetate (3 × 60 mL). The combined organic extracts were washed with saturated aqueous 
sodium chloride solution (60 mL), the washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by column 
chromatography on silica gel. 
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Enol ether S104 
Compound S104 was prepared by following general procedure B. After the standard work-up 
procedure was performed, the residue was purified by column chromatography on silica gel (3% ethyl 
acetate in hexanes) to yield enol ether S104 (122 mg, 96%) as a colorless oil. 
TLC (3% ethyl acetate in hexanes), Rf = 0.49 (UV, KMnO4) 
1H NMR (CDCl3, 599 MHz): δ = 7.49 (d, J = 7.6 Hz, 2H), 7.29–7.25 (m, 2H), 7.25–7.20 (m, 3H), 
6.98–6.91 (m, 3H), 5.87 (t, J = 7.4 Hz, 1H), 2.24–2.19 (m, 2H), 1.46–1.40 (m, 2H), 1.38–1.31 (m, 
2H), 0.89 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 157.6, 148.8, 135.7, 129.6, 128.6, 127.9, 125.4, 121.4, 118.5, 115.6, 
31.6, 25.7, 22.6, 14.1. 
IR (Diamond-ATR, neat) ෤߭max: 2925 (w), 1595 (m), 1488 (vs), 1446 (m), 1216 (vs), 1163 (m), 1041 
(m), 749 (vs), 689 (vs). 
HRMS (EI) calc. for C18H20O [M]+: 252.1509; found: 252.1502. 
 
 
Enol ether S105 
Compound S105 was prepared by following general procedure B. After the standard work-up 
procedure was performed, the residue was purified by column chromatography on silica gel (5% ethyl 
acetate in hexanes) to yield enol ether S105 (116 mg, 78%) as a yellow oil. 
TLC (5% ethyl acetate in hexanes), Rf = 0.49 (UV, KMnO4) 
1H NMR (CDCl3, 400 MHz): δ = 8.18–8.11 (m, 2H), 7.45–7.41 (m, 2H), 7.33–7.27 (m, 3H), 7.06–
7.01 (m, 2H), 5.94 (t, J = 7.4 Hz, 1H), 2.21–2.13 (m, 2H), 1.46–1.38 (m, 2H), 1.37–1.30 (m, 2H), 0.88 
(t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 162.8, 148.4, 142.2, 134.4, 128.8, 128.5, 126.1, 125.1, 119.1, 115.7, 
31.3, 25.7, 22.5, 14.0. 
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IR (Diamond-ATR, neat) ෤߭max: 2927 (w), 1590 (s), 1514 (s), 1489 (s), 1339 (vs), 1239 (vs), 1162 (s), 
1110 (s), 1037 (m), 847 (s), 750 (s), 693 (vs). 
HRMS (EI) calc. for C18H19NO3 [M]+: 297.1359; found: 297.1368. 
 
 
Enol ether S106 
Compound S106 was prepared by following general procedure B. After the standard work-up 
procedure was performed, the residue was purified by column chromatography on silica gel 
(10% ethyl acetate in hexanes) to yield enol ether S106 (125 mg, 90%) as a pale yellow solid. 
TLC (10% ethyl acetate in hexanes), Rf = 0.44 (UV, KMnO4) 
1H NMR (CDCl3, 400 MHz): δ = 7.45–7.40 (m, 2H), 7.36–7.31 (m, 2H), 7.22–7.13 (m, 3H), 6.94–
6.90 (m, 2H), 5.83 (t, J = 7.4 Hz, 1H), 2.14–1.97 (m, 2H), 1.37–1.18 (m, 4H), 0.78 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 161.0, 148.2, 134.5, 134.2, 128.7, 128.4, 125.0, 119.1, 119.0, 116.3, 
104.9, 31.3, 25.6, 22.5, 13.9. 
IR (Diamond-ATR, neat) ෤߭max: 2927 (w), 2225 (m), 1601 (vs), 1501 (vs), 1446 (m), 1238 (vs), 
1164 (s), 1038 (w), 835 (s), 766 (m), 693 (m). 
HRMS (EI) calc. for C19H19NO [M]+: 277.1461; found: 277.1465. 
 
 
Enol ether S107 
Compound S107 was prepared by following general procedure B. After the standard work-up 
procedure was performed, the residue was purified by column chromatography on silica gel (3% ethyl 
acetate in hexanes) to yield enol ether S107 (126 mg, 94%) as a colorless oil. 
TLC (3% ethyl acetate in hexanes), Rf = 0.42 (UV, KMnO4) 
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1H NMR (CDCl3, 599 MHz): δ = 7.47–7.45 (m, 2H), 7.30–7.26 (m, 2H), 7.25–7.21 (m, 1H), 6.93–
6.86 (m, 4H), 5.84 (t, J = 7.4 Hz, 1H), 2.23–2.19 (m, 2H), 1.45–1.39 (m, 2H), 1.38–1.31 (m, 2H), 0.89 
(t, J = 7.3 Hz, 3H). 
13C NMR (CDCl3, 151 MHz): δ = 158.5, 156.9, 153.6, 149.1, 135.5, 128.6, 128.0, 125.4, 118.5, 116.5, 
116.5, 116.1, 115.9, 31.6, 25.7, 22.6, 14.0. 
19F NMR (CDCl3; 282 MHz): δ = –123.4. 
IR (Diamond-ATR, neat) ෤߭max: 2926 (w), 1499 (vs), 1446 (w), 1197 (s), 1092 (w), 1041 (w), 829 (m), 
737 (m), 692 (m). 
HRMS (EI) calc. for C18H19FO [M]+: 270.1414; found: 270.1405. 
 
 
Enol ether S108 
Compound S108 was prepared by following general procedure B. After the standard work-up 
procedure was performed, the residue was purified by column chromatography on silica gel (5% ethyl 
acetate in hexanes) to yield enol ether S108 (131 mg, 93%) as a yellow oil. 
TLC (5% ethyl acetate in hexanes), Rf = 0.49 (KMnO4, UV). 
1H NMR (CDCl3, 599 MHz): δ = 7.48 (d, J = 7.3 Hz, 2H), 7.27 (t, J = 7.5 Hz, 2H), 7.22 (t, J = 7.2 Hz, 
1H), 6.89–6.86 (m, 2H), 6.78–6.75 (m, 2H), 5.81 (t, J = 7.4 Hz, 1H), 3.73 (s, 3H), 2.25–2.20 (m, 2H), 
1.46–1.40 (m, 2H), 1.39–1.32 (m, 2H), 0.89 (t, J = 7.3 Hz, 3H). 
13C NMR (CDCl3, 150 MHz): δ = 154.3, 151.6, 149.3, 135.9, 128.5, 127.9, 125.5, 118.3, 116.3, 114.8, 
55.8, 31.7, 25.7, 22.6, 14.1. 
IR (Diamond-ATR, neat) ෤߭max: 2926 (w), 2855 (w), 1501 (vs), 1445 (m), 1206 (vs), 1179 (m), 1040 
(m), 825 (s), 730 (s), 692 (m). 
HRMS (EI) calc. for C19H22O2 [M]+: 282.1614; found: 282.1629 
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3.3.5.  X-Ray Crystallographic Data 
The data collections were performed either on an Oxford Diffraction Xcalibur diffractometer, 
on a Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα-
radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 1.171.33.41) 
was applied for the integration, scaling and multi-scan absorption correction of the data. The structures 
were solved by direct methods with SIR97[180] and refined by least-squares methods against F2 with 
SHELXL-97.[181] All non-hydrogen atoms were refined anisotropically. The hydrogen atoms were 
placed in ideal geometry riding on their parent atoms. Further details are summarized in the tables at 
the different sections. 
 
3.3.5.1.Ketone 29 
 
 
CCDC 1510948 contains the supplementary crystallographic data for ketone 29. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Table 18. Crystallographic data for ketone 29. 
net formula C26H40O4Si 
Mr/g mol−1 444.67 
crystal size/mm 0.090 × 0.070 × 0.050 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
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space group 'P 21' 
a/Å 7.7016(3) 
b/Å 13.7604(5) 
c/Å 12.1094(5) 
α/° 90 
β/° 101.7470(11) 
γ/° 90 
V/Å3 1256.44(8) 
Z 2 
calc. density/g cm−3 1.175 
μ/mm−1 0.122 
absorption correction multi-scan 
transmission factor range 0.9165–0.9585 
refls. measured 22027 
Rint 0.0326 
mean σ(I)/I 0.0302 
θ range 3.080–26.38 
observed refls. 4663 
x, y (weighting scheme) 0.0450, 0.1910 
hydrogen refinement constr 
Flack parameter 0.02(4) 
refls in refinement 5132 
parameters 288 
restraints 1 
R(Fobs) 0.0313 
Rw(F2) 0.0782 
S 1.037 
shift/errormax 0.001 
max electron density/e Å−3 0.259 
min electron density/e Å−3 −0.163 
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3.3.5.2.Xanthogenate 32 
 
 
CCDC 1510949 contains the supplementary crystallographic data for xanthogenate 32. These data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Table 19. Crystallographic data for xanthgenate 32. 
net formula C28H42O5S2Si 
Mr/g mol−1 550.82 
crystal size/mm 0.100 × 0.090 × 0.080 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 6.9050(2) 
b/Å 12.1975(4) 
c/Å 34.5705(11) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2911.66(16) 
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Z 4 
calc. density/g cm−3 1.257 
μ/mm−1 0.259 
absorption correction multi-scan 
transmission factor range 0.8834–0.9281 
refls. measured 27302 
Rint 0.0298 
mean σ(I)/I 0.0280 
θ range 3.177–26.41 
observed refls. 5582 
x, y (weighting scheme) 0.0272, 0.9303 
hydrogen refinement constr 
Flack parameter −0.019(17) 
refls in refinement 5959 
parameters 334 
restraints 0 
R(Fobs) 0.0286 
Rw(F2) 0.0645 
S 1.074 
shift/errormax 0.001 
max electron density/e Å−3 0.239 
min electron density/e Å−3 −0.194 
 
3.3.5.3.Ketone 34 
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CCDC 1510950 contains the supplementary crystallographic data for ketone 34. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Table 20. Crystallographic data for ketone 34. 
net formula C21H28O4 
Mr/g mol−1 344.43 
crystal size/mm 0.100 × 0.090 × 0.020 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 10.1322(3) 
b/Å 10.7189(3) 
c/Å 16.5723(4) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1799.85(9) 
Z 4 
calc. density/g cm−3 1.271 
μ/mm−1 0.086 
absorption correction multi-scan 
transmission factor range 0.8781–0.9582 
refls. measured 22043 
Rint 0.0623 
mean σ(I)/I 0.0384 
θ range 3.027–25.69 
observed refls. 3179 
x, y (weighting scheme) 0.0269, 0.8345 
hydrogen refinement mixed 
Flack parameter 0.1(5) 
refls in refinement 3382 
parameters 234 
restraints 0 
R(Fobs) 0.0380 
Rw(F2) 0.0874 
S 1.091 
shift/errormax 0.001 
max electron density/e Å−3 0.218 
min electron density/e Å−3 −0.189 
C-H: constr, O-H: refall. 
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3.3.3.4. Ferrocenecarboxylate ester S86 
 
 
CCDC 1499443 contains the supplementary crystallographic data for ferrocenecarboxylate ester S86. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
Table 21:  Ferrocenecarboxylate ester S86. 
net formula C39H44FeO4S 
Mr/g mol−1 664.65 
crystal size/mm 0.100 × 0.030 × 0.010 
T/K 153.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21 1' 
a/Å 14.3768(19) 
b/Å 7.3244(9) 
c/Å 17.1643(19) 
α/° 90 
β/° 111.981(4) 
γ/° 90 
V/Å3 1676.0(4) 
Z 2 
calc. density/g cm−3 1.317 
μ/mm−1 0.552 
absorption correction Multi-Scan 
transmission factor range 0.6807–0.7454 
refls. measured 23821 
Rint 0.0775 
mean σ(I)/I 0.0749 
θ range 3.168–26.371 
observed refls. 5507 
x, y (weighting scheme) 0.0267, 0.3292 
hydrogen refinement constr 
Flack parameter 0.008(10) 
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refls in refinement 6743 
parameters 411 
restraints 1 
R(Fobs) 0.0447 
Rw(F2) 0.0844 
S 1.039 
shift/errormax 0.001 
max electron density/e Å−3 0.317 
min electron density/e Å−3 −0.433 
 
3.3.3.5. (–)-Cyclosmenospongine (4) 
 
 
CCDC 1499442 contains the supplementary crystallographic data (–)-Cyclosmenospongine (4). These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
Table 22: (–)-Cyclosmenospongine (4). 
net formula C21H29NO3 
Mr/g mol−1 343.45 
crystal size/mm 0.100 × 0.060 × 0.050 
T/K 153.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 10.7772(8) 
b/Å 11.6369(8) 
c/Å 14.6780(10) 
α/° 90 
β/° 90 
γ/° 90 
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V/Å3 1840.8(2) 
Z 4 
calc. density/g cm−3 1.239 
μ/mm−1 0.082 
absorption correction Multi-Scan 
transmission factor range 0.9033–0.9590 
refls. measured 42454 
Rint 0.0806 
mean σ(I)/I 0.0501 
θ range 3.358–27.484 
observed refls. 3522 
x, y (weighting scheme) 0.0379, 0.4490 
hydrogen refinement C-H: constr, N-H: refall 
Flack parameter 0.1(2) 
refls in refinement 4086 
parameters 238 
restraints 0 
R(Fobs) 0.0489 
Rw(F2) 0.0947 
S 1.074 
shift/errormax 0.001 
max electron density/e Å−3 0.232 
min electron density/e Å−3 −0.191 
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3.3.6. 1H and 13C NMR Spectra 
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3.4. Supporting Information for Chapter 2.3.1. 
 
 
 
 
 
Sequential O–H/C–H Bond Insertion of Phenols Initiated by the 
Gold(I)-Catalyzed Cyclization of 1-Bromo-1,5-Enynes 
 
 
Reprinted with permission from: 
K. Speck, K. Karaghiosoff, T. Magauer, Org. Lett. 2015, 17, 1982–1985. 
Copyright © 2015 American Chemical Society. 
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3.4.1. Optimization Studies 
3.4.1.1. Catalyst Screening: 
To a solution of p-cresol (40.6 mg, 0.38 mmol, 1.50 equiv) and catalyst (Table 1, 5 mol %) in 
dichloromethane (1.0 mL) was added bromide 1a (46.8 mg, 0.25 mmol, 1 equiv) at 23 °C. After 
complete consumption of bromide 1a (judged by TLC analysis) the reaction mixture was filtered 
through a short plug of silica and the filtrate was concentrated. 1,3,5-trimethoxybenzene (2.00 mg, 
11.9 mol) was added and the yield for 2a /3a was calculated from the 1H-NMR spectrum. 
 
Table 23: Catalyst screening. 
 
Entry Catalyst Time [h] Yield 2a / 3a [%]  
1 IPrAuNTf2   2.0 62 / 5 
2 (t-Bu)3PAuNTf2  2.0 66 / 4 
3 Ph3PAuNTf2 2.0 62 / 5 
4 (PhO)3PAuNTf2 1.5 62 / 5 
5 (2,4-t-BuPhO)3PAuNTf2 1.5 64 / 4 
6 HNTf2 24 0 
7 AuCl 3.0 7 of 25 
8 AuCl3 3.0 11 of 25 
9 PtCl2 3.0 0 
10 InI3/AgSbF6  –20 °C to 0 °C 3.0 43 / 4 
11 InI3 3.0 44 / 8 
12 InI3/ AgNTf2 3.5 47 / 9 
13 (t-Bu)3PAuCl 5.0 0 
14 (t-Bu)3PAuBF4 5.0  11 of 25 
15 (t-Bu)3PAuSbF6 4.0 39 / 4 
16 (t-Bu)3PAuOTf 0.5 65 
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3.4.2. Mechanistic Studies 
3.4.2.1. Deuterium Labeling  
 
Phenol 21 
To a solution of p-cresol (17.2 mg, 0.16 mmol, 1.50 equiv) and (t-Bu)3PAuNTf2 (3.61 mg, 
5.32 mol, 5 mol %) was added bromide 20 (20.0 mg, 0.11 mmol, 1 equiv) at 23 °C. After 3.5 h, the 
reaction mixture was filtered through a short plug of silica and the filtrate was concentrated. The 
residue was purified by column chromatography on silica gel (5% ethyl acetate in hexanes initially, 
grading to 10% ethyl acetate in hexanes) to afford phenol 21 (15.8 mg, 50%) as a pale yellow oil. 
TLC (20% ethyl acetate in hexanes): Rf = 0.37 (UV, KMnO4). 
1H NMR (CDCl3, 300 MHz): δ = 6.93 (dd, J = 8.1 Hz, 2.2 Hz, 1H), 6.83 (d, J = 2.1 Hz, 1H), 6.70 (d, 
J = 8.1 Hz, 1H), 4.80 (s, 1H), 4.27–4.11 (m, 1H), 2.61–2.30 (m, 3H), 2.27 (s, 3H), 2.01–1.81 (m, 1H), 
1.10 (s, 3H), 1.06 (s, 3H). 
13C NMR (CDCl3, 75 MHz): δ = 151.7, 149.5, 130.2, 129.7, 129.0, 128.5, 117.0, 116.1, 51.7, 30.3, 
29.3, 29.0 (t, J = 19.9 Hz), 20.8, 20.5, 20.2. 
IR (Diamond-ATR, neat) ෤߭max: 3446 (br w), 2960 (s), 2686 (m), 1611 (w), 1507 (s), 1461 (m), 1260 
(m), 1192 (m), 1106 (m), 867 (w), 810 (m). 
HRMS (EI) calc. for C15H18D79BrO [M]+: 295.0682; found: 295.0680. 
 
 
Figure 15: Comparison of 1H-NMR spectra of 2a and 21 (400 MHz, CDCl3). 
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Phenols 23 and 24 
To a solution of phenol-d6 (37.6 mg, 0.38 mmol, 1.50 equiv) and (t-Bu)3PAuNTf2 (8.49 mg, 
0.01 mmol, 5 mol %) was added bromide 1a (46.8 mg, 0.25 mmol, 1 equiv) at 23 °C. After 3 h, the 
reaction mixture was filtered through a short plug of silica and the filtrate was concentrated. The 
residue was purified by flash-column chromatography on silica gel (5% ethyl acetate in hexanes 
initially, grading to 10% ethyl acetate in hexanes) to furnish ortho-substituted 24 (24.9 mg, 35%) as a 
pale yellow oil. To obtain an analytical pure sample, 24 was further purified by preparative TLC 
(3% acetone in toluene). The fractions containing starting phenol and para-substituted 23 were further 
purified on silica gel (dichloromethane) to yield para-substituted 23 (11.1 mg, 15%) as a white solid. 
23: 
TLC (dichloromethane): Rf = 0.30 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 4.84 (s, 1H), 3.89–3.80 (m, 0.5H; 0.5D), 2.91 (hept, J = 6.9 Hz, 1H), 
2.52–2.37 (m, 2H), 2.37–2.26 (m, 1H), 1.88–1.72 (m, 1H), 1.09 (d, J = 6.9 Hz, 2.6H, 0.4D), 1.05 (d, 
J = 6.9 Hz, 2.7H, 0.3D). 
13C NMR (CDCl3, 101 MHz): δ = 154.8, 148.5, 148.5, 137.0, 136.9, 128.81 (t, J = 23.3 Hz), 118.7, 
118.6, 115.6, 115.3, 115.1, 56.3, 32.7, 32.5, 31.2, 29.7, 29.6, 29.4, 20.8, 20.7, 20.6, 20.5, 20.3 (t, 
J = 19.6 Hz). 
IR (Diamond-ATR, neat) ෤߭max: 3330 (br w), 2960 (m), 1643 (w), 1577 (m), 1434 (s), 1400 (m), 1310 
(m), 1205 (s), 911 (w), 730 (w). 
HRMS (EI) calc. for C14H13D479BrO [M]+: 284.0714; found: 284.0698;     
          calc. for C14H12D579BrO [M]+: 285.0777; found: 285.0757;                                           
          calc. for C14H11D679BrO [M]+: 286.0839; found: 286.0848. 
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Figure 16: a) 1H-NMR spectrum of 7p (400 MHz, CD2Cl2); b) 1H-NMR spectrum of 23 (400 MHz, CD2Cl2); c) 
2H-NMR spectrum of 23 (400 MHz, CH2Cl2). 
24: 
TLC (20% ethyl acetate in hexanes): Rf = 0.49 (UV, KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 5.02 (s, 1H), 4.26–4.20 (m, 0.5H; 0.5D), 2.95 (hept, J = 6.9 Hz, 
1H), 2.52–2.41 (m, 2H), 2.40–2.31 (m, 1H), 1.91–1.79 (m, 1H), 1.10 (d, J = 6.9 Hz, 2.5H; 0.5D), 1.06 
(d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.2, 150.0, 129.9, 121.1, 121.1, 120.8, 120.6, 117.0, 117.0, 116.1, 
115.9, 115.6, 51.2, 30.9, 30.8, 29.8, 29.7, 29.6, 29.5, 29.4, 29.4, 29.3, 20.7, 20.7, 20.5, 20.4. 
IR (Diamond-ATR, neat) ෤߭max: 3422 (br w), 2960 (vs), 1644 (w), 1568 (m), 1457 (m), 1382 (m), 
1234 (m), 1172 (s), 910 (w), 857 (w). 
HRMS (EI) calc. for C14H13D479BrO [M]+: 284.0714; found: 284.0695;                                                                 
         calc. for C14H12D579BrO [M]+: 285.0777; found: 285.0753;                                           
         calc. for C14H11D679BrO [M]+: 286.0839; found: 286.0698. 
 
 
Ether 25 
To a solution of p-cresol (170 mg, 1.57 mmol, 1.05 equiv) and and (t-Bu)3PAuNTf2 (51.0 mg, 
0.08 mmol, 5 mol %) was added bromide 1a (281 mg, 1.50 mmol, 1 equiv) at –30 °C. After 2 h, the 
BrHOa)
7o
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reaction mixture was filtered through a short plug of silica and the filtrate was concentrated. The 
residue was purified via column chromatography on silica gel (5% ethyl acetate in pentane) to yield 
ether 25 (223 mg, 51%) as a pale yellow oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.58 (UV, KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 7.06 (d, J = 8.3 Hz, 2H), 6.89 (d, J = 8.3 Hz, 2H), 6.14–6.06 (m, 
1H), 3.18–3.06 (m, 1H), 2.40–2.10 (m, 7H), 1.34 (s, 3H), 1.25 (s, 3H). 
13C NMR (CD2Cl2, 101 MHz): δ = 153.0, 136.5, 133.4, 129.9, 124.6, 122.1, 83.0, 59.0, 31.5, 27.4, 
25.3, 24.0, 21.0. 
IR (Diamond-ATR, neat) ෤߭max: 2978 (w), 2934 (w), 1611 (w), 1506 (vs), 1461 (w), 1368 (w), 1224 (s), 
1267 (m), 946 (w), 829 (w). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0621. 
 
 
Ether S32 
To a solution of p-flurophenol (88.3 mg, 0.79 mmol, 1.05 equiv) and (t-Bu)3PAuNTf2 
(51.0 mg, 0.08 mmol, 5 mol %) in dichloromethane (13 mL) was added bromide 1a (140 mg, 
0.75 mmol, 1 equiv) at –30 °C. After 4 h, saturated aqueous sodium bicarbonate solution (25 mL) was 
added and the aqueous phase was extracted with dichloromethane (3 × 25 mL). The combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified via column chromatography on silica gel (10% ethyl acetate in 
hexanes) to yield ether S32 (168 mg, 75%) as a pale yellow oil. 
TLC (10% ethyl acetate in hexanes): Rf = 0.60 (UV, KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 7.04–6.92 (m, 4H), 6.15–6.09 (m, 1H), 3.17–3.02 (m, 1H), 2.40–
2.23 (m, 2H), 2.23–2.10 (m, 2H), 1.33 (s, 3H), 1.25 (s, 3H). 
13C NMR (CD2Cl2, 101 MHz): δ = 159.6 (d, J = 240.6 Hz), 151.3 (d, J = 2.6 Hz), 136.6, 126.2 (d, 
J = 8.3 Hz), 122.0, 115.8 (d, J = 22.8 Hz), 83.5, 58.9, 31.5, 27.4, 25.0, 24.0. 
19F NMR (CD2Cl2, 376 MHz): δ = –121.2. 
IR (Diamond-ATR, neat) ෤߭max: 2979 (w), 2937 (w), 1613 (w), 1500 (vs), 1367 (w), 1204 (s), 1125 (m), 
889 (w), 856 (m), 801 (w). 
HRMS (EI) calc. for C15H1979BrFO [M]+: 298.0369; found: 298.0362. 
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3.4.2.2. NMR Studies 
a) Low Temperature 1H NMR studies 
To a solution of bromide 1a (13.1 mg, 0.07 mmol, 1 equiv) and p-cresol (11.4 mg, 0.11 mmol, 
1.5 equiv) in dichloromethane-D2 (0.7 mL) in an NMR-tube was added (t-Bu)3PAuNTf2 (2.38 mg, 
3.50 mol, 5 mol %) at –35 °C. After complete conversion to 25 (1.5 h), the reaction mixture was 
allowed to warm to 25 °C. An 1H-NMR spectrum was measured at the indicated times. After 
completion of the reaction 1,3,5-trimethoxybenzene (1.00 mg, 5.95 mol) was added and the yield 
was calculated from the 1H-NMR spectrum.  
 
 
Figure 17: Selective synthesis of ether 25 at –35 °C and its conversion to 2a via the intermediacy of 26 (1H 
NMR, CD2Cl2, 400 MHz). 
 
b) Conversion of 25 to 1a 
To a solution of (t-Bu)3PAuNTf2 (2.30 mg, 3.50 mol, 5 mol %) in dichloromethane-D2 (0.5 
mL) in an NMR-tube was added a solution of ether 25 (20.0 mg, 0.07 mmol, 1 equiv) in 
dichloromethane-D2 (0.2 mL) at 23 °C. An 1H-NMR spectrum was measured at the indicated times. 
After completion of the reaction 1,3,5-trimethoxybenzene (1.00 mg, 5.95 mol) was added and the 
yield was calculated from the 1H-NMR spectrum.  
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Figure 18: Monitoring the conversion of ether 25 to 2a via the intermediacy of 26 (1H NMR, CD2Cl2, 400 MHz).  
 
c) 31P NMR studies 
To a solution of bromide 1a (13.1 mg, 0.07 mmol, 1 equiv) and p-cresol (11.4 mg, 0.11 mmol, 
1.5 equiv) in dichloromethane-D2 (0.7 mL) in an NMR-tube was added (t-Bu)3PAuNTf2 (2.38 mg, 
3.50 mol, 5 mol %) at –50 °C. After complete conversion to ether 25 (3.5 h) the reaction mixture was 
allowed to warm to 25 °C.  
 
 
Figure 19: a) 31P-NMR spectrum of (t-Bu)3PAuNTf2 (23 °C, CD2Cl2, 162 MHz), b) 31P-NMR after 1.5 h (–50 °C, 
CD2Cl2, 162 MHz), c) 31P-NMR spectrum after 5.0 h (25 °C, CD2Cl2, 162 MHz). The spectrum shows that the 
catalyst was fully regenerated after complete formation of 25.  
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3.4.3. Experimental Procedures 
3.4.3.1. Synthesis of Gold Catalysts 
 
Chloro(triphenylphosphine)gold(I) S33 
To a solution of sodium tetrachloroaurate (100 mg, 0.25 mmol, 1 equiv) in water (3 mL)     
2,2´-thiodiethanol (75.5 L, 0.75 mmol, 3.00 equiv) was added dropwise at 0 °C over a period of 
45 min, followed by a solution of triphenylphosphite (65.9 mg, 0.25 mmol. 1.00 equiv) in ethanol 
(3 mL). The resulting white suspension was allowed to warm to 23 °C. After 30 min, the reaction 
mixture was filtered and the filtrate was washed with methanol (5 mL). The residue was dissolved in a 
minimum amount of dichloromethane and the product was precipitated with pentane to give S33 
(95.7 mg, 77%) as a colorless microcrystalline powder. The obtained analytical data were in full 
agreement with the data previously reported.[194] 
 
 
[Bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) S34 
To a solution of silver bis(trifluoromethanesulfonyl)imide (38.8 mg, 0.10 mmol, 1.00 equiv) in 
dichloromethane (0.5 mL) was added a solution of S33 (49.5 mg. 0.10 mmol, 1 equiv) in 
dichloromethane (1 mL) at 23 °C. After 15 min, the reaction mixture was filtered through a plug of 
Celite and the filtrate was concentrated. The residue was dissolved in a minimum amount of 
dichloromethane and the product was precipitated by the addition of pentane (15 mL). The formed 
suspension was filtered to give S34 (54 mg, 73%) as a white microcrystalline solid. The obtained 
analytical data were in full agreement with the data previously reported.[194] 
 
P AuO Cl
3  
Chloro(triphenylphosphite)gold(I) S35 
To a solution of sodium tetrachloroaurate (100 mg, 0.25 mmol, 1 equiv) in water (3 mL) was 
added 2,2´-thiodiethanol (75.5 L, 0.75 mmol, 3.00 equiv) dropwise at 0 °C over a period of 45 min, 
followed by a solution of triphenylphosphite (78.0 mg, 0.25 mmol. 1.00 equiv) in pentane (3 mL). The 
resulting white suspension was allowed to warm to 23 °C. After 30 min, the reaction mixture was 
filtered and washed with methanol (5 mL). The residue was dissolved in a minimum amount of 
dichloromethane and the product precipitated with pentane to give S35 (92.0 mg, 67%) as a white 
powder. The obtained data were in full agreement with those reported in literature.[195] 
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[Bis(trifluoromethanesulfonyl)imidate](triphenylphosphite)gold(I) S36 
To a solution of silver bis(trifluoromethanesulfonyl)imide (38.8 mg, 0.10 mmol, 1.00 equiv) in 
dichloromethane (0.5 mL) was added a solution of S35 (54.3 mg. 0.10 mmol, 1 equiv) in 
dichloromethane (1 mL) at 23 °C. After 3 h, the reaction mixture was filtered through a plug of Celite 
and the filtrate was concentrated to give S36 (78 mg, 99%) as a pale yellow solid. The obtained 
analytical data were in full agreement with the data previously reported.[195] 
 
 
Chloro[tris(2,4-di-tert-butylphenyl)phosphite]gold(I) S37 
To a solution of sodium tetrachloroaurate (100 mg, 0.25 mmol, 1 equiv) in water (1 mL) was 
added 2,2´-thiodiethanol (75.5 L, 0.75 mmol, 3.00 equiv) dropwise at 0 °C over a period of 45 min, 
followed by a solution of tris(2,4-di-tert-butylphenyl)phosphite (163 mg, 0.25 mmol. 1.00 equiv) in 
pentane (3 mL). The resulting white suspension was allowed to warm to 23 °C. After 30 min, the 
reaction mixture was filtered and the residue was washed with methanol (5 mL) to give S37(169 mg, 
77%) as a white powder. The obtained analytical data were in full agreement with the data previously 
reported.[196] 
 
 
[Bis(trifluoromethanesulfonyl)imidate](2,4-di-tert-butylphenyl)phosphite)gold(I) S38 
To a solution of silver bis(trifluoromethanesulfonyl)imide (38.8 mg, 0.10 mmol, 1.00 equiv) in 
dichloromethane (0.5 mL) was added a solution of S37 (54.3 mg. 0.10 mmol, 1 equiv) in 
dichloromethane (2 mL) at 23 °C. After 30 min, the reaction mixture was filtered through a plug of 
Celite and the filtrate was concentrated to give S38 (51.9 mg, 46%) as a white solid. The obtained 
analytical data were in full agreement with the data previously reported.[197] 
 
 
IPrAuNTf2 S39 
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To a solution of IPrAuCl (62.2 mg, 0.10 mmol, 1 equiv) in dichloromethane (2 mL) was added 
silver bis(trifluoromethanesulfonyl)imide (38.8 mg, 0.10 mmol, 1.00 equiv) at 23 °C. After 5 min, the 
reaction mixture was filtered through a plug of Celite and the filtrate was concentrated. The residue 
was dissolved in a minimum amount of dichloromethane and precipitated with pentane (15 mL). The 
resulting white solid was filtered to give S39 (78 mg, 90%) as a white powder. The obtained analytical 
data were in full agreement with the data previously reported.[198] 
 
3.4.3.2. Synthesis of Enynes 
 
2-Cyclopropylpropan-2-ol S40 
To a solution of cyclopropyl methyl ketone (50.0 g, 594 mmol, 1 equiv) in ether (200 mL) was 
added dropwise a solution of methyl magnesium bromide (3.0 M in ether, 258 mL, 773 mmol, 
1.30 equiv) at 0 °C over a period of 1 h. The cooling bath was removed and the mixture was allowed 
to warm to 23 °C. After 1 h, excess methyl magnesium bromide was carefully quenched with saturated 
aqueous ammonium chloride solution (400 mL). The layers were separated and the aqueous phase was 
extracted with ether (2 × 200 mL). The combined organic extracts were washed with saturated 
aqueous sodium chloride solution (400 mL), the washed solution was dried over potassium carbonate, 
the dried solution was filtered and the filtrate was carefully concentrated (700 mbar). The residue was 
subjected to distillation to yield 2-cyclopropylpropan-2-ol S40 (41.2 g, 69%) as a colorless oil (boiling 
point 121–122 °C, 1013 mbar). Characterization data obtained for S40 were in full agreement with 
values previously reported.[199] 
 
 
Bromide S41 
Lithium bromide (37.4 g, 430 mmol, 1.16 equiv) was added to neat alcohol S40 (39.2 g, 
391 mmol, 1 equiv) and the resulting suspension was cooled to 0 °C. Hydrobromic acid (48 %, 42 mL, 
1.05 equiv) was added dropwise over a period of 10 min and the resulting solution was stirred at 0 °C. 
After 45 min, the reaction mixture was diluted with ether (600 mL) and saturated aqueous sodium 
bicarbonate solution (200 mL) was added to the resulting biphasic mixture. The phases were separated 
and the organic layer was sequentially washed with saturated aqueous sodium bicarbonate solution 
(200 mL) and saturated aqueous sodium chloride solution (200 mL). The washed organic extract was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was carefully concentrated on 
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a rotary evaporator (600 mbar, 40 °C) and by careful distillation (600 mbar, 80 °C oil bath). 
Distillation of the residue afforded 5-bromo-2-methylpent-2-ene S41 (55.3 g, 87%) as a colorless oil 
(boiling point: 59–61 °C, 35 mbar). The obtained data were in full agreement with those reported in 
the literature.[199] 
 
 
Akyne 1f 
To a suspension of lithium acetylide ethylenediamine complex (39.7 g, 388 mmol, 1.15 equiv 
in dimethyl sulfoxide (200 mL) was added dropwise bromide S41 (55.0 g, 337 mmol, 1 equiv) under 
vigorous stirring at 0 °C over a period of 35 min. After 15 min, the reaction mixture was allowed to 
warm to 23 °C. After 2 h, the mixture was cooled to 15 °C and excess lithium acetylide was carefully 
quenched by the addition of water (800 mL). The aqueous phase was extracted with pentane 
(3 × 200 mL), the combined organic extracts were filtered through a plug of Celite and the filtrate was 
carefully concentrated. Distillation of the residue afforded alkyne 1f (15.8 g, 43%) as a colorless oil 
(boiling point: 120–125 °C, 1013 mbar). Characterization data obtained for 1f were in full agreement 
with the values previously reported.[200] 
 
 
Bromo alkyne 1a 
To a solution of alkyne 1f (3.00 g, 27.7 mmol, 1 equiv) in acetone (90 mL) were sequentially 
added silver nitrate (471 mg, 2.77 mmol, 0.10 equiv) and N-bromosuccinimide (5.92 g, 33.3 mmol, 
1.20 equiv) at 23 °C. After 30 min, the blue-greyish suspension was poured into water (30 mL). The 
aqueous layer was extracted with hexanes (3 × 50 mL) and the combined organic extracts were 
washed with saturated aqueous sodium chloride solution (50 mL). The washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by column chromatography on silica gel (pentane) to afford bromide 1a (4.10 g, 79%) as a 
colorless oil. 
TLC (pentane), Rf = 0.52 (KMnO4). 
1H NMR (CDCl3, 300 MHz): δ = 5.19–5.07 (m, 1H), 2.25–2.13 (m, 4H), 1.69 (s, 3H), 1.60 (s, 3H). 
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13C NMR (CDCl3, 75 MHz): δ = 133.6, 122.6, 80.5, 37.9, 27.3, 25.9, 20.4, 18.0. 
IR (Diamond-ATR, neat) ෤߭max: 2968 (s), 2913 (vs), 2865 (m), 1674 (w), 1444 (vs), 1376 (vs), 
1320 (m), 1108 (m), 983 (m), 822 (vs). 
HRMS (EI) calc. for C8H1179Br [M]+: 186.0044; found: 186.0043.  
 
 
Chloro alkyne 1b 
To a solution of alkyne 1f (200 mg, 1.85 mmol, 1 equiv) in tetrahydrofuran (6.0 mL) was 
added n-butyllithium (2.48 M in hexanes, 0.78 mL, 1.94 mmol, 1.05 equiv) at –78 °C. After 1 h, a 
solution of para-toluenesulfonyl chloride (370 mg, 1.94 mmol, 1.05 equiv) in tetrahydrofuran 
(2.5 mL) was added dropwise at this temperature. The mixture was then allowed to warm to –40 °C 
over 2 h and then was warmed to 24 °C. After 1 h, the mixture was diluted with water (10 mL) and the 
aqueous phase was extracted with ether (3 × 30 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (30 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
column chromatography on silica gel (5% ethyl acetate in hexanes) to give chloro enyne 1b (169 mg, 
64%) as a pale yellow oil. 
TLC (hexanes), Rf = 0.58 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.19–5.09 (m, 1H), 2.23–2.14 (m, 4H), 1.71 (s, 3H), 1.62 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 133.5, 122.5, 69.7, 57.2, 27.3, 25.9, 19.4, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 2969 (m), 2916 (s), 2858 (m), 1450 (m), 1432 (m), 1378 (m), 1323 (w), 
1078 (m), 983 (w), 823 (m). 
HRMS (EI) calc. for C8H1135Cl [M]+: 142.0549; found: 142.0532. 
 
 
Iodo alkyne 1c 
To a solution of alkyne 1f (200 mg, 1.85 mmol, 1 equiv) in acetone (6.0 mL) were sequentially 
added silver nitrate (31.4 mg, 0.19 mmol, 0.10 equiv) and N-iodosuccinimide (499 mg, 2.22 mmol, 
1.20 equiv) at 23 °C under exclusion of light. After 1 h, the suspension was poured into water 
(20 mL). The aqueous layer was extracted with hexanes (3 × 30 mL) and the combined organic 
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extracts were washed with saturated aqueous sodium chloride solution (20 mL). The washed solution 
was dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residue was purified by column chromatography on silica gel (2% ethyl acetate in hexanes) to afford 
iodide 1c (289 mg, 67%) as a colorless oil. 
TLC (hexanes), Rf = 0.33 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.22–5.05 (m, 1H), 2.40–2.31 (m, 2H), 2.25–2.15 (m, 1H), 1.70 (s, 
3H), 1.62 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 133.5, 122.4, 94.8, 27.4, 25.9, 21.4, 17.9, –7.1. 
IR (Diamond-ATR, neat) ෤߭max: 2966 (s), 2912 (vs), 1673 (w), 1446 (s), 1375 (s), 1319 (m), 1252 (w), 
1107 (m), 983 (m), 822 (s). 
HRMS (EI) calc. for C7H8127I [M–CH3]+: 218.9671; found: 218.9660. 
 
 
Enyne 1d 
To a solution of alkyne 1f (250 mg, 2.31 mmol, 1 equiv) in tetrahydrofuran (5.0 mL) was 
added n-butyllithium (2.48 M in hexanes, 0.98 mL, 2.43 mmol, 1.05 equiv) at –78 °C. After 1 h, 
methyl chloroformate (0.19 mL, 2.43 mmol, 1.05 equiv) was added dropwise to the reaction mixture at 
–78 °C. The reaction mixture was slowly allowed to warm to –30 °C. After 1.5 h, saturated aqueous 
ammonium chloride solution (20 mL) was added to the reaction mixture and the aqueous phase was 
extracted with ether (3 × 30 mL). The combined organic extracts were washed with saturated aqueous 
sodium chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by column 
chromatography on silica gel (10% ethyl acetate in hexanes) to give enyne 1d (345 mg, 90%) as 
colorless oil. 
TLC (10% ethyl acetate in hexanes), Rf = 0.38 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.12 (t, J = 6.9 Hz, 1H), 3.74 (s, 3H), 2.36–2.21 (m, 4H), 1.69 (s, 
3H), 1.61 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.4, 134.1, 121.8, 89.8, 72.9, 52.7, 26.4, 25.8, 19.3, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 2917 (w), 2238 (m), 1712 (vs), 1434 (m), 1377 (w), 1247 (vs), 1070 (s), 
901 (w), 752 (s). 
HRMS (EI) calc. for C10H14O2 [M]+: 166.0994; found: 166.0996. 
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Enyne 1e 
To a solution of alkyne 1f (200 mg, 1.85 mmol, 1 equiv) in tetrahydrofuran (6.0 mL) was 
added n-butyllithium (2.24 M in hexanes, 0.87 mL, 1.94 mmol, 1.05 equiv) at –78 °C. After 1 h, 
methyl iodide (345 mL, 5.55 mmol, 3.00 equiv) was added dropwise to the reaction mixture at –78 °C. 
The cooling bath was then removed and the reaction mixture was allowed to warm to 24 °C. After 
20 min, saturated aqueous ammonium chloride solution (10 mL) was added and the aqueous phase 
was extracted with ether (3 × 30 mL). The combined organic extracts were washed with saturated 
aqueous sodium chloride solution (30 mL). The washed solution was dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by column 
chromatography on silica gel (2% ether in pentane) to give enyne 1e (147 mg, 65%) as a colorless oil. 
TLC (hexanes), Rf = 0.34 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.19–5.13 (m, 1H), 2.20–2.09 (m, 4H), 1.78 (t, J = 2.4 Hz, 3H), 1.70 
(s, 3H), 1.62 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 132.9, 123.2, 79.4, 75.6, 28.0, 25.9, 19.4, 17.9, 3.7. 
IR (Diamond-ATR, neat) ෤߭max: 2968 (m), 2919 (s), 2858 (m), 1436 (s), 1377 (m), 1326 (w), 1107 (m), 
984 (w), 824 (m). 
HRMS (EI) calc. for C9H14 [M]+: 122.1096; found: 122.1085.  
 
 
Enyne 1g 
To a solution of alkyne 1f (200 mg, 1.85 mmol, 1 equiv) in a mixture of diisopropylamine 
(5.0 mL) and dichloromethane (1.0 mL) was added copper (I) iodide (35.2 mg, 0.19 mmol, 
0.10 equiv), bis(triphenylphosphine)palladium(II) chloride (13 mg, 0.02 mmol, 0.01 equiv) and 
iodobenzen (453 mg, 2.22 mmol, 1.20 equiv) at 23 °C. After 5 h, water (30 mL) was added to the 
reaction mixture and the aqueous phase was extracted with dichloromethane (3 × 30 mL) and the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by column chromatography on silica gel (hexanes) 
to give enyne 1g (289 mg, 85%) as a colorless oil. 
TLC (hexanes), Rf = 0.23 (UV, KMnO4). 
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1H NMR (CDCl3, 400 MHz): δ = 7.42–7.36 (m, 2H), 7.31–7.24 (m, 3H), 5.23 (t, J = 7.0 Hz, 1H), 2.42 
(t, J = 7.3 Hz, 2H), 2.34–2.26 (m, 2H), 1.73 (s, 3H), 1.66 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 133.3, 131.7, 128.3, 127.6, 124.2, 122.9, 90.4, 80.7, 27.7, 25.9, 
20.1, 18.0. 
IR (Diamond-ATR, neat) ෤߭max: 2969 (w), 2914 (m), 1599 (w), 1490 (m), 1442 (m), 1376 (w), 1070 (w), 
824 (w), 755 (vs), 691 (s). 
HRMS (EI) calc. for C14H16 [M]+: 184.1252; found: 184.1238. 
 
 
Enyne 1h 
To a solution of alkyne 1f (200 mg, 1.85 mmol, 1 equiv) in tetrahydrofuran (6.0 mL) was 
added n-butyllithium (2.48 M in hexanes, 0.87 mL, 1.94 mmol, 1.05 equiv) at –78 °C. After 1 h, 
chlorotrimethylsilane (0.26 mL, 2.03 mmol, 1.10 equiv) was added dropwise to the reaction mixture at 
–78 °C. The reaction mixture was then slowly allowed to warm to 24 °C. After 3 h, water (10 mL) was 
added to the reaction mixture and the aqueous phase was extracted with ether (3 × 30 mL). The 
combined organic extracts were washed with saturated aqueous sodium chloride solution (30 mL). The 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by column chromatography on silica gel (2% ethyl acetate in 
hexanes) to give enyne 1h (284 mg, 85%) as a colorless oil. 
TLC (hexanes), Rf = 0.32 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.18–5.12 (m, 1H), 2.23–2.19 (m, 4H), 1.70 (s, 3H), 1.62 (s, 3H), 
0.15 (s, 9H). 
13C NMR (CDCl3, 101 MHz): δ = 133.2, 122.8, 107.6, 84.4, 27.6, 25.9, 20.5, 18.0, 0.3. 
IR (Diamond-ATR, neat) ෤߭max: 2963 (w), 2172 (w), 1265 (m), 1250 (m), 1046 (w), 895 (w), 841 (vs), 
736 (vs), 704 (s). 
HRMS (EI) calc. for C11H2028Si [M]+: 180.1334; found: 180.1312. 
 
 
Aldheyde S43 
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Aldehyde S43 was preapared according to a literature procedure.[201] To a solution of tertiary 
alcohol[202] S42 (1.70 g, 15.0 mmol, 1 equiv) and N,N-diisoproylethylamine (130 L, 0.75 mmol, 0.05 
equiv) in triethyleneglycol divinyl ether (4.5 mL) in a pressure tube was added 1,10-phenathroline-
Pd(OAc)2 (38.4 mg, 0.08 mmol, 0.5 mol %) at 23 °C and reaction mixture was heated to 85 °C. After 
15 h, the mixture was heated to 125 °C. After 24 h, the mixture was allowed to cool to 23 °C and the 
residue was directly purified by column chromatography on silica gel (10% ether in pentane) to afford 
aldehyde S43 (307 mg, 15%) as a colorless oil. 
TLC (pentane), Rf = 0.47 (KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 9.70 (t, J = 3.0 Hz, 1H), 5.23 (s, 1H), 2.41 (d, J = 3.0 Hz, 2H), 1.73 
(s, 3H), 1.69 (s, 3H), 1.21 (s, 6H). 
13C NMR (CD2Cl2, 101 MHz): δ= 204.1, 133.2, 132.1, 56.5, 34.6, 30.0, 28.2, 19.4. 
IR (Diamond-ATR, neat) ෤߭max: 2962 (m), 2730 (w), 1720 (vs), 1632 (w), 1449 (w), 1366 (w), 1172 (w), 
1045 (w), 820 (w). 
HRMS (EI) calc. for C9H16O [M]+: 140.1201; found: 140.1190. 
 
 
Enyne 1i 
To a solution of aldehyde S43 (260 mg, 1.85 mmol, 1 equiv) in methanol (9 mL) was added 
potassium carbonate (384 mg, 2.78 mmol, 1.50 equiv) and Bestmann–Ohira´s reagent[203] (dimethyl 
(1-diazo-2-oxopropyl)phosphonate) (534 mg, 2.78 mmol, 1.50 equiv) at 23 °C. After 3h, water (30 
mL) was added to the reaction mixture and the aqueous phase was extracted with pentane (4 × 30 mL). 
The combined organic extracts were washed with saturated aqueous sodium chloride solution (30 mL), 
the washed solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
carefully concentrated (23 °C, 500 mbar). The residue was dissolved in acetone (8 mL) and silver 
nitrate (31.4 mg, 0.19 mmol, 0.01 equiv) was added followed by N-bromosuccinimide (379 mg, 
2.13 mmol, 1.15 equiv) at 23 °C. After 3 h, the blue-greyish suspension was poured into water 
(40 mL). The aqueous layer was extracted with pentane (3 × 30 mL) and the combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by column chromatography on silica gel (pentane) to afford 
bromide 1i (156 mg, 39%) as a colorless oil. 
TLC (pentane), Rf = 0.72 (KMnO4). 
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1H NMR (CD2Cl2, 400 MHz): δ = 5.18–5.13 (m, 1H), 2.25 (s, 2H), 1.72 (s, 3H), 1.69 (s, 3H), 1.16 (s, 
6H). 
13C NMR (CD2Cl2, 101 MHz): δ= 132.6, 132.5, 79.6, 38.6, 35.8, 35.1, 28.3, 28.3, 19.3. 
IR (Diamond-ATR, neat) ෤߭max: 2964 (s), 2928 (m), 1664 (w), 1466 (m), 1447 (m), 1364 (m), 1072 (m), 
981 (m), 818 (s). 
HRMS (DEI) calc. for C10H1579Br [M]+: 214.0357; found: 214.0353. 
 
 
Enyne S44 
According to a literature procedure[204], potassium carbonate (1.13 g, 8.16 mmol, 1.00 equiv), 
sodium sulphite (514 mg, 4.08 mmol, 0.50 equiv), copper(I) iodide (31.1 mg, 0.16 mmol 0.02 equiv) 
and 1,8-diazabicyclo[5.4.0)undec-7-ene (DBU) (1.30 mg, 0.01 mmol, 1 mol %) were added to a 
solution of 3,3-dimethylallyl chloride (1.28 g, 12.2mmol, 1 equiv) and ethynynltrimethylsilane in 
dimethylformamide (15 mL) at 23 °C. After 22 h, the reaction mixture was partitioned between 
saturated aqueous ammonium chloride solution (90 mL) and pentane (90 mL). The aqueous phase was 
extracted with pentane (2 × 90 mL). The combined organic extracts were washed with saturated 
aqueous sodium chloride solution (30 mL), the washed solution was dried over sodium sulfate and the 
dried solution was filtered. The filtrate was carefully concentrated (23 °C, 500 mbar). The residue was 
purified by column chromatography on silica gel (pentane) to afford alkyne S44 (570 mg, 42%) as a 
colorless oil. 
TLC (pentane), Rf = 0.20 (KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 5.18–5.12 (m, 1H), 2.92 (d, J = 6.8 Hz, 2H), 1.71 (s, 3H), 1.62 (s, 
3H), 0.13 (s, 9H) 
13C NMR (CD2Cl2, 101 MHz): δ = 134.5, 119.1, 106.4, 84.0, 25.8, 19.5, 17.9, 0.3. 
IR (Diamond-ATR, neat) ෤߭max: 2961 (w), 2176 (m), 1450 (w), 1283 (w), 1248 (m), 1031 (w), 1004 (w), 
836 (vs), 758 (s). 
HRMS (EI) calc. for C10H1828Si [M]+: 166.1178; found: 166.1174. 
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Enyne S45 
To a solution of TMS-alkyne S44 (100 mg, 0.60 mmol, 1 equiv) in methanol (2 mL) was 
added potassium carbonate (91.4 mg, 0.66 mmol, 1.10 equiv) at 23 °C. After 3.5 h, water (5 mL) was 
added to the reaction mixture and the aqueous phase was extracted with pentane (3 × 5 mL). The 
combined organic extracts were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was carefully concentrated (23 °C water bath, 500 mbar). The residue was dissolved in acetone 
(2 mL) and silver nitrate (10.2 mg, 0.06 mmol, 0.01 equiv), followed by N-bromosuccinimide 
(123 mg, 0.69 mmol, 1.15 equiv) were added at 23 °C. After 1.5 h, the suspension was poured into 
water (5 mL). The aqueous layer was extracted with pentane (3 × 10 mL) and the combined organic 
extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by column chromatography on silica gel (pentane) to afford 
bromide S45 (53.6 mg, 52%) as a colorless oil. 
TLC (pentane), Rf = 0.56 (KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 5.19–5.11 (m, 1H), 2.90 (d, J = 6.9 Hz, 2H), 1.71 (s, 3H), 1.62 (s, 
3H). 
13C NMR (CD2Cl2, 101 MHz): δ = 135.2, 118.2, 79.6, 37.6, 25.7, 19.2, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 2970 (m), 2914 (m), 1673 (w), 1447 (s), 1376 (s), 1286 (s), 1102 (s), 
917 (m), 832 (vs). 
HRMS (EI) calc. for C7H979Br [M]+: 171.9888; found: 171.9876. 
 
 
Alcohol S46 
To a solution of -valerolactone (2.00 g, 20.0 mmol, 1 equiv) in dichloromethane (2 mL) was 
added diisobutylaluminum hydride (1.00 M in dichloromethane, 24.0 mL, 24.0 mmol, 1.20 equiv) at    
–78 °C dropwise over a period of 20 min. After 40 min, ethyl acetate (5 mL) was added to the reaction 
mixture, followed by a saturated aqueous solution of potassium sodium tartrate (5 mL). The biphasic 
mixture was allowed to warm to 23 °C. After 3 h, water (10 mL) was added and the mixture was 
extracted with dichloromethane (2 × 50 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to give the crude lactol.   
Potassium tert-butoxide (2.58 g, 23 mmol, 1.15 equiv) was added to a suspension of 
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isopropyltriphenylphosphonium iodide (9.08 g, 21 mmol, 1.05 equiv) in tetrahydrofuran (40 mL) at     
–78 °C. After 5 min, the dark red mixture was allowed to warm to 0 °C. After 30 min, a solution of the 
crude lactol in tetrahydrofuran (10 mL) was added to the reaction mixture. The mixture was allowed to 
warm to 23 °C and after 23 h, water (50 mL) was added and the reaction mixture was extracted with 
ether (3 × 75 mL). The combined organic extracts were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The residue was purified by column chromatography on 
silica gel (50% ethyl acetate in hexanes) to yield alcohol S46 (1.39 g, 54%) as a pale yellow oil. The 
obtained analytical data for S46 were in full agreement with those previously reported.[205] 
 
 
Aldehyde S47 
A solution of dimethyl sulfide (2.08 mL, 29.2 mmol, 3.00 equiv) in dichloromethane (11 mL) 
was added to a solution of oxalylchloride (2 M in dichloromethane, 7.31 mL, 14.6 mmol, 1.10 equiv) 
in dichloromethane (11 mL) at –78 °C. After 10 min, a solution of alcohol S42 (1.25 g, 9.75 mmol, 
1 equiv) in dichloromethane (16 mL) was added dropwise to the reaction mixture at –78 °C over a 
period of 15 min. After 30 min, triethylamine (8.13 mL, 58.5 mmol, 6.00 equiv) was added and the 
reaction mixture was allowed to warm to 23 °C. After 30 min, water (50 mL) was added and the 
aqueous phase was extracted with dichloromethane (3 × 50 mL). The combined organic extracts were 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
residue was purified by column chromatography on silica gel (20% ether in pentane) to yield aldehyde 
S47 (1.20 g, 98%) as a pale yellow oil. The obtained analytical data were in full agreement with the 
ones previously reported.[205] 
 
 
Enyne S48 
To a solution of carbon tetrabromide (6.31 g, 19.0 mmol, 2.00 equiv) in dichloromethane 
(7.0 mL) was added triphenylphosphine (9.98 g, 38.0 mmol, 4.00 equiv) at 0 °C. After 30 min, a 
solution of aldehyde S47 (1.20 g, 9.51 mmol, 1 equiv) in dichloromethane (4.5 mL) was added at 0 °C 
and the reaction mixture was allowed to warm to 23 °C. After 1 h, the mixture was filtered through a 
short plug of silica, the filter cake was washed with a 1:5 mixture of ether in pentane (400 mL) and the 
filtrate was concentrated to give the crude dibromoolefin.   
To a solution of the crude dibromoolefin in tetrahydrofuran (24 mL) was added n-butyllithium 
(2.31 M in hexanes, 9.06 mL, 20.9 mmol, 2.20 equiv) at –78 °C. After 20 min, saturated aqueous 
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ammonium chloride solution (50 mL) was added and the aqueous phase was extracted with ether 
(3 × 75 mL). The combined organic extracts were washed with saturated aqueous sodium chloride 
solution (50 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the residue was purified by column chromatography on 
silica gel (pentane) to afford enyne S48 (412 mg, 36%) as a colorless oil. 
TLC (pentane), Rf = 0.38 (KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 5.09 (t, J = 6.9 Hz, 1H), 2.16 (td, J = 7.2 Hz, 2.5 Hz, 2H), 2.08 (q, 
J = 7.3 Hz, 2H), 1.96 (t, J = 2.5 Hz, 1H), 1.69 (s, 3H), 1.61 (s, 3H), 1.54 (q, J = 7.4 Hz, 2H). 
13C NMR (CD2Cl2, 101 MHz): δ = 133.0, 124.0, 85.2, 68.5, 29.3, 27.5, 26.0, 18.3, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 3308 (m), 2967 (m), 2930 (s), 1450 (s), 1377 (m), 1235 (w), 1108 (w), 
852 (w), 825 (w). 
HRMS (EI) calc. for C9H13 [M–H]+: 121.1017; found: 121.0998. 
 
 
Enyne S49 
To a solution of alkyne S48 (350 mg, 2.86 mmol, 1 equiv) in acetone (11 mL) was added 
silver nitrate (48.6 mg, 0.29 mmol, 0.01 equiv) followed by N-bromosuccinimide (586 mg, 3.29 mmol, 
1.15 equiv) at 23 °C. After 45 min, the suspension was poured into water (40 mL). The aqueous layer 
was extracted with pentane (3 × 30 mL) and the combined organic extracts were dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 
column chromatography on silica gel (pentane) to afford bromide S49 (426 mg, 74%) as a colorless 
oil. 
TLC (pentane), Rf = 0.45 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.07 (tq, J = 7.2 Hz, 1.5 Hz, 1H), 2.19 (t, J = 7.1 Hz, 2H), 2.07 (q, J 
= 7.4 Hz, 2H), 1.69 (s, 3H), 1.61 (s, 3H), 1.55 (p, J = 7.3 Hz, 2H). 
13C NMR (CDCl3, 101 MHz): δ = 132.8, 123.5, 80.5, 37.7, 28.5, 27.1, 25.9, 19.3, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 2967 (m), 2929 (vs), 2860 (m), 1673 (w), 1447 (s), 1376 (m), 1108 (w), 
984 (w), 856 (w). 
HRMS (DEI) calc. for C9H1279Br [M–H]+: 199.0122; found: 199.0109. 
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Silyl ether S51 
To a solution of alcohol S50[206] (1.18 g, 8.37 mmol, 1 equiv) in dichloromethane (7 mL) was 
added imidazole (1.00 g, 14.6 mmol, 1.75 equiv) and tert-butyldimethylsilyl chloride (1.45 g, 
9.62 mmol, 1.15 equiv) at 0 °C. After 15 min, the reaction mixture was allowed to warm to 23 °C. 
After further 1 h, the mixture was diluted with dichloromethane (40 mL) and the organic layer was 
washed with saturated aqueous sodium chloride solution (30 ml). The aqueous phase was extracted 
with dichloromethane (40 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated to give silyl protected alcohol S51 (2.14 g, 
99%) as a colorless oil, which was used without further purification. 
TLC (10% ethyl acetate in hexanes), Rf = 0.69 (KMnO4, UV). 
1H NMR (CDCl3, 400 MHz): δ = 3.51 (t, J = 6.4 Hz, 2H), 2.02 (t, J = 6.4 Hz, 2H), 0.89 (s, 9H), 0.07 
(s, 6H). 
13C NMR (CDCl3, 101 MHz): δ = 59.9 (p, J = 21.9 Hz), 35.5, 30.8, 26.1, 18.5, –5.2. 
IR (Diamond-ATR, neat) ෤߭max: 2953 (m), 2928 (m), 2855 (m), 1471 (w), 1253 (s), 1177 (s), 1086 (s), 
1045 (s), 8632 (vs), 775 (s). 
MS (EI) calc. for C5H10D279BrO28Si+ [M–t-Bu]+: 196.9966; found: 1960.9973. 
 
 
Alkyne S52 
To a suspension of lithium acetylide ethylenediamine complex (0.89 g, 9.63 mmol, 1.15 
equiv) in dimethylsulfoxide (6 mL) was added bromide S51 (2.14 g, 8.37 mmol, 1 equiv) dropwise at 
0 °C under vigorous stirring. After 30 min, the reaction mixture was allowed to warm to 23 °C. After 
3 h, excess lithium acetylide was carefully quenched by the addition of water (20 mL). The aqueous 
phase was extracted with ether (3 × 50 mL) and the combined organic extracts were washed with 
saturated aqueous sodium chloride solution (30 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
column chromatography on silica gel (10% ether in pentane) to yield alkyne S52 (1.28 g, 76%) as a 
colorless oil. 
TLC (10% ether in pentane): Rf = 0.69 (KMnO4, UV). 
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1H NMR (CDCl3, 400 MHz): δ = 2.27 (td, J = 7.1, 2.7 Hz, 2H), 1.93 (t, J = 2.7 Hz, 1H), 1.71 (t, 
J = 7.1 Hz, 2H), 0.89 (s, 9H), 0.05 (s, 6H). 
13C NMR (CDCl3, 101 MHz): δ = 84.4, 68.4, 60.9 (p, J = 21.6 Hz), 31.4, 26.1, 18.5, 14.9, –5.2. 
IR (Diamond-ATR, neat) ෤߭max: 3310 (w), 2928 (w), 1471 (w), 1254 (m), 1152 (m), 1099 (m), 1051 (m), 
908 (s), 832 (s), 775 (s), 731 (s). 
MS (DEI) calc. for C7H15D2O28S [M–C4H5]+: 147.1; found: 147.1, calc. C7H11D2O28S [M–t-Bu]+: 
143.1; found: 143.1. 
 
 
TMS alkyne S53 
n-Butyllithium (2.20 M in hexanes, 2.98 mL, 6.55 mmol, 1.05 equiv) was added dorpwise to a 
solution of alkyne S52 (1.25 g, 6.24 mmol, 1 equiv) in tetrahydrofuran (18 mL) at –78 °C. After 
30 min, chlorotrimethylsilane (0.88 mL, 6.86 mmol, 1.10 equiv) was added dropwise to the reaction 
mixture over a period of 10 min. The reaction mixture was then allowed to warm to 0 °C. After 
30 min, saturated ammonium chloride solution (50 mL) was added to the reaction mixture and the 
aqueous solution was extracted with ether (3 × 50 mL). The combined organic extracts were washed 
with saturated aqueous sodium chloride solution (30 mL). The washed organic extract was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated to yield TMS-alkyne 
S53 (1.72 g, 99%) as a yellow oil, which was used in the next reaction without further purification. 
TLC (5% ether in hexanes): Rf = 0.56 (KMnO4, UV). 
1H NMR (CDCl3, 400 MHz): δ = 2.30 (t, J = 7.0 Hz, 2H), 1.69 (t, J = 7.0 Hz, 2H), 0.90 (s, 9H), 0.14 
(s, 9H), –0.06 (s, 6H). 
13C NMR (CDCl3, 101 MHz): δ = 107.2, 84.7, 77.5, 60.9 (p, J = 21.6 Hz), 31.5, 26.11, 18.5, 16.3, 0.3, 
–5.2.  
IR (Diamond-ATR, neat) ෤߭max: 2956 (w), 2176 (w), 1472 (w), 1249 (m), 1153 (m), 1099 (m), 1051 (m), 
831 (vs), 774 (s), 758 (s), 698 (m). 
HRMS (EI) calc. for C13H25D2O28Si2 [M–CH3]+: 257.1726; found: 257.1706. 
 
 
Alcohol S54 
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To a solution of silyl ether S53 (1.70 mg, 6.24 mmol, 1 equiv) in a 1:1 mixture of 
dichloromethane and methanol (16 mL) was added camphorsulfonic acid (725 mg, 3.12 mmol, 
0.50 equiv) at 0 °C. After 1.5 h, triethylamine (0.87 mL, 6.24 mmol, 1.00 equiv) was added to the 
reaction mixture and the mixture was concentrated. The residue was purified by column 
chromatography on silica gel (30% ethyl acetate in hexanes) to give alcohol S54 (857 mg, 87%) as a 
colorless oil. 
TLC (40% ethyl acetate in hexanes): Rf = 0.22 (KMnO4, UV). 
1H NMR (CDCl3, 400 MHz): δ = 2.35 (t, J = 6.9 Hz, 2H), 1.76 (t, J = 6.9 Hz, 2H), 1.52 (br s, 1H), 
0.15 (s, 9H). 
13C NMR (CDCl3, 101 MHz): δ = 106.8, 85.4, 61.2 (p, J = 22.6 Hz), 31.1, 16.7, 0.2. 
IR (Diamond-ATR, neat) ෤߭max: 3334 (br w), 2958 (w), 2174 (m), 1248 (s), 1202 (w), 1135 (w), 966 
(m), 836 (vs), 758 (s), 697 (m). 
HRMS (EI) calc. for C7H10D2O228Si [M–CH3]+: 143.0861; found: 143.0862. 
 
 
Aldehyde S55 
To a solution of oxalylchloride (2.0 M in dichloromethane, 4.05 mL, 8.10 mmol, 1.5 equiv) in 
dichloromethane (6.0 mL) was added a solution of dimethylsulfoxide (1.15 mL, 16.2 mmol, 
3.00 equiv) in dichloromethane (6.0 mL) at –78 °C. After 10 min, a solution of alcohol S54 (855 mg, 
5.40 mmol, 1 equiv) in dichloromethane (12 mL) was added dropwise at –78 °C. After 30 min, 
triethylamine (4.50 mL, 32.4 mmol, 6.00 equiv) was added and the reaction mixture was allowed to 
warm to 23 °C. After 15 min, water (50 mL) was added to the reaction mixture and the aqueous phase 
was extracted with dichloromethane (3 × 50 mL). The combined organic extracts were washed with 
saturated aqueous sodium chloride solution (30 mL) and the washed solution was dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 
column chromatography on silica gel (10% ether in pentane) to yield aldehyde S55 (763 mg, 91%) as 
a colorless oil. 
TLC (20% ether in pentane): Rf = 0.32 (KMnO4, UV). 
1H NMR (CDCl3, 400 MHz): δ = 2.71–2.64 (m, 2H), 2.58–2.50 (m, 2H), 0.14 (s, 9H). 
13C NMR (CDCl3, 101 MHz): δ = 200.2 (t, J = 26.7 Hz), 104.9, 85.9, 42.5, 13.2, 0.2.  
IR (Diamond-ATR, neat) ෤߭max: 2959 (w), 2177 (w), 2083 (w), 1714 (m), 1407 (w), 1249 (m), 1093 (w), 
910 (w), 836 (vs), 758 (s). 
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HRMS (EI) calc. for C7H11DO28Si [M–CH3]+: 140.0642; found: 140.0633. 
 
 
Enyne S56 
To a yellow suspension of iso-propyltriphenylphosphonium iodide (1.47 g, 3.41 mmol, 
1.30 equiv) in tetrahydrofuran (20 mL) was added n-butyllithium (2.31 M in hexanes, 1.36 mL, 3.15 
mmol, 1.20 equiv) at 0 °C. After 30 min, a solution of aldehyde S55 (406 mg, 2.62 mmol, 1 equiv) in 
tetrahydrofuran (3.0 mL) was added to the dark red suspension. Stirring was continued at 0 °C for 
5 min and the reaction mixture was then allowed to warm to 23 °C. After 40 min, the mixture was 
diluted with water (50 mL). The aqueous phase was extracted with ether (3 × 50 mL). The combined 
organic extracts were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The residue was purified by flash-column chromatography on silica gel (5% ether in 
pentane) to furnish enyne S56 (404 mg, 85%) as a colorless oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.67 (KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 2.25–2.16 (m, 4H), 1.70 (s, 3H), 1.62 (s, 3H), 0.15 (s, 9H). 
13C NMR (CDCl3, 101 MHz): δ = 133.0, 122.5 (t, J = 23.1 Hz), 107.6, 84.4, 27.5, 25.8, 20.5, 18.0, 
0.3. 
IR (Diamond-ATR, neat) ෤߭max: 2961 (w), 2175 (w), 1448 (w), 1248 (m), 1044 (w), 887 (m), 837 (vs), 
758 (s), 734 (s), 697 (m). 
HRMS (EI) calc. for C11H19D28Si [M]+: 181.1397; found: 181.1385. 
 
 
Enyne S57 
To a solution of TMS-alkyne S56 (404 mg, 2.23 mmol, 1 equiv) in methanol (7.5 mL) was 
added potassium carbonate (339 mg, 2.45 mmol, 1.10 equiv) at 23 °C. After 10 h, water (20 mL) was 
and the aqueous phase was extracted with pentane (3 × 30 mL). The combined organic extracts were 
dried over sodium sulfate, the dried solution was filtered and the filtrate was carefully concentrated 
(23 °C water bath, 500 mbar). The residue was purified by column chromatography on silica gel 
(2% ether in pentane) to afford alkyne S57 (98.9 mg, 41%) as a colorless oil. 
TLC (pentane): Rf = 0.26 (KMnO4). 
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1H NMR (CD2Cl2, 400 MHz): δ = 2.19 (s, 4H), 1.98–1.94 (m, 1H), 1.70 (s, 3H), 1.62 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 133.6, 122.7 (t, J = 23.4 Hz), 85.0, 68.4, 27.7, 25.8, 19.32, 18.0. 
IR (Diamond-ATR, neat) ෤߭max: 2954 (s), 2928 (s), 2857 (s), 2174 (m), 1463 (m), 1249 (m), 838 (s), 
826 (s), 775 (s), 680 (w). 
HRMS (EI) calc. for C8H11D [M]+: 109.1002; found: 109.1003. 
 
 
Enyne 20 
To a solution of alkyne S57 (40 mg, 0.37 mmol, 1 equiv) in acetone (1.2 mL) was added silver 
nitrate (6.22 mg, 0.04 mmol, 0.01 equiv) followed by N-bromosuccinimide (75.0 mg, 0.42 mmol, 
1.15 equiv) at 23 °C. After 45 min, the suspension was poured into water (10 mL). The aqueous layer 
was extracted with pentane (3 × 10 mL) and the combined organic extracts were dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 
column chromatography on silica gel (pentane) to afford bromide 20 (61.4 mg, 89%) as a colorless oil. 
TLC (pentane), Rf = 0.72 (KMnO4). 
1H NMR (CD2Cl2, 400 MHz): δ = 2.22–2.17 (m, 4H), 1.70 (s, 3H), 1.62 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 133.8, 122.5 (t, J = 23.1 Hz), 80.9, 37.7, 27.4, 25.9, 20.6, 18.0. 
IR (Diamond-ATR, neat) ෤߭max: 2967 (m), 2912 (s), 2855 (m), 1663 (w), 1447 (s), 1373 (m), 1336 (w), 
1134 (m), 682 (m). 
HRMS (EI) calc. for C8H10D79Br [M]+: 187.0107; found: 187.0110. 
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3.4.3.3. Cyclization Products 
 
Scheme 27: Complete reaction scope. 
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General Procedure A: 
To a solution of the 1,5-enyne (0.25 mmol, 1 equiv) and phenol (1.25 mmol, 5.00 equiv) in 
dichloromethane (1.0 mL) was added (t-Bu)3PAuNTf2 (5 mol %) at 0 °C under an argon atmosphere. 
After complete consumption of the 1,5-enyne, the mixture was allowed to warm to 23 °C and the 
reaction was monitored by thin layer chromatography. After completion of the reaction, the mixture 
was concentrated and the residue was purified by flash column chromatography on silica gel (ethyl 
acetate in hexanes or dichloromethane) to afford the title compound. 
 
General Procedure B: 
To a solution of the 1,5-enyne (0.25 mmol, 1 equiv) and phenol (2.50 mmol, 10.0 equiv) in 
dichloromethane (1.0 mL) was added (t-Bu)3PAuNTf2 (5 mol %) at –20 °C under an argon 
atmosphere. After complete consumption of the 1,5-enyne, the mixture was allowed to warm to 23 °C 
and the reaction was monitored by thin layer chromatography. After completion of the reaction, the 
mixture was concentrated and the residue was purified by flash column chromatography on silica gel 
(ethyl acetate in hexanes or dichloromethane) to afford the title compound. 
 
General Procedure C: 
To a solution of the 1,5-enyne (0.25 mmol, 1 equiv) and p-fluorophenol (0.26 mmol, 
1.05 equiv) in dichloromethane (1.0 mL) was added (t-Bu)3PAuNTf2 (5 mol %) at –20 °C under an 
argon atmosphere. After complete consumption of the 1,5-enyne, the phenol (1.25 mmol, 5.00 equiv) 
was added and the mixture was allowed to warm to 23 °C. The reaction was monitored by thin layer 
chromatography chromatography. After completion of the reaction, the mixture was concentrated and 
the residue was purified by flash column chromatography on silica gel (ethyl acetate in hexanes or 
dichloromethane) to afford the title compound. 
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Phenol 2a 
Phenols 2a and 3a were prepared according to General Procedure A. After 1 h, the reaction 
mixture was concentrated and the residue was purified by flash-column chromatography on silica gel 
(10% ethyl acetate in hexanes) to furnish bis-alkylated phenol 3a (3.0 mg, 5%, d.r. = 1.7:1) as a pale 
yellow oil and phenol 2a (56.2 mg, 76%) as a pale yellow oil.  
2a: 
TLC (20% ethyl acetate in hexanes): Rf = 0.47 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.93 (dd, J = 8.1 Hz, 2.2 Hz, 1H), 6.84 (d, J = 2.0 Hz, 1H), 6.70 (d, 
J = 8.1 Hz, 1H), 4.79 (s, 1H), 4.21–4.12 (m, 1H), 2.97 (hept, J = 6.9 Hz, 1H), 2.57–2.30 (m, 3H), 2.27 
(s, 3H), 1.98–1.84 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 151.7, 149.6, 130.1, 129.7, 128.9, 128.5, 117.0, 116.1, 51.8, 30.3, 
29.4, 29.3, 20.8, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3429 (br w), 2959 (s), 1610 (w), 1504 (vs), 1458 (m), 1256 (m), 1105 
(m), 1037 (m), 808 (vs), 734 (s). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0603. 
3a: 
TLC (10% ethyl acetate in hexanes): Rf = 0.48 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz, major diastereomer marked with *): δ = 6.73 (s, 2H), 5.11* (s, 1H), 5.04 
(s, 1H), 4.23–4.10 (m, 2H), 2.96 (hept, J = 6.9 Hz, 2H), 2.53–2.29 (m, 6H), 2.25 (s, 3H), 2.00–1.85 
(m, 2H), 1.10 (d, J = 6.9 Hz, 6H), 1.06 (d, J = 6.9 Hz, 6H). 
13C NMR (CDCl3, 101 MHz, major diastereomer marked with *): δ = 150.2*, 150.1, 149.6*, 149.4, 
129.6, 129.4, 128.1*, 127.9, 117.2, 117.2*, 52.0, 30.3, 29.4*, 29.4, 29.2, 21.0, 21.0*, 20.6, 20.4, 
20.3*. 
IR (Diamond-ATR, neat) ෤߭max: 3507 (br w), 2960 (vs), 1645 (w), 1474 (vs), 1310 (m), 1200 (s), 908 
(m), 864 (s), 734 (s), 610 (w). 
HRMS (ESI) calc. for C23H2979Br2O2 [M–H]–: 479.0663; found: 479.0591. 
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Phenol 2b 
Phenol 2b was prepared according to General Procedure B. After 2 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (5% ethyl 
acetate in hexanes) to give phenol 2b (34.8 mg, 56%) as a pale yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.61 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.93 (dd, J = 8.1 Hz, 1.9 Hz, 1H), 6.85 (d, J = 1.9 Hz, 1H), 6.70 (d, 
J = 8.1 Hz, 1H), 4.83 (s, 1H), 4.23–4.09 (m, 1H), 2.99 (hept, J = 6.9 Hz, 1H), 2.59–2.33 (m, 3H), 2.27 
(s, 3H), 1.96–1.78 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 151.7, 146.0, 130.2, 129.5, 128.7, 128.4, 125.6, 116.0, 49.9, 29.9, 
28.6, 27.6, 20.8, 20.6, 20.4. 
IR (Diamond-ATR, neat) ෤߭max: 3398 (br w), 2962 (s), 1612 (w), 1509 (s), 1462 (m), 1259 (m), 1204 
(m), 1086 (m), 931 (w), 811 (m). 
HRMS (EI) calc. for C15H1935ClO [M]+: 250.1124; found: 250.1116. 
 
 
Phenol 2c 
Phenol 2c was prepared according to General Procedure A under the exclusion of light. After 
8 h, the reaction mixture was concentrated and the residue was purified by flash-column 
chromatography on silica gel (5% ethyl acetate in hexanes) to yield phenol 2c (5.5 mg, 6%) as a pale 
yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.26 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.94 (dd, J = 8.2 Hz, 2.1 Hz, 1H), 6.81 (d, J = 2.1 Hz, 1H), 6.70 (d, 
J = 8.2 Hz, 1H), 4.79 (s, 1H), 4.19–4.04 (m, 1H), 2.86 (hept, J = 6.9 Hz, 1H), 2.67–2.32 (m, 3H), 2.27 
(s, 3H), 2.02–1.91 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 156.2, 151.8, 130.1, 130.0, 129.4, 128.6, 116.2, 95.2, 55.1, 32.8, 
30.6, 30.1, 20.8, 20.6, 20.4. 
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IR (Diamond-ATR, neat) ෤߭max: 3444 (br w), 2960 (s), 1611 (w), 1502 (s), 1459 (m), 1257 (m), 1193 
(m), 1103 (m), 917 (w), 810 (w). 
HRMS (EI) calc. C15H19127IO [M]+: 342.0481; found: 342.0475. 
 
 
Compounds S58, S59 and S60 
Compounds S58, S59 and S60 were prepared according to General Procedure A. After 19 h, 
the reaction mixture was concentrated and the residue was purified by flash-column chromatography 
on silica gel (2% ethyl acetate in hexanes initially, grading to 10% ethyl acetate in hexanes) to yield 
cyclopentene S58 (9.1 mg, 21%) as a pale yellow oil, enolether S59 (6.1 mg, 9 %) as a colorless oil 
and ether S60 (7.8 mg, 11%) as a pale yellow oil. 
Cyclopentene S58: 
TLC (10% ethyl acetate in hexanes): Rf = 0.32 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.89 (s, 1H), 4.72 (s, 1H), 4.68 (s, 1H), 3.71 (s, 3H), 3.57 (d, 
J = 9.8 Hz, 1H), 2.62–2.39 (m, 2H), 2.29–2.15 (m, 1H), 1.86–1.74 (m, 1H), 1.71 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 165.6, 147.2, 145.2, 138.2, 109.9, 51.5, 32.2, 30.6, 20.6. 
IR (Diamond-ATR, neat) ෤߭max: 2948 (w), 1720 (s), 1630 (w), 1506 (w), 1436 (m), 1280 (m), 1195 (s), 
1097 (m), 890 (w), 753 (w). 
HRMS (EI) calc. C10H14O2 [M]+: 166.0994; found: 166.0980. 
Enolether S59: 
TLC (5% ethyl acetate in hexanes): Rf = 0.41 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.17 (d, J = 8.2 Hz, 2H), 6.86 (d, J = 8.2 Hz, 2H), 5.24 (t, 
J = 7.2 Hz, 1H), 4.78 (s, 1H), 3.61 (s, 3H), 2.95 (t, J = 7.8 Hz, 2H), 2.45–2.37 (m, 2H), 2.34 (s, 3H), 
1.71 (s, 3H), 1.66 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 176.7, 167.9, 151.3, 135.4, 132.7, 130.6, 123.2, 121.4, 95.2, 50.9, 
31.6, 26.2, 25.9, 21.0, 17.9. 
IR (Diamond-ATR, neat) ෤߭max: 2926 (w), 1715 (vs), 1631 (s), 1505 (s), 1435 (m), 1206 (m), 1153 (s), 
1121 (vs), 1034 (m), 836 (m). 
HRMS (EI) calc. C17H22O3 [M]+: 274.1569; found: 274.1554. 
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Ether S60: 
TLC (5% ethyl acetate in hexanes): Rf = 0.24 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.04 (d, J = 8.2 Hz, 2H), 6.84 (d, J = 8.2 Hz, 2H), 6.82–6.79 (m, 
1H), 3.70 (s, 3H), 3.35 (d, J = 9.4 Hz, 1H), 2.65–2.49 (m, 1H), 2.48–2.35 (m, 1H), 2.29 (s, 3H), 2.28–
2.23 (m, 1H), 2.21–2.10 (m, 1H), 1.20 (s, 3H), 1.16 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 167.2, 152.7, 145.2, 138.1, 132.9, 129.5, 124.2, 83.6, 54.3, 51.6, 
32.8, 27.6, 24.6, 24.1, 20.9. 
IR (Diamond-ATR, neat) ෤߭max: 2979 (w), 1718 (vs), 1630 (w), 1507 (vs), 1435 (m), 1293 (m), 1224 
(vs), 1194 (s), 1092 (s), 840 (m). 
HRMS (EI) calc. C17H23O3 [M+H]+: 275.1642; found: 275.1630. 
 
 
Ether S61 
Ether S61 was prepared according to General Procedure B. After 8 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (3% ethyl 
acetate in hexanes) to yield ether S61 (3.0 mg, 5%) as a colorless oil.  
TLC (hexanes): Rf = 0.13 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.05 (d, J = 8.3 Hz , 2H), 6.89 (d, J = 8.3 Hz, 2H), 5.53–5.50 (m, 
1H), 2.98–2.90 (m, 1H), 2.30 (s, 3H), 2.29–2.13 (m, 2H), 2.14–2.01 (m, 1H), 1.90 (s, 3H), 1.86–1.75 
(m, 1H), 1.23 (s, 3H), 1.18 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 152.9, 141.5, 132.5, 129.5, 128.8, 124.1, 83.5, 58.2, 30.9, 27.9, 
25.1, 22.8, 20.9, 18.3. 
IR (Diamond-ATR, neat) ෤߭max: 2976 (w), 2851 (w), 1610 (w), 1507 (s), 1382 (w), 1226 (s), 1146 (m), 
1123 (m), 907 (w), 835 (w). 
HRMS (EI) calc. C16H21O [M–H]+: 229.1592; found: 229.1569. 
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Ether S62 
Etherl S62 was prepared according to General Procedure A. After 2.5 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel (5% 
ethyl acetate in hexanes) to yield phenol S62 (9.0 mg, 17%) as a yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.75 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.87 (dd, J = 8.2 Hz, 1.8 Hz, 1H), 6.77 (d, J = 1.8 Hz, 1H), 6.63 (d, 
J = 8.2 Hz, 1H), 3.10–1.77 (m, 1H), 2.23 (s, 3H), 2.04–1.77 (m, 6H), 1.68 (dd, J = 11.7 Hz, 4.0 Hz, 
1H), 1.07 (d, J = 4.5 Hz, 3H), 1.05 (d, J = 4.4 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 151.9, 130.5, 128.2, 128.0, 127.6, 115.6, 89.4, 39.8, 36.2, 36.1, 
35.3, 34.6, 20.6, 18.1, 17.8. 
IR (Diamond-ATR, neat) ෤߭max: 2962 (m), 1494 (s), 1468 (m), 1365 (w), 1234 (m), 1162 (m), 1040 (w), 
979 (w), 920 (m), 913 (m). 
HRMS (EI) calc. C15H19O [M–H]+: 215.1436; found: 215.1440. 
 
 
Phenol 2g 
Phenol 2g was prepared according to General Procedure A. After 5.5 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel (hexanes 
initially, grading to 10% ethyl acetate in hexanes) to furnish phenol 2h (6.0 mg, 8%) as a pale yellow 
oil and ether S63 (9.6 mg, 10%) as a colorless yellow oil.  
2g: 
TLC (20% ethyl acetate in hexanes): Rf = 0.41 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.22 (t, J = 7.5 Hz, 2H), 7.17–7.10 (m, 3H), 6.81 (d, J = 7.2 Hz, 
2H), 6.60 (d, J = 8.2 Hz, 1H), 5.26 (s, 1H), 4.39–4.32 (m, 1H), 2.93 (hept, J = 6.8 Hz, 1H), 2.75–2.64 
(m, 1H), 2.63–2.40 (m, 2H), 2.17 (s, 3H), 1.95–1.83 (m, 1H), 1.18 (d, J = 6.8 Hz, 3H), 1.02 (d, J = 6.8 
Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 152.1, 149.5, 137.3, 136.3, 130.3, 129.9, 129.5, 128.2, 128.1, 128.0, 
126.6, 116.0, 52.1, 31.0, 30.6, 27.8, 21.9, 21.4, 20.7. 
IR (Diamond-ATR, neat) ෤߭max: 3456 (br w), 2958 (s), 1599 (w), 1500 (s), 1465 (m), 1258 (m), 1195 
(m), 810 (m), 766 (m), 699 (vs). 
332                      EXPERIMENTAL SECTION 
HRMS (EI) calc. for C21H24O [M]+: 292.1827; found: 292.1824.  
S63: 
TLC (10% ethyl acetate in hexanes): Rf = 0.66 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ 7.43 (d, J = 7.7 Hz, 2H), 7.32–7.24 (m, 2H), 7.19 (t, J = 7.2 Hz, 1H), 
6.27 (dt, J = 3.3 Hz, 1.8 Hz, 1H) 4.78 (s, 1H), 4.72 (s, 1H), 3.78 (d, J = 9.0 Hz, 1H), 2.65–2.38 (m, 
2H), 2.37–2.21 (m, 1H), 1.94–1.76 (m, 1H), 1.64 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 147.9, 143.9, 136.6, 128.6, 128.3, 126.9, 126.1, 111.0, 53.4, 32.1, 
31.1, 19.8. 
IR (Diamond-ATR, neat) ෤߭max: 3058 (w), 2940 (m), 1646 (w), 1496 (m), 1446 (m), 1034 (w), 890 (m), 
817 (w), 755 (s), 69s (s). 
HRMS (EI) calc. for C14H16[M]+: 184.1252; found: 184.1245. 
 
 
Phenols 4o and 4p 
Phenols 4o and 4p were prepared according to General Procedure A. After 2 h, the reaction 
mixture was concentrated and the residue was purified by flash-column chromatography on silica gel 
(5% ethyl acetate in hexanes) to furnish ortho-substituted 4o (69.0 mg, 47%) as a colorless oil. The 
fractions containing starting phenol and para-substituted 4p were further purified on silica gel 
(dichloromethane) to yield para-substituted 4p (26.0 mg, 18%) as a colorless oil. 
4o: 
TLC (10% ethyl acetate in hexanes): Rf = 0.52 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.93 (d, J = 7.7 Hz, 1H), 6.72 (d, J = 7.7 Hz, 1H), 6.63 (s, 1H), 4.86 
(s, 1H), 4.23–4.08 (m, 1H), 2.96 (hept, J = 6.9 Hz, 1H), 2.53–2.31 (m, 3H), 2.29 (s, 3H), 1.96–1.83 
(m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.7, 149.5, 138.1, 128.9, 126.2, 121.8, 117.1, 116.9, 51.2, 30.4, 
29.3, 29.2, 21.2, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3499 (br w), 2960 (vs), 1619 (w), 1457 (s), 1417 (s), 1284 (s), 1209 (s), 
1105 (s), 910 (m), 810 (s). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0605. 
4p: 
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TLC (dichloromethane): Rf = 0.29 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.91 (d, J = 8.7 Hz, 1H), 6.68–6.60 (m, 2H), 4.59 (s, 1H), 4.17–4.03 
(m, 1H), 2.96 (hept, J = 6.9 Hz, 1H), 2.50–2.24 (m, 6H), 1.80–1.66 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 
1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.8, 148.3, 137.7, 134.5, 128.0, 117.8, 117.3, 113.0, 51.7, 31.2, 
29.2, 28.7, 20.6, 20.5, 19.8. 
IR (Diamond-ATR, neat) ෤߭max: 3325 (br w), 2960 (s), 1609 (m), 1586 (m), 1499 (s), 1458 (s), 1243 (s), 
1197 (s), 952 (m), 856 (s). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0609. 
 
 
Phenols 5o and 5p 
Phenols 5o and 5p were prepared according to General Procedure A. After 2 h, the reaction 
mixture was concentrated and the residue was purified by flash-column chromatography on silica gel 
(3% ethyl acetate in hexanes initially, grading to 10% ethyl acetate in hexanes) to furnish ortho-
substituted 5o (9.7 mg, 19%) as a colorless oil. The fractions containing starting phenol and para-
substituted 5p were further purified on silica gel (dichloromethane) to yield para-substituted 5p 
(35.1 mg, 48%) as a pale yellow oil. 
5o: 
TLC (10% ethyl acetate in hexanes): Rf = 0.52 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.04 (d, J = 7.3 Hz, 1H), 6.91 (d, J = 7.5 Hz, 1H), 6.81 (t, J = 7.5 
Hz, 1H), 4.97 (s, 1H), 4.26–4.12 (m, 1H), 2.97 (hept, J = 6.9 Hz, 1H), 2.59–2.32 (m, 3H), 2.25 (s, 3H), 
2.01–1.81 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 152.4, 149.8, 129.5, 128.6, 126.9, 124.2, 120.5, 117.0, 30.2, 29.4, 
29.3, 20.6, 20.3, 16.1. 
IR (Diamond-ATR, neat) ෤߭max: 3507 (br w), 2961 (s), 1594 (w), 1467 (vs), 1326 (m), 1260 (m), 1188 
(m), 1084 (m), 834 (m), 744 (s). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0609. 
5p: 
TLC (dichloromethane): Rf = 0.43 (UV, KMnO4). 
334                      EXPERIMENTAL SECTION 
1H NMR (CDCl3, 400 MHz): δ = 6.90 (d, J = 2.0 Hz, 1H), 6.86 (dd, J = 8.1 Hz, 2.0 Hz, 1H), 6.72 (d, 
J = 8.1 Hz, 1H), 4.65 (s, 1H), 3.91–3.78 (m, 1H), 2.92 (hept, J = 6.9 Hz, 1H), 2.55–2.36 (m, 2H), 
2.36–2.28 (m, 1H), 2.24 (s, 3H), 1.92–1.74 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 152.6, 147.8, 136.6, 130.4, 126.1, 123.8, 118.5, 115.1, 56.0, 32.4, 
29.3, 29.0, 20.7, 20.5, 16.1. 
IR (Diamond-ATR, neat) ෤߭max: 3401 (br m), 2960 (vs), 1612 (w), 1505 (vs), 1460 (m), 1265 (s), 1203 
(s), 1115 (vs), 817 (m), 756 (w). 
HRMS (EI) calc. for C15H1979BrO [M]+: 294.0619; found: 294.0618. 
 
Br
Br OH
+
(t-Bu)3PAuNTf20 °C to 23 °C
(54%)
HO
1a 6  
Phenol 6 
Phenol 6 was prepared according to General Procedure A. After 2.5 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel 
(dichloromethane) to give phenol 6 (41.8 mg, 54%) as a pale yellow oil.  
TLC (dichloromethane): Rf = 0.57 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.75 (s, 2H), 4.50 (s, 1H), 3.84–3.74 (m, 1H), 2.93 (hept, J= 6.9 Hz, 
1H), 2.51–2.26 (m, 3H), 2.24 (s, 6H), 1.87–1.75 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 
3H). 
13C NMR (CDCl3, 101 MHz): δ = 151.0, 147.7, 135.9, 127.8, 123.1, 118.5, 56.0, 32.5, 29.3, 29.1, 
20.7, 20.5, 16.2. 
IR (Diamond-ATR, neat) ෤߭max: 3572 (br w), 2961 (s), 1643 (w), 1487 (vs), 1463 (m), 1310 (m), 1196 
(vs), 1154 (m), 871 (m), 733 (w). 
HRMS (EI) calc. for C16H2179BrO [M]+: 308.0776; found: 308.0782. 
 
 
Phenols 7o and 7p 
Phenols 7o and 7p were prepared according to General Procedure A. After 1 h, the reaction 
mixture was concentrated and the residue was purified by flash-column chromatography on silica gel 
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(10% ethyl acetate in hexanes) to furnish ortho-substituted 7o (33.8 mg, 48%) as a pale yellow oil. 
The fractions containing starting phenol and para-substituted 7p were further purified on silica gel 
(dichloromethane) to yield para-substituted 7p (15.2 mg, 22%) as a pale yellow oil. 
7o: 
TLC (20% ethyl acetate in hexanes): Rf = 0.48 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.14 (td, J = 7.7 Hz, 1.7 Hz, 1H), 7.06 (dd, J = 7.7 Hz, 1.7 Hz, 1H), 
6.91 (td, J = 7.4 Hz, 0.9 Hz, 1H), 6.80 (dd, J = 8.0 Hz, 0.9 Hz, 1H), 5.01 (s, 1H), 4.27–4.21 (m, 1H), 
2.98 (hept, J = 6.9 Hz, 1H), 2.55–2.31 (m, 3H), 1.98–1.85 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.08 (d, J 
= 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.9, 149.6, 129.4, 129.0, 128.0, 121.1, 116.8, 116.1, 51.3, 30.3, 
29.3, 29.2, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3445 (br w), 2961 (s), 1593 (m), 1502 (m), 1456 (vs), 1327 (m), 1097 
(m), 911 (w), 861 (m), 751 (vs). 
HRMS (EI) calc. for C14H1779BrO [M]+: 280.0463; found: 280.0464. 
7p: 
TLC (dichloromethane): Rf = 0.38 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.02 (d, J = 8.4 Hz, 2H), 6.78 (d, J = 8.4 Hz, 2H), 4.72 (s, 1H), 
3.90–3.82 (m, 1H), 2.92 (hept, J = 6.9 Hz, 1H), 2.51–2.37 (m, 2H), 2.37–2.26 (m, 1H), 1.88–1.77 (m, 
1H), 1.09 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 154.3, 147.9, 136.7, 128.8, 118.4, 115.5, 55.9, 32.3, 29.2, 29.1, 
20.7, 20.4. 
IR (Diamond-ATR, neat) ෤߭max: 3327 (br m), 2961 (s), 1613 (m), 1512 (vs), 1458 (m), 1362 (w), 1235 
(s), 1172 (m), 912 (w), 830 (s). 
HRMS (EI) calc. for C14H1779BrO [M]+: 280.0463; found: 280.0459. 
 
 
Phenol 8 
Phenol 8 was prepared according to a modified General Procedure A (catalyst was added to 
the reaction mixture at 23 °C). After 1 h, the reaction mixture was concentrated and the residue was 
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purified by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to furnish 
phenol 8 (61.8 mg, 73%) as a pale yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.46 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.13 (dd, J = 8.3 Hz, 2.5, 1H), 7.04 (d, J = 2.4 Hz, 1H), 6.72 (d, J = 
8.3 Hz, 1H), 4.79 (br s, 1H), 4.23–4.15 (m, 1H), 2.99 (hept, J = 6.9 Hz, 1H), 2.53–2.29 (m, 3H), 1.97–
1.86 (m, 1H), 1.28 (s, 9H), 1.11 (d, J = 6.9 Hz, 3H), 1.08 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 151.5, 149.5, 143.5, 128.4, 126.0, 124.6, 117.1, 115.5, 51.6, 34.2, 
31.7, 30.4, 29.3, 29.1, 20.7, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3432 (br w), 2962 (vs), 1610 (w), 1506 (s), 1464 (m), 1362 (m), 1264 
(s), 1124 (m), 891 (w), 818 (m). 
HRMS (EI) calc. for C18H2579BrO [M]+: 336.1089; found: 336.1072. 
 
 
Phenol 9 
Phenol 9 was prepared according to General Procedure C. After 1 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (10% ethyl 
acetate in hexanes) to furnish phenol 9 (75.1 mg, 76%) as a pale yellow oil.  
TLC (5% ethyl acetate in hexanes): Rf = 0.41 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.23 (d, J = 2.4 Hz, 1H), 6.91 (d, J = 2.4 Hz, 1H), 5.07 (s, 1H), 
4.14–4.04 (m, 1H), 3.00 (hept, J = 6.9 Hz, 1H), 2.60–2.32 (m, 3H), 2.09–1.94 (m, 1H), 1.43 (s, 9H), 
1.30 (s, 9H), 1.13 (d, J = 6.9 Hz, 3H), 1.09 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 150.8, 150.3, 142.1, 135.8, 127.9, 124.2, 122.7, 117.2, 53.3, 35.0, 
34.4, 31.8, 30.1, 29.9, 29.4, 29.3, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3503 (br w), 2951 (vs), 2869 (m), 1654 (w), 1478 (s), 1362 (s), 1236 
(m), 1200 (s), 878 (m), 767 (w). 
HRMS (EI) calc. for C22H3379BrO [M]+: 392.1715; found: 392.1716. 
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Phenol 10 
Phenol 10 was prepared according to General Procedure A. After 2 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (5% ethyl 
acetate in hexanes initially, grading to 20% ethyl acetate in hexanes) to give phenol 10 (53.5 mg, 62%) 
as a pale yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.30 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.98 (dd, J = 8.1 Hz, 2.0, 1H), 6.88 (d, J = 2.0 Hz, 1H), 6.74 (d, 
J = 8.1 Hz, 1H), 4.93 (br s, 1H), 4.25–4.12 (m, 1H), 3.66 (t, J = 7.3 Hz, 2H), 3.06–2.91 (m, 3H), 2.55–
2.29 (m, 3H), 1.95–1.82 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 152.8, 149.8, 130.5, 129.5, 129.4, 128.2, 116.6, 116.3, 51.5, 45.4, 
38.7, 30.3, 29.3, 29.2, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3524 (br w), 2959 (s), 2360 (w), 1610 (m), 1504 (vs), 1432 (s), 1259 
(s), 1187 (s), 1103 (s), 816 (s). 
HRMS (EI) calc. for C16H2079Br35ClO [M]+: 342.0386; found: 342.0381. 
 
 
Phenol 11 
Phenol 11 was prepared according to General Procedure A with using an excess of 
10 equivalents of anisol. After 1 h, the reaction mixture was concentrated and the residue was purified 
by flash-column chromatography on silica gel (10% ethyl acetate in hexanes) to furnish phenol 11 
(52.8 mg, 68%) as a pale yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.31 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.74 (d, J = 8.6 Hz, 1H), 6.68 (dd, J = 8.7 Hz, 3.0 Hz, 1H), 6.61 (d, 
J = 3.0 Hz, 1H), 4.65 (s, 1H), 4.25–4.16 (m, 1H), 3.75 (s, 3H), 2.96 (hept, J = 6.9 Hz, 1H), 2.54–2.41 
(m, 2H), 2.41–2.29 (m, 1H), 1.95–1.85 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 53.9, 149.7, 147.7, 130.7, 116.8, 116.6, 114.6, 112.5, 55.8, 51.4, 
30.3, 29.3, 29.2, 20.6, 20.3. 
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IR (Diamond-ATR, neat) ෤߭max: 3395 (br w), 2960 (m), 1609 (w), 1503 (vs), 1431 (s), 1266 (m), 1200 
(vs), 1039 (s), 857 (m), 804 (m). 
HRMS (EI) calc. for C15H1979BrO2 [M]+: 310.0568; found: 310.0562. 
 
 
Phenol 12 
Phenol 12 was prepared according to General Procedure A. After 3 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (5% ethyl 
acetate in hexanes initially, grading to 15% ethyl acetate in hexanes) to give phenol 12 (78.9 mg, 59%) 
as a yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.33 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.73–7.64 (m, 4H), 7.47–7.28 (m, 6H), 6.62–6.52 (m, 2H), 6.39 (d, J 
= 2.7 Hz, 1H), 4.43 (s, 1H), 4.10–3.98 (m, 1H), 2.76 (hept, J = 6.9 Hz, 1H), 2.35–2.22 (m, 1H), 2.22–
2.02 (m, 2H), 1.65–1.52 (m, 1H), 1.09 (s, 9H), 0.97 (d, J = 6.9 Hz, 3H), 0.81 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 149.7, 149.0, 147.5, 135.7, 135.7, 133.3, 133.3, 130.3, 129.8, 129.8, 
127.8, 127.7, 119.6, 118.6, 116.6, 116.5, 50.4, 30.3, 29.1, 28.8, 26.7, 20.3, 20.3, 19.6. 
IR (Diamond-ATR, neat) ෤߭max: 3388 (br w), 2960 (w), 2858 (w), 1497 (m), 1427 (m), 1186 (m), 
971 (m), 907 (s), 730 (vs), 698 (vs). 
HRMS (EI) calc. for C30H3579BrO228Si [M]+: 534.1590; found: 534.1574. 
 
 
Phenols 13o and 13p 
Phenols 13o and 13p were prepared according to General Procedure A. After 1.5 h, the 
reaction mixture was concentrated and the residue was purified by flash-column chromatography on 
silica gel (5% ethyl acetate in hexanes) to furnish ortho-substituted 13o (21.0 mg, 25%) as a pale 
yellow oil and para-substituted 13p (25.0 mg, 30%) as a pale yellow oil. 
13o: 
TLC (10% ethyl acetate in hexanes): Rf = 0.26 (UV, KMnO4). 
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1H NMR (CDCl3, 400 MHz): δ = 8.17–8.12 (m, 1H), 7.82–7.76 (m, 1H), 7.50–7.44 (m, 2H), 7.42 (d, 
J = 8.5 Hz, 1H), 7.17 (d, J = 8.5 Hz, 1H), 5.62 (s, 1H), 4.39–4.26 (m, 1H), 3.00 (hept, J = 6.9 Hz, 1H), 
2.67–2.52 (m, 2H), 2.52–2.40 (m, 1H), 2.11–1.96 (m, 1H), 1.15 (d, J = 6.9 Hz, 3H), 1.10 (d, 
J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 150.3, 149.2, 133.8, 127.8, 127.2, 126.0, 125.5, 125.1, 122.6, 121.4, 
120.6, 117.1, 52.6, 30.2, 29.7, 29.5, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3491 (br w), 2961 (vs), 1655 (m), 1575 (s), 1464 (m), 1383 (s), 
1268 (s), 1072 (m), 807 (vs), 746 (s). 
HRMS (EI) calc. for C18H1979BrO [M]+: 330.0619; found: 330.0613. 
13p: 
TLC (10% ethyl acetate in hexanes): Rf = 0.17 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 8.25 (d, J = 8.5 Hz, 1H), 8.02 (d, J = 8.2 Hz, 1H), 7.61–7.45 (m, 
2H), 7.08 (d, J = 7.5 Hz, 1H), 6.78 (d, J = 7.5 Hz, 1H), 5.19 (s, 1H), 4.75–4.60 (m, 1H), 3.06 (hept, 
J = 6.9 Hz, 1H), 2.69–2.50 (m, 1H), 2.36 (br s, 2H), 1.85 (br s, 1H), 1.16 (d, J = 6.9 Hz, 3H), 1.12 (d, 
J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 150.3, 149.6, 133.0, 131.7, 126.6, 125.0, 125.0, 123.6, 123.4, 122.5, 
116.6, 108.3, 76.8, 51.2, 31.9, 29.3, 28.5, 20.7, 20.5. 
IR (Diamond-ATR, neat) ෤߭max: 3410 (br m), 2960 (s), 1626 (m), 1587 (s), 1381 (vs), 1274 (s), 
1052 (s), 907 (m), 823 (m), 759 (vs). 
HRMS (EI) calc. for C18H1979BrO [M]+: 330.0619; found: 330.0615. 
 
 
Phenol 14 
Phenol 14 was prepared according to General Procedure A. After 4 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (15% ethyl 
acetate in hexanes) to give phenol 14 (68.2 mg, 77%) as a pale yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.22 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.02 (dd, J = 8.2 Hz, 2.1 Hz, 1H), 6.93 (d, J = 2.1 Hz, 1H), 6.71 (d, 
J = 8.2 Hz, 1H), 5.29 (s, 1H), 4.25–4.15 (m, 1H), 3.69 (s, 3H), 3.55 (s, 2H), 2.96 (hept, J = 6.9 Hz, 
1H), 2.56–2.22 (m, 3H), 1.94–1.82 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
340                      EXPERIMENTAL SECTION 
13C NMR (CDCl3, 101 MHz): δ = 172.8, 153.2, 149.7, 129.9, 129.4, 128.7, 126.1, 116.7, 116.3, 52.2, 
51.3, 40.6, 30.3, 29.3, 29.2, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3412 (br w), 2959 (m), 1714 (s), 1611 (w), 1508 (m), 1435 (s), 1262 
(s), 1147 (s), 1015 (m), 806 (m). 
HRMS (EI) calc. for C17H2179BrO3 [M]+: 352.0674; found: 352.0669. 
 
 
Phenol 15 
Phenol 15 was prepared according to General Procedure B. After 1 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel 
(dichloromethane) to give phenol 15 (12.0 mg, 7%) as a pale yellow oil.  
TLC (dichloromethane): Rf = 0.48 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.22 (dd, J = 8.6 Hz, 2.5 Hz, 1H), 7.13 (d, J = 2.4 Hz, 1H), 6.68 (d, 
J = 8.5 Hz, 1H), 5.02 (s, 1H), 4.21–4.12 (m, 1H), 2.96 (hept, J = 6.9 Hz, 1H), 2.54–2.41 (m, 2H), 
2.41–2.31 (m, 1H), 1.93–1.80 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.1, 150.4, 131.8, 131.7, 130.7, 117.9, 115.9, 113.1, 51.4, 30.2, 
29.3, 29.3, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3438 (br w), 2962 (s), 1489 (s), 1431 (s), 1324 (m), 1266 (s), 1167 (m), 
1109 (m), 873 (w), 810 (m). 
HRMS (EI) calc. for C14H1679Br2O [M]+: 357.9568; found: 357.9553. 
 
 
Phenol 16 
Phenol 16 was prepared according to General Procedure B. After 2 h, the reaction mixture was 
concentrated and the residue was purified by flash-column chromatography on silica gel (3% ethyl 
acetate in hexanes) to yield phenol 16 (17.4 mg, 24%) as a pale yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.25 (UV, KMnO4). 
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1H NMR (CDCl3, 400 MHz): δ = 6.86–6.78 (m, 1H), 6.78–6.70 (m, 2H), 4.80 (br s, 1H), 4.26–4.16 
(m, 1H), 2.96 (hept, J = 6.9 Hz, 1H), 2.54–2.30 (m, 3H), 1.95–1.79 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 
1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 157.4 (d, J = 238 Hz), 150.2, 149.7 (d, J = 2.0 Hz), 131.2 (d, 
J = 6.6 Hz), 116.9 (d, J = 8.1 Hz), 116.0, 115.3 (d, J = 23.4 Hz), 114.1 (d, J = 23.2 Hz), 51.1, 30.3, 
29.3, 29.1, 20.6, 20.3. 
19F NMR (CDCl3, 282 MHz): δ = –123.5. 
IR (Diamond-ATR, neat) ෤߭max: 3426 (br w), 2962 (s), 1619 (w), 1504 (vs), 1434 (s), 1258 (s), 1172 (s), 
873 (m), 809 (m), 749 (w). 
HRMS (EI) calc. for C14H1679BrFO [M]+: 298.0369; found: 298.0356. 
 
 
Phenol 17 
Phenol 17 was prepared according to General Procedure A. After 2.5 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel 
(10% ethyl acetate in hexanes) to give phenol 17 (22.0 mg, 23%) as a pale yellow oil.  
TLC (20% ethyl acetate in hexanes): Rf = 0.43 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.80 (dd, J = 8.6 Hz, 2.7 Hz, 1H), 6.75–6.68 (m, 2H), 5.09 (s, 1H), 
4.24–4.12 (m, 1H), 2.95 (hept, J = 6.9 Hz, 1H), 2.52–2.39 (m, 2H), 2.39–2.30 (m, 1H), 1.97–1.83 (m, 
1H), 1.34 (s, 9H), 1.08 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 177.8, 151.5, 150.0, 144.7, 130.3, 121.7, 120.6, 116.7, 116.3, 51.6, 
39.2, 30.2, 29.3, 29.2, 27.3, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3443 (br w), 2962 (m), 1723 (s), 1504 (m), 1434 (s), 1262 (s), 1141 
(vs), 1030 (m), 900 (m), 799 (w). 
HRMS (EI) calc. for C19H2579BrO3 [M]+: 380.0987; found: 380.0985. 
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Phenol 30 and cyclopentene 31 
Phenol 2c and cyclopentene 31 were prepared according to General Procedure A. After 8 h, 
the reaction mixture was concentrated and the residue was purified by flash-column chromatography 
on silica gel (10% ethyl acetate in hexanes) to yield phenol 30 (23.3 mg, 29%) as a pale yellow oil and 
bromide 31 (23.4 mg, 41%) as a colorless oil.  
30: 
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ 6.94 (dd, J = 8.1 Hz, 2.0 Hz, 1H), 6.86 (d, J = 2.0 Hz, 1H), 6.70 (d, 
J = 8.1 Hz, 1H), 4.90 (s, 1H), 4.13 (t, J = 8.4 Hz, 1H), 2.61 (hept, J = 7.1 Hz, 1H), 2.28 (s, 3H), 2.27–
2.20 (m, 1H), 1.83 (dd, J = 13.0 Hz, 8.0 Hz, 1H), 1.31 (d, J = 7.1 Hz, 3H), 1.32 (d, J = 7.1 Hz, 3H), 
1.18 (s, 3H), 1.14 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ 155.5, 152.0, 130.3, 130.0, 128.8, 128.5, 117.0, 116.2, 50.4, 48.0, 
47.2, 27.8, 27.5, 27.3, 20.8, 20.6, 20.4. 
IR (Diamond-ATR, neat) ෤߭max: 3442 (br w), 2957 (s), 1611 (w), 1502 (s), 1462 (m), 1363 (s), 1258 (s), 
1199 (s), 1098 (s), 810 (vs). 
HRMS (EI) calc. C17H2379BrO [M]+: 322.0932; found: 322.0924. 
31: 
TLC (10% ethyl acetate in hexanes): Rf = 0.72 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 5.93 (s, 1H), 4.95 (s, 1H), 4.76 (s, 1H), 2.83 (d, J = 2.6 Hz, 1H), 
2.20 (d, J = 16.1 Hz, 1H), 2.03 (dd, J = 16.1 Hz, 2.9 Hz, 1H), 1.65 (s, 3H), 1.13 (s, 3H), 1.00 (s, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 144.0, 131.8, 123.6, 114.9, 69.9, 47.3, 42.3, 32.5, 25.0. 21.1. 
IR (Diamond-ATR, neat) ෤߭max: 2957 (vs), 2926 (s), 1644 (w), 1618 (w), 1464 (m), 1371 (m), 1167 (w), 
895 (m), 862 (m), 816 (s). 
HRMS (EI) calc. C10H1579BrO [M]+: 214.0357; found: 214.0369. 
 
 
Phenol S64 
Phenol S64 was prepared according to General Procedure A. After 2 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel 
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(1% dichloromethane in hexanes initially, grading to 20% dichloromethane in hexanes) to give phenol 
S64 (20.0 mg, 21%) as a pale yellow oil.  
TLC (30% dichloromethane in hexanes): Rf = 0.25 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 6.81 (s, 2H), 4.66 (s, 1H), 3.87–3.78 (m, 1H), 3.13 (hept, J = 6.8 Hz, 
2H), 2.96 (hept, J = 6.9 Hz, 1H), 2.50–2.24 (m, 3H), 1.89–1.78 (m, 1H), 1.27 (d, J = 6.9 Hz, 6H), 1.26 
(d, J = 6.9 Hz, 6H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 148.7, 147.7, 135.9, 133.6, 122.5, 118.8, 56.4, 32.5, 29.3, 28.9, 
27.4, 22.9, 22.9, 20.7, 20.4. 
IR (Diamond-ATR, neat) ෤߭max: 3578 (br w), 2961 (vs), 2689 (m), 1643 (m), 1468 (s), 1309 (m), 
1199 (s), 1152 (m), 876 (w), 764 (w). 
HRMS (EI) calc. for C20H2979BrO [M]+: 364.1402; found: 364.1387. 
 
 
Phenol S65 
Phenol S65 was prepared according to General Procedure A. After 3.5 h, the reaction mixture 
was concentrated and the residue was purified by flash-column chromatography on silica gel 
(5% ethyl acetate in hexanes initially, grading to 10% ethyl acetate in hexanes) to give phenol S65 
(51.2 mg, 28%) as a pale yellow oil.  
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.54 (d, J = 7.3 Hz, 2H), 7.41 (t, J = 7.7 Hz, 2H), 7.37 (dd, 
J = 8.3 Hz, 2.3 Hz, 1H), 7.33–7.27 (m, 2H), 6.87 (d, J = 8.3 Hz, 1H), 5.05 (s, 1H), 4.36–4.20 (m, 1H), 
3.00 (hept, J = 6.9 Hz, 1H), 2.61–2.45 (m, 2H), 2.44–2.33 (m, 1H), 2.03–1.89 (m, 1H), 1.12 (d, 
J =6.9 Hz, 3H), 1.09 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.5, 149.9, 141.1, 134.1, 129.5, 128.8, 127.9, 126.9, 126.7, 126.6, 
116.7, 116.5, 51.6, 30.4, 29.4, 29.3, 20.7, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3430 (br w), 2960 (m), 1608 (m), 1485 (vs), 1454 (m), 1265 (s), 
1109 (m), 821 (m), 762 (vs), 698 (s). 
HRMS (EI) calc. for C20H2179BrO [M]+: 356.0776; found: 356.0771. 
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Phenol S66 
Phenol S66 was prepared according to a modified General Procedure C. (t-Bu)3PAuNTf2 
(3.61 mg, 5.32 mol, 5 mol %) was added to a solution of bromide 1a (46.8 mg, 0.25 mmol, 1 equiv) 
and p-fluorophenol (29.4 mg, 0.26 mmol, 1.05 equiv) in dichloromethane (1 mL) at –30 °C. After 
45 min, 4-hydroxyphenylacetonitrile (172 mg, 1.25 mmol, 5 equiv) was added and the reaction 
mixture was allowed to warm to 0 °C. After 1 h, methanesulfonic acid (81.1 L, 1.25 mmol, 5 equi) 
was slowly added and the reaction mixture was allowed to warm to 23 °C. After 1 h, the reaction 
mixture was concentrated and the residue was purified by column chromatography on silica gel 
(10% ethyl acetate in hexanes initially, grading to 30% ethyl acetate in hexanes) to give phenol S66 
(15.4 mg, 19%) as a white solid. 
TLC (30% ethyl acetate in hexanes): Rf = 0.33 (UV, KMnO4). 
1H NMR (CDCl3, 400 MHz): δ = 7.08 (d, J = 8.2 Hz, 1H), 6.97 (s, 1H), 6.80 (d, J = 8.2 Hz, 1H), 5.09 
(s, 1H), 4.26–4.15 (m, 1H), 3.67 (s, 2H), 2.97 (hept, J = 6.8 Hz, 1H), 2.58–2.42 (m, 2H), 2.42–2.31 
(m, 1H), 1.95–1.80 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ = 153.8, 150.3, 130.2, 128.7, 127.6, 122.1, 118.4, 116.9, 116.1, 51.6, 
30.2, 29.4, 29.3, 23.1, 20.6, 20.3. 
IR (Diamond-ATR, neat) ෤߭max: 3368 (s), 2961 (m), 1611 (w), 1509 (s), 1438 (m), 1270 (s), 1118 (m), 
900 (w), 807 (s), 740 (w). 
HRMS (EI) calc. for C16H1879BrNO [M]+: 319.0527; found: 319.0564. 
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